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ABSTRACT 
 
C. Guy Goodman: Stereoconvergent Transformations of Carbonyls for Expedient 
Synthesis of Stereochemically Complex Small Molecules 
(Under the direction of Jeffrey S. Johnson) 
 
I. A Primer on Dynamic Kinetic Resolutions and Extant Methods for Oxo-
Ester Synthesis 
 A two part overview that details: 1) the principles of dynamic kinetic resolution 
and its application in modern asymmetric catalysts and 2) current synthetic methods 
for generation of enolizable β-substituted α-keto esters and α-substituted β-oxo 
esters.    
II. Asymmetric Transfer Hydrogenation-Dynamic Kinetic Resolution of β-
Stereogenic α-Keto Esters 
 Two systems for dynamic kinetic resolution via asymmetric transfer 
hydrogenation (DKR-ATH) of racemic β-stereogenic-α-keto esters yielding optically 
active α-hydroxy esters are presented. In the first of these reports a previously 
unreported Stetter addition of ethyl gloxylate provides β-stereogenic-α,δ-diketo 
esters, which are reduced to α-hydroxy δ-keto esters. Stereo- and chemoselective 
mono-reduction provides formal glycolate Michael products.   
In the second disclosure, β-amino α-keto esters are reduced to the 
corresponding anti-β-amino α-hydroxy esters. Both reports employ formic acid as 
 iv 
the organic reductant , and use a Ru(II)-amido complex bearing a bulky m-
terphenylsulfonamide ligand which imparts remarkable levels of diastereo- and 
enantiocontrol.  
 
III. N-Heterocyclic Carbene-Catalyzed Dynamic Kinetic Resolutions of β-
Stereogenic α-Keto Esters 
 The development of two distinct N-Heterocyclic carbene catalyzed dynamic 
kinetic resolutions of β-halo-α-keto esters are discussed. In the first of these, an 
asymmetric cross-benzoin addition is described.  The resulting fully substituted β-
halo glycolic ester products are obtained with high levels of enantio- and 
diastereocontrol, and the reaction products undergo highly diastereoselective 
substrate-controlled reduction to give functionalized stereotriads. Mechanistic 
studies show that the high chemoselectivity observed is a result of greater 
electrophilicity of the α-keto ester toward the Breslow intermediate.   
In the second report development of an asymmetric homoenolate (a3 − d3-
umpolung addition) of α,β-enals, forming γ-butyrolactones with three contiguous 
stereocenters is described. The addition occurs with high regio-, diastereo-, and 
enantiocontrol and constitutes the first stereoconvergent homoenolate process.  
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IV. Complexity Generating Dynamic Kinetic Resolutions of β-Oxo Acid 
Derivatives 
  Dynamic kinetic resolutions of α-stereogenic-β-formyl amides in asymmetric 
2-aza-Cope rearrangements are described. Chiral phosphoric acids catalyze this 
rare example of a non-hydrogenative DKR of a β-oxo acid derivative. The [3,3]-
rearrangement occurs with high diastereo- and enantiocontrol, forming β-imino 
amides that can be deprotected to the primary β-amino amide or reduced to the 
corresponding diamine.  
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CHAPTER 1 
 
A PRIMER ON DYNAMIC KINETIC RESOLUTIONS AND EXTANT METHODS 
FOR OXO-ESTER SYNTHESIS 
 
1.1 Dynamic Kinetic Resolutions 
1.1.1 Key Principles 
Synthetic methods that deliver enantioenriched small molecules on 
industrial scale are of great importance for human health. Towards this end three 
primary approaches to access single enantiomer therapeutics are typically 
employed: asymmetric catalysis, implementation of chiral feedstock provided by 
nature, and resolution of a pair of enantiomers. Of these, resolution strategies are 
particularly useful in kilogram scale synthesis due to A) cost effective access to 
functionalized racemic materials, B) numerous broadly applicable resolution 
platforms, and C) operational simplicity of those methods.  
 In classical resolutions, a chiral resolving agent is associatew with a 
racemate forming separable diastereomers, often through crystallization. In 
contrast, kinetic resolution (KR) relies on chiral catalyst or reagent control for the 
selective reaction of a single enantiomer of the racemic starting material via 
energy differences between diastereomeric transition states. Provided a large 
relative rate difference exists (kR>>kS,) a single enantiomer of product (PR) and a 
single enantiomer of starting material (SS) can be isolated (Scheme 1A).1 An 
archetypical kinetic resolution is the Sharpless asymmetric epoxidation of 
2 
racemic allylic alcohol 1 under the control of a chiral titanium catalyst providing 
(1S,2S,3S)-2  in 97:3 er and 52% yield (Scheme 1B) with concomitant recovery 
of (R)-1 in 45% yield and 98:2 er.2 
Scheme 1. Principles of Kinetic Resolutions  
 
As there is no method for epimerization, typical kinetic resolutions, are 
inherently limited to a 50% theoretical yield of enantiomerically pure product.3 A 
potential solution to this low theoretical yield is presented when a pathway for 
interconversion of starting material enantiomers exists. Provided that the rate of 
racemization through an achiral intermediate I is at least as fast as conversion of 
the faster reacting enantiomer of starting material to product (i.e., krac≥kR>>kS) a 
dynamic kinetic resolution (DKR) can occur (Scheme 2A).1 This process is 
governed by Curtin−Hammett kinetics where the degree of stereoselectivity is 
determined by the magnitude of ΔΔG‡ (Scheme 2B).3  
While in a KR [SS]/[SR] varies as a function of time, in an efficient DKR 
[SS]/[SR] = 1.0 at all times. The net outcome of these principles is that under a 
DKR manifold, a racemic starting material can be converted to a single 
stereoisomeric product with 100% theoretical yield via the faster reacting 
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enantiomer. As a result using facile modes of racemization is critical to producing 
an efficacious DKR.1,3-5  
Scheme 2. Dynamic Kinetic Enantioselective Reactions 
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1.1.2 Racemization by Tautomerization 
Noyori reported the first chemical DKR, converting α-alkyl-β-keto ester 3 
to β-hydroxy ester 4 via asymmetric hydrogenation (Scheme 3).6 Interconversion 
of (R)-3 and (S)-3 is through the tautomeric, achiral enol and is sufficiently facile 
due to the low pKa of the α-proton.  
Scheme 3. First Reported Chemical DKR with β-Keto Esters 
 
Since this seminal report, enolization as a racemization mode has been 
used for hydrogenative DKRs of a number of differentially substituted β-keto 
esters.1,3-5,7-11  Additionally, carbonyls with α-protons having a higher pKa than 
those of β-keto esters have also been shown as competent DKR substrates. 
Aldehydes, ketones, and azlactones have all been deployed in a number of DKR 
reactions including asymmetric hydrogenation,12-16 aldol additions17-20 and 
transesterifications.21-25 For example ruthenium diamino diphosphine 6, catalyzes 
the hydrogenative DKR of α-aryl aldehyde 5 forming primary alcohol 7 in 96% ee 
(Scheme 4).12   
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Scheme 4. Stereoconvergent Hydrogenation of α-Branched 
Aldehydes 
 
 
Tautomerization of imines to enamines has been utilized as a similarly 
effective method of enantiomerization.26-29  List has demonstrated that under 
chiral phosphoric acid catalysis and using Hantzsch ester 9 as an organic 
reductant the reductive amination of racemic aldehyde 8 occurs to provide 10 in 
92% yield and 99:1 er (Scheme 5).26 
Scheme 5. Organocatalytic Reductive Amination DKR of α-Branched 
Aldehydes 
 
 
 These selected examples represent a much larger set of DKR reactions 
that use tautomerization as the mechanism for racemization. This 
enantiomerization modality will be featured prominently in Chapters 2-4. 
1.1.3 Additional Pathways for Enantiomerization  
While the following will not be used in subsequent chapters, a number of 
additional modes of racemization have been applied in highly selective DKRs. 
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When a heteroatom is present at the stereogenic center, redox cycling through 
intermediate carbonyls (X = O) or imines (X = N) has been shown to effectively 
interconvert enantiomers as part of DKR reactions. 
 The preponderance of these methods are chemoenzymatic, utilizing 
metal catalysts for redox cycling and enzymes for selective substrate 
transformation. Enzymes are frequently employed for DKR acylations of 
secondary alcohols and numerous other reaction modalities. While they 
frequently exhibit phenomenal spatial selectivity they are typically highly specific 
with little substrate generality.30 Therefore, while the significance of enzymatic 
DKRs is acknowledged, the focus of all subsequent discussion will be solely on 
the development of chemical DKRs. The first chemical acylative DKR of 
secondary alcohols was disclosed by Fu,31 using  (C5Ph5)Ru(CO)2Cl as a redox 
cycling catalyst in conjunction with ferrocene-based chiral N,N-dimethyl amino 
pyridine (DMAP) catalyst 12 providing 13 in 95% yield and 87% ee (Scheme 6). 
Ruthenium-promoted equilibration between acetophenone and 1-phenylethanol 
resulted in a rate of racemization sufficient for dynamic conversion.  
Scheme 6. Acylative DKR of Alcohols by Redox Cycling 
 
 
 
Ph Me
OH
(±)11
+ tAmOH/PhCH3 (1:1), 10 °C
Ph Me
O
13
Me
O
achiral ketone
Ph Me
O
Me O
O
OiPr
O
N
NMe2
Fe
Ph
Ph
Ph
PhPh
(1.5 equiv)
12
(C5Ph5)Ru(CO)2Cl (5 mol %)
KOtBu (4 mol %)
12 (1 mol %)
95% yield
87% ee
7 
 
Zhao has reported a rare example where redox cycling and 
tautomerization are used in tandem resulting in the stereoconvergence of four 
isomers to a single product.32 Subjecting alcohol 14 to a dual catalytic system 
consisting of iridium diamine 15 and spinol derived phosphoric acid 16 delivers 
reductive amination product 17 with high stereoselectivity (Scheme 7). This 
convergence of starting materials is the result of both redox cycling (alcohol into 
ketone via hydrogen borrowing) and imine/enamine racemization of the α-
stereocenter. 
Scheme 7. Reductive Amination DKR via Hydrogen Borrowing and 
Enamine Imine Tautomerization  
 
 
Although less frequently used, racemization by addition-elimination and 
Schiff base formation are both precedented; 1,3-5 however, they are not utilized in 
subsequent chapters. 
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catalyst−driven solely by the spontaneity of racemization. Conversely in a DyKAT, 
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enantiomeric substrates are interconverted through diastereomeric complexes 
formed by association of a chiral catalyst with substrate, implying the potential for 
a different rate of equilibration for each enantiomer. The net effect of this is 
twofold: 1) unlike in a DKR a DyKAT can result in an accumulation of one 
enantiomer (or with catalyst associated--diastereomer) over the other; 2) 
interconversion of diastereomers can be more favorable than in a DKR due to the 
potential for an enthalpic driving force.1 There are four classifications of DyKATs, 
however all following chapters will focus on only traditional DKRs; consequently, 
understanding the above principles is an adequate conceptual framework for the 
work contained herein. 
1.2 Oxo-Esters 
This dissertation will focus on the reactivity of stereochemically labile oxo-
acid derivatives; therefore, a short discussion on the utility of their reaction 
products is warranted. For both α- and β-oxo acids a number of functionally rich 
and biologically relevant products are accessible via addition of a nucleophile or 
through amine condensation and subsequent nucleophile addition. Direct 
nucleophilic addition to an α-keto ester results in the formation of an α-glycolic 
acid derivative. This scaffold is present in critical therapeutics, has been utilized 
as a vehicle for drug delivery, and has additional roles in consumer health.33-35 
Condensation of an amine followed by addition of a nucleophile delivers α-amino 
acid surrogates. While natural α-amino acids are the building blocks of proteins, 
utilization of unnatural variants as biologic modifiers constitutes a growing sector 
of pharmaceuticals and plays a central role in biomedical research.36-39 Identical 
9 
reaction platforms with β-keto esters deliver β-hydroxy acids, utilized in 
pharmaceuticals40 and personal health products,33,41 and β-amino acids which 
are structural motifs present in the structures of taxol,42 cocaine,43 and 
penicillin,44 among others45; representing some of the most influential modern 
pharmaceuticals.  
Scheme 8. Synthetic Utility of α- and β-Oxo Acid Addition Products. 
 
Of particular difficulty for these important scaffolds is the generation of 
single enantiomer products bearing non-quaternary stereocenters vicinal to the 
hydroxyl or amino group. Establishing this stereocenter prior to reaction with the 
carbonyl is complicated by the high acidity of the carbonyl α-proton (pKa = 11 and 
13 for β-oxo esters and α-keto esters respectively)46 as it predisposes the 
established stereocenter to racemization before nucleophile addition (Scheme 9). 
This same stereolability implicates use of these substrates in DKRs which can 
deliver products not prone to racemization while simultaneously establishing both 
both relative and absolute stereochemistry. 
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Scheme 9. Complications of Nucleophile Additions to 
Stereochemically Defined α- and β-Oxo Esters    
 
Since a DKR approach to stereochemically rich α- and β-amino or hydroxy 
acids requires only synthetic access to racemic, rather than enantiopure, starting 
oxo-acids, there is also a significant advantage in available product diversity.  
1.2.1 Synthesis of Racemic β-Stereogenic α-Keto Acid Derivatives 
There are numerous methods for the synthesis of non-quaternary racemic 
β-substituted α-keto acid derivatives that provide access to a wide array of 
diverse β-functionality. Many rely on the generation and subsequent addition of 
glyoxylate acyl anion equivalents to assorted electrophiles. Of these umpolung 
(polarity inversion) strategies the Stetter addition of glyoxylate to a Michael 
acceptor is the most efficient. Our group has described N-heterocyclic carbene 
(NHC) catalyzed addition of ethyl glyoxylate 18 to alkylidene malonate 19 
delivering racemic α-keto ester 20 (Scheme 10A).47 In a related report cyanide 
addition to silyl glyoxylate 21 is followed by cross-benzoin condensation with 
aldehyde 22 delivering β-siloxyl α-keto ester 22 (Scheme 10B).48 Takahashi has 
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also reported the use of protected cyanohydrin 24 as a glyoxylate equivalent for 
the generation of β-acetoxy α-keto ester 26 (Scheme 10C).49  
Scheme 10. Synthesis of β-Stereogenic α-Keto Esters Using 
Glyoxylate Equivalents 
 
 
Structural reorganization to unveil racemic α-keto acid scaffolds have also 
been demonstrated. Our group has utilized aerobic deacylation of acetoacetate 
derivative 27 delivering α-keto ester 29.50 Mechanistically this process is 
proposed to proceed via enolate peroxidation followed by formation and 
subsequent fragmentation of endoperoxide 28 (Scheme 11A).  In a distinct 
strategy, the Darzens reaction using dichloroacetate 30 and aldehyde 31 delivers 
epoxychloride 32 which upon nucleophilic ring opening eliminates chloride to 
form α-keto ester 33 (Scheme 11B).51 
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Scheme 11. Synthesis of β-Stereogenic α-Keto Esters via Structural 
Rearrangements  
 
A number of β-substituents can be accessed using two-step protocols that 
terminate in oxidation of α-diazo esters to keto esters. Addition of diazo acetate 
34 into tosylaldimine 35 followed by oxidation with Oxone® delivers β-amino α-
keto ester 36.52 The use of α-diazo ester 37  for condensation with aldehyde 38 
provides β-hydroxy α-diazo ester 39.53  
Scheme 12. Synthesis of β-Stereogenic α-Keto Esters from α-Diazo 
Esters 
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Two-step protocols that generate the α-ketone via ozonolysis have been 
reported including Morita-Baylis-Hillman (MBH) addition of vinyl acetates,54 
Michael addition of enol acetates,55 and conjugate addition of methyl nitroacetate 
to enones.56 Collectively, these and other transformations57-59 encompass the 
synthesis of a wide variety of β-substituted α-keto acid surrogates including β-
oxo, -alkyl, -allyl, -vinyl, -aryl, -amino, -thiol, -cyano, -ester, -silyl, and -acetyl 
groups.   
1.2.2 Asymmetric Synthesis of β-Stereogenic α-Keto Acid Derivatives 
Many of the above reaction platforms have been rendered asymmetric 
yielding enantioenriched β-stereogenic α-keto acid derivatives. Prominent are the 
use of 1,2 dicarbonyl pronucleophiles in conjugate additions.60 Multiple catalysts 
have been used for the addition of pyruvates such as 40 to nitro olefins.60-64 
While most of these reports are limited to β-alkyl substitution, the use of 
Takemoto’s urea 42 as a catalyst allows formation of β-aryl and heteroaryl 
substituted ketone 43 (Scheme 13A).62  
Azodicarboxylate 44 was employed with guanidine catalyst 46 for the 
generation of β-amino α-keto ester 47. This product was reduced directly to the 
corresponding β-amino α-hydroxy ester 48 due to observed stereoablation during 
attempted silica-gel chromatography (Scheme 13B).65 In a related report N-
fluorobenzenesulfonamide 50 was used as an electrophilic source of fluorine for 
the synthesis of β-fluoro α-keto ester 52, which is directly reduced to β-fluoro α-
hydroxy ester 53 (Scheme 13C).66 In both of these methods the product 
structural diversity is limited to β-alkyl substitution.   
14 
Mannich additions of pyruvate to aldimines have been used for the 
asymmetric synthesis of γ-amino α-keto acid derivatives, albeit without a method 
that can prevent epimerization with β-aryl substitution.67-69  
 Scheme 13. Asymmetric Synthesis of β-Stereogenic α-Keto Acid  
 Derivatives with 1,2-Dicarbonyl Pronucleophiles. 
 
 
 
 Diazoacetates can be used for asymmetric synthesis of β-oxo α-keto70 or 
α-diazo esters71 under the control of chiral Lewis acids. Additionally both Lewis 
acid72-73 and guanidine−74 catalyzed asymmetric Claisen rearrangements have 
been reported; however, none of these methods can tolerate β-aryl substitution.  
Finally, a limited number asymmetric methods that use glyoxylate anion 
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unsaturated aldehyde 55 followed by aldehyde reduction, alcohol protection, and 
ketone deprotection provides β-alkyl α-keto ester 57 in low yields (Scheme 
14A).75  In the most atom economical route to date Rovis disclosed an 
asymmetric carbene catalyzed Stetter reaction using glyoxamide 58 and  
alkylidene malonate 59 generating β-alkyl α-keto amide 61 (Scheme 14B).76 This 
method was later extended to include  alkylidene ketoamide electrophiles.77  
Scheme 14. Asymmetric Synthesis of β-Stereogenic α-Keto Acid 
Derivatives from Glyoxylate Equivalents. 
 
 
One central problem with current methods for the asymmetric synthesis of 
β-stereogenic α-keto esters is the limited number of β-substituents allowed. To 
date, there remains only a single method that generates stereoenriched β-aryl α-
keto esters due to difficulty in maintaining the integrity of the established 
stereocenter; i.e. products are susceptible to base catalyzed racemization.  
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16 
racemic, and non-quaternary α-substituted β-oxo acid derivatives. Aside from 
simple enolate alkylation, other commonly employed pathways include Claisen 
condensation,78-79 aldol condensation,80-81 conjugate additions,82-83 as well as 
enolate functionalization with other electrophilic reagents including sources of 
nitrogen,84 oxygen,85 arenes,86 and halogens (Scheme 15A).87-88 Claisen 
condensation89 or aldol addition and subsequent oxidation90-91 starting from 
simple esters can also be used to generate mono-substituted β-oxo acid 
derivatives (Scheme 15B). 
Scheme 15. General Strategies for the Construction of Non-
Quaternary Racemic α-Stereogenic β-Keto Acid Derivatives 
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was introduced by Evans in 1984, relying on the use of chiral oxazolidinone 
auxiliaries. Acylation of the lithium enolate of 62 resulted in highly 
diastereoselective formation of 63, though this report was limited to alkyl 
substitution at the α-stereocenter (Figure 16A).92 In an expansion of this work 
use of xylose derived oxazolidinone 64 allows for aromatic substitution at the α-
stereocenter providing 65, albeit with generally poor diastereoselection (Figure 
16B).93 The surprisingly slow rate of epimerization for these 1,3-dicarbonyls is 
proposed to stem from disfavored enolate formation due to developing allylic 
strain wherein both carbonyl π-systems must be co-planar with the methine 
hydrogen in order to form the enol.92  
Scheme 16. Approach to the Asymmetric Synthesis of α-Stereogenic 
β-Keto Acid Derivatives via Chiral Auxiliaries 
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In contrast there are only two described methods for the catalytic 
asymmetric synthesis of these same substrates. Hydroformylation of 
dialkylacrylamide 66 provides α-methyl β-formyl amide 67 in moderate 
enantioselectivity with product diversity limited to α-methyl substitution (Figure 
17A).96 The catalytic Roskamp reaction has been employed for access to a range 
of α-alkyl β-keto esters. Feng has disclosed the use of a N,N-dioxide-scandium 
(III) complex for addition of diazo-ester 69 to aldehyde 70 providing β-keto ester 
71 with high yield and enantioselection (Figure 17B).97  The Roskamp reaction 
has also been catalyzed by oxazaborolidiniums,98 and under the control of a 
chiral camphorsultam auxillary.99  
Scheme 17. Catalytic Asymmetric Synthesis of α-Stereogenic β-oxo 
Acid Derivatives 
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1.3 Proposed Strategy for the Synthesis of New α- and β-Hydroxy or Amino 
Acids  
 
The difficulty that underlies the synthesis of both non quaternary β-
stereogenic α-keto and α-stereogenic β-keto acids is linked to stereoablation by 
tautomerization; however, this challenge present for stepwise stereocenter 
generation with subsequent diastereoselective nucleophile addition can be 
rendered advantageous in the development of dynamic methods for concurrent 
generation of both relative and absolute stereocontrol. Our proposed area of 
study was the design of DKR reactions that take advantage of the high kinetic 
acidity of substituents, which are ineffectual in current asymmetric strategies to 
deliver complementary, and previously inaccessible small molecules.  
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CHAPTER 2 
 
ASYMMETRIC TRANSFER HYDROGENATION-DYNAMIC KINETIC 
RESOLUTION OF β-STEREOGENIC α-KETO ESTERS 
 
2.1 Introduction 
Chapter 1, demonstrated that the use of hydrogenative DKRs with α-
substituted β-keto esters has been used to great effect in industrial processes, 
creating >100 tons of enantioenriched consumer material each year.1 Previous to 
our group’s involvement, the development an analogous hydrogenative DKR of 
β-substituted α-keto esters was limited to enzymatic catalysis.2 In 2012 we 
reported a ruthenium-catalyzed asymmetric transfer hydrogenation (ATH), of the 
α-keto ester 1  where initial α-ketone reduction was followed by in situ 
diastereoselective lactonization of intermediate 3 providing tri-substituted γ-
butyrolactone 4 in high yield and with excellent stereoselection (Scheme 1).3  
A number of salient features of this protocol include 1) the use of formic 
acid as an organic reductant,4-6 2) generation of the requisite racemic α-keto 
esters by a NHC-catalyzed Stetter reaction between ethyl glyoxylate and 
benzylidene malonates, and 3) deployment of diamino terphenyl sulphonamide 
ligand 6 for use in ATH reactions.  
The operational simplicity of the method is appealing as active ruthenium 
complex 2 is generated by simple ligation of 6 with [RuCl2(p-cymene)]2 (5), does 
not require rigorous air free handling, and is stable as a precomplexed solution 
30 
for >1 month.4 The ease of reaction setup, atom economy, and exquisite 
selectivity demonstrated in the formation of 4 led us to consider what other 
enantioenriched β-stereogenic α-hydroxy esters could accessed via this 
methodology. The remainder of this chapter will discuss our subsequent studies 
in using DKR-ATH processes catalyzed by 2 and related architectures.     
Scheme 1. First Highly Enantioselective ATH-DKR of α-Keto Esters 
for the Formation of β-Aryl γ-Butryolactones 
 
 
2.2 Chemoselective Dynamic Asymmetric Reduction of α,δ-Diketo Esters*
* 
A primary tenant of our program was providing access to highly 
stereocomplex and chemically interesting small molecules by ATH-DKR; 
consequently, we targeted the use of α,δ-diketo ester 7. We anticipated that 
under our developed ATH-DKR conditions reduction of the α-ketone followed by 
diastereoselective reduction of intermediate α-hydroxy δ-keto ester 8 would 
deliver 1,3-diol 9 (Scheme 2). 
Two step conjugate addition/oxidation methods for the preparation of the 
requisite α,δ-diketo ester 7 were known. These reported modalities of oxidation 
                                         
*Reproduced in part by permission of the American Chemical Society: Steward, K. M.; Corbett,  M. T.; Goodman, C. G.; 
Johnson, J. S. J. Am. Chem. Soc. 2012, 134, 20197-20206. 
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included aerobic deacylation,7 aerobic oxidation8 and ozonoloysis of nitronates9 
or enol acetate intermediates.10 However, we believed that a direct one step 
Stetter reaction between commercial ethyl glyoxylate and α,β-enones 
represented the most ideal approach vector to these substrates. While this 
reaction was unsuccessful utilizing thiazolium carbenes,10 our group’s previous 
success using the triazolium carbene derived from salt 1211 for the formation of 
(±)-1,4 indicated that a similar strategy might be applicable for the direct 
synthesis of 7.
Scheme 2. Proposed ATH-DKR of α ,δ-Diketo Esters to Form α ,δ-
Dihydroxy Esters 
 
 
As outlined in Scheme 3, the Stetter addition of ethyl glyoxylate 10 to α,β-
enone 11 was efficient, and scalable, yielding a wide array of α,δ-diketo esters 
7a-n. This method was tolerant of diverse ketonic substitution (7a-f), as well as 
multiple β-substituents (7g-n). Of particular note is that with 
dibenzylideneacetone 7e, exclusive monoaddition is observed.  
With appropriate substrates in hand, our investigation into the proposed 
DKR-ATH began with the examination of the reduction of 7a. As shown in Table 
1, our initial studies revealed unexpected chemoselectively for reduction of solely 
the α-ketone, providing exclusive formation of δ-keto-α-hydroxy ester 8a as a 
single diastereomer. 
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Subjection of 7a to the previously reported reaction conditions;4 2 mol % of 
[RuCl2(p-cymene)]2 and diamine ligand 6 (Ru atom:L mole ratio 1:2) in DMF at 
70 °C, provided 8a in 96% yield and a 91:9 er (Table 1, entry 1). Lower levels of 
selectivity were observed when the reduction was run at room temperature 
(Table 1, entry 2). 
Scheme 3. Scope of the Glyoxylate Stetter Addition with Enonesa,b 
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(a) Conditions: Unless otherwise noted, all reactions were performed on a 2.0 
mmol scale in PhCH3 (4 mL) at ambient temperature. (b) Yields reported are for 
isolated compounds. (c) Reaction performed on a 20 mmol scale. 
Further optimization revealed that higher levels of enantioselectivity (97:3 er) 
could be obtained by running the reaction in DMSO at room temperature (Table 1, 
entry 6). The chemoselectivity observed is remarkable as 
(arene)RuCl(sulfonamide) catalysts have been extensively used for the 
asymmetric transfer hydrogenation of aryl ketones.5 
Table 1: Chemoselective DKR-ATH: Reaction Optimizationa  
 
entry solvent temperature yieldb erc 
1 DMF 70 °C 94 91:9 
2 DMF rt 93 87:13 
3 2-MeTHF 70 °C 90 65:35 
4 DCE 70 °C 91 78:22 
5 DMSO 70 °C 96 97:3 
6 DMSO rt 98 97:3 
a) All reactions run on a 0.15 mmol scale. b)  Isolated yield. c) Determined by 
SFC analysis. 
 Methods for the selective reduction of an aldehyde in the presence of less 
reactive carbonyls, i.e. ketones and esters, are well-established.12 Significant 
progress has been made in achieving the inverse process, the selective 
reduction of a ketone in the presence of an aldehyde,13-15 but examples of 
chemoselective ketone reductions are less documented.16 The tactic applied in 
our system takes advantage of the heightened reactivity enjoyed by α-
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dicarbonyls and establishes an unusually simple catalytic method for achieving 
the formal asymmetric glycolate Michael construct (Scheme 4). 
Scheme 4. ATH-DKR of α ,δ-Diketo Esters Delivers Formal Glycolate 
 Michael Products 
 
Access to δ-oxygenated glycolic acid derivatives via asymmetric glycolate 
Michael reactions are limited. The most common approach to this class of 
compounds is the addition of stoichiometric chiral glycolate enolates to α,β-
unsaturated ketones and esters;17-19 in each case, the protected glycolate is 
obtained (Scheme 5). Previous to our work, only a single catalytic 
enantioselective variant had been disclosed using oxazolones as the α-hydroxy 
acid surrogate (Scheme 5B).20  
Scheme 5. Strategies to Access δ-Oxygenated Glycolic Acid 
 Derivatives 
 
 
     With optimal reduction conditions to afford these formal glycolate Michael 
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ester with perfect diastereoselectivity was observed, irrespective of the electronic 
characteristics of the δ-ketone (Scheme 6).  
Scheme 6. Variation of δ-Ketone in the Chemoselective ATH-DKR of 
α ,δ-Diketo Estersa 
  
a) Yields are of isolated compounds. Diastereomeric ratio determined by 1H NMR 
spectroscopic analysis of crude reaction mixture. Enantiomeric ratio determined 
by SFC analysis. b) Reaction performed using 0.05 mol % of [RuCl2(p-cymene)]2. 
 High yields and enantioselectivites were obtained with both electron-poor 
(8b) and electron-rich (8c) aryl ketones. Use of a non-aromatic methyl ketone 
gave 8d in 85% yield and 93:7 dr while enone 8e was provided in 99:1 er with no 
over-reduction observed. To demonstrate the catalytic efficiency of this system, 
the reduction of 7a was performed using 0.05 mol% of [RuCl2(p-cymene)]2 dimer; 
no loss in reaction efficiency was observed as 8a was obtained in 98:2 er. 
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Modulation of the β-position to include electron rich and electron poor arenes 
had no deleterious effects on selectivity. Sterically encumbered 8i was obtained 
in 87% yield with 83:17 er. Incorporation of a nonaromatic ester at the β-position 
provided 8l with 91:9 er. Changing the β-substitutent to heteroaromatic indole 
delivered 8n with 98:2 er (Scheme 7). 
Scheme 7. Variation of the β-Substitutent  in the Chemoselective 
ATH-DKR of α ,δ-Diketo Estersa  
 
a) Yields are of isolated compounds. Diastereomeric ratio determined by 
1H NMR analysis of crude reaction mixture. Enantiomeric ratio determined 
by SFC analysis. b) Reaction performed using 0.05 mol % of [RuCl2(p-
cymene)]2. 
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Baeyer-Villiger oxidation and subsequent in situ lactonization. Spectral data were 
in agreement with those reported in the literature (Scheme 8).4  
Scheme 8. Stereochemical Analysis of δ-Keto α-Hydroxy Esters 
 
 To determine if the [RuCl2(p-cymene)]2/diamine 6 catalyst system was 
uniquely effective for the reduction of α-keto esters, the chemoselectivity of 
transfer hydrogenation catalysts known to reduce simple ketones was evaluated 
with 7a. The use of 14 in the reduction, a known ligand for the reduction of 
acetophenone (this reduction was performed during the course of this study), 
also afforded 8a as the sole product, albeit only 69:31 er (Scheme 9).  
 Scheme 9. Investigation into Observed Chemoselectivity of ATH-DKR 
 
 This result caused us to wonder if the δ-ketone was possibly undergoing in 
situ “protection” as a lactol following reduction of the α-keto ester with this 
intermediate masking the δ-ketone from further reduction. To test this hypothesis, 
the reduction was monitored by 1H NMR spectroscopy in DMSO-d6, but formation 
of lactol 15 was not detected: only the diketo ester 7a and hydroxy ester 13a 
were observed (Scheme 10).  
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 Scheme 10. 1H NMR Showing Absence of in situ Lactol Formation 
 
 We also examined the transfer hydrogenation of several other ketone 
substrates using the standard reaction conditions outlined in Scheme 6. 
Interestingly, acetophenone and ethyl 2-ethyl-3-oxobutanoate, which are typically 
the test substrates for new transfer hydrogenation catalysts, are not reduced with 
this catalyst system (Scheme 11), suggesting the catalyst has a distinct 
preference for electronically activated α-keto esters.  
In summary, our investigations into the ATH-DKR of α,δ-diketo esters 
revealed a formal asymmetric glycolate Michael process via chemoselective 
reduction of the α-ketone. The requisite α-keto esters were prepared via a 
previously unreported carbene-catalyzed glyoxylate Stetter reaction. The 
reduction proceeds with high enantio- and diastereoselectivity for a number of 
electronic- and functionally rich substrates. 
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 Scheme 11. Chemoselectivity of the [RuCl2(p-cymene)]2/Diamine 6 
 Catalyst System 
 
 The overall process for the generation of these β-substituted glycolates is 
highly atom efficient with the only stoichiometric byproducts generated being 
water (in the formation of the enones) and CO2 (in the ATH-DKR). Two of the 
reaction steps are catalytic and the Stetter reaction proceeds with complete atom 
economy. Overall, the α-hydroxy ester 8 is in created in three operationally 
simple steps, with high ee, from four inexpensive and nontoxic starting materials 
(Scheme 12). 
Scheme 12. Atom Economy in the Synthesis of β- 
Substituted α-Hydroxy Esters 
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effective for the reduction of electronically activated α-keto esters, as other 
ketone substrates are unreactive under the standard reaction conditions.
41 
2.3 Asymmetric Synthesis of anti-β-Amino-α-Hydroxy Esters via Dynamic 
Kinetic Resolution of β-Amino-α-Keto Esters**2 
Concurrent with the reduction of α,δ-diketo esters discussed in Chapter 2 
Sections 2 and 3, our group also disclosed the DKR-ATH of β-chloro α-keto ester 
16 to β-hydroxy ester 17. For this substrate class the highest stereoselection was 
obtained using [RuCl2(p-cymene)]2 in combination with diphenylethylenediamine 
derived ligand 18 (Scheme 13A).21 Subsequently, we disclosed the DKR-ATH of 
β-aryl α-keto phosphonates  using the originally disclosed ruthenium complex 3. 
This transformation provides 20 with exquisite stereoselectivity; although of some 
curiousity is that the observed relative stereochemistry of this reduction is 
contrary to that observed in the reduction of β-aryl α-keto ester 1 (Scheme 
13B).22 
Scheme 13.  Recent Developments in the ATH-DKR of α-Keto Esters 
and Congeners 
 
                                         
**Reproduced in part by permission of the American Chemical Society: Goodman, C.G.; Do, D. T.; Johnson J. S. Org Lett, 
2013, 15, 2446-2449.  
 
 
tBuO
O
O
R
Cl
HCO2H:NEt3 (5:2)
solvent, temperature
[RuCl2(p-cymene)]2 (0.5 mol %), 
18 (1 mol %)
18
tBuO
O
OH
R
Cl
17
18 examples
73-95% yield
4:1-20:1 dr
97:3-99.5:0.5 er
P
O
O
R
Ar
HCO2H:NEt3 (5:2)
solvent, temperature
[RuCl2(p-cymene)]2 (2 mol %), 
6 (8 mol %) P
O
OH
R
Ar
20
13 examples
86-94% yield
5:1-20:1 dr
98:2-99.5:0.5 er
MeO
MeO
(±)-16
R = aryl, alkyl
(±)-19
R = alkyl
MeO
MeO
A)
B) Ru
N
H2
N
Cl
Ar
Ar
O2S
21
general catalyst architecture 
for ATH-DKR of α-keto esters
R
HN
H2N
O2S
42 
As the presence of α-hydroxy-β-amino acids in biologically important 
structures is well-documented,23-27 we began studies to elucidate whether the Ru 
(II) catalyst system would promote the highly stereoselective reduction of β-
amino α-keto esters (Scheme 14). 
Scheme 14. Proposed ATH-DKR of β-Amino α-Keto Esters 
 
Driven by their pharmaceutical importance, multiple methods for 
accessing enantioenriched variants of β-amino α-hydroxy esters have been 
reported.28-39 The use of alkene starting materials is common. For example, 
Jacobsen has reported diastereoselective nucleophile opening of chiral epoxides 
using manganese (III) salen 23 furnishing amino alcohol 25 via the intermediacy 
of chiral epoxide 24 (Scheme 15A).28-30 Oxyamination of alkene 26 using 
Sharpless aminohydroxylation provides syn β-amino α-hydroxy ester 28 in good 
yield and enantioselection with hydroxycarbamate 25 serving as the source of 
both oxygen and nitrogen (Scheme 15B)31-35 Zhang has reported the asymmetric 
hydrosilylation of α-acetoxy-β-enamino ester 29 affording syn α-acetoxy β-amino 
ester 31 (Scheme 15C).36  
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Mannich reaction with tert-butyl diazoacetate. The oxidation occurs without 
racemization and the reduction proceeds with perfect diastereoselectivity yielding 
anti β-amino α-hydroxy ester 33 (Scheme 16A).40  Both asymmetric41 and 
diastereoselective42 Henry reactions with subsequent nitro-group reduction have 
also been reported. Of these, the most efficient for both number of steps and 
stereoselectivity utilizes chiral glyoxylate 34 giving α-hydroxy ester 35 in 81% 
yield and 87:13 dr (Scheme 16B).43 
Scheme 15. Synthesis of β-Amino α-Hydroxy Esters from Alkenes 
 
Access to β-amino α-hydroxy esters was also reported using asymmetric 
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bisoxazoline-copper (II) complexes provides β-amino α-oxo ester 39, which is 
reduced to β-amino α-hydroxy ester 40 using L-Selectride (Scheme 16D).46 
Somfai has also disclosed synthesis of β-amino α-hydroxy esters by tosic acid 
cleavage of oxazolidinones (formed via 1,3 dipolar cycloadditions), however 
attempts to render the latter enantioselective resulted in only 24% ee.47 
Scheme 16. Multistep Syntheses of β-Amino α-Hydroxy Esters 
  
In assessing these various methods, we noticed that few afforded 
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51 We believed that these synthetic issues could be addressed using our 
previously described ATH-DKR to provide facile access to enantioenriched β-
amino-α-hydroxy esters from β-amino α-keto esters.  
In principle, the most atom-efficient route towards the requisite β-amino-α-
keto esters would be a glyoxylate aza-benzoin reaction mediated by a NHC 
catalyst. Suitable precedent for aza-benzoin reactions,52,53 in combination with 
our recent success using NHC-catalyzed glyoxylate acyl anion equivalents4,21 
suggested that this disconnection was feasible. 
Due to ease of handling and overall stability profile, we elected to use 
amido-sulfones 41 as a synthetic precursor to the necessary imines.  
 Scheme 17. Synthesis of Amido Sulfones  
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These masked imines are readily available via condensation of carbamate 
and aldehyde, followed by addition of sulfinate to the formed iminium (Scheme 
17).53,54   
With amido sulfones in hand we used the triazolium carbene derived from 12 to 
effect aza-benzoin addition of ethyl glyoxylate into the in situ formed imines 
(Scheme 18). However, β-amino α-keto esters 42a and 42b were obtained in low 
and variable yields and proved unstable under all silica gel purification protocols 
tested, making this an unsuitable method for scalable synthesis.  
 Scheme 18. Attempts at the Aza Benzoin Addition of Ethyl Glyoxylate 
 into in situ Generated Aldimines  
 
 
 Despite its inefficiency, this method did provide us with sufficient amounts 
of the desired α-keto ester with which to examine the DKR-ATH for proof of 
concept. Guided by our previous works4 we began by screening catalyst 
complexes 3 and 21 which arise from diarylethylene diamine monosulfonamide 
ligands and [RuCl2(p-cymene)]2.4,5,55,56 The use of complex 21a for an ATH-DKR 
of 42 afforded complete anti diastereoselection but low enantioselection. 
Switching to complex 3 maintained high dr concurrent with high enantioselection 
for both Cbz- and Boc-protected amines, with Cbz providing slightly higher 
enantioselectivity (Table 2, entries 2 and 3). When the solvent was changed from 
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DMSO to DMF, an increase in selectivity for the Boc protected 43a was observed 
(Table 2, entry 4). 
Searching for higher selectivity, we switched to complex 21b, which gave 
42a in 99:1 er (Table 1, entry 5). Due to the observation of retro-Mannich 
products in the crude reaction mixture (by 1H NMR) we attempted to subvert this 
pathway lowering the temperature to 0 °C; however, this change only resulted in 
decreased yield (Table 1, entry 6). This brief optimization study revealed that 
high levels of enantioselectivity can be obtained with two convenient carbamate 
protecting groups through judicious selection of catalyst.  Due to the superior 
enantioselection using Boc-protected amine, it was selected as the protecting 
group for our subsequent studies. With proof of concept for the DKR-ATH 
established, attention returned to improving the synthesis of the requisite β-
amino-α-keto esters. 
A survey of the literature revealed conditions reported by Wang and 
coworkers, which proved effective for generation of β-sulfonamido-α-keto 
esters.58 This route employs pre-generating N-sulfonyl imines from the 
corresponding amido sulfones followed by Mannich addition of ethyl diazoacetate 
(Scheme 19). 
On the basis of precedent, subsequent oxidation was expected to furnish 
α-keto esters primed for reduction.40,58 This general strategy has previously been 
exploited to access enantioenriched β-amino α-hydroxy esters via asymmetric 
Mannich addition followed by diastereoselective reduction.40 Our hope was to 
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develop a method in which both stereocenters would be set during the reduction 
from a racemic starting material. 
 Table 2: DKR-ATH of β-amino α-Keto Ester Optimization 
 
Trial PG Complex Solvent Temp 
(°C) 
Yieldb  
(%) 
drc erd 
1 Boc 21a DMSO rt 59 >20:1 77:23 
2 Boc 21b DMSO rt 67 >20:1 94:6 
3 Cbz 3 DMSO rt 77 >20:1 97:3 
4 Boc 3 DMF rt 65 >20:1 97:3 
5 Boc 21b DMF rt 73 >20:1 99:1 
6 Boc 21b DMF 0 62 >20:1 98:2 
7 Cbz 21b DMF rt 71 >20:1 94:6 
a)Reaction optimization took place using a crude mixture of compounds obtained 
via aza-benzoin reaction which included the desired starting material (cf. Scheme 
18). b)Isolated yield calculated based on the assumption of pure α-keto ester 
starting material; actual yields are probably somewhat higher. c)Determined by 1H 
NMR analysis of crude reaction mixture. d)Determined by chiral HPLC or SFC 
analysis.  
 
The described Mannich reaction was conducted at room temperature for 
all aromatic substituted aldimines, and at -40 °C for aliphatic substrates to 
subvert enamine formation (Scheme 20). As expected the DBU catalyzed 
Mannich addition delivered a wide array of β-amino α-diazo esters for conversion 
into β-amino α-hydroxy esters.  
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 Scheme 19. Literature Precedented Mannich Addition 
  
With α-diazo esters in hand, we then turned to a two-step oxidation-
reduction sequence (Scheme 21). We employed previously described conditions 
for oxidation of α-diazo esters to their corresponding α-keto esters using 
commercially available Oxone®.40 As we had anticipated using this protocol, the 
unchromatographed α-keto esters were sufficiently pure for direct use in the 
optimized reduction conditions: exposure of β-amino-α-keto esters (±)-42 to Ru-
complex 21b and HCO2H/Et3N yielded products 43a-o (Scheme 21). 
Our substrate scope sought to probe both electronic and steric controls for 
this reaction system.  Heteroaromatic (43l-43m) as well as electron-rich (43f-
43h) and -poor (43g) aromatic systems all provide high dr and enantioselectivity. 
Additionally, 43j showed only reduction of the α-ketone leaving the alkene intact, 
although the reaction proceeded with negligible diastereoselectivity. Products 
43c-43e showed that while steric encumbrance does affect the dr, 
enantioselectivity remained high. In testing 46o for the application of this method 
towards aliphatic β-substitution, we observed full reduction of the ketone, albeit 
with low stereoselectivity. 
As was already noted, this reaction is tolerant to different amine protecting 
groups (4a and 4b) providing further flexibility in substrate design. The resultant 
alcohols are often solids and a single recrystallization could regularly provide er 
values above 99.5:0.5 (parenthetical values in Scheme 21). 
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 Scheme 20. Substrate Scope for the Mannich Addition of Ethyl 
 Diazoacetate 
 
 
a) The imine 41 was generated from the corresponding amido sulfone (see 
section 2.5.3 for details).  Isolated yields over the two steps are reported. b) 
Mannich addition conducted at -40 °C.  
 
To determine the stereochemistry imparted by the DKR-ATH, (+)-43b was 
independently synthesized from the known enantioenriched epoxide 46 (Scheme 
22A).59 The stereochemistry was then assigned based on comparison of this 
product and (-)-43b (prepared by DKR-ATH, Scheme 21) using 1H NMR and 
chiral SFC analysis. Lastly, the utility of Boc and Cbz protecting groups was 
demonstrated by the deprotection of 43a under acidic conditions and 43b with 
trimethylsilyl iodide, both of which resulted in free amine (-)-47 (Scheme 22B). 
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 Scheme 21. Substrate Scope for the ATH-DKR of β-Amino α-Keto 
 Esters 
 
a) Isolated yields are reported. b)Determined by 1H NMR analysis of crude 
reaction mixture. c)Determined by chiral HPLC or SFC analysis. d)Recrystallized 
er values are in parentheses 
 
Our investigations resulted in a simple and practical implementation of 
racemic β-amino-α-keto esters for synthetic access to enantiomerically enriched 
anti-β-amino-α-hydroxy esters via DKR-ATH. The net effects of our studies 
include the expansion of the product classes that are known to be accessible via 
ATH-DKR using terphenyl-based catalysts 3 and 21b while delivering a 
biologically relevant small molecule in a conveniently configured form.  
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 Scheme 22. Determination of Product Stereochemistry and 
 Synthesis of Free Amine 
 
 
At this point in our study of the ATH-DKR of α-keto esters, we felt catalyst 
architecture 21 was proven to be both robust and general to a wide array of β-
substituted α-keto esters. Therefore in order to continue to progression of the 
field we decided to shift focus from developing hydrogenative DKR’s dynamic 
methods that occur via carbon nucleophile additions to β-stereogenic α-keto 
esters.
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2.4 Experimental Data and Conditions for the Chemoselective Dynamic 
Asymmetric Reduction of α,δ-Diketo Esters‡ 
3 
2.4.1 General Information 
Methods: Infrared (IR) spectra were obtained using a Jasco 260 Plus 
Fourier transform infrared spectrometer. Proton and carbon magnetic resonance 
spectra (1H NMR, 13C NMR, and 19F NMR) were recorded on a Bruker model 
DRX 400 or 600 (1H NMR at 400 MHz or 600 MHz, 13C NMR at 100 MHz or 150 
MHz, and 19F NMR at 376 MHz or 565 MHz) spectrometer with solvent 
resonance as the internal standard (1H NMR: CDCl3 at 7.26 ppm and 13C NMR: 
CDCl3 at 77.0 ppm). 1H NMR data are reported as follows: chemical shift, 
multiplicity (s = singlet, bs = broad singlet, d = doublet, dd = doublet of doublet, t 
= triplet, q = quartet, sept = septuplet, oct = octuplet, m = multiplet), coupling 
constants (Hz), and integration. Supercritical fluid chromatography was 
performed on a Berger SFC system equipped with Chiralcel AD, AS, OD, and 
WO columns (φ 4.6 mm x 250 mm). Samples were eluted with SFC grade CO2 at 
the indicated percentage of MeOH with an oven temperature of 40 ºC. Optical 
rotations were measured using a 2 mL cell with a 1 dm path length on a Jasco 
DIP 1000 digital polarimeter. Mass spectra were obtained using a Micromass 
Quattro II (triple quad) instrument with nanoelectrospray ionization (Note: All 
samples prepared in methanol). Analytical thin layer chromatography (TLC) was 
performed on Whatman or Sorbtech 0.25 mm silica gel 60 plates. Visualization 
was accomplished with UV light and/or aqueous ceric ammonium molybdate 
                                         ‡Reproduced in part by permission of the American Chemical Society: Steward, K. M.; Corbett,  M. T.; Goodman, C. G.; 
Johnson, J. S. J. Am. Chem. Soc. 2012, 134, 20197-20206. 
 
54 
solution followed by heating. Purification of the reaction products was carried out 
by using Siliaflash-P60 silica gel (40-63µm) purchased from Silicycle. All 
reactions were carried out under an atmosphere of nitrogen in flame-dried 
glassware with magnetic stirring. Yield refers to isolated yield of analytically pure 
material unless otherwise noted. Yields and diastereomeric ratios (dr) are 
reported for a specific experiment and as a result may differ slightly from those 
found in the tables, which are averages of at least two experiments. 
Materials: enones were prepared according to known procedures. Ethyl 
glyoxylate was purchased from Sigma Aldrich as a 40% solution in toluene and 
distilled under reduced pressure prior to use (the concentration after distillation 
was determined by 1H NMR spectroscopy). N,N-Dimethylformamide (DMF) was 
distilled from phosphorous pentoxide and stored under nitrogen over 3Å 
molecular sieves. Dimethyl sulfoxide (DMSO) was distilled from calcium hydride 
and stored under nitrogen over 3Å molecular sieves. Triethylamine (NEt3) was 
freshly distilled from calcium hydride prior to use. Toluene (PhCH3), diethyl ether 
(Et2O), dichloromethane (CH2Cl2), and tetrahydrofuran (THF) were dried by 
passage through a column of neutral alumina under nitrogen prior to use. All 
other reagents were purchased from commercial sources and were used as 
received unless otherwise noted.  
2.4.2 General Procedure A for the Preparation of β-Substituted α ,δ-Diketo 
 Esters 7a-n 
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To a flame-dried 10-mL round-bottomed flask equipped with a magnetic 
stir bar were added enone 11 (2.0 mmol, 1.0 equiv), ethyl glyoxylate 10 (4.0 
mmol, 2.0 equiv) and triazolium salt 12 (0.40 mmol, 0.20 equiv). The flask was 
sealed with a rubber septum and purged with nitrogen. Toluene (0.5 M 
concentration with respect to enone) followed by triethylamine (2.0 mmol, 1.0 
equiv) were then added. The reaction was stirred at room temperature for 16 h 
and diluted with ethyl acetate and water. The organic layer was washed with 
brine and dried over sodium sulfate. Concentration in vacuo afforded the β-
substituted α,δ-diketo esters which were purified by flash chromatography using 
the indicated solvent systems. 
Ethyl 2,5-dioxo-3,5-diphenylpentanoate (7a): The title 
compound was prepared according to General Procedure A on a 
20 mmol scale. Flash chromatography (20% EtOAc/hexanes) provided 7a (6.02 g, 
19.4 mmol, 97% yield) as a white solid. Analytical data for 7a: 1H NMR (600 MHz, 
CDCl3): δ 7.96 (d, J = 7.2 Hz, 2H) 7.58-7.56 (m, 1H), 7.47-7.44 (m, 2H), 7.36-
7.35 (m, 4H), 7.31-7.29 (m, 1H), 5.16 (dd, J = 10.8 Hz, 3.6 Hz, 1H), 4.32-4.24 (m, 
2H), 4.04 (dd, J = 18 Hz, 10.8 Hz, 1H), 3.44 (dd, J = 18 Hz, 3.6 Hz, 1H), 1.31 (t, J 
= 7.2 Hz, 3H); 13C NMR (150 MHz, CDCl3): δ 197.4, 192.2, 160.3, 135.9, 135.3, 
133.5, 129.1, 128.9, 128.6, 128.2, 128.0, 62.5, 48.4, 43.2, 13.9; IR (thin film, cm-
1): 1669, 1494, 1450, 1400, 1362, 1277, 1207, 1098, 1036, 844, 751, 689, 563; 
m.p. 128-130 ºC; TLC (20% EtOAc/hexanes) Rf : 0.33; HRMS (ESI): Calculated 
for [M+H]+ C19H19O4: 311.1283, Found: 311.1281. 
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Ethyl 5-(4-iodophenyl)-2,5-dioxo-3-phenylpentanoate 
(7b): The title compound was prepared according to General 
Procedure A. Flash chromatography (20% EtOAc/hexanes) provided 7b (0.829 g, 
1.90 mmol, 95% yield) as a white solid. Analytical data for 7b: 1H NMR (600 MHz, 
CDCl3): δ 7.82 (d, J = 8.4 Hz, 2H), 7.65 (d, J = 8.4 Hz, 2H), 7.38-7.28 (m, 5H), 
5.14 (dd, J = 10.8 Hz, 4.0 Hz, 1H), 4.34-4.21 (m, 2H), 3.97 (dd, J = 10.8 Hz, 18.2 
Hz, 1H), 3.36 (dd, J = 18.2 Hz, 4.0 Hz, 1H), 1.30 (t, J = 7.2 Hz, 3H); 13C NMR 
(150 MHz, CDCl3): δ 196.7, 192.0, 160.2, 138.0, 135.2, 135.1, 129.5, 129.2, 
128.8, 128.0, 101.6, 62.6, 48.4, 42.9, 13.9; IR (thin film, cm-1): 1728, 1681, 1581, 
1494, 1455, 1394, 1274, 1204, 1097, 1037, 1002, 818, 753, 700, 560; m.p. 131-
134 ºC; TLC (20% EtOAc/hexanes) Rf : 0.42; HRMS (ESI): Calculated for [M+H]+ 
C19H18IO4: 437.0250, Found: 437.0254. 
Ethyl 5-(4-methoxyphenyl)-2,5-dioxo-3-
phenylpentanoate (7c): The title compound was 
prepared according to General Procedure A. Flash chromatography (20% 
EtOAc/hexanes) provided 7c (0.585 g, 1.72 mmol, 97% yield) as a yellow solid. 
Analytical data for 7c: 1H NMR (600 MHz, CDCl3): δ 7.93 (d, J = 9.0 Hz, 2H), 
7.35-7.33 (m, 4H), 7.30-7.28 (m, 1H), 6.91 (d, J = 8.4 Hz, 2H), 5.13 (dd, J = 10.8 
Hz, 3.6 Hz, 1H), 4.33-4.24 (m, 2H), 3.99 (dd, J = 18.0 Hz, 10.8 Hz, 1H), 3.86 (s, 
3H), 3.40 (dd, J = 18.0 Hz, 3.6 Hz, 1H), 1.31 (t, J = 7.2 Hz, 3H); 13C NMR (150 
MHz, CDCl3): δ 195.9, 192.3, 163.8, 160.4, 135.5, 130.5, 129.1, 129.0, 127.9, 
113.8, 62.5, 55.5, 48.4, 43.1, 13.9; IR (thin film, cm-1): 2360, 1726, 1669, 1600, 
1509, 1454, 1421, 1260, 1169, 1030, 833, 699; m.p. 118-120 ºC; TLC (20% 
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EtOAc/hexanes) Rf : 0.26; HRMS (ESI): Calculated for [M+H]+ C20H21O5: 
341.1389, Found: 341.1392. 
Ethyl 2,5-dioxo-3-phenylhexanoate (7d): The title compound 
was prepared according to General Procedure A. Flash 
chromatography (20% EtOAc/hexanes) provided 7d (0.357 g, 1.44 mmol, 72% 
yield) as a clear oil. Analytical data for 7d: 1H NMR (600 MHz, CDCl3): δ 7.36-
7.26 (m, 5H), 4.96 (dd, J = 10.8 Hz, 4.2 Hz, 1H), 4.30-4.20 (m, 2H), 3.50 (dd, J = 
18.0 Hz, 10.8 Hz, 1H), 2.85 (dd, J = 18.0 Hz, 4.2 Hz, 1H) 2.20 (s, 3H), 1.29 (t, J = 
7.2 Hz); 13C NMR (150 MHz, CDCl3): δ 205.9, 192.2, 160.3, 135.1, 129.1, 128.8, 
127.9, 62.4, 48.5, 47.0, 29.5, 13.8; IR (thin film, cm-1): 2984, 1729, 1455, 1363, 
1271, 1165, 1098, 1027, 752, 700, 516; TLC (20% EtOAc/hexanes) Rf : 0.28; 
HRMS (ESI): Calculated for [M+H]+ C14H17O4: 249.1127, Found: 249.1121. 
(E)-Ethyl 2,5-dioxo-3,7-diphenylhept-6-enoate (7e):The 
title compound was prepared according to General Procedure 
A. Flash chromatography (20% EtOAc/hexanes) provided 7e (0.612 g, 1.82 mmol, 
91% yield) as a clear oil. Analytical data for 7e: 1H NMR (600 MHz, CDCl3): δ 
7.57 (d, J = 16.2 Hz, 1 H), 7.53-7.52 (m, 2H), 7.40-7.38 (m, 3H), 7.36-7.32 (m, 
4H), 7.30-7.28 (m, 1H), 6.72 (d, J = 16.2 Hz, 1H), 5.07 (dd, J = 10.2 Hz, 4.2 Hz, 
1H), 4.32-4.22 (m, 2H), 3.74 (dd, J = 18.0 Hz, 10.2 Hz, 1H), 3.14 (dd, J = 18.0 Hz, 
4.2 Hz, 1H), 1.29 (t, J = 7.2 Hz); 13C NMR (150 MHz, CDCl3): δ 197.2, 192.2, 
160.4, 143.6, 135.4, 134.2, 130.7, 129.1, 129.0, 128.8, 128.3, 127.9, 125.3, 62.4, 
48.4, 44.6, 13.9; IR (thin film, cm-1): 2360, 1727, 1655, 1610, 1494, 1451, 1337, 
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1274, 1176, 1070, 1035, 753, 699; TLC (20% EtOAc/hexanes) Rf : 0.34; HRMS 
(ESI): Calculated for [M+H]+ C21H21O4: 337.1440, Found: 337.1447. 
Ethyl 5-(benzo[d][1,3]dioxol-5-yl)-2,5-dioxo-3-
phenylpentanoate (7f):  The title compound was prepared 
according to General Procedure A. Flash chromatography (20% EtOAc/hexanes) 
provided 7f (0.652 g, 1.84 mmol, 92% yield) as a clear oil. Analytical data for 7f: 
1H NMR (600 MHz, CDCl3): δ 7.55 (d, J = 8.4 Hz, 1 H), 7.39 (s, 1H), 7.34-7.33 (m, 
4H), 7.29-7.27 (m, 1H), 6.82 (d, J = 8.4 Hz, 1H), 6.02 (s, 2H), 5.12 (dd, J = 10.8 
Hz, 4.2 Hz, 1H), 4.32-4.22 (m, 2H), 3.95 (dd, 18.0 Hz, 10.8 Hz, 1H), 3.35, (dd, J 
= 18.0 Hz, 3.6 Hz, 1H), 1.30 (t, J = 7.2 Hz, 3H); 13C NMR (150 MHz, CDCl3): δ 
195.3, 192.2, 160.3, 152.0, 148.1, 135.3, 130.7, 129.0, 128.8, 127.9, 124.5, 
107.8, 107.8, 101,9, 62.4, 48.4, 43.0, 13.8; IR (thin film, cm-1): 1727, 1670, 1603, 
1488, 1444, 1365, 1254, 1091, 1036, 932, 809, 753, 700; TLC (20% 
EtOAc/hexanes) Rf : 0.29; HRMS (ESI): Calculated for [M+H]+ C20H19O6: 
355.1182, Found: 355.1179. 
Ethyl 3-(4-chlorophenyl)-2,5-dioxo-5-phenylpentanoate (7g): 
The title compound was prepared according to General 
Procedure A. Flash chromatography (20% EtOAc/hexanes) 
provided 7g (0.648 g, 1.88 mmol, 94% yield) as a clear oil. Analytical data for 7g: 
1H NMR (600 MHz, CDCl3): δ 7.94 (d, J = 8.0 Hz, 2H), 7.59-7.56 (m, 1H), 7.48-
7.44 (m, 2H), 7.33 (d, J = 8.4 Hz, 2H), 7.29 (d, J = 8.4 Hz, 2H), 5.13 (dd, J = 10.4 
Hz, 4.0 Hz, 1H), 4.36-4.23 (m, 2H), 3.99 (dd, J = 18.4 Hz, 10.4 Hz, 1H), 3.43 (dd, 
J = 18.4 Hz, 4.0 Hz, 1H), 1.33 (t, J = 7.2 Hz); 13C NMR (150 MHz, CDCl3): δ 
EtO
O
O
Ph O
O
O
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197.1, 191.8, 160.2, 135.7, 134.0, 133.9, 133.6, 130.2, 129.3, 128.7, 128.2, 62.7, 
47.7, 43.1, 13.9; IR (thin film, cm-1): 2983, 1729, 1681, 1596, 1490, 1449, 1273, 
1207, 1092, 1037, 761, 688, 563;TLC (20% EtOAc/hexanes) Rf : 0.38; HRMS 
(ESI): Calculated for [M+H]+ C19H18ClO4: 345.0894, Found: 345.0894. 
Ethyl 3-(4-methoxyphenyl)-2,5-dioxo-5-phenylpentanoate 
(7h): The title compound was prepared according to General 
Procedure A. Flash chromatography (20% EtOAc/hexanes) 
provided 7h (0.653 g, 1.92 mmol, 96% yield) as a clear oil. Analytical data for 7h: 
1H NMR (600 MHz, CDCl3): δ 7.95 (d, J = 7.2 Hz, 2H), 7.58-7.55 (m, 1H), 7.47-
7.43 (m, 2H), 7.26 (d, J = 8.8 Hz, 2H), 6.88 (d, J = 8.8 Hz, 2H), 5.10 (dd, J = 10.4 
Hz, 4.0 Hz, 1H), 4.34-4.21 (m, 2H), 3.99 (dd, J = 18.4 Hz, 10,4 Hz, 1H), 3.79 (s, 
3H), 3.40 (dd, 18.4 Hz, 4.0 Hz, 1H), 1.31 (t, J = 7.2 Hz); 13C NMR (150 MHz, 
CDCl3): δ 197.5, 192.1, 160.4, 159.3, 136.0, 133.4, 130.0, 128.6, 128.1, 126.9, 
114.5, 62.4, 55.2, 47.5, 42.9, 13.9; IR (thin film, cm-1): 2982, 2837, 1728, 1681, 
1609, 1511, 1449, 1361, 1255, 1180, 1095, 1036, 833, 796, 690, 552; TLC (20% 
EtOAc/hexanes) Rf : 0.23; HRMS (ESI): Calculated for [M+H]+ C20H21O5: 
341.1389, Found: 341.1385. 
Ethyl 2,5-dioxo-5-phenyl-3-(o-tolyl)pentanoate (7i): The title 
compound was prepared according to General Procedure A. Flash 
chromatography (20% EtOAc/hexanes) provided 7i (0.454 g, 1.40 
mmol, 70% yield) as a clear oil. Analytical data for 7i: 1H NMR (600 MHz, CDCl3): 
δ 7.95 (d, J = 7.2 Hz, 2H), 7.58-7.55 (m, 1H), 7.46-7.44 (m, 2H), 7.25-7.24 (m, 
1H), 7.21-7.15 (m, 2H), 7.07-7.06 (m, 1H), 5.38 (dd, J = 10.2 Hz, 3.6 Hz, 1H), 
EtO
O
O
OPh
Me
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4.25-4.11 (m, 2H), 3.93 (dd, J = 18.0 Hz, 10.2 Hz, 1H), 3.27 (dd, J = 18.0 Hz, 3.6 
Hz, 1H), 2.54 (s, 3H), 1.26 (t, J = 7.2 Hz, 3H); 13C NMR (150 MHz, CDCl3): δ 
197.3, 192.3, 160.5, 137.1, 136.0, 133.8, 133.4, 131.3, 128.6, 127.8, 127.5, 
126.5, 62.4, 44.5, 42.2, 19.7, 13.8; IR (thin film, cm-1): 2982, 2359, 1727, 1683, 
1596, 1490, 1448, 1359, 1240, 1094, 1038, 757, 689; TLC (20% 
EtOAc/hexanes) Rf : 0.38; HRMS (ESI): Calculated for [M+H]+ C20H21O4: 
325.1440, Found: 325.1449. 
Ethyl 2,5-dioxo-5-phenyl-3-(m-tolyl)pentanoate (7j): The title 
compound was prepared according to General Procedure A. 
Flash chromatography (20% EtOAc/hexanes) provided 7j (0.603 
g, 1.86 mmol, 93% yield) as a clear oil. Analytical data for 7j: 1H NMR (600 MHz, 
CDCl3): δ 7.96 (d, J = 7.2 Hz, 2H), 7.58-7.56 (m, 1H), 7.46-7.44 (m, 2H), 7.24-
7.23 (m, 1H), 7.15-7.14 (m, 2H), 7.11-7.10 (m, 1H), 5.12 (dd, J = 10.8 Hz, 3.6 Hz, 
1H), 4.34-4.24 (m, 2H), 4.03 (dd, J = 18.6 Hz, 10.8 Hz, 1H), 3.41 (dd, J = 18.6 Hz, 
3.6 Hz, 1H), 2.34 (s, 3H), 1.31 (t, J = 6.6 Hz, 3H) ; 13C NMR (150 MHz, CDCl3): δ 
197.4, 192.2, 160.3, 138.8, 136.0, 135.2, 133.4, 129.4, 129.0, 128.7, 128.6, 
128.1, 125.9, 62.4, 48.3, 43.1, 21.3, 13.9; IR (thin film, cm-1): 2982, 1730, 1681, 
1596, 1491, 1449, 1358, 1240, 1095, 1038, 757, 689, 560; TLC (20% 
EtOAc/hexanes) Rf : 0.40; HRMS (ESI): Calculated for [M+H]+ C20H21O4: 
325.1440, Found: 325.1441. 
Ethyl 2,5-dioxo-5-phenyl-3-(p-tolyl)pentanoate (7k): The title 
compound was prepared according to General Procedure A. 
Flash chromatography (20% EtOAc/hexanes) provided 7k (0.615 
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g, 1.90 mmol, 95% yield) as a clear oil. Analytical data for 7k: 1H NMR (600 MHz, 
CDCl3): δ 7.95 (d, J = 7.8 Hz, 2H), 7.58-7.55 (m, 1H), 7.46-7.44 (m, 2H), 7.23 (d, 
J = 8.4 Hz, 2H), 7.16 (d, J = 8.4 Hz, 2H), 5.12 (dd, J = 10.8 Hz, 3.6 Hz, 1H), 4.33-
4.23 (m, 2H), 4.01 (dd, J = 18.0 Hz, 10.8 Hz, 1H), 3.40 (dd, J = 18.0 Hz, 3.6 Hz, 
1H), 2.33 (s, 3H), 1.31 (t, J = 7.2 Hz, 3H); 13C NMR (150 MHz, CDCl3): δ 197.4, 
192.2, 160.4, 137.8, 136.0, 133.4, 132.2, 129.8, 128.7, 128.6, 128.1, 62.4, 48.0, 
43.0, 21.0, 13.9; IR (thin film, cm-1): 2983, 1727, 1682, 1512, 1449, 1273, 1204, 
1095, 1038, 764, 689, 544; TLC (20% EtOAc/hexanes) Rf : 0.37; HRMS (ESI): 
Calculated for [M+H]+ C20H21O4: 325.1440, Found: 325.1440. 
Diethyl 2-oxo-3-(2-oxo-2-phenylethyl)succinate (7l): The title 
compound was prepared according to General Procedure A. 
Flash chromatography (20% EtOAc/hexanes) provided 7l (0.563 g, 1.84 mmol, 
92% yield) as a clear oil. Analytical data for 7l: 1H NMR (400 MHz, CDCl3): δ 
12.89 (s, 1H), 7.96 (d, J = 8.0 Hz, 2H), 7.60-7.56 (m, 1H), 7.48-7.45 (m, 2H), 4.91 
(dd, J = 9.2 Hz, 4.4 Hz, 1H), 4.43-4.37 (m, 2H), 4.25-4.18 (m, 2H), 3.79 (dd, J = 
18.0 Hz, 9.2 Hz, 1H), 3.67 (dd, 18.0 Hz, 4.4 Hz, 1H), 1.40 (t, J = 8.0 Hz, 3H), 
1.24 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 196.2, 188.5, 168.3, 160.2, 
135.6, 133.7, 133.1, 128.7, 128.6, 128.2, 128.0, 62.8, 62.1, 48.2, 37.6, 35.8, 14.0, 
13.9; IR (thin film, cm-1): 2983, 2936, 1731, 1683, 1597, 1449, 1368, 1256, 1097, 
1042, 859, 760, 690; TLC (20% EtOAc/hexanes) Rf : 0.26; HRMS (ESI): 
Calculated for [M+H]+ C16H19O6: 307.1182, Found: 307.1190. 
Ethyl 3-(benzo[d][1,3]dioxol-5-yl)-2,5-dioxo-5-
phenylpentanoate (7m): The title compound was prepared 
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according to General Procedure A. Flash chromatography (20% EtOAc/hexanes) 
provided 7m (0.665 g, 1.88 mmol, 94% yield) as a clear oil. Analytical data for 
7m: 1H NMR (600 MHz, CDCl3): δ  7.95 (d, J = 7.8 Hz, 2H), 7.58-7.56 (m, 1H), 
7.47-7.44 (m, 2H), 6.83 (s, 1H), 6.80-6.76 (m, 2H), 5.95 (s, 2H), 5.06 (dd, J = 
10.8 Hz, 3.6 Hz, 1H), 4.35-4.25 (m, 2H), 3.96 (dd, J = 18.0 Hz, 10.8 Hz, 1H), 3.40 
(dd, J = 18.0 Hz, 3.6 Hz, 1H), 1.33 (t, J = 7.2 Hz, 3H); 13C NMR (150 MHz, 
CDCl3): δ 197.4, 191.9, 160.4 148.2, 147.4, 135.9, 133.5, 128.6, 128.1, 122.4, 
109.1, 108.8, 101.2, 62.5, 47.9, 43.0, 13.9; IR (thin film, cm-1): 2984, 2905, 1727, 
1681, 1596, 1504, 1486, 1447, 1361, 1247, 1232, 1095, 1037, 930, 859, 811, 
765, 689; TLC (20% EtOAc/hexanes) Rf : 0.28; HRMS (ESI): Calculated for 
[M+H]+ C20H19O6: 355.1182, Found: 355.1185. 
Tert-butyl 3-(1-ethoxy-1,2,5-trioxo-5-phenylpentan-3-yl)-1H-
indole-1-carboxylate (7n): The title compound was prepared 
according to General Procedure A. Flash chromatography (20% 
EtOAc/hexanes) provided 7n (0.628 g, 1.40 mmol, 70% yield) as a yellow solid. 
Analytical data for 7n: 1H NMR (400 MHz, CDCl3): δ  8.17 (d, J = 7.6 Hz, 1H), 
7.96 (d, J = 7.6 Hz, 2H), 7.75-7.73 (m, 1H), 7.59-7.55 (m, 1H), 7.52 (s, 1H), 7.47-
7.7.43 (m, 2H), 7.38-7.34 (m, 1H), 7.31-7.27 (m, 1H), 5.42 (dd, J = 10.8 Hz, 3.6 
Hz, 1H), 4.30-4.26 (m, 2H), 4.11 (dd, J = 18.4 Hz, 10.8 Hz, 1H), 3.54 (dd, J = 
18.4 Hz, 3.6 Hz, 1H), 1.67 (s, 9H), 1.29 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, 
CDCl3): δ 197.4, 191.3, 160.4, 149.2, 135.7, 135.6, 133.5, 128.9, 128.6, 128.1, 
124.9, 124.6, 122.9, 119.3, 115.3, 114.6, 84.0, 62.6, 42.1, 39.0, 28.2, 13.8; IR 
(thin film, cm-1): 2984, 2905, 1727, 1681, 1596, 1504, 1486, 1447, 1361, 1247, 
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1232, 1095, 1037, 930, 859, 811, 765, 689; TLC (20% EtOAc/hexanes) Rf : 0.37; 
HRMS (ESI): Calculated for [M+H]+ C26H28NO6: 450.1916, Found: 450.1923. 
2.4.3  General Procedure B for the Preparation of Racemic δ-Keto α-
 Hydroxy Esters 8a-n 
 
 
Lithium triethylborohydride (0.95 equiv, 1.0 M solution in THF) was added 
to a solution of β-substituted α,δ-diketo ester (1.0 equiv) in THF (0.5 M 
concentration) at -78 °C. The reaction was allowed to stir at this temperature for 
10 minutes and quenched with saturated ammonium chloride. The reaction was 
further diluted with diethyl ether and water. The organic layer was washed with 
brine, dried over sodium sulfate and concentrated in vacuo to give δ-keto α-
hydroxy esters 8 which were purified by flash chromatography using the indicated 
solvent systems. 
2.4.4 General Procedure C for the ATH-DKR of a,δ-Diketo Esters 7a-n 
 
 
To a flame-dried 1-dram vial equipped with a magnetic stir bar were added 
[RuCl2(p-cymene)]2 (0.02 equiv) and ligand 6 (0.08 equiv). The vial was sealed 
with a rubber septum and purged with nitrogen. DMSO (0.5 mL) was added and 
the rubber septum was quickly replaced with a PTFE-lined screw cap. The 
mixture was heated at 70 ºC for 30 min and cooled to ambient temperature. A 
solution of β-substituted α,δ-diketo ester (1.0 equiv in 1.0 mL DMSO) followed by 
RO
O
O
R1
R2
O
LiBHEt3 (0.95 equiv)
THF -78 °C RO
O
OH
R1
R3
O
(±)-7 (±)-8
EtO
O
O
R2
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HCO2H:NEt3 (5:2)
DMSO, rt
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6 (8 mol %)
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O
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OR1O
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64 
formic acid:triethylamine 5:2 azeotrope (5.0 equiv) were added. The vial was 
purged with nitrogen and the reaction was stirred at room temperature for 1-2 
hours and diluted with ethyl acetate and water. The organic layer was washed 
with water (x2), brine, and dried over sodium sulfate. Concentration in vacuo 
afforded the δ-keto α-hydroxy esters, which were purified by flash 
chromatography using the indicated solvent systems. 
(2R,3R)-Ethyl 2-hydroxy-5-oxo-3,5-diphenylpentanoate (8a): 
The title compound was prepared via a modification of General 
Procedure C (lower catalyst loading) using α,δ-diketo ester 7a (1.92 g, 6.20 mmol, 
1.0 equiv), [RuCl2(p-cymene)]2 (1.9 mg, 0.0031 mmol, 0.0005 equiv), 6 (7.5 mg, 
0.0124 mmol, 0.002 equiv), and HCOOH:NEt3 5:2 azeotrope (2.68 g, 31.0 mmol, 
5.0 equiv). Flash chromatography (20% EtOAc/hexanes) provided δ-keto α-
hydroxy ester 8a (1.88 g, 0.601 mmol, 97% yield) as a white solid. Analytical data 
for 8a: 1H NMR (600 MHz, CDCl3): δ 8.03 (d, J = 7.2 Hz, 2H), 7.60-7.57 (m, 1H), 
7.50-7.47 (m, 2H), 7.35-7.33 (m, 2H), 7.31-7.29 (m, 2H), 7.27-7.24 (m, 1H), 4.66 
(dd, J = 6.0 Hz, 3.0 Hz, 1H), 4.18-4.11 (m, 2H), 3.97 (ddd, 8.4 Hz, 6.0 Hz, 3.0 Hz, 
1H), 3.80 (dd, J = 8.4 Hz, 18.0 Hz, 1H), 3.47 (dd, J = 18.0 Hz, 6.0 Hz, 1H), 2.92 
(d, J = 6.0 Hz, 1H), 1.26 (t, J =7.2 Hz, 3H); 13C NMR (150 MHz, CDCl3): δ 198.3, 
173.6, 139.0, 136.9, 133.2, 128.6, 128.6, 128.3, 128.0, 127.3, 72.5, 61.7, 43.6, 
40.4, 14.1; IR (thin film, cm-1): 3503, 3029, 2981, 1733, 1684, 1597, 1579, 1495, 
1449, 1369, 1267, 1212, 1103, 1022, 753, 703, 691, 554; m.p. 145-147 °C; TLC 
(30% EtOAc/hexanes): Rf : 0.37; HRMS (ESI): Calculated for [M+Na] 
C19H20NaO4: 335.1259, Found: 335.1259; SFC Analysis: WO column, 5% 
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MeOH, 1.5 mL/min, 150 bar, 210 nm; tR (minor) = 9.3 min, tR (major) = 10.1 min, 98:2 
er; [α]D25 +30.6 (c = 5.6, CHCl3). 
(2R,3R)-Ethyl 2-hydroxy-5-(4-iodophenyl)-5-oxo-3-
phenylpentanoate (8b): The title compound was prepared 
according to General Procedure C using α,δ-diketo ester 7b (68.0 mg, 0.155 
mmol, 1.0 equiv), [RuCl2(p-cymene)]2 (1.9 mg, 0.0031 mmol, 0.02 equiv), 6 (7.5 
mg, 0.0124 mmol, 0.08 equiv), and HCOOH:NEt3 5:2 azeotrope (67 mg, 0.775 
mmol, 5.0 equiv). Flash chromatography (20% EtOAc/hexanes) provided δ-keto 
α-hydroxy ester 8b (62 mg, 0.141 mmol, 91% yield) as a white solid. Analytical 
data for 8b: 1H NMR (600 MHz, CDCl3): δ 7.84 (d, J = 8.4 Hz, 2H), 7.72 (d, J = 
8.4 Hz, 2H), 7.33-7.26 (m, 4H), 7.25-7.24 (m, 1H), 4.55 (dd, J = 6.0 Hz, 3.6 Hz, 
1H), 4.17-4.10 (m, 2H), 3.94 (ddd, J = 8.4 Hz, 6.0 Hz, 3.6 Hz, 1H), 3.73 (dd, J = 
18.0 Hz, 8.4 Hz, 1H), 3.40 (dd, J = 18.0 Hz, 6.0 Hz, 1H), 2.93 (d, J = 6.0 Hz, 1H), 
1.26 (t, J = 7.2 Hz, 3H); 13C NMR (150 MHz, CDCl3): δ 197.6, 173.5, 138.7, 137.9, 
136.2, 129.4, 128.6, 128.3, 127.4, 101.2, 72.4, 61.8, 43.5, 40.3, 14.1; IR (thin film, 
cm-1): 3503, 3029, 2980, 2360, 1732, 1685, 1580, 1455, 1393, 1266, 1211, 1102, 
1058, 990, 813, 755, 702, 555; m.p. 153-155 °C; TLC (30% EtOAc/hexanes): Rf : 
0.42; HRMS (ESI): Calculated for [M+Na] C19H19INaO4: 461.0226, Found: 
461.0220; SFC Analysis: WO column, 5% MeOH, 1.5 mL/min, 150 bar, 210 nm; 
tR (minor) = 9.3 min, tR (major) = 10.1 min, 96:4 er; [α]D25 +34.3 (c = 12.5, CHCl3). 
(2R,3R)-Ethyl 2-hydroxy-5-(4-methoxyphenyl)-5-oxo-3-
phenylpentanoate (8b): The title compound was 
prepared according to General Procedure C using α,δ-diketo ester 7c (53.0 mg, 
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0.155 mmol, 1.0 equiv), [RuCl2(p-cymene)]2 (1.9 mg, 0.0031 mmol, 0.02 equiv), 6 
(7.5 mg, 0.0124 mmol, 0.08 equiv), and HCOOH:NEt3 5:2 azeotrope (67 mg, 
0.775 mmol, 5.0 equiv). Flash chromatography (20% EtOAc/hexanes) provided 
δ-keto α-hydroxy ester 8c (49.8 mg, 0.152 mmol, 94% yield) as a clear oil. 
Analytical data for 8c: 1H NMR (600 MHz, CDCl3): δ 8.01 (d, J = 8.4 Hz, 2H), 
7.34-7.24 (m, 5H), 6.95 (d, J = 8.4 Hz, 2H), 4.59 (dd, J = 6.0 Hz, 3.0 Hz, 1H), 
4.19-4.11 (m, 2H), 3.96 (ddd, J = 8.4 Hz, 6.0 Hz, 3.0 Hz, 1H), 3.89 (s, 3H), 3.74 
(dd, J = 18.0 Hz, 8.4 Hz, 1H), 3.40 (dd, J = 18.0 Hz, 6.0 Hz, 1H), 2.91 (d, J =6.0 
Hz, 1H), 1.26 (t, J = 7.2 Hz, 3H); 13C NMR (150 MHz, CDCl3): δ 196.8, 173.7, 
163.5, 139.0, 130.4, 130.0, 128.6, 128.3, 127.3, 113.7, 72.5, 61.8, 55.4, 43.7, 
39.9, 14.1; IR (thin film, cm-1): 3503, 2980, 2935, 2360, 1732, 1675, 1600, 1575, 
1510, 1455, 1419, 1369, 1259, 1214, 1171, 1103, 1025, 991, 832, 703, 554; TLC 
(30% EtOAc/hexanes): Rf : 0.30; HRMS (ESI): Calculated for [M+Na] 
C20H22NaO5: 365.1365, Found: 365.1364; SFC Analysis: WO column, 5% 
MeOH, 1.5 mL/min, 150 bar, 210 nm; tR (minor) = 9.3 min, tR (major) = 10.1 min, 96:4 
er; [α]D25 +47.2 (c = 2.7, CHCl3). 
(2R,3R)-Ethyl 2-hydroxy-5-oxo-3-phenylhexanoate (8d): The 
title compound was prepared according to General Procedure C 
using α,δ-diketo ester 7d (38.0 mg, 0.155 mmol, 1.0 equiv), [RuCl2(p-cymene)]2 
(1.9 mg, 0.0031 mmol, 0.02 equiv), 6 (7.5 mg, 0.0124 mmol, 0.08 equiv), and 
HCOOH:NEt3 5:2 azeotrope (67 mg, 0.775 mmol, 5.0 equiv). Flash 
chromatography (20% EtOAc/hexanes) provided δ-keto α-hydroxy ester 8d (33.0 
mg, 0.132 mmol, 85% yield) as a clear oil. Analytical data for 8d: 1H NMR (600 
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MHz, CDCl3): δ 7.28-7.27 (m, 2H), 7.24-7.23 (m, 3H), 4.48 (dd, J = 6.0 Hz, 3.0 Hz, 
1H), 4.14-4.07 (m, 2H), 3.72 (ddd, J = 8.4 Hz, 6.0 Hz, 3.0 Hz, 1H), 3.12 (dd, J = 
17.7 Hz, 7.8 Hz, 1H), 2.92 (dd, J = 17.7 Hz, 6.0 Hz, 1H), 2.83 (d, J = 6.0 Hz, 1H), 
2.16 (s, 3H), 1.24 (t, J = 7.2 Hz, 3H); 13C NMR (150 MHz, CDCl3): δ  207.0, 173.6, 
138.6, 128.6, 128.3, 127.4, 72.4, 61.8, 45.3, 43.3, 30.6, 14.1; IR (thin film, cm-1): 
3502, 2983, 2937, 1731, 1717, 1494, 1455, 1366, 1213, 1165, 1106, 1025, 864, 
758, 703, 542; TLC (30% EtOAc/hexanes): Rf : 0.22; HRMS (ESI): Calculated for 
[M+Na] C14H18NaO4: 273.1103, Found: 273.1107; SFC Analysis: AS column, 7% 
MeOH, 1.5 mL/min, 150 bar, 210 nm; tR (minor) = 6.4 min, tR (major) = 9.2 min, 93:7 
er; [α]D25 +47.2 (c = 2.7, CHCl3). 
(2R,3R,E)-Ethyl 2-hydroxy-5-oxo-3,7-diphenylhept-6-
enoate (8e): The title compound was prepared according to 
General Procedure C using α,δ-diketo ester 7e (52.1 mg, 0.155 mmol, 1.0 equiv), 
[RuCl2(p-cymene)]2 (1.9 mg, 0.0031 mmol, 0.02 equiv), 6 (7.5 mg, 0.0124 mmol, 
0.08 equiv), and HCOOH:NEt3 5:2 azeotrope (67 mg, 0.775 mmol, 5.0 equiv). 
Flash chromatography (20% EtOAc/hexanes) provided δ-keto α-hydroxy ester 8e 
(46.0 mg, 0.136 mmol, 88% yield) as a white solid. Analytical data for 8e: 1H 
NMR (600 MHz, CDCl3): δ 7.62, (d, J = 16.2 Hz, 1H), 7.57-7.55 (m, 2H), 7.43-
7.41 (m, 3H), 7.33-7.29 (m, 4H), 7.27-7.24 (m, 1H), 6.76 (d, J = 16.2 Hz, 1H), 
4.56 (dd, J = 6.0 Hz, 3.0 Hz, 1H), 4.19-4.11 (m, 2H), 3.88 (ddd, J = 8.4 Hz, 6.0 
Hz, 3.0 Hz, 1H), 3.47 (dd, J = 17.4 Hz, 8.4 Hz, 1H), 3.19 (dd, J = 17.4 Hz, 6.0 Hz, 
1H), 2.94 (d, J = 6.0 Hz, 1H), 1.26 (t, J = 7.2 Hz, 3H); 13C NMR (150 MHz, 
CDCl3): δ 198.3, 173.6, 143.0, 138.8, 134.4, 130.5, 128.9, 128.6, 128.3, 128.3, 
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127.3, 126.4, 72.5, 61.8, 43.7, 42.5, 14.1; IR (thin film, cm-1): 3503, 1733, 1684, 
1655, 1610, 1576, 1495, 1450, 1259, 1210, 1176, 1096, 1024, 976, 749, 703, 
554; TLC (30% EtOAc/hexanes): Rf : 0.33; HRMS (ESI): Calculated for [M+Na] 
C21H22NaO4: 361.1416, Found: 361.1416; SFC Analysis: WO column, 5% 
MeOH, 1.5 mL/min, 150 bar, 210 nm; tR (minor) = 15.0 min, tR (major) = 16.1 min, 99:1 
er; [α]D25 +47.3 (c = 5.3, CHCl3). 
(2R,3R)-Ethyl 5-(benzo[d][1,3]dioxol-5-yl)-2-hydroxy-5-
oxo-3-phenylpentanoate (8f): The title compound was 
prepared according to General Procedure C using α,δ-diketo ester 7f (55.0 mg, 
0.155 mmol, 1.0 equiv), [RuCl2(p-cymene)]2 (1.9 mg, 0.0031 mmol, 0.02 equiv), 6 
(7.5 mg, 0.0124 mmol, 0.08 equiv), and HCOOH:NEt3 5:2 azeotrope (67 mg, 
0.775 mmol, 5.0 equiv). Flash chromatography (20% EtOAc/hexanes) provided 
δ-keto α-hydroxy ester 8f (54.0 mg, 0.152 mmol, 98% yield) as a clear oil. 
Analytical data for 8f: 1H NMR (600 MHz, CDCl3): δ 7.65 (dd, J = 8.4 Hz, 1.8 Hz, 
1H), 7.48 (d, J = 1.8 Hz, 1H), 7.33-7.28 (m, 4H), 7.25-7.24 (m, 1H), 6.87 (d, J 
=8.4 Hz, 1H), 6.06 (s, 2H), 4.58 (dd, J = 6.0 Hz, 3.0 Hz, 1H), 4.26-4.05 (m, 2H), 
3.94 (ddd, J = 8.4 Hz, 6.0 Hz, 3.0 Hz, 1H), 3.71 (dd, J = 18.0 Hz, 8.4 Hz, 1H), 
3.37 (dd, J = 18.0 Hz, 6.0 Hz, 1H), 2.89 (d, J = 6.0 Hz, 1H) 1.26 (t, J = 7.2 Hz, 
3H); 13C NMR (150 MHz, CDCl3): δ 196.3, 173.7, 151.8, 148.2, 139.0, 131.9, 
128.6, 128.3, 127.3, 124.4, 107.9, 107.8, 101.8, 72.5, 61.8, 43.8, 40.1, 14.1; IR 
(thin film, cm-1): 3503, 2980, 1731, 1684, 1597, 1492, 1448, 1413, 1365, 1266, 
1212, 1095, 1015, 785, 690, 546; TLC (30% EtOAc/hexanes): Rf : 0.28; HRMS 
(ESI): Calculated for [M+Na] C20H20NaO6: 379.1158, Found: 379.1161; SFC 
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Analysis: WO column, 5% MeOH, 1.5 mL/min, 150 bar, 210 nm; tR (minor) = 15.2 
min, tR (major) = 16.3 min, 99:1 er; [α]D25 +32.9 (c = 10.0, CHCl3). 
(2R,3R)-Ethyl 3-(4-chlorophenyl)-2-hydroxy-5-oxo-5-
phenylpentanoate (8g): The title compound was prepared 
according to General Procedure C using α,δ-diketo ester 7g 
(53.0 mg, 0.155 mmol, 1.0 equiv), [RuCl2(p-cymene)]2 (1.9 mg, 0.0031 mmol, 
0.02 equiv), 6 (7.5 mg, 0.0124 mmol, 0.08 equiv), and HCOOH:NEt3 5:2 
azeotrope (67 mg, 0.775 mmol, 5.0 equiv). Flash chromatography (20% 
EtOAc/hexanes) provided δ-keto α-hydroxy ester 8g (50.0 mg, 0.146 mmol, 94% 
yield) as a clear oil. Analytical data for 8g: 1H NMR (600 MHz, CDCl3): δ 7.98 (d,  
J = 7.2 Hz, 2H), 7.58-7.55 (m, 1H), 7.47-7.44 (m, 2H), 7.26 (d, J = 8.4 Hz, 2H), 
7.24 (d, J = 8.4 Hz, 2H), 4.55 (dd, J = 5.4 Hz, 3.0 Hz, 1H), 4.17-4.10 (m, 2H), 
3.93 (ddd, J = 7.8 Hz, 6.6 Hz, 3.0 Hz, 1H), 3.70 (dd, J = 18.0 Hz, 7.8 Hz, 1H), 
3.43 (dd, J = 18.0 Hz, 6.6 Hz, 1H), 2.91 (d, J = 5.4 Hz, 1H), 1.24 (t, J = 7.2 Hz, 
3H); 13C NMR (150 MHz, CDCl3): δ 197.3, 173.5, 137.5, 136.8, 133.3, 133.2, 
130.0, 128.6, 128.4, 128.0, 72.4, 62.0, 43.0, 40.5, 14.2; IR (thin film, cm-1): 3503, 
2982, 2905, 1733, 1676, 1603, 1504, 1489, 1443, 1367, 1256, 1097, 1037, 933, 
808, 757, 703, 556; TLC (30% EtOAc/hexanes): Rf : 0.38; HRMS (ESI): 
Calculated for [M+Na] C19H19ClNaO6: 369.0870, Found: 369.0873; SFC 
Analysis: OD column, 10% MeOH, 1.5 mL/min, 150 bar, 210 nm; tR (minor) = 8.8 
min, tR (major) = 9.8 min, 98:2 er; [α]D25 +48.4 (c = 4.2, CHCl3). 
(2R,3R)-Ethyl 2-hydroxy-3-(4-methoxyphenyl)-5-oxo-5-
phenylpentanoate (8h): The title compound was prepared 
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according to General Procedure C using α,δ-diketo ester 7h (53.0 mg, 0.155 
mmol, 1.0 equiv), [RuCl2(p-cymene)]2 (1.9 mg, 0.0031 mmol, 0.02 equiv), 6 (7.5 
mg, 0.0124 mmol, 0.08 equiv), and HCOOH:NEt3 5:2 azeotrope (67 mg, 0.775 
mmol, 5.0 equiv). Flash chromatography (20% EtOAc/hexanes) provided δ-keto 
α-hydroxy ester 8h (52.0 mg, 0.152 mmol, 98% yield) as a clear oil. Analytical 
data for 8h: 1H NMR (600 MHz, CDCl3): δ 7.99 (d, J = 7.2 Hz, 2H), 7.57-7.54 (m, 
1H), 7.46-7.44 (m, 2H), 7.22 (d, J = 8.4 Hz, 2H), 6.80 (d, J = 8.4 Hz, 2H), 4.54 
(dd,  J = 6.0 Hz, 3.0 Hz, 1H), 4.17-4.09 (m, 2H), 3.90 (ddd, J = 8.4 Hz, 6.0 Hz, 
3.0 Hz, 1H), 3.76 (s, 3H), 3.71 (dd, J = 18.0 Hz, 8.4 Hz, 1H), 3.41 (dd, J = 18.0 
Hz, 6.0 Hz, 1H), 2.86 (d, J = 6.0 Hz, 1H), 1.25 (t, J = 7.2 Hz, 3H); 13C NMR (150 
MHz, CDCl3): δ 198.4, 173.7, 158.7, 137.0, 133.1, 130.9, 128.6, 128.1, 113.7, 
72.7, 61.8, 55.1, 42.8, 40.6, 14.2; IR (thin film, cm-1): 3502, 2935, 1731, 1683, 
1612, 1597, 1580, 1514, 1448, 1366, 1251, 1180, 1100, 1032, 837, 757, 691; 
TLC (30% EtOAc/hexanes): Rf : 0.33; HRMS (ESI): Calculated for [M+Na] 
C20H22NaO5: 365.1365, Found: 365.1366; SFC Analysis: AD column, 10% 
MeOH, 1.5 mL/min, 150 bar, 210 nm; tR (minor) = 13.2 min, tR (major) = 16.8 min, 96:4 
er; [α]D25 +34.6 (c = 6.3, CHCl3). 
(2R,3R)-Ethyl 2-hydroxy-5-oxo-5-phenyl-3-(o-tolyl)pentanoate 
(8i): The title compound was prepared according to General 
Procedure C using α,δ-diketo ester 7i (50.0 mg, 0.155 mmol, 1.0 
equiv), [RuCl2(p-cymene)]2 (1.9 mg, 0.0031 mmol, 0.02 equiv), 6 (7.5 mg, 0.0124 
mmol, 0.08 equiv), and HCOOH:NEt3 5:2 azeotrope (67 mg, 0.775 mmol, 5.0 
equiv). Flash chromatography (20% EtOAc/hexanes) provided δ-keto α-hydroxy 
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ester 8i (44.0 mg, 0.135 mmol, 87% yield) as a clear oil. Analytical data for 8i: 1H 
NMR (600 MHz, CDCl3): δ 7.97 (d, J = 6.6 Hz, 2H), 7.56-7.51 (m, 2H), 7.46-7.43 
(m, 2H), 7.15-7.08 (m, 3H), 4.63 (d, J = 4.2 Hz, 1H), 4.24 (ddd, J = 7.8 Hz, 6.0 Hz, 
4.2 Hz, 1H), 4.14-4.08 (m, 1H), 4.01-3.95 (m, 1H), 3.72 (dd, J = 18.0 Hz, 7.8 Hz, 
1H), 3.36 (dd, J = 18.0 Hz, 6.0 Hz, 1H), 3.03 (bs, 1H), 2.41 (s, 3H), 1.12 (t, J = 
7.2 Hz, 3H); 13C NMR (150 MHz, CDCl3): δ 198.5, 173.9, 138.2, 136.8, 136.2, 
133.2, 130.4, 128.6, 128.1, 127.5, 126.9, 126.0, 72.4, 61.8, 41.3, 40.9, 37.7, 19.8, 
13.8; IR (thin film, cm-1): 3495, 2980, 1732, 1624, 1597, 1490, 1448, 1365, 1259, 
1216, 1115, 1094, 1022, 754, 730, 690; TLC (30% EtOAc/hexanes): Rf : 0.40; 
HRMS (ESI): Calculated for [M+Na] C20H22NaO4: 349.1416, Found: 349.1422; 
SFC Analysis: AD column, 10% MeOH, 1.5 mL/min, 150 bar, 210 nm; tR (minor) = 
14.6 min, tR (major) = 11.6 min, 83:17 er; [α]D25 +1.9 (c = 2.7, CHCl3). 
(2R,3R)-Ethyl 2-hydroxy-5-oxo-5-phenyl-3-(m-
tolyl)pentanoate (8j): The title compound was prepared 
according to General Procedure C using α,δ-diketo ester 7j (50.0 
mg, 0.155 mmol, 1.0 equiv), [RuCl2(p-cymene)]2 (1.9 mg, 0.0031 mmol, 0.02 
equiv), 6 (7.5 mg, 0.0124 mmol, 0.08 equiv), and HCOOH:NEt3 5:2 azeotrope (67 
mg, 0.775 mmol, 5.0 equiv). Flash chromatography (20% EtOAc/hexanes) 
provided δ-keto α-hydroxy ester 8j (49.0 mg, 0.152 mmol, 98% yield) as a clear 
oil. Analytical data for 8j: 1H NMR (600 MHz, CDCl3): δ 8.00 (d, J = 8.4 Hz, 2H), 
7.57-7.55 (m, 1H), 7.47-7.44 (m, 2H), 7.17-7.15 (m, 1H), 7.11-7.08 (m, 1H), 7.04-
7.03 (m, 1H), 4.56 (dd, J = 6.0 Hz, 3.0 Hz, 1H), 4.15-4.11 (m, 2H), 3.91 (ddd, J = 
8.4 Hz, 5.4 Hz, 3.0 Hz, 1H), 3.76 (dd, J = 18.0 Hz, 8.4 Hz, 1H), 3.42 (dd, J = 18.0 
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Hz, 5.4 Hz, 1H), 2.85 (d, J = 6 Hz, 1H), 2.31 (s, 3H), 1.24 (t, J = 7.2 Hz, 3H); 13C 
NMR (150 MHz, CDCl3): δ 198.3, 173.7, 138.8, 137.8, 137.0, 133.1, 129.4, 128.6, 
128.2, 128.1, 128.1, 125.6, 72.5, 61.7, 43.6, 40.3, 21.4, 14.1; IR (thin film, cm-1): 
3505, 2980, 2922, 1733, 1685, 1597, 1448, 1365, 1265, 1207, 1104, 1023, 1001, 
757, 709, 691; TLC (30% EtOAc/hexanes): Rf : 0.43; HRMS (ESI): Calculated for 
[M+Na] C20H22NaO4: 349.1416, Found: 349.1419; SFC Analysis: AD column, 
10% MeOH, 1.5 mL/min, 150 bar, 210 nm; tR (minor) = 9.6 min, tR (major) = 7.9 min, 
98:2 er; [α]D25 +22.6 (c = 9.0, CHCl3). 
(2R,3R)-Ethyl 2-hydroxy-5-oxo-5-phenyl-3-(p-
tolyl)pentanoate (8k): The title compound was prepared 
according to General Procedure C using α,δ-diketo ester 7k (50.0 
mg, 0.155 mmol, 1.0 equiv), [RuCl2(p-cymene)]2 (1.9 mg, 0.0031 mmol, 0.02 
equiv), 6 (7.5 mg, 0.0124 mmol, 0.08 equiv), and HCOOH:NEt3 5:2 azeotrope (67 
mg, 0.775 mmol, 5.0 equiv). Flash chromatography (20% EtOAc/hexanes) 
provided δ-keto α-hydroxy ester 8k (48.0 mg, 0.151 mmol, 97% yield) as a clear 
oil. Analytical data for 8k: 1H NMR (600 MHz, CDCl3): δ 7.99 (d, J = 7.8 Hz, 2H), 
7.57-7.54 (m, 1H), 7.47-7.44 (m, 2H), 7.19 (d, J = 7.8 Hz, 2H), 7.08 (d, J = 7.8 Hz, 
2H), 4.55 (dd, J = 6.0 Hz, 3.0 Hz, 1H), 4.17-4.09 (m, 2H), 3.91 (ddd, J = 8.4 Hz, 
6.0 Hz, 3.0 Hz, 1H), 3.74 (dd, J = 18.0 Hz, 8.4 Hz, 1H), 3.42 (dd, J = 18.0 Hz, 6.0 
Hz, 1H), 2.85 (d, J = 6.0 Hz, 1H), 2.29 (s, 3H), 1.25 (t, J = 7.2 Hz, 3H); 13C NMR 
(150 MHz, CDCl3): δ 198.3, 173.7, 137.0, 136.8, 135.8, 133.1, 129.0, 128.5, 
128.4, 128.1, 72.6, 61.7, 43.2, 40.4, 21.0, 14.1; IR (thin film, cm-1): 3509, 2981, 
2923, 1731, 1684, 1597, 1515, 1448, 1336, 1265, 1210, 1100, 1022, 757, 691, 
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550; TLC (30% EtOAc/hexanes): Rf : 0.43; HRMS (ESI): Calculated for [M+Na] 
C20H22NaO4: 349.1416, Found: 349.1422; SFC Analysis: AD column, 10% 
MeOH, 1.5 mL/min, 150 bar, 210 nm; tR (minor) = 12.8 min, tR (major) = 10.6 min, 98:2 
er; [α]D25 +32.1 (c = 8.0, CHCl3). 
(2R,3S)-Diethyl 2-hydroxy-3-(2-oxo-2-phenylethyl)succinate 
(8l): The title compound was prepared according to General 
Procedure C using α,δ-diketo ester 7l (47.0 mg, 0.155 mmol, 1.0 
equiv), [RuCl2(p-cymene)]2 (1.9 mg, 0.0031 mmol, 0.02 equiv), 6 (7.5 mg, 0.0124 
mmol, 0.08 equiv), and HCOOH:NEt3 5:2 azeotrope (67 mg, 0.775 mmol, 5.0 
equiv). Flash chromatography (20% EtOAc/hexanes) provided δ-keto α-hydroxy 
ester 8l (44.0 mg, 0.144 mmol, 93% yield) as a clear oil. Analytical data for 8l: 1H 
NMR (600 MHz, CDCl3): δ 8.00 (d,  J = 7.2 Hz, 2H), 7.60-7.56 (m, 1H), 7.49-7.46 
(m, 2H), 4.37 (d, J = 2.8 Hz, 1H), 4.33-4.28 (m, 2H), 4.21-4.11 (m, 2H), 3.79 (ddd, 
J = 8.4 Hz, 5.6 Hz, 8.4 Hz, 1H), 3.71 (dd, J = 18.0 Hz, 8.4 Hz, 1H), 3.25 (dd, J = 
18.0 Hz, 5.6 Hz, 1H), 3.19 (bs 1H), 1.34 (t, J = 7.2 Hz, 3H), 1.21 (t, J = 7.2 Hz, 
3H); 13C NMR (150 MHz, CDCl3): δ 197.7, 173.3, 171.2, 136.6, 133.4, 128.6, 
128.1, 70.9, 62.2, 61.2, 44.1, 36.7, 14.1, 14.0; IR (thin film, cm-1): 3487, 2982, 
1734, 1685, 1449, 1366, 1226, 1180, 1111, 1032, 861, 759, 691; TLC (30% 
EtOAc/hexanes): Rf : 0.23; HRMS (ESI): Calculated for [M+Na] C16H20NaO6: 
331.1158, Found: 338.1165; SFC Analysis: AD column, 10% MeOH, 1.5 mL/min, 
150 bar, 210 nm; tR (minor) = 7.3 min, tR (major) = 6.5 min, 91:9 er; [α]D25 +27.5 (c = 
4.2, CHCl3). 
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(2R,3R)-Ethyl 3-(benzo[d][1,3]dioxol-5-yl)-2-hydroxy-5-oxo-5-
phenylpentanoate (8m): The title compound was prepared 
according to General Procedure C using α,δ-diketo ester 7m 
(55.0 mg, 0.155 mmol, 1.0 equiv), [RuCl2(p-cymene)]2 (1.9 mg, 0.0031 mmol, 
0.02 equiv), 6 (7.5 mg, 0.0124 mmol, 0.08 equiv), and HCOOH:NEt3 5:2 
azeotrope (67 mg, 0.775 mmol, 5.0 equiv). Flash chromatography (20% 
EtOAc/hexanes) provided δ-keto α-hydroxy ester 8m (53.0 mg, 0.149 mmol, 96% 
yield) as a clear oil. Analytical data for 8m: 1H NMR (600 MHz, CDCl3): δ 7.99 (d, 
J = 7.2 Hz, 2H), 7.57-7.55 (m, 1H), 7.47-7.44 (m, 2H), 6.84 (s, 1H), 6.74-6.73 (m, 
1H), 6.70-6.69 (m, 1H), 5.91 (s, 2H), 4.52 (dd, J = 6.0 Hz, 3.0 Hz, 1H), 4.21-4.10 
(m, 2H), 3.87 (ddd, J = 8.4 Hz, 6.0 Hz, 3.0 Hz, 1H), 3.67 (dd, J = 18.0 Hz, 8.4 Hz, 
1H), 3.41 (dd, J = 18.0 Hz, 6.0 Hz, 1H), 2.89 (d, J = 6.0 Hz, 1H), 1.26 (t, J = 7.2 
Hz, 3H); 13C NMR (150 MHz, CDCl3): δ 198.2, 173.7, 147.5, 146.7, 136.9, 133.2, 
132.6, 128.6, 128.1, 121.9, 109.0, 108.0, 100.9, 72.6, 61.8, 43.2, 40.6, 14.2; IR 
(thin film, cm-1): 3503, 2982, 2902, 1733, 1684, 1504, 1487, 1446, 1239, 1098, 
1038, 933, 811, 759, 690; TLC (30% EtOAc/hexanes): Rf : 0.28; HRMS (ESI): 
Calculated for [M+Na] C20H20NaO6: 379.1158, Found: 379.1162; SFC Analysis: 
AD column, 10% MeOH, 1.5 mL/min, 150 bar, 210 nm; tR (minor) = 16.5 min, tR 
(major) = 12.8 min, 98:2 er; [α]D25 +30.8 (c = 7.0, CHCl3). 
Tert-butyl 3-((2R,3R)-1-ethoxy-2-hydroxy-1,5-dioxo-5-
phenylpentan-3-yl)-1H-indole-1-carboxylate (8n): The title 
compound was prepared according to General Procedure C 
using α,δ-diketo ester 7n (70.0 mg, 0.155 mmol, 1.0 equiv), [RuCl2(p-cymene)]2 
75 
(1.9 mg, 0.0031 mmol, 0.02 equiv), 6 (7.5 mg, 0.0124 mmol, 0.08 equiv), and 
HCOOH:NEt3 5:2 azeotrope (67 mg, 0.775 mmol, 5.0 equiv). Flash 
chromatography (20% EtOAc/hexanes) provided a-hydroxy ester 8n (60.0 mg, 
0.133 mmol, 86% yield) as a clear oil. Analytical data for 8n: 1H NMR (400 MHz, 
CDCl3) δ 8.09-8.07 (m, 1H), 8.00-7.98 (m, 2H), 7.68-7.66 (m, 1H), 7.58-7.54 (m, 
2H), 7.47-7.44 (m, 2H), 7.31-7.26 (m, 1H), 7.25-7.21 (m, 1H), 4.62 (dd, J = 6.0 
Hz, 2.8 Hz, 1H), 4.32 (ddd, J = 8.4 Hz, 6.0 Hz, 2.8 Hz, 1H), 4.09-4.01 (m, 2H), 
3.81 (dd, J = 18.0 Hz, 8.4 Hz, 1H), 3.42 (dd, J = 18.0 Hz, 6.0 Hz, 1H), 3.09 (d,  J 
= 6.0 Hz, 1H), 1.67 (s, 9H), 1.15 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3): 
δ 198.2, 173.4, 136.8, 133.2, 130.0, 128.6, 128.1, 124.4, 124.0, 122.3, 119.3, 
118.2, 115.2, 83.7, 71.7, 61.9, 41.0, 34.5, 28.2, 13.9; IR (thin film, cm-1): 3502, 
2979, 2932, 1732, 1685, 1452, 1375, 1309, 1256, 1217, 1157, 1107, 1090, 1020, 
856, 765, 749, 690; TLC (30% EtOAc/hexanes): Rf : 0.40; HRMS (ESI): 
Calculated for [M+Na] C26H29NNaO6: 474.1893, Found: 474.1899; SFC 
Analysis: AD column, 10% MeOH, 1.5 mL/min, 150 bar, 210 nm; tR (minor) = 29.4 
min, tR (major) = 23.5 min, 98:2 er; [α]D25 +21.5 (c = 8.7, CHCl3). 
2.4.5 Baeyer-Villiger Oxidation of 8c 
 
To a 1-dram vial equipped with a magnetic stir bar were added 8c (34.2 
mg, 0.100 mmol, 1.0 equiv), m-CPBA (86.3 mg, 0.500 mmol, 5.0 equiv), TFA 
(11.4 mg, 0.100 mmol, 1.0 equiv) and CH2Cl2 (1 mL). The reaction was stirred at 
room temperature overnight and then diluted with water and ethyl acetate. The 
EtO
O
OH
Ph O
OMe
m-CPBA, TFA
CH2Cl2, rt
72%
EtO
O
O
Ph
O13c 14
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organic was washed with water followed by brine, dried over sodium sulfate and 
concentrated in vacuo. Flash chromatography provided 14 (17.0 mg, 0.072 mmol, 
72% yield) as a white solid whose spectral data, including [α]D25, were in 
agreement with the known cis-lactone.4 
2.4.6 Preparation of m-Terphenyl Sulfonyl Chloride4 
 
 To a flame-dried 50-mL round-bottomed flask equipped with a magnetic 
stir bar and rubber septum were added 1,3-dichlorobenezne (1.47 g, 10.0 mmol, 
1.0 equiv) and THF (25 mL). The solution was cooled to -78 ºC and nBuLi (1.6 M 
in hexanes, 11.0 mmol, 1.1 equiv) was added dropwise over 10 min. The 
resultant white slurry was stirred at -78 ºC for 1.5 hrs. While being kept at -78 ºC, 
this reaction mixture was then added to a room temperature solution of 
phenylmagnesium bromide [prepared from bromobenzene (3.14 g, 20.0 mmol, 
2.0 equiv) and magnesium (578 mg, 24.0 mmol, 2.4 equiv)] in 30 mL of THF via 
cannula. The mixture was heated at reflux overnight, cooled to ambient 
temperature, and then to -78 ºC. Sulfuryl chloride (1 M in CH2Cl2, 20.0 mmol, 2.0 
equiv) was added via syringe in a single portion and the reaction was warmed 
slowly to room temperature overnight. After being cooled to 0 ºC, the reaction 
mixture was diluted with 1 M HCl and extracted three times with diethyl ether. 
The combined organic extracts were washed with brine, dried over sodium 
sulfate and concentrated in vacuo. The crude brown solid was recrystallized from 
Cl Cl 1) nBuLi, -78 °C, THF
2) PhMgBr, -78 °C to reflux
3) SO2Cl2, -78 °C to rt
SO2Cl
PhPh
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hexanes and CHCl3 to give the desired sulfonyl chloride (2.0 g, 6.1 mmol, 61% 
yield) whose spectral properties matched those reported in the literature.4 
2.4.6 Preparation of 64 
 
 
A 10-mL round-bottomed flask equipped with a magnetic stir bar was charged 
with (1S,2S)-1,2-di(1-naphthyl)-1,2-ethanediamine dihydrochloride (250 mg, 
0.649 mmol, 1.0 equiv). Dichloromethane (3 mL) and 2 M NaOH (3 mL) were 
added sequentially and the biphashic mixture was cooled to 0 ºC. m-Terphenyl 
sulfonyl chloride4 (213 mg, 0.649 mmol, 1.0 equiv) was added and the reaction 
was warmed to room temperature and stirred for 3 h. The reaction mixture was 
diluted with ethyl acetate and water. The organic was washed with brine, dried 
over sodium sulfate and concentrated in vacuo. Flash chromatography (50% 
EtOAc/hexanes) provided 6 (330 mg, 0.545 mmol, 84% yield) as a white solid. 
Analytical data for 6: 1H NMR (400 MHz, CDCl3): δ 8.07 (d, J = 8.0 Hz, 1H), 7.78 
(d, J = 8.0 Hz, 1H), 7.74 (d, J = 7.6 Hz, 1H), 7.72-7.67 (m, 2H), 7.66-7.02 (m, 
20H), 6.97 (bs, 1H), 6.72 (bs, 1H), 5.57 (d, J = 6.4 Hz, 1H), 4.95 (d, J = 7.6 Hz), 
4.68 (bs, 1H), 1.75 (bs, 2H); 13C NMR (100 MHz, CDCl3): δ 141.9, 140.9, 139.7, 
137.8, 135.3, 133.8, 133.6, 131.6, 131.0, 130.7, 130.0, 129.2, 128.8, 128.6, 
128.2, 127.9, 127.7, 127.7, 126.1, 126.0, 125.4, 125.3, 125.1, 125.0, 124.3, 
123.6, 122.9, 122.4; IR (thin film, cm-1): 2926, 2357, 1868, 1716, 1608, 1541, 
HN
H2N
O2S
⋅
•  2 HCl
SO2Cl
PhPh
2 M NaOH, CH2Cl2
0 °C to rt, 3 h
6
H2N
H2N
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1507, 1456, 1338, 1158, 1028, 929, 778, 759, 700, 664, 592, 529; m.p. 158-160 
ºC; TLC (50% EtOAc/hexanes) Rf : 0.25; LRMS (ESI): Calculated for [M+H]+ 
C40H33N2O2S: 605.23, Found: 605.29; [α]D25 +170.6 (c = 1.30, CHCl3
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2.5 Experimental Data and Conditions for the Asymmetric Synthesis of anti-
β-Amino-α-Hydroxy Esters via Dynamic Kinetic Resolution of β-Amino-α-
Keto Esters‡‡4 
2.5.1 General Information: 
 Methods: Infrared (IR) spectra were obtained using a Jasco 260 Plus 
fourier transform infrared spectrometer. Proton and carbon magnetic resonance 
spectra (1H NMR and 13C NMR) were recorded on a Bruker model DRX 400 or 
600 (1H NMR at 400 MHz or 600 MHz and 13C NMR at 100 MHz or 150 MHz) 
spectrometer with solvent resonance as the internal standard (1H NMR: CDCl3 at 
7.26 ppm and DMSO at 2.54; 13C NMR: CDCl3 at 77.0 ppm and DMSO at 40.45). 
1H NMR data are reported as follows: chemical shift, multiplicity (s = singlet, bs = 
broad singlet, d = doublet, dd = doublet of doublet, t = triplet, dt= doublet of triplet, 
q = quartet, m = multiplet), coupling constants (Hz), and integration. Supercritical 
fluid chromatography was performed on a Berger SFC system equipped with 
Chiracel AD, AS, OD, and WO columns (φ 4.6 mm x 250 mm). Samples were 
eluted with SFC grade CO2 at the indicated percentage of methanol with an oven 
temperature of 40 °C. HPLC analysis was performed on an Agilent Technologies 
1200 system equipped with Chiralpak IA, IB, and IC columns (constant flow at 
1.00 mL/min). Samples were eluted with the indicated percentages of HPLC 
grade isopropanol in hexanes. Optical rotations were measured using a 2 mL cell 
with a 1 dm path length on a Jasco DIP 1000 digital polarimiter. Mass spectra 
were obtained using a Finnigan linear trap quadrapole Fourier transform (LTQ-
FT) spectrometer. Analytical thin layer chromatography (TLC) was performed on 
                                         
‡‡Reproduced in part by permission of the American Chemical Society: Goodman, C.G.; Do, D. T.; Johnson J. S. Org 
Lett, 2013, 15, 2446-2449.  
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Sorbtec 0.25 mm silica gel 60 plates. Visualization was accomplished with UV 
light and/or either butanolic ninhydrin or aqueous ceric ammonium molybdate 
solution followed by heating. Product purification was accomplished using 
Siliaflash-P60 silica gel (40-63 µm) purchased from Silicycle. Unless otherwise 
noted all reactions were carried out under an atmosphere of nitrogen in flame-
dried glassware with magnetic stirring. Yields and diastereomeric ratios (dr) are 
reported for a specific experiment and as a result may differ slightly from those 
found in the reported tables, which represent an average of at least two trials.
Materials: Amido sulfones 1a-b,54,55 NHC catalyst 2,11 ligands for 
complexes 5-7,4,21 epoxide 9,59 ethyl diazoacetate,60 tert-butyl carbamate61, 4-
(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde,62 tert-butyl 2-formyl-
1H-indole-1-carboxylate63 were all prepared according to literature procedures. 
Ethyl glyoxylate was purchased from Sigma Aldrich as a 50% solution in toluene 
and distilled under reduced pressure prior to use (the concentration after 
distillation was determined by 1H NMR spectroscopy). N,N-Dimethylformamide 
(DMF) was distilled from phosphorous pentoxide and stored over 3 Å molecular 
sieves under an atmosphere of N2. Dimethyl sulfoxide (DMSO) was distilled from 
calcium hydride and stored over 3 Å molecular sieves under an atmosphere of N2. 
Triethylamine (Et3N) was distilled from calcium hydride prior to use. Acetonitrile 
(CH3CN) was distilled from calcium hydride prior to use. Methanol (MeOH) was 
distilled from 3 Å molecular sieves prior to use. HPLC grade chloroform (CHCl3) 
and ethanol (EtOH) were used directly from the bottle. Dichloromethane (DCM) 
and tetrahydrofuran (THF) were passed through a column of neutral alumina 
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under nitrogen prior to use. All other reagents were purchased from commercial 
sources and were used as received unless otherwise noted.  
2.5.2 General Procedure A for the Preparation of Amido Sulfones 41c-41o 
 
Method 1: 
A 50 mL round-bottomed flask equipped with a magnetic stir bar was 
charged with aldehyde (10.0 mmol, 1 equiv), carbamate (10.0 mmol, 1 equiv), 
and THF (3.5 mL). To this solution was added H2O (10 mL) and benzene sulfinic 
acid-sodium salt (10.0 mmol, 1 equiv). Formic acid (90% in H2O) was added (50 
mmol, 5.0 equiv). The reaction was stirred at room temperature for 48 hours then 
diluted with DCM and water. The organic layer was separated, and the aqueous 
layer was extracted with DCM (2 x 30 mL). The combined organic extracts were 
dried over Na2SO4, filtered and concentrated in vacuo. The crude residue was 
stirred as a suspension in 20% Et2O/Hexanes for 1 hour. Filtration with 20% 
Et2O/Hexanes provided analytically pure amido sulfones.  
Method 2: 
A 50 mL round-bottomed flask equipped with a magnetic stir bar was 
charged with aldehyde (10.0 mmol, 1 equiv), carbamate (10.0 mmol, 1 equiv), 
and DCM (10.0 mL). To this solution was added H2O (10 mL) and benzene 
sulfinic acid-sodium salt (10.0 mmol, 1 equiv). Formic acid (90% in H2O) was 
added last (50 mmol, 5.0 equiv). The reaction was stirred at room temperature for 
48 hours then diluted with DCM and water. The organic layer was separated, and 
R1
O
H H2N
O
O
R2
NaSO2Ph (1.0 equiv)
HCO2H (5.0 equiv)
H2O/DCM, rt
+
R1 SO2Ph
HN O
O
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the aqueous layer was extracted with DCM (2 x 30 mL). The combined organic 
extracts were dried over Na2SO4, filtered and concentrated in vacuo. The crude 
residue was stirred as a suspension in 20% Et2O/Hexanes for 1 h. Filtration with 
20% Et2O/Hexanes provided analytically pure amido-sulfones.   
tert-Butyl ((phenylsulfonyl)(p-tolyl)methyl)carbamate (41c): 
The title compound was prepared according to General 
Procedure A (method 1) using para-tolualdehyde (10.0 mmol) affording amido-
sulfone 41c (2.06 g, 5.7 mmol, 57% yield) as a white solid. Analytical data for 
41c: mp 175-175.6 °C; 1H NMR (400 MHz, CDCl3): δ 7.93-7.91 (d, J = 7.6 Hz, 
2H), 7.63-7.62 (m, 1H), 7.55-7.51 (t, J = 7.6 Hz, 2H), 7.34-7.32 (d, J = 7.6 Hz, 
2H), 7.23-7.21 (d, J = 7.6 Hz, 2H), 5.91-5.88,  (d, J = 10.4 Hz, 1H), 5.79-5.76 (d, 
J = 10.4 Hz, 1H), 2.37 (s, 3 H), 1.24 (s, 9H); 13C NMR (100 MHz, CDCl3): δ 153.4, 
140.0, 137.0, 133.8, 129.4, 129.0, 128.7, 126.7, 81.1, 73.7, 27.9, 21.2; IR (thin 
film cm-1): 3357, 2980, 1699, 1506, 1446, 1367, 1308, 1246, 1165, 1142, 1084, 
603; TLC (25% EtOAc/hexanes): RF 0.41; HRMS (ESI): Calcd. for [M + H]+ 
C19H23NO4S: 362.1426, Found: 362.1406.  
 tert-Butyl ((phenylsulfonyl)(m-tolyl)methyl)carbamate (41d): 
The title compound was prepared according to General 
Procedure A (method 1) using meta-tolualdehyde (10.0 mmol) affording amido-
sulfone 41d (2.09 g, 5.8 mmol, 58% yield) as a white solid. Analytical data for 
41d: mp 169.8-170.0 °C; 1H NMR (400 MHz, CDCl3): δ 7.94-7.93 (d, J = 7.6 Hz, 
2H), 7.67-7.64 (m, 1H), 7.57-7.53 (m, 2H), 7.33-7.24 (m, 4H), 5.91-5.89,  (d, J = 
10.4 Hz, 1H), 5.78-5.76 (d, J = 10.4 Hz, 1H), 2.38 (s, 3 H), 1.26 (s, 9H); 13C NMR 
NHBoc
Me
SO2Ph
NHBoc
SO2Ph
Me
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(100 MHz, CDCl3): δ 138.6, 133.9, 130.7, 129.7, 129.5, 129.0, 128.6, 126.0, 81.2, 
73.9, 27.9, 21.4; IR (thin film cm-1): 3353, 2979, 1698, 1507, 1308, 1251, 1144, 
1082, 716, 690, 588; TLC (25% EtOAc/hexanes): RF 0.41; HRMS (ESI): Calcd. 
for [M + NH4]+ C19H23NO4S: 379.1692, Found: 379.1716.  
 tert-Butyl ((phenylsulfonyl)(o-tolyl)methyl)carbamate (41e): 
The title compound was prepared according to General Procedure 
A (method 1) using ortho-tolualdehyde (10.0 mmol) affording amido-sulfone 41e 
(2.17 g, 6.0 mmol, 60% yield) as a white solid. Analytical data for 41e: mp 141-
142 °C; 1H NMR (400 MHz, CDCl3): δ 7.94-7.92 (d, J = 7.2 Hz, 2H), 7.67-7.63 (t, 
J = 7.2 Hz, 1H), 7.57-7.52 (t, J = 7.6 Hz, 2H), 7.46-7.43 (d, J = 8.0 Hz, 1H), 7.33-
7.28 (m, 2H), 7.26-7.22 (m, 2H), 6.26-6.23 (d, J = 10.8 Hz, 1H), 5.74-5.71 (d, J = 
10.8 Hz, 1H), 2.45 (s, 3 H), 1.26 (s, 9H); 13C NMR (150 MHz, CDCl3): δ 153.5, 
138.2, 137.2, 133.9, 130.8, 129.7, 129.3, 129.1, 129.0, 127.5, 126.5, 81.1, 69.6, 
28.0, 19.7; IR (thin film cm-1): 3349, 2979, 1704, 1517, 1496, 1447, 1393, 1368, 
1248, 1163, 1083, 1046, 729; TLC (20% EtOAc/hexanes): RF 0.38; HRMS (ESI): 
Calcd. for [M + Na]+ C19H23NO4S: 384.1246, Found: 384.1243.  
tert-Butyl ((4-
methoxyphenyl)(phenylsulfonyl)methyl)carbamate (41f): 
The title compound was prepared according to General Procedure A (method 1) 
using para-anisaldehyde (10.0 mmol) affording amido-sulfone 41f (2.82 g, 7.48 
mmol, 75% yield) as a white solid. Analytical data for 41f: mp 115-116 °C; 1H 
NMR (400 MHz, CDCl3): δ 7.95-7.93 (d, J = 8.0 Hz, 2H), 7.68-7.65 (t, J = 7.6 Hz, 
1H), 7.58-7.54 (t, J = 7.6 Hz, 2H), 7.40-7.38 (d, J = 8.0 Hz, 2H), 6.98-6.96 (d, J = 
NHBoc
SO2Ph
Me
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8.0 Hz, 2H), 5.91-5.88,  (d, J = 10.4 Hz, 1H), 5.69-5.67 (d, J = 10.4 Hz, 1H), 3.86 
(s, 3 H), 1.28 (s, 9H); 13C NMR (150 MHz, CDCl3): δ163.7, 160.7, 153.5, 136.8, 
133.8, 130.2, 129.7, 129.4, 129.0, 128.8, 121.5, 114.3, 114.2, 81.1, 73.5, 55.3, 
55.3, 27.9; IR (thin film cm-1): 3356, 2963, 2840, 1698, 1610, 1541, 1507, 1447, 
1368, 1308, 1243, 1168, 1141, 1032, 839, 774; TLC (20% EtOAc/hexanes): RF 
0.45; HRMS (ESI): Calcd. for [M + Na]+ C19H23NO5S: 400.1195, Found: 400.1194.  
tert-Butyl ((4-
chlorophenyl)(phenylsulfonyl)methyl)carbamate (41g): The 
title compound was prepared according to General Procedure A (method 1) using 
para-chlorobenzaldehyde (10.0 mmol) affording amido-sulfone 41g (2.5 g, 6.5 
mmol, 65% yield) as a white solid. Analytical data for 41g: mp 171-173 °C; 1H 
NMR (400 MHz, CDCl3): δ 7.95-7.93 (d, J = 7.2 Hz, 2H), 7.71-7.67 (t, J = 8.4 Hz, 
1H), 7.60-7.56 (t, J = 7.2 Hz, 2H), 7.45-7.39 (m, 4H), 5.94-5.91 (d, J = 10.8 Hz, 
1H), 5.70-5.67 (d, J = 10.8 Hz, 1H), 1.29 (s, 9H); 13C NMR (150 MHz, CDCl3): δ 
153.4, 136.5, 136.1, 134.1, 130.2, 129.4, 129.1, 129.0, 128.3, 81.4, 73.1, 27.9; 
IR (thin film cm-1): 3340, 2979, 1698, 1520, 1491, 1368, 1308, 1249, 1143, 1083, 
1016, 731; TLC (20% EtOAc/hexanes): RF 0.35 HRMS (ESI): Calcd. for [M + 
Na]+ C18H20ClNO4S: 382.0880, Found: 382.0883.  
tert-Butyl (benzo[d][1,3]dioxol-5-yl(phenylsulfonyl)methyl)carbamate (41h): 
The title compound was prepared according to General 
Procedure A (method 1) using piperonal (10.0 mmol) affording 
amido-sulfone 41h (2.50 g, 6.4 mmol, 64% yield) as a white solid. Analytical data 
for 41h: mp 188.8-190.0 °C; 1H NMR (400 MHz, CDCl3): δ 8.66-8.63 (d, J = 10.4 
NHBoc
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Cl
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O
O
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Hz, 1H), 7.90-7.88 (d, J = 7.6 Hz, 2H), 7.77-7.74 (t, J = 7.6 Hz, 1H), 7.63-7.59 (t, 
J = 7.6 Hz, 2H), 7.29 (s, 1H), 7.09-7.07 (d, J = 8.4 Hz, 1H), 6.92-6.90 (d, J = 8.0 
Hz, 1H), 6.05 (s, 2H), 5.95-5.93,  (d, J = 10.4 Hz, 1H), 3.32 (s, 1H), 1.16 (s, 9H); 
13C NMR (100 MHz, CDCl3): δ 154.9, 149.0, 148.1, 138.1, 134.8, 130.0, 129.9, 
125.3, 124.6, 110.8, 108.8, 192.3, 80.2, 75.0, 28.7; IR (thin film cm-1): 3356, 1713, 
1490, 1445, 1369, 1302, 1248, 1145, 1040, 936, 638, 601; TLC (25% 
EtOAc/hexanes): RF 0.20; HRMS (ESI): Calcd. for [M + H]+ C19H21NO6S: 
392.1168, Found: 392.1192.  
 tert-Butyl ((phenylsulfonyl)(4-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)phenyl)methyl)carbamate (41i): The title 
compound was prepared according to General Procedure A 
(method 1) using 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-benzaldehyde9 
(10.0 mmol) affording amido-sulfone 41i (3.22 g, 6.8 mmol, 68% yield) as a white 
solid. Analytical data for 41i: mp 175-175.6 °C; 1H NMR (400 MHz, CDCl3): δ 
7.97-7.82 (m, 5H), 7.65-7.61 (t, J=7.6, 1H), 7.54-7.50 (m, 2H), 7.44-7.42 (m, 2H), 
5.96-5.93 (d, J = 10.4 Hz, 1H), 5.86-5.84 (d, J = 10.8 Hz, 1H), 1.34 (s, 12H), 1.25 
(s, 9H); 13C NMR (100 MHz, CDCl3): δ 153.5, 136.8, 135.0, 133.9, 132.6, 129.4, 
129.0, 128.1, 124.8, 84.0, 81.2, 74.0, 28.2, 28.0, 24.8; IR (thin film cm-1): 3339, 
2979, 1705, 1521, 1362, 1331, 1143, 1088, 857, 724, 658, 586, 536; TLC (25% 
EtOAc/hexanes): RF 0.24; HRMS (ESI): Calcd. for [M + NH4]+ C24H32BNO6S: 
491.2387, Found: 491.2425.  
 (E)-tert-Butyl (3-phenyl-1-(phenylsulfonyl)allyl)carbamate 
(41j): The title compound was prepared according to General 
NHBoc
SO2Ph
BO
O
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Procedure A (method 1) using trans-cinnamaldehyde (10.0 mmol) affording 
amido-sulfone 41j (2.87 g, 7.7 mmol, 77% yield) as a white solid. Analytical data 
for 41j: mp 163.2-164.0 °C; 1H NMR (400 MHz, CDCl3): δ 7.60-7.53 (m,  3H), 
7.41-7.37 (m, 2H), 7.28-7.18 (m, 3H), 7.17-7.16 (m, 2H), 6.7-6.65 (m, 1H), 6.48-
6.47 (d, J = 8 Hz, 1 H), 5.44-5.38 (m, 1H), 4.62-4.59 (d, J = 9.6 Hz), 1.44 (s, 9H); 
13C NMR (100 MHz, CDCl3): δ 137.3, 133.5, 132.8, 131.4, 129.3, 129.2, 128.7, 
128.6, 98.7, 73.5, 28.1; IR (thin film cm-1): 3367, 2979, 1703, 1668, 1507, 1294, 
1254, 1144, 1083, 962, 687, 574; TLC (20% EtOAc/hexanes): RF 0.52; HRMS 
(ESI): Calcd. for [M + H]+ C20H23NO4S: 374.1426, Found: 374.1440.  
 tert-Butyl (86aphthalene-2-
yl(phenylsulfonyl)methyl)carbamate (41k): The title 
compound was prepared according to General Procedure A (method 1) using 2-
napthaldehyde (10.0 mmol) affording amido-sulfone 41k (2.38 g, 6.0 mmol, 60% 
yield) as a white solid. Analytical data for 41k: mp 174.4-175.0 °C; 1H NMR (400 
MHz, CDCl3): δ 7.96-7.85 (m, 6H), 7.65-7.63 (m, 1H), 7.56-7.52 (m, 5H), 6.11-
6.08 (d, J = 10 Hz, 1H), 5.89-5.86,  (d, J = 10 Hz, 1H), 1.28 (s, 9H); 13C NMR 
(150 MHz, CDCl3): δ 136.9, 134.0, 133.7, 132.9, 129.5, 129.1, 128.6, 128.3, 
127.7, 127.2, 127.1, 126.7, 125.5, 74.1, 28.0; IR (thin film cm-1): 3364, 2980, 
1700, 1506, 1368, 1309, 1246, 1140, 1082, 746, 689, 649, 590; TLC (25% 
EtOAc/hexanes): RF 0.24; HRMS (ESI): Calcd. for [M + NH4]+ C22H23NO4S: 
415.1692, Found: 415.1715.  
 tert-Butyl (furan-2-yl(phenylsulfonyl)methyl)carbamate (41l): 
The title compound was prepared according to General Procedure A 
NHBoc
SO2Ph
O SO2Ph
NHBoc
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(method 1) using furfural (10.0 mmol) affording amido-sulfone 41l (2.02 g, 6.0 
mmol, 60% yield) as a white solid. Analytical data for 41l: mp 159.8-161.2 °C; 1H 
NMR (400 MHz, CDCl3): δ 7.90-7.88 (d, J=7.6 Hz, 2H), 7.64-7.63 (m, 1H), 7.55-
7.51 (m, 2H), 7.48 (m, 1H), 6.58-6.57 (d, J = 2.8 Hz, 1H), 6.44-6.43,  (d, J = 1.6 
Hz, 1H), 6.04-6.01 (d, J = 10.4 Hz, 1H), 5.86-5.84 (d, J = 10.4 Hz), 1.28 (s, 9H); 
13C NMR (150 MHz, CDCl3): δ 153.3, 144.2, 142.9, 136.4, 134.0, 129.4, 129.0, 
112.3, 111.1, 81.3, 68.9, 27.9, 27.7; IR (thin film cm-1): 3276, 2981, 1700, 1368, 
1308, 1143, 1082, 1013, 759, 687, 575; TLC (25% EtOAc/hexanes): RF 0.22; 
HRMS (ESI): Calcd. for [M + H]+ C16H19NO5S: 338.1062, Found: 338.1081.  
tert-Butyl ((phenylsulfonyl)(thiophen-2-yl)methyl)carbamate 
(41m): The title compound was prepared according to General 
Procedure A (method 1) using 2-Thiophenecarboxaldehyde (10.0 mmol) 
affording amido-sulfone 41m (1.24 g, 3.5 mmol, 35% yield) as a white solid. 
Analytical data for 41m: mp 151.0-152.0 °C; 1H NMR (400 MHz, CDCl3): δ 7.93-
7.91 (d, J=7.6 Hz, 2H), 7.67-7.63 (t, J = 7.6 Hz, 1H), 7.56-7.52 (t, J = 7.6 Hz, 2H), 
7.42-7.41 (dd, J = 5.2 Hz, 1.2 Hz, 1H), 7.27-7.26 (m, 1H), 7.08-7.06,  (dd, J = 5.2 
Hz, 3.6 Hz, 1H), 6.20-6.17 (d, J = 10.8 Hz, 1H), 5.66-5.64 (d, J = 10 Hz, 1H), 1.26 
(s, 9H); 13C NMR (100 MHz, CDCl3): δ 142.0, 136.6, 134.1, 131.5, 129.5, 129.0, 
127.7, 127.3, 81.4, 70.2, 28.0; IR (thin film cm-1): 3325, 2979, 1701, 1508, 1368, 
1309, 1249, 1143, 853, 688, 590, 551; TLC (25% EtOAc/hexanes): RF 0.24; 
HRMS (ESI): Calcd. for [M + H]+ C16H19NO4S2: 354.0833, Found: 354.0855.  
tert-Butyl((phenylsulfonyl)(p-tolyl)methyl)carbamate (41n): 
The title compound was prepared according to General 
S
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Procedure B (method 2) using tert-butyl 2-formyl-1H-indole-1-carboxylate10 (10.0 
mmol) affording amido-sulfone 41n (2.77 g, 5.7 mmol, 57% yield) as a white solid. 
Analytical data for 41n: mp 136-137 °C; 1H NMR (400 MHz, CDCl3): δ 8.19-8.17 
(d, J=8.0 Hz, 1H), 8.01-7.89 (d, J=7.6 Hz, 2H), 7.88 (s,1H), 7.68-7.63 (m, 2H), 
7.58-7.54 (t, J = 7.6 Hz, 2H), 7.38-7.34 (d, J = 7.6 Hz, 1H), 7.31-7.27 (t, J = 7.6 
Hz, 1H), 6.22-6.20 (d, J = 10.0 Hz, 1H), 5.69-5.66 (d, J = 10.0 Hz, 1H), 1.68 (s, 9 
H), 1.25 (s, 9H); 13C NMR (150 MHz, CDCl3): δ 153.4, 149.1, 136.8, 135.2, 133.9, 
129.5, 129.0, 128.4, 126.6, 125.1, 123.2, 119.5, 115.3, 110.4, 84.5, 81.2, 67.9, 
28.0, 27.9; IR (thin film cm-1): 3649, 3001, 2979, 2814, 1741, 1680, 1558, 1397, 
1360, 1242, 1156, 1133, 1102, 760; TLC (20% EtOAc/hexanes): RF 0.52; HRMS 
(ESI): Calcd. for [M + Na]+ C25H30N2O6S: 509.1723, Found: 509.1762.  
tert-Butyl((phenylsulfonyl)(p-tolyl)methyl)carbamate (41o): 
The title compound was prepared according to General 
Procedure A (method 1) using hydrocinnamaldehyde (10.0 
mmol) affording amido-sulfone 41o (3.15 g, 8.4 mmol, 84% yield) as a white solid. 
Note: Carbamate 1o shows existence of slow rotation (rotamers) in 1H NMR 
spectra obtained at ambient temperature. Analytical data for 1o: mp 128.0-
128.8 °C; 1H NMR (400 MHz, CDCl3, rt): δ 7.92-7.90 (d, J = 7.6 Hz, 2H), 7.69-
7.63 (m, 1H), 7.59-7.53 (m, 2H), 7.33-7.31 (m 2H), 7.29-7.28 (m, 1H), 7.27-7.19 
(m, 2H), 5.11-5.08,  (d, J = 10.8 Hz, 1H), 4.91-4.85 (dt, J = 10.8 Hz, 3.2 Hz, 1H), 
2.93-2.86 (m, 1H), 2.80-2.72 (m, 1H), 2.68-2.60 (m, 1H), 2.14-2.06 (m, 1H), 1.25 
(s, 7H), 1.08 (s, 2H); 1H NMR (600 MHz, CDCl3, 55 °C): δ 7.98-7.88 (m, 2H), 7.60 
(bs, 1H), 7.51 (m, 2H), 7.27-7.26 (m 2H), 7.21-7.16 (m, 3H), 4.99 (bs, 1H), 4.87 
SO2Ph
NHBoc
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(bs,1H), 2.86 (bs, 1H), 2.75 (bs, 1H), 2.59 (bs, 1H), 2.08 (bs, 1H), 1.24-1.12 (bs, 
9H); 13C NMR (100 MHz, CDCl3, rt): δ 153.6, 139.7, 136.8, 133.8, 129.2, 129.0, 
128.6, 128.4, 126.4, 80.8, 70.2, 31.4, 28.0, 27.9, 27.5; IR (thin film cm-1): 3336, 
2978, 1718, 1520, 1447, 1367, 1309, 1246, 1142, 1083, 749, 688, 598, 545; TLC 
(25% EtOAc/hexanes): RF 0.53; HRMS (ESI): Calcd. for [M + H]+ C20H25NO4S: 
376.1582, Found: 376.1608.  
2.5.3 General Procedure B for the Preparation of α-Diazo Esters 45a-o 
 
A 50 mL round-bottomed flask equipped with a magnetic stir bar and a reflux 
condenser was charged with CsF (6.0 mmol, 2 equiv) and heated under vacuum 
(~ 0.5 kPa, 95 °C) for 2 min. Amido-sulfone (2.0 mmol, 1 equiv) was then added 
and the flask was sealed with a rubber septum and purged with N2. THF was 
added to give a solution with [41]0 = 0.1 M and the nitrogen line was removed. 
The reaction was heated at 60 °C for 12 h, filtered through celite using DCM, and 
concentrated in vacuo. The crude residue was immediately dissolved in CH3CN 
(16 mL) and the reaction flask was sealed with a rubber septum and purged with 
N2. Ethyl diazoacetate (2.6 mmol, 1.3 equiv) was added followed by DBU (0.6 
mmol, 0.3 equiv). The reaction was stirred at room temperature for 3-6 h 
(monitored by TLC), then diluted with EtOAc and water. The organic layer was 
washed with water (3 x 50 mL), brine, and dried over Na2SO4. Concentration in 
vacuo afforded the α-diazo esters which were purified by flash chromatography 
using an eluent gradient of 7.5% EtOAc/hexanes to 15% EtOAc/hexanes.  
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Ethyl 3-((tert-butoxycarbonyl)amino)-2-diazo-3-phenylpropanoate (45a): The 
title compound was prepared according to General Procedure B 
using 41a (2.0 mmol) affording β-amino-α-diazo ester 45a (0.41 g, 
1.28 mmol, 64% yield) as a yellow oil. Analytical data for 45a: 1H 
NMR (400 MHz, CDCl3): δ 7.35-7.28 (m, 5H), 5.66 (bs, 1H), 5.51 (bs, 1H), 4.23-
4.18 (m, 2H), 1.44 (s, 9H), 1.25-1.22 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, 
CDCl3): δ 165.8, 154.9, 139.0, 128.7, 128.5, 128.3, 127.9, 126.1, 125.7, 80.2, 
76.7, 60.9, 51.0, 28.2, 14.3; IR (thin film cm-1): 3346, 2979, 2095, 1698, 1496, 
1247, 1168, 885, 701; TLC (15% EtOAc/hexanes): RF 0.24; HRMS (ESI): Calcd. 
for [M + Na]+ C16H21N3O4: 342.1430, Found: 342.1443. 
Ethyl 3-(((benzyloxy)carbonyl)amino)-2-diazo-3-
phenylpropanoate (45b): The title compound was prepared 
according to General Procedure B using 41b (2.0 mmol) affording β-amino-α-
diazo ester 45b (0.40 g, 1.18 mmol, 59% yield) as a yellow oil. Analytical data for 
45b: 1H NMR (400 MHz, CDCl3): δ 7.37-7.31 (m, 10H), 6.04 (bs, 1H), 5.81-5.79 
(d, J = 7.2 Hz, 1H), 5.15 (s, 2H), 4.25-4.19 (m, 2H), 1.26-1.23 (t, J = 7.2 Hz, 3H); 
13C NMR (100 MHz, CDCl3): δ 155.6, 138.5, 136.1, 129.0, 128.5, 128.2, 128.1, 
126.1, 67.2, 61.1, 51.7, 14.3; IR (thin film cm-1): 3330, 2096, 1697, 1523, 1497, 
1454, 1372, 1244, 1103, 1027, 938, 699; TLC (15% EtOAc/hexanes): RF 0.10; 
HRMS (ESI): Calcd. for [M + Na]+ C19H19N3O4: 376.1274, Found: 376.1289. 
Ethyl 3-((tert-butoxycarbonyl)amino)-2-diazo-3-(p-
tolyl)propanoate (45c): The title compound was prepared 
according to General Procedure B using 41c (2.0 mmol) 
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affording β-amino-α-diazo ester 45c (0.47 g, 1.42 mmol, 71% yield) as a yellow 
solid. Analytical data for 45c: mp 70.8-71.4 °C; 1H NMR (400 MHz, CDCl3): δ 
7.23-7.22 (m, 2H), 7.17-7.15 (m, 2H), 5.64-5.62 (d, J = 8 Hz, 1H), 5.41 (bs, 1H), 
4.22-4.20 (m, 2H), 2.33 (s, 3H), 1.45 (s, 9H) 1.26-1.23 (t, J = 7.2 Hz, 3H); 13C 
NMR (100 MHz, CDCl3): δ 165.8, 154.8, 137.7, 136.0, 129.4, 129.1, 126.0, 80.1, 
60.9, 50.8, 28.2, 21.0, 14.3; IR (thin film cm-1): 3352, 2950, 2931, 2014, 1699, 
1513, 1369, 1291, 1247, 1169, 1100, 1020, 889, 741; TLC (15% 
EtOAc/hexanes): RF 0.21; HRMS (ESI): Calcd. for [M + H]+ C17H23N3O4: 
334.1767, Found: 334.1780.  
Ethyl 3-((tert-butoxycarbonyl)amino)-2-diazo-3-(m-
tolyl)propanoate (45d): The title compound was prepared 
according to General Procedure B using 41d (2.0 mmol) 
affording β-amino-α-diazo ester 45d (0.47 g, 1.42 mmol, 71% yield) as a yellow 
oil. Analytical data for 45d: 1H NMR (400 MHz, CDCl3): δ 7.24-7.22 (m, 1H), 7.14-
7.09 (m, 3H), 5.64-5.62 (d, J = 6.8 Hz, 1H), 5.47 (bs, 1H), 4.23-4.18 (q, J = 7.2 
Hz, 2H), 2.34 (s, 3H), 1.45 (s, 9H), 1.26-1.22 (t, J = 7.2 Hz, 3H); 13C NMR (100 
MHz, CDCl3): δ 165.8, 154.8, 138.9, 138.5, 128.8, 128.7, 126.8, 123.1, 80.2, 60.9, 
28.2, 21.4, 14.3; IR (thin film cm-1): 3348, 2979, 2931, 2094, 1699, 1493, 1368, 
1292, 1250, 1165, 1100, 878, 779, 709; TLC (15% EtOAc/hexanes): RF 0.21; 
HRMS (ESI): Calcd. for [M + Na]+ C17H23N3O4: 356.1587, Found: 356.1603. 
Ethyl 3-((tert-butoxycarbonyl)amino)-2-diazo-3-(o-
tolyl)propanoate (45e): The title compound was prepared 
according to General Procedure B using 41e (2.0 mmol) affording β-amino-α-
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diazo ester 45e (0.46 g, 1.38 mmol, 69% yield) as a yellow solid. Analytical data 
for 45e: mp 85-86 °C; 1H NMR (400 MHz, CDCl3): δ 7.33-7.30 (m, 1H), 7.22-7.19 
(m, 3H), 5.81 (d, J = 6.8 Hz, 1H), 5.15 (bs, 1H), 4.25-4.19 (q, J = 7.2 Hz, 2H), 
2.38 (s, 3H), 1.43 (s, 9H), 1.27-1.23 (t, J = 7.2 Hz, 3H); 13C NMR (150 MHz, 
CDCl3): δ 165.7, 154.7, 137.0, 135.3, 130.9, 128.0, 126.3, 125.5, 80.2, 61.0, 47.8, 
28.2, 19.1, 14.3; IR (thin film cm-1): 3353, 2979, 2094, 1699, 1507, 1368, 1333, 
1286, 1245, 1169, 1100, 1019, 888, 740; TLC (20% EtOAc/hexanes): RF 0.36; 
HRMS (ESI): Calcd. for [M + Na]+ C17H23N3O4: 356.1587, Found: 356.1584.  
Ethyl 3-((tert-butoxycarbonyl)amino)-2-diazo-3-(4-
methoxyphenyl)propanoate (45f): The title compound was 
prepared according to General Procedure B using 41f (2.0 mmol) affording β-
amino-α-diazo ester 45f (0.42 g, 1.20 mmol, 60% yield) as a yellow solid. 
Analytical data for 45f: mp 97-98 °C; 1H NMR (600 MHz, CDCl3): δ 7.27 (d, J = 
8.4 Hz, 2H), 6.88 (d, J = 8.4 Hz, 2H), 5.6 (bs, 1H), 5.38 (bs, 1H), 4.22-4.19 (q, J = 
7.2 Hz, 4H), 3.79 (s, 3H), 1.45 (s, 9H), 1.26-1.23 (t, J = 7.2 Hz, 3H); 13C NMR 
(150 MHz, CDCl3): δ 159.3, 154.8, 131.1, 127.4, 114.2, 60.94, 55.3, 50.6, 28.3, 
14.4; IR (thin film cm-1): 3353, 2979, 2934, 2361, 2094, 1698, 1513, 1369, 1294, 
1249, 1168, 1100, 1032, 844, 741; TLC (20% EtOAc/hexanes): RF 0.28; HRMS 
(ESI): Calcd. for [M + Na]+ C17H23N3O5: 372.1536, Found: 372.1535.  
Ethyl 3-((tert-butoxycarbonyl)amino)-3-(4-chlorophenyl)-2-
diazopropanoate (45g): The title compound was prepared 
according to General Procedure B using 41g (2.0 mmol) 
affording β-amino-α-diazo ester 45g (0.38 g, 1.08 mmol, 54% yield) as a yellow 
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solid. Analytical data for 45g: mp 102-103 °C; 1H NMR (400 MHz, CDCl3): δ 
7.34-7.32 (d,  J = 8.8 Hz, 1H), 7.30-7.28 (d,  J = 8.8 Hz, 1H), 5.64-5.62 (d, J = 7.6 
Hz, 1H), 5.44 (bs, 1H), 4.24-4.19 (q, J = 7.2 Hz, 2H), 2.34 (s, 3H), 1.45 (s, 9H), 
1.27-1.23 (t, J = 7.2 Hz, 3H); 13C NMR (150 MHz, CDCl3): δ 165.7, 154.9, 137.6, 
133.8, 129.0, 127.6, 80.5, 61.1, 50.7, 28.3, 14.4; IR (thin film cm-1): 3344, 2979, 
2933, 2096, 1735, 1699, 1506, 1454, 1371, 1308, 1253, 1156, 1077, 1019, 766, 
747; TLC (20% EtOAc/hexanes): RF 0.38; HRMS (ESI): Calcd. for [M + Na]+ 
C16H20ClN3O4: 376.1040, Found: 376.1039.  
Ethyl 3-(benzo[d][1,3]dioxol-5-yl)-3-((tert-
butoxycarbonyl)amino)-2-diazopropanoate (45h): The title 
compound was prepared according to General Procedure B 
using 41h (2.0 mmol) affording β-amino-α-diazo ester 45h (0.52 g, 1.42 mmol, 
71% yield) as a yellow solid. Analytical data for 45h: mp 102-102.7 °C; 1H NMR 
(400 MHz, CDCl3): δ 6.83-6.75 (m, 3H), 5.94 (s, 2H), 5.57-5.55 (d, J = 7.2 Hz, 
1H), 5.39 (bs, 1H), 4.23-4.18 (q, J = 7.2 Hz, 2H), 1.44 (s, 9H), 1.26-1.23 (t, J = 
7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 165.8, 154.8, 148.1, 147.3, 133.0, 
119.5, 108.3, 106.8, 101.2, 80.3, 61.0, 28.2, 14.4; IR (thin film cm-1): 3351, 2979, 
2933, 2094, 1693, 1490, 1368, 1247, 1167, 930, 741; TLC (15% 
EtOAc/hexanes): RF 0.13; HRMS (ESI): Calcd. for [M + Na]+ C17H21N3O6: 
386.1328, Found: 386.1346.  
Ethyl 3-((tert-butoxycarbonyl)amino)-2-diazo-3-(4-
(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)phenyl)propanoate (45i): The title compound was 
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prepared according to General Procedure B using 41i (2.0 mmol) affording β-
amino-α-diazo ester 45i (0.42 g, 0.94 mmol, 47% yield) as a yellow solid. 
Analytical data for 45i: mp 51.2-53.0 °C; 1H NMR (400 MHz, CDCl3): δ 7.81-7.79 
(d, J = 8 Hz, 2H), 7.35-7.33 (d, J = 8 Hz, 2H), 5.68-5.66 (d, J = 7.2 Hz, 1H), 5.40 
(bs, 1H), 4.23-4.18 (q, J = 7.2 Hz, 2H), 1.45 (s, 9H), 1.34 (s, 12H) 1.26-1.22 (t, J 
= 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 154.9, 135.3, 125.4, 83.8, 61.0, 
28.3, 24.8, 14.4; IR (thin film cm-1): 3350, 2979, 2932, 2095, 1698, 1612, 1508, 
1362, 1247, 1145, 1020, 888, 740; TLC (15% EtOAc/hexanes): RF 0.14; HRMS 
(ESI): Calcd. for [M + NH4]+ C22H32BN3O6: 463.2728, Found: 463.2750.  
 (E)-Ethyl 3-((tert-butoxycarbonyl)amino)-2-diazo-5-
phenylpent-4-enoate (45j): The title compound was prepared 
according to General Procedure B using 41j (2.0 mmol) affording β-amino-α-
diazo ester 45j (0.33 g, 0.96 mmol, 48% yield) as a yellow solid. Analytical data 
for 45i: mp 76.0-76.6 °C; 1H NMR (400 MHz, CDCl3): δ 7.37-7.24 (m, 5H), 6.63-
6.59 (d, J = 15.6 Hz, 1H), 6.33-6.27 (dd, J = 16 Hz, 6.4 Hz, 1H), 5.40 (bs, 1H), 
4.27-4.22 (q, J = 7.2 Hz, 2H), 1.46 (s, 9H), 1.29-1.26 (t, J = 7.2 Hz, 3H); 13C NMR 
(100 MHz, CDCl3): δ 154.8, 135.9, 131.7, 128.5, 128.0, 126.6, 125.6, 80.2, 76.7, 
60.9, 49.8, 29.2 14.4; IR (thin film cm-1): 3345, 2979, 2933, 2094, 1696, 1496, 
1369, 1292, 1168, 1016, 967, 745, 693; TLC (15% EtOAc/hexanes): RF 0.20; 
HRMS (ESI): Calcd. for [M + H]+ C18H23N3O4: 346.1767, Found: 346.1781.  
Ethyl 3-((tert-butoxycarbonyl)amino)-2-diazo-3-
(naphthalen-2-yl)propanoate (45k): The title compound was 
prepared according to General Procedure B using 41k (2.0 mmol) affording β-
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amino-α-diazo ester 45k (0.47 g, 1.26 mmol, 63% yield) as a yellow oil. 
Analytical data for 45k: 1H NMR (400 MHz, CDCl3): δ 7.86-7.80 (m, 4H), 7.51-
7.44 (m, 3H), 5.85-5.83 (d, J = 7.2 Hz, 1H), 5.52(bs, 1H), 4.27-4.19 (m, 2H), 1.47 
(s, 9H), 1.27-1.24 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 154.9, 133.2, 
133.0, 128.9, 128.0, 127.6, 126.4, 126.3, 125.0, 124.2, 61.1, 28.3, 14.4; IR (thin 
film cm-1): 3346, 2979, 2933, 2094, 1696, 1507, 1369, 1250, 1167, 1098, 1020, 
861, 745; TLC (15% EtOAc/hexanes): RF 0.19; HRMS (ESI): Calcd. for [M + Na]+ 
C20H23N3O4: 392.1587, Found: 392.1606. 
Ethyl 3-((tert-butoxycarbonyl)amino)-2-diazo-3-(furan-2-
yl)propanoate (45l): The title compound was prepared according 
to General Procedure B using 41l (2.0 mmol) affording β-amino-α-diazo ester 45l 
(0.47 g, 1.26 mmol, 63% yield) as a yellow solid. Analytical data for 45l: mp 68.2-
69.4 °C; 1H NMR (400 MHz, CDCl3): δ 7.35 (s, 1H), 6.33-6.32 (m, 1H), 6.28-6.27 
(d, J = 3.2 Hz, 1H), 5.70-5.68 (d, J = 6.8, 1H), 5.43 (bs, 1H), 4.25-4.18 (q, J = 7.2 
Hz, 2H), 1.45 (s, 9H), 1.27-1.24 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 
154.6, 151.1, 142.4, 110.5, 107.0, 61.0, 28.2, 14.4; IR (thin film cm-1): 3343, 2980, 
2934, 2099, 1699, 1505, 1370, 1254, 1169, 1012, 880, 741, 598; TLC (15% 
EtOAc/hexanes): RF 0.20; HRMS (ESI): Calcd. for [M + H]+ C14H19N3O5: 
310.1403, Found: 310.1415.  
Ethyl 3-((tert-butoxycarbonyl)amino)-2-diazo-3-(furan-2-
yl)propanoate (45m): The title compound was prepared 
according to General Procedure B using 41m (2.0 mmol) affording β-amino-α-
diazo ester 45m (0.47 g, 1.26 mmol, 63% yield) as a yellow oil. Analytical data for 
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45m: 1H NMR (400 MHz, CDCl3): δ 7.21-7.19 (dd, J = 5.2 Hz, 1.2 Hz, 1H), 6.97-
6.96 (dd, J = 2.4 Hz, 1.2 Hz, 1H), 6.93-6.91 (m, 1H), 5.86-5.84 (d, J = 67.6, 1H), 
5.68 (bs, 1H), 4.24-4.18 (q, J = 7.2 Hz, 2H), 1.43 (s, 9H), 1.26-1.22 (t, J = 7.2 Hz, 
3H); 13C NMR (150 MHz, CDCl3): δ 165.4, 154.5, 143.0, 126.9, 125.0, 124.6, 
80.3, 61.0, 47.6, 28.1, 14.2; IR (thin film cm-1): 3393, 2979, 2934, 1730, 1497, 
1368, 1252, 1164, 1043, 853, 708; TLC (15% EtOAc/hexanes): RF 0.10; HRMS 
(ESI): Calcd. for [M + Na]+ C14H19N3O4S: 348.0994, Found: 348.0990. 
tert-Butyl-2-(1-((tert-butoxycarbonyl)amino)-2-diazo-3-
ethoxy-3-oxopropyl)-1H-indole-1-carboxylate (45n): The title 
compound was prepared according to General Procedure B 
using 41n (2.0 mmol) affording β-amino-α-diazo ester 45n (0.57 g, 1.24 mmol, 
62% yield) as a yellow solid. Analytical data for 45n: mp 122-123 °C; 1H NMR 
(600 MHz, CDCl3): δ 8.12 (s, 1H), 7.56 (s, 1H), 7.52-7.50 (d, J = 8.4 Hz, 1H), 
7.35-7.32 (t, J = 7.8 Hz, 1H), 7.27-7.24 (dd, J = 7.8 Hz, J = 1.2 Hz, 1H),  5.88 (bs, 
1H), 5.40 (bs, 1H), 4.27-4.23 (q, J = 7.2 Hz, 2H), 1.67 (s, 9H), 1.48 (s, 9H), 1.29-
1.26 (t, J = 7.2 Hz, 3H); 13C NMR (150 MHz, CDCl3): δ 154.9, 149.5, 127.9, 126.1, 
124.9, 123.6, 122.9, 119.0, 115.5, 84.1, 61.1, 28.3, 28.1, 14.4; IR (thin film cm-1): 
3360, 2979, 2934, 2096, 1735, 1699, 1506, 1454, 1371, 1308, 1253, 1156, 1077, 
1019, 766, 747; TLC (20% EtOAc/hexanes): RF 0.38; HRMS (ESI): Calcd. for [M 
+ Na]+ C23H30N4O6: 481.2063, Found: 481.2068.  
2.5.4 Preparation of α−Diazo Ester 45o 
A 50 mL round-bottomed flask equipped with a magnetic stir bar was 
charged with CsCO3 (10.0 mmol, 5 equiv) and heated under vacuum (~ 0.5 kPa, 
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95 °C) for 2 min. 41o (2.0 mmol, 1 equiv) was then added and the flask was 
sealed with a rubber septum and purged with N2. DCM was added to give a 
solution with [41o] = 0.1 M and the nitrogen line was removed. The reaction was 
heated at 45 °C for 90 min, filtered through celite using 20% DCM/hexanes, and 
concentrated in vacuo. The crude residue was immediately solvated with 16 mL 
of CH3CN and the reaction flask was sealed with a rubber septum, purged with 
nitrogen, and cooled to -40 °C. Ethyl diazoacetate (2.6 mmol, 1.3 equiv) was 
added followed by DBU (0.6 mmol, 0.3 equiv). The flask was stirred at -40 °C for 
52 h (monitored by TLC) then diluted with EtOAc and water. The organic layer 
was washed with water (3 x 30 mL), brine, and dried over Na2SO4. Concentration 
in vacuo afforded 45o which was purified by flash chromatography using an 
eluent gradient of 5% EtOAc/hexanes to 10% EtOAc/hexanes.  
Ethyl 3-((tert-butoxycarbonyl)amino)-2-diazo-5-
phenylpentanoate (45o): 2.0 mmol scale: (0.43 g, 1.16 mmol, 
58% yield) as a yellow oil. Analytical data for 45o: 1H NMR (400 MHz, CDCl3): δ 
7.28-7.27 (m, 2H), 7.19-7.17 (m, 3H), 5.15 (bs,1H), 4.33 (bs, 1H), 4.23-4.18 (q, J 
= 7.2 Hz, 2H), 2.70-2.68 (m, 2H), 2.14 (bs, 1H), 1.44 (s, 9H), 1.29-1.26 (t, J = 7.2 
Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 155.1, 140.6, 128.5, 128.3, 126.1, 79.9, 
60.7, 48.3, 35.0, 32.6, 28.2, 14.4; IR (thin film cm-1): 3349, 2979, 2930, 2092, 
1694, 1496, 1368, 1293, 1170, 1114, 1024, 873, 743, 700; TLC (15% 
EtOAc/hexanes): RF 0.21; HRMS (ESI): Calcd. for [M + Na]+ C18H25N3O4: 
370.1743, Found: 370.1761. 
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2.5.5 Preparation of complex 21b 
 
To a flame-dried 1-dram vial equipped with a magnetic stir bar were added 
[RuCl(arene)]2 (0.005 mmol, 1.0 equiv), N-((1S,2S)-2-amino-1,2-diphenylethyl)-
[1,1':3',1''-terphenyl]-2'-sulfonamide (0.02 mmol, 4.0 equiv), and DMF (1.0 mL). 
The vial was capped with a PTFE-lined screw cap, and heated to 70 °C for 30 
min. Complex 7 was used without purification as a solution of DMF.   
2.5.6 General Procedure C for the ATH-DKR of β-Amino-α-Keto-Esters 
 
Method 1: 
A 50 mL round-bottomed flask equipped with a magnetic stir bar was charged 
with Oxone® (2.5 mmol, 5 equiv), NaHCO3 (10 mmol, 20 equiv), 15 mL of 1:2 
(v/v) acetone/H2O  and cooled to 0 °C. To this mixture, a solution of diazo ester 
45 (0.5 mmol) dissolved in DCM ([45]0) = 0.05 M) was added and the solution 
was warmed to rt. Upon complete oxidation to the α-keto ester (monitored by 
color change and/or TLC analysis), the reaction mixture was diluted with 
DCM/H2O. The organic layer was separated, and the aqueous layer was 
extracted with DCM (2 x 30 mL). The combined organic extracts were dried over 
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Na2SO4, filtered and concentrated in vacuo providing 46. This crude residue was 
dissolved in DMF (2.5 mL) and the reaction flask was sealed with a rubber 
septum and purged with nitrogen. Complex 21b (0.01 mmol, 0.02 equiv) was 
added as a DMF solution (see above), followed by HCO2H:Et3N (5:2 azeotrope, 
2.5 mmol, 5 equiv). The flask was stirred at rt for 18 h (monitored by TLC) then 
diluted with EtOAc and water. The organic layer was washed with water (3 x 20 
mL), brine, and dried over Na2SO4. Concentration in vacuo afforded the α-
hydroxy esters, which were purified by flash chromatography using the indicated 
solvent systems. In some cases products were then recrystallized using 20% 
Et2O/hexanes. 
Method 2: 
A 50 mL round-bottomed flask equipped with a magnetic stir bar was charged 
with Oxone® (0.6 mmol, 1.2 equiv), NaHCO3 (2.5 mmol, 5 equiv), 15 mL 1:2 (v/v) 
acetone/H2O  and cooled to 0 °C. To this mixture, a solution of diazo ester 45 
(0.5 mmol) dissolved in DCM ([45]0) = 0.05 M) was added and the solution was 
warmed to rt. Upon complete oxidation to the α-keto ester (monitored by color 
change and/or TLC analysis), the reaction mixture was diluted with DCM/H2O. 
The organic layer was separated, and the aqueous layer was extracted with DCM 
(2 x 30 mL). The combined organic extracts were dried over Na2SO4, filtered and 
concentrated in vacuo providing 46. The crude residue was dissolved in DMF 
(2.5 mL) and the reaction flask was sealed with a rubber septum and purged with 
nitrogen. Complex 21b  (0.01 mmol, 0.02 equiv) was added followed by 
HCO2H:Et3N (5:2 azeotrope, 2.5 mmol, 5 eqiv.). The flask was stirred at rt for 18 
100 
h (monitored by TLC) then diluted with EtOAc and water. The organic layer was 
washed with water (3 x 20 mL), brine, and dried over Na2SO4. Concentration in 
vacuo afforded the α-hydroxy-esters which were purified by flash 
chromatography using the indicated solvent systems. In some cases products 
were then recrystallized using 20% Et2O/hexanes. 
(2R,3R)-Ethyl 3-((tert-butoxycarbonyl)amino)-2-hydroxy-3-
phenylpropanoate (43a): The title compound was prepared according to 
General Procedure C (method 1) using 45a (0.5 mmol) affording β-amino-α-
hydroxy ester 43a (0.11 g, 0.37 mmol, 74% overall yield) as a white solid.  
 Analytical data for 42a: 1H NMR (400 MHz, CDCl3, rotamers 
observed): δ 7.37-7.30 (m, 5H), 6.05-6.03 (d, J = 6.8 Hz, 1H), 
5.62-5.61 (d, J = 5.6 Hz, 1H), 4.23-4.16 (m, 2H), 1.41 (s, 9H), 1.23-1.20 (t, J = 
7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 189.4, 159.6, 154.7, 133.7, 129.2, 
128.9, 128.5, 80.3, 76.7, 62.7, 61.0, 28.2, 13.7.  
 Analytical data for 43a: mp 116.8-117.2 °C; 1H NMR (400 MHz, 
CDCl3, rotamers observed): δ 7.28-7.26 (m, 5H), 5.64-5.62 (d, J = 
7.6 Hz, 1H), 5.12-5.10 (d, J = 7.2 Hz, 1H), 4.57 (bs, 1H), 4.16-4.08 (m, 2H), 2.94-
2.93 (d, J = 6.4 Hz), 1.42 (s, 9H), 1.25-1.22 (t, J = 7.2 Hz, 3H); 13C NMR (100 
MHz, CDCl3): δ 171.8, 154.9, 128.3, 128.1, 127.4, 79.8, 73.2, 62.0, 56.5, 28.3, 
14.0; IR (thin film cm-1): 3372, 1716, 1696, 1520, 1457, 1366, 1169, 1112, 700, 
618, 522; TLC (25% EtOAc/hexanes): RF 0.34; HRMS (ESI): Calcd. for [M + H]+ 
C16H23NO5: 310.1654, Found: 310.1668. SFC analysis: AD column, 2% modifier, 
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1.5 mL/min, 150 bar, 210 nm; tR (minor) = 23.4 min, tR (major) = 19.0 min, 99:1 er 
(>99.5:0.5 recryst.); [α]D25 -81.5 (c = 0.3, CHCl3).  
(2R,3R)-Ethyl 3-(((benzyloxy)carbonyl)amino)-2-hydroxy-3-
phenylpropanoate (43b): The title compound was prepared according to 
General Procedure C (method 1) using 45b (0.5 mmol) affording β-amino-α-
hydroxy ester (−)-43b (0.13 g, 0.39 mmol, 78% overall yield) as a white solid. 
The product was recrystallized using 20% Et2O/hexanes.  
 Analytical data for 42b: 1H NMR (400 MHz, CDCl3): δ 7.35-7.34 
(m, 10H), 6.14-6.13 (d, J = 6.8 Hz, 1H), 6.00-5.98 (d, J = 6.4 Hz, 
1H) 5.14-5.04 (m, 2H), 4.22-4.19 (m, 2H), 1.24-1.20 (t, J = 7.2 Hz, 3H); 13C NMR 
(100 MHz, CDCl3): δ 188.8, 159.5, 155.2, 135.9, 133.4, 129.2, 129.1, 128.5, 
128.4, 128.1, 128.1, 77.3, 67.1, 62.7, 61.3, 13.7.  
 Analytical data for (−)-43b: mp 108.5-109.0 °C; 1H NMR (400 
MHz, CDCl3): δ 7.35-7.28 (m, 10H), 5.87-5.85 (d, J = 9.2 Hz, 1H), 
5.18-5.14 (m, 1H), 5.11-5.04 (m, 2H), 4.61-4.58 (dd, J = 6.4 Hz, 3.2 Hz, 1H), 
4.17-4.09 (m, 2H), 2.91-2.90 (d, J = 6.4 Hz, 1H), 1.26-1.22 (t, J = 7.2 Hz, 3H); 13C 
NMR (100 MHz, CDCl3): δ 171.7, 155.5, 136.2, 128.5, 128.4, 128.3, 127.5, 73.0, 
67.0, 62.2, 56.9, 14.0; IR (thin film cm-1): 3750, 3735, 3710, 3689, 3675, 3649, 
3381, 3064, 1726, 1521, 1221, 1114, 1026, 700; TLC (25% EtOAc/hexanes): RF 
0.17; HRMS (ESI): Calcd. for [M + H]+ C19H21NO5: 344.1498, Found: 344.1512. 
SFC analysis: WO column, 7% MeOH, 1.5 mL/min, 150 bar, 210 nm; tR (minor) = 
9.7 min, tR (major) = 12.0 min, 94:6 er (>99.5:0.5 recryst.); [α]D25 +6.2 (c = 0.25, 
CHCl3).  
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(2R,3R)-Ethyl 3-((tert-butoxycarbonyl)amino)-2-hydroxy-3-(p-
tolyl)propanoate (43c): The title compound was prepared according to General 
Procedure C (method 1) using 45c (0.5 mmol) affording β-amino-α-hydroxy ester 
43c (0.14 g, 0.44 mmol, 88% overall yield) as a white solid. The product was 
recrystallized using 20% Et2O/hexanes.  
  Analytical data for 42c: 1H NMR (400 MHz, CDCl3, rotamers 
observed): δ 7.20-7.14 (m, 4H), 6.14-6.13 (d, J = 6.8 Hz, 1H), 
6.02-6.00 (d, J = 6.8 Hz, 1H) 5.58-5.56 (d, J = 6 Hz, 1H), 4.24-4.15 (m, 2H), 2.31 
(s, 3H), 1.41 (s, 9H), 1.24-1.20 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 
189.4, 159.7, 154.7, 138.9, 130.6, 129.9, 128.4, 80.2, 76.7, 62.6, 60.7, 28.2, 21.1, 
13.8.  
 Analytical data for 43c: mp 74.6-75.0 °C; 1H NMR (400 MHz, 
CDCl3, rotamers observed): δ 7.15-7.08 (m, 4H), 5.60-5.58 (d, 
J = 8.4 Hz, 1H), 5.08-5.07 (d, J = 6 Hz, 1H), 4.56 (bs, 1H), 4.18-4.09 (m, 2H), 
2.89 (bs, 1H) 2.30 (s, 3H), 1.42 (s, 9H) 1.27-1.23 (t, J = 7.2 Hz, 3H); 13C NMR 
(100 MHz, CDCl3): δ 171.9, 155.0, 137.8, 133.8, 129.1, 127.3, 79.8, 73.2, 62.0, 
56.3, 28.3, 21.1, 14.1; IR (thin film cm-1): 3392, 2979, 1716, 1507, 1336, 1247, 
1167, 1119, 1021, 882, 570; TLC (25% EtOAc/hexanes): RF 0.38; HRMS (ESI): 
Calcd. for [M + H]+ C17H25NO5: 324.1811, Found: 324.1825. HPLC analysis: 
Chiralpak IA, H/IPA = 90:10, flow rate = 1.0 mL/min, 210 nm; tR (minor) = 8.3 min, tR 
(major) = 11.1 min, 99:1 er (>99.5:0.5 recryst.); [α]D25 -272.6 (c = 0.28, CHCl3).  
(2R,3R)-Ethyl 3-((tert-butoxycarbonyl)amino)-2-hydroxy-3-(m-
tolyl)propanoate (43d): The title compound was prepared according to General 
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Procedure C (method 1) using 45c (0.5 mmol) affording β-amino-α-hydroxy ester 
43d (0.14 g, 0.44 mmol, 88% overall yield) as a white solid. The product was 
recrystallized using 20% Et2O/hexanes.  
  Analytical data for 42d: 1H NMR (400 MHz, CDCl3, rotamers 
observed) : δ 7.27-7.22 (m, 2H), 7.14-7.10 (m, 2H), 6.03-6.01 
(d, J = 6.8 Hz, 1H), 5.59-5.57 (d, J = 6.0 Hz, 1H) 4.26-4.17 (m, 2H), 2.33 (s, 3H), 
1.42 (s, 9H), 1.26-1.22 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 189.5, 
160.0, 154.7, 139.0, 133.5, 129.8, 129.1, 125.6, 80.3, 76.7, 62.6, 70.0, 28.2, 21.3, 
13.8.  
Analytical data for 43d: mp 98.8-99.2 °C; 1H NMR (400 MHz, 
CDCl3, rotamers observed): δ 7.20-7.16 (m, 1H), 7.08-7.04 (m, 
3H) 5.62-5.60 (d, J = 8.4 Hz, 1H), 5.08-5.07 (d, J = 6 Hz, 1H), 
4.58-4.55 (dd, J = 6.4 Hz, 3.2 Hz, 1H), 4.16-4.10 (m, 2H), 2.92-2.90 (d, J = 7.2 
Hz, 1H) 2.31 (s, 3H), 1.43 (s, 9H) 1.26-1.23 (t, J = 7.2 Hz, 3H); 13C NMR (100 
MHz, CDCl3): δ 171.9, 155.0, 137.9, 136.7, 128.9, 128.3, 128.2, 124.4, 79.8, 73.2, 
62.0, 56.6, 28.3, 21.4, 14.6; IR (thin film cm-1): 3392, 2979, 2933, 1716, 1506, 
1366, 1245, 1165, 1114, 1021, 864, 779, 710; TLC (25% EtOAc/hexanes): RF 
0.38; HRMS (ESI): Calcd. for [M + H]+ C17H25NO5: 324.1811, Found: 324.1824. 
HPLC analysis: Chiralpak IA, H/IPA = 90:10, flow rate = 1.0 mL/min, 210 nm; tR 
(minor) = 6.8 min, tR (major) = 8.7 min, 98:2 er (>99.5:0.5 recryst.); [α]D25 -64.27 (c = 
0.15, CHCl3).  
(2R,3R)-Ethyl 3-((tert-butoxycarbonyl)amino)-2-hydroxy-3-(o-
tolyl)propanoate (43e): The title compound was prepared according to General 
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Procedure C (method 1) using 45e (0.5 mmol) affording β-amino-α-hydroxy ester 
43e (0.12 g, 0.36 mmol, 72% overall yield) as a white solid.   
  Analytical data for 42e: 1H NMR (400 MHz, CDCl3): δ 7.26-7.24 
(m, 2H), 7.19-7.14 (m, 1H), 6.98-6.96 (d, J = 7.6 Hz, 1H), 6.29-
6.27 (d, J = 7.6 Hz, 1H),  5.39-5.37 (bd, 1H) 4.26-4.13 (m, 2H), 2.59 (s, 3H), 1.45 
(s, 9H), 1.24-1.20 (t, J = 6.8 Hz, 3H). 
 Analytical data for 43e: mp 73-74 °C; 1H NMR (400 MHz, CDCl3): 
δ 7.42-7.40 (bm,1H), 7.17-7.11(m, 3H), 5.42-5.39 (bm, 2H), 4.60 
(bs, 1H), 4.18-4.10 (m, 1H), 4.05-3.97 (m, 1H), 3.09-3.07 (d, J = 6.4 Hz, 1H), 
2.42 (s, 3H), 1.42 (s, 9H) 1.16-1.12 (t, J = 7.2 Hz, 3H); 13C NMR (150 MHz, 
CDCl3): δ 172.2, 155.1, 136.0, 130.6, 127.9, 126.8, 126.2, 79.8, 72.7, 62.0, 51.6, 
28.3, 19.5, 13.8; IR (thin film cm-1): 3394, 3058, 2979, 2934, 1714, 1496, 1367, 
1245, 1169, 1126, 1021, 880, 759, 733; TLC (20% EtOAc/hexanes): RF 0.24; 
HRMS (ESI): Calcd. for [M + Na]+ C17H25NO5: 346.1631, Found: 346.1629. SFC 
analysis: OD column, 5 % modifier, 1.5 mL/min, 150 bar, 210 nm; tR (minor) = 8.7 
min, tR (major) = 9.7 min, 95:5 er; [α]D25 -424.9 (c = 0.85, CHCl3).  
(2R,3R)-Ethyl 3-((tert-butoxycarbonyl)amino)-2-hydroxy-3-(4-
methoxyphenyl)propanoate (43f): The title compound was prepared according 
to General Procedure C  (method 1) using 45f (0.5 mmol) affording β-amino-α-
hydroxy ester 43f (0.14 g, 0.41 mmol, 81% overall yield) as a white solid.  
  Analytical data for 42f: 1H NMR (400 MHz, CDCl3): δ 7.24-
7.21 (d, J = 8.8 Hz, 2H), 6.89-6.85 (d, J = 8.8 Hz, 2H), 6.00-
OH
NHBoc
Me
O
EtO
O
NHBocO
EtO
Me
OMeO
NHBocO
EtO
105 
5.98 (d, J = 6.8 Hz, 1H), 5.56-5.54 (bd, 1H) 4.25-4.16 (m, 2H), 3.78 (s, 3H), 1.41 
(s, 9H), 1.26-1.22 (t, J = 8.0 Hz, 3H). 
 Analytical data for 43f: mp 124-125 °C; 1H NMR (400 MHz, 
CDCl3): δ 7.19-7.17 (d, J = 8.4 Hz, 2H), 6.82-6.81 (d, J = 8.4 
Hz, 2H 5.58 (bm, 1H), 5.07-5.04 (bm, 1H), 4.56 (bs, 1H), 4.16-4.10 (m, 2H), 3.76 
(s, 3H), 2.96 (bs, 1H) 1.42 (s, 9H) 1.26-1.23 (t, J = 7.2 Hz, 3H); 13C NMR (150 
MHz, CDCl3): δ 171.9, 159.3, 154.9, 128.9, 128.6, 113.7, 79.8, 73.2, 62.0, 55.9, 
55.2, 55.1, 28.3, 14.1; IR (thin film cm-1): 3392, 2979, 2935, 1715, 1613, 1512, 
1366, 1299, 1249, 1167, 1118, 1031, 933, 882, 848, 735; TLC (20% 
EtOAc/hexanes): RF 0.15; HRMS (ESI): Calcd. for [M + Na]+ C17H25NO6: 
362.1580, Found: 362.1578. SFC analysis: WO column, 5 % modifier, 1.5 
mL/min, 150 bar, 210 nm; tR (minor) = 7.3 min, tR (major) = 8.0 min, 99:1 er; [α]D25 -
155.3 (c = 0.70, CHCl3).  
(2R,3R)-Ethyl 3-((tert-butoxycarbonyl)amino)-3-(4-chlorophenyl)-2-
hydroxypropanoate (43g): The title compound was prepared according to 
General Procedure C (method 1) using 45g (0.5 mmol) affording β-amino-α-
hydroxy ester 43g (0.12 g, 0.34 mmol, 68% overall yield) as a white solid.  
 Analytical data for 42g: 1H NMR (400 MHz, CDCl3): δ 7.35-
7.26 (d, J = 8.4 Hz, 2H), 7.28-7.26 (d, J = 8.4 Hz, 2H), 6.03-
6.01 (d, J = 6.4 Hz, 1H), 5.67-5.65 (bd, 1H) 4.27-4.18 (m, 2H), 1.41 (s, 9H), 1.27-
1.23 (t, J = 7.2 Hz, 3H).  
Analytical data for 43g: mp 128-129 °C; 1H NMR (400 MHz, 
CDCl3): δ 7.29-7.26 (d, J = 8.4 Hz, 2H), 7.22-7.19 (d, J = 8.4 Hz, 
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2H), 5.60-5.57 (d, J = 7.6 Hz, 1H), 5.09-5.07 (bm, 1H), 4.57-4.55 (bm, 1H), 4.19-
4.10 (m, 2H), 2.91-2.89 (d, J = 6.0 Hz, 1H) 2.31 (s, 3H), 1.42 (s, 9H) 1.27-1.23 (t, 
J = 7.2 Hz, 3H); 13C NMR (150 MHz, CDCl3): δ 171.7, 154.9, 135.5, 134.0, 128.9, 
128.6, 80.1, 72.9, 62.3, 55.9, 28.3, 14.1; IR (thin film cm-1): 3385, 2979, 2933, 
1716, 1492, 1392, 1367, 1249, 1168, 1116, 1015, 883, 849, 737; TLC (20% 
EtOAc/hexanes): RF 0.24; HRMS (ESI): Calcd. for [M + Na]+ C16H22ClNO5: 
366.1085, Found: 366.1082 HPLC analysis: Chiralpak IA, H/IPA = 96:4, flow rate 
= 1.0 mL/min, 210 nm; tR (minor) = 18.0 min, tR (major) = 24.7 min, 98:2 er; [α]D25 -
242.3 (c = 0.8, CHCl3).  
(2R,3R)-Ethyl 3-(benzo[d][1,3]dioxol-5-yl)-3-((tert-butoxycarbonyl)amino)-2-
hydroxypropanoate (43h): The title compound was prepared according to 
General Procedure C (method 1) using 45h (0.5 mmol) affording β-amino-α-
hydroxy ester 43h (0.14 g, 0.39 mmol, 78% overall yield) as a white solid. The 
product was recrystallized using 20% Et2O/hexanes. 
 Analytical data for 42h: 1H NMR (400 MHz, CDCl3, rotamers 
observed): δ 6.77-6.74 (m, 3H), 5.93 (bs, 3H), 5.61-5.59 (d, J = 
5.2 Hz, 1H), 4.24-4.17 (m, 2H) 1.39 (s, 9H), 1.26-1.22 (t, J = 7.2 Hz, 3H); 13C 
NMR (150 MHz, CDCl3): δ 188.9, 159.6, 154.7, 148.2, 148.1, 127.0, 122.3, 108.7, 
108.7, 101.3, 80.2, 62.6, 60.4, 30.8, 28.1, 13.7.  
Analytical data for 43h: mp 112.4-112.8 °C; 1H NMR (400 MHz, 
CDCl3, rotamers observed): δ 6.78 (s, 1H), 6.71 (s, 2H) 5.94-
5.93 (m 2H), 5.55-5.53 (d, J = 8 Hz, 1H), 4.55-4.53 (t, J = 3.2 Hz, 
1H), 4.20-4.11 (m, 2H), 2.90-2.89 (d, J = 6.4 Hz, 1H), 1.43 (s, 9H) 1.28-1.25 (t, J 
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= 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 171.8, 154.9, 147.7, 147.4, 121.0, 
108.1, 107.9, 101.1, 79.9, 73.2, 62.1, 56.3, 28.3, 14.1; IR (thin film cm-1): 3393, 
2979, 1715, 1505, 1489, 1445, 1367, 1247, 1167, 1038, 933; TLC (25% 
EtOAc/hexanes): RF 0.20; HRMS (ESI): Calcd. for [M + H]+ C17H23NO7: 354.1553, 
Found: 354.1566. HPLC analysis: Chiralpak IA, H/IPA = 90:10, flow rate = 1.0 
mL/min, 210 nm; tR (minor) = 12.4 min, tR (major) = 14.4 min, 98:2 er (>99.5:0.5 
recryst.); [α]D25 -55.4 (c = 0.35, CHCl3).  
(2R,3R)-Ethyl 3-((tert-butoxycarbonyl)amino)-2-hydroxy-3-(4-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propanoate (43i): The title 
compound was prepared according to General Procedure C (method 1) using 45i 
(0.5 mmol) affording β-amino-α-hydroxy ester 43i (0.16 g, 0.38 mmol, 76% 
overall yield) as a clear oil.  
  Analytical data for 42i: 1H NMR (400 MHz, CDCl3): δ 
7.81-7.79 (m, 2H), 7.35-7.33 (m, 2H), 6.08-6.07 (d, J = 6.8 
Hz, 1H), 5.67-5.66 (d, J = 6.0 Hz, 1H), 4.22-4.17 (m, 2H) 
1.42 (s, 9H), 1.34 (s, 12H), 1.26-1.23 (t, J = 7.2 Hz, 3H); 13C NMR (150 MHz, 
CDCl3): δ 189.2, 159.5, 154.6, 136.6, 135.3, 127.7, 83.9, 80.3, 62.7, 61.2, 28.2, 
24.8. 
Analytical data for 43i: 1H NMR (400 MHz, CDCl3): δ 7.74-
7.72 (d, J = 7.6 Hz, 2H), 7.26-7.24 (m, 2H), 5.66-5.64 (d, J 
= 8.4 Hz, 1H), 5.12-5.11 (d, J = 6 Hz, 1H), 4.55 (bs, 1H), 
4.16-4.07 (m, 2H), 2.95-2.93 (d, J = 6.0 Hz, 1H), 1.41 (s, 9H), 1.32 (s, 12H), 1.26-
1.23 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 171.8, 154.9, 139.8, 134.8, 
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126.8, 83.8, 79.9, 73.1, 62.1, 56.6, 29.7, 28.3, 28.2, 24.9, 24.8, 14.1; IR (thin film 
cm-1): 3364, 2979, 1716, 1614, 1507, 1361, 1261, 1145, 1022, 962, 858, 803, 
660, 578; TLC (25% EtOAc/hexanes): RF 0.28; HRMS (ESI): Calcd. for [M + H]+ 
C22H37BNO7: 436.2506, Found: 436.2529. SFC analysis: AS column, 2% MeOH, 
1.5 mL/min, 150 bar, 210 nm; tR (minor) = 9.5 min, tR (major) = 12.9 min, 99:1 er; 
[α]D25 -20.53 (c = 0.40, CHCl3). 
(2R,3R,E)-Ethyl 3-((tert-butoxycarbonyl)amino)-2-hydroxy-5-phenylpent-4-
enoate (43j): The title compound was prepared according to General Procedure 
C (method 2) using 45j (0.5 mmol) affording β-amino-α-hydroxy ester 43j (0.07 g, 
0.22 mmol, 43% overall yield) as a clear oil.  
 Analytical data for 42j: 1H NMR (600 MHz, CDCl3): δ 7.36-
7.25 (m, 5H), 6.74-6.71 (d, J = 6.2 Hz, 1H), 6.10-6.07 (dd, J = 
15.6 Hz, 4.8 Hz, 1H), 5.68 (bs, 1H), 4.38-4.31 (m, 2H) 1.45 (s, 9H), 1.36-1.33 (t, J 
= 7.2 Hz, 3H); 13C NMR (150 MHz, CDCl3): δ 189.5, 160.0, 154.7, 136.2, 135.6, 
128.6, 128.5, 126.7, 121.0, 80.4, 62.9, 59.0, 28.2, 13.9.  
 Analytical data for 43j: 1H NMR (150 MHz, CDCl3) 43j exists 
as rotamers at room temperature in analogy to 1o: δ 7.33-7.28 
(m, 4H), 7.25-7.24 (m, 1H), 6.61-6.58 (d, J = 16.2 Hz, 1H), 6.05-6.02 (dd, J = 
16.2 Hz, 7.8 Hz, 1H), 5.24-5.22 (d, J = 9 Hz, 1H), 4.73 (bs, 1H), 4.31-4.20 (m, 
2H), 3.12 (bs, 1H), 1.46 (s, 9H), 1.29-1.25 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, 
CDCl3): δ 172.3, 155.1, 136.2, 133.7, 128.5, 128.0, 126.6, 123.2, 79.9, 73.0, 62.2, 
55.2, 28.4, 14.2; IR (thin film cm-1): 3383, 2979, 2931, 1716, 1497, 1367, 1247, 
1168, 1101, 1020, 748, 694; TLC (25% EtOAc/hexanes): RF 0.31; HRMS (ESI): 
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Calcd. for [M + H]+ C18H25NO5: 336.1811, Found: 336.1825. SFC analysis: OD 
column, 1.5% MeOH, 1.5 mL/min, 150 bar, 210 nm; tR (minor) = 29.5 min, tR (major) = 
32.2 min, 92:8 er; [α]D25  -158.96 (c = 0.25, CHCl3). 
(2R,3R)-Ethyl 3-((tert-butoxycarbonyl)amino)-2-hydroxy-3-(naphthalen-2-
yl)propanoate (43k): The title compound was prepared according to General 
Procedure C (method 1) using 45k (0.5 mmol) affording β-amino-α-hydroxy ester 
43k (0.15 g, 0.41 mmol, 82% overall yield) as a white solid. The product was 
recrystallized using 20% Et2O/hexanes. 
  Analytical data for 42k: 1H NMR (400 MHz, CDCl3, rotamers 
observed): δ 7.86-7.79 (m, 4H), 7.51-7.49 (m, 2H), 7.45-7.43 
(m, 1H), 6.25-6.23 (d, J = 6.8 Hz, 1H), 4.23-4.14 (m, 2H) 1.43 (s, 9H), 1.23-1.19 
(t, J = 7.2 Hz, 3H); 13C NMR (150 MHz, CDCl3): δ 189.3, 159.6, 154.7, 133.3, 
131.1, 129.3, 128.2, 128.1, 127.7, 126.8, 126.6, 125.6, 80.4, 62.8, 61.1, 28.3, 
13.8.  
  Analytical data for 43k: mp 123.4-124.2 °C; (400 MHz, CDCl3, 
rotamers observed): δ 7.81-7.77 (m, 3H), 7.73 (bs, 1H), 7.48-
7.45 (m, 2H), 7.41-7.31 (m, 1H), 5.75-5.74 (d, J = 7.6 Hz, 1H), 5.30-5.28 (d, J = 
8.0 Hz, 1H), 4.66-4.65 (d, J = 2.8 Hz, 1H), 4.15-4.09 (q, J = 7.2 Hz, 2H), 2.99-
2.97 (d, J = 6 Hz, 1H), 1.43 (s, 9H), 1.25-1.22 (t, J = 7.2 Hz, 3H); 13C NMR (100 
MHz, CDCl3): δ 171.8, 155.0, 134.4, 133.0, 128.1, 127.9, 127.6, 126.7, 126.2, 
126.1, 125.2, 79.9, 73.3, 62.1, 56.7, 28.3, 14.1; IR (thin film cm-1): 3393, 2979, 
2934, 1714, 1499, 1367, 1248, 1166, 1020, 859, 749; TLC (25% 
EtOAc/hexanes): RF 0.31; HRMS (ESI): Calcd. for [M + H]+ C20H25NO5: 360.1811, 
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Found: 360.1827. SFC analysis: AS column, 3% MeOH, 1.5 mL/min, 150 bar, 
210 nm; tR (minor) = 12.9 min, tR (major) = 15.9 min, 97:3 er (>99.5:0.5 recryst.); [α]D25 
-159.0 (c = 0.25, CHCl3)  
(2R,3S)-Ethyl 3-((tert-butoxycarbonyl)amino)-3-(furan-2-yl)-2-
hydroxypropanoate (43l): The title compound was prepared according to 
General Procedure C (method 1) using 45l (0.5 mmol) affording β-amino-α-
hydroxy ester 43l (0.10 g, 0.33 mmol, 66% overall yield) as a white solid.  
 Analytical data for 42l: 1H NMR (600 MHz, CDCl3): δ 7.36-7.26 (m, 
1H), 6.36-6.33 (m, 2H), 6.19-6.18 (m, 1H), 5.56 (bs, 1H), 4.25-4.22 
(m, 2H) 1.40 (s, 9H), 1.26-1.24 (m, 3H); 13C NMR (150 MHz, CDCl3): δ 187.2, 
159.5, 154.7, 146.1, 143.7, 111.0, 110.3, 80.5, 62.7, 54.7, 28.1, 13.7.  
 Analytical data for 43l: mp 65.2-65.8 °C; 1H NMR (400 MHz, 
CDCl3): δ 7.32-7.31 (m, 1H), 6.30-6.29 (m, 1H), 6.21-6.20 (d, J = 
3.6 Hz, 1H), 5.48-5.45 (d, J = 8.4 Hz, 1H), 5.27-5.26 (m, 1H), 4.50 (bs,1H), 4.26-
4.19 (m, 2H), 3.00 (bs, 1H), 1.45 (s, 9H), 1.28-1.25 (t, J = 7.2 Hz, 3H); 13C NMR 
(100 MHz, CDCl3): δ 171.6, 154.9, 150.6, 142.3, 110.2, 107.7, 80.1, 77.2, 62.0, 
51.4, 28.2, 28.1, 14.0; IR (thin film cm-1): 3383, 2979, 2934, 1716, 1501, 1368, 
1251, 1166, 1012, 875, 741, 599; TLC (25% EtOAc/hexanes): RF 0.34; HRMS 
(ESI): Calcd. for [M + H]+ C14H21NO6: 300.1447, Found: 300.1458. HPLC 
analysis: Chiralpak IA, H/IPA = 90:10, flow rate = 1.0 mL/min, 210 nm; tR (minor) = 
12.3 min, tR (major) = 16.8 min, 95:5 er (>99.5:0.5 recryst.); [α]D25 = -92.2 (c = 1.1, 
CHCl3). 
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(2R,3S)-Ethyl 3-((tert-butoxycarbonyl)amino)-2-hydroxy-3-(thiophen-2-
yl)propanoate (43m): The title compound was prepared according to General 
Procedure C (method 1) using 45m (0.5 mmol) affording β-amino-α-hydroxy 
ester 43m (0.11 g, 0.35 mmol, 69% overall yield) as a white solid.  
  Analytical data for 42m: 1H NMR (400 MHz, CDCl3): δ 7.29-7.28 
(dd, J = 4.8 Hz, 1.2 Hz, 1H), 6.96-6.92 (m, 2H), 6.29-6.27 (d, J = 
6.8 Hz, 1H), 5.61-5.60 (d, J = 5.6 Hz, 1H), 4.25-4.19 (m, 2H) 1.39 (s, 9H), 1.25-
1.22 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 187.7, 159.6, 154.5, 135.5, 
127.6, 127.3, 127.2, 80.5, 77.2, 62.7, 55.6, 28.1, 13.7. 
 Analytical data for 43m: mp 68.6-70.2 °C; 1H NMR (400 MHz, 
CDCl3): δ 7.20-7.19 (d, J = 4.8 Hz, 1H), 6.96-6.91 (m, 1H), 5.50-
5.44 (m, 2H), 4.58-4.57 (d, J = 2.8 Hz, 1H), 4.18-4.13 (q, J = 7.2 Hz, 2H), 3.20-
3.19 (d, J = 1.6 Hz, 1H), 1.43 (s, 9H), 1.25-1.21 (t, J = 7.2 Hz, 3H); 13C NMR (100 
MHz, CDCl3): δ 171.5, 154.7, 138.9, 126.5, 126.1, 125.3, 80.1, 72.9, 62.2, 52.8, 
28.3, 14.0; IR (thin film cm-1): 3393, 2979, 2934, 1715, 1498, 1367, 1249, 1166, 
1114, 1020, 877, 704; TLC (25% EtOAc/hexanes): RF 0.38; HRMS (ESI): Calcd. 
for [M + H]+ C14H21NO5S: 316.1218, Found: 316.1229. SFC analysis: AS column, 
3% MeOH, 1.5 mL/min, 150 bar, 210 nm; tR (minor) = 6.1 min, tR (major) = 7.3 min, 
97:3 er (99:1 recryst.); [α]D25 -272.6 (c = 0.5, CHCl3). 
tert-butyl 2-((1R,2R)-1-((tert-butoxycarbonyl)amino)-3-ethoxy-2-hydroxy-3-
oxopropyl)-1H-indole-1-carboxylate (43n): The title compound was prepared 
according to General Procedure C (method 2) using 45n (0.5 mmol) affording β-
amino-α-hydroxy ester 43n (0.09 g, 0.20 mmol, 40% overall yield) as a white 
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solid. Due to partial epoxidation, β-amino-α-keto ester 42n was never formed 
cleanly and the crude reaction mixture was simply subjected to the reduction 
conditions.  
 Analytical data for 43n: mp 70-72 °C; 1H NMR (600 MHz, 
CDCl3): δ 8.1 (bs, 1H), 7.66-7.64 (d, J = 7.8 Hz, 1H), 7.32-7.28 
(t, J = 7.2 Hz, 1H), 7.25-7.22 (t, J = 7.2 Hz, 1H), 5. 48-5.46 (dd, 
J = 9.0 Hz, 1H), 5.41-5.38 (d, J = 9 Hz, J = 2.4 Hz, 1H), 4.71-4.69 (dd, J = 6.0 Hz, 
J = 2.4 Hz, 1H), 4.10-4.07 (m, 1H), 4.06-3.96 (m, 1H), 3.19-3.18 (d, J = 6.0 Hz, 
1H), 1.66 (s, 9H), 1.44 (s, 9H), 1.17-1.14 (t, J = 7.2 Hz, 3H); 13C NMR (150 MHz, 
CDCl3): δ 172.0, 155.0, 124.7, 124.2, 122.6, 119.5, 115.2, 84.0, 80.0, 72.8, 62.2, 
49.3, 28.3, 28.2, 13.9; IR (thin film cm-1): 3384, 2978, 1734, 1717, 1540, 1520, 
1507, 1456, 1373, 1255, 1157, 1019, 857, 748; TLC (20% EtOAc/hexanes): RF 
0.15; HRMS (ESI): Calcd. for [M + Na]+ C23H32N2O7: 471.2108, Found: 471.2108. 
SFC analysis: WO column, 5 % modifier, 1.5 mL/min, 150 bar, 210 nm; tR (minor) = 
13.0 min, tR (major) = 12.2 min, 97:3 er; [α]D25 -247.5 (c = 1.25, CHCl3).  
(2R,3R)-Ethyl 3-((tert-butoxycarbonyl)amino)-2-hydroxy-5-phenylpentanoate 
(43o): The title compound was prepared according to General Procedure C 
(method 1) using 45o (0.5 mmol) affording β-amino-α-hydroxy ester 43o (0.11 g, 
0.32 mmol, 63% overall yield) as a white solid.  
 Analytical data for 42o: 1H NMR (400 MHz, CDCl3): δ 7.30-
7.28 (m, 2H), 7.21-7.16 (m, 3H), 5.21-5.19 (d, J = 8 Hz, 1H), 
4.93 (bs, 1H), 4.32-4.27 (q, J = 7.2 Hz, 2H), 2.73-2.69 (m, 2H), 2.25-2.23 (m, 1H), 
1.89-1.84 (m, 1H), 1.45 (s, 9H), 1.34-1.31 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, 
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CDCl3): δ 193.1, 160.4, 155.2, 140.3, 128.5, 128.3, 126.2, 80.2, 77.2, 62.5, 56.7, 
32.7, 31.6, 29.6, 28.2, 13.8. 
Analytical data for 43o: mp 84.8-85.6 °C; 1H NMR (400 MHz, 
CDCl3): δ 7.28-7.26 (m, 2H), 7.21-7.19 (m, 3H), 4.83-4.80 (d, J 
= 10 Hz, 1H), 4.26-4.11 (m, 4H), 3.28 (bs, 1H), 2.73-2.68 (m, 2H), 1.94-1.88 (q, J 
= 7.6 Hz, 2H), 1.41 (s, 9H), 1.32-1.28 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, 
CDCl3): δ 173.6, 155.3, 141.5, 128.4, 128.3, 125.9, 79.4, 72.2, 62.2, 52.7, 34.3, 
32.4, 28.2, 14.0; IR (thin film cm-1): 3371, 2979, 2932, 1715, 1498, 1455, 1391, 
1366, 1247, 1170, 1107, 1028, 861, 754, 700; TLC (20% EtOAc/hexanes): RF 
0.34; HRMS (ESI): Calcd. for [M + H]+ C18H27NO5: 338.1967, Found: 338.1983. 
HPLC analysis: Chiralpak IB, H/IPA = 95:05, flow rate = 1.0 mL/min, 210 nm; tR 
(minor) = 11.8 min, tR (major) = 8.2 min, 60:40 er ; [α]D25 +55.9 (c = 0.75, CHCl3). 
2.5.7 Synthesis of (+)-47 from epoxide 46 
 
Step 1: A 1 dram vial equipped with a magnetic stir bar was charged with epoxide 
4659 (1.0 mmol, 1 equiv), NaN3 (2.0 mmol, 2 equiv), NH4Cl (100 mmol, 100 equiv), 
and 80% EtOH/H2O (.05 M). The reaction mixture was heated to 65 °C for 18 h 
then diluted with DCM and water. The organic layer was separated, and the 
aqueous layer was extracted with DCM (2 x 50 mL). The combined organic 
extracts were dried over Na2SO4, filtered and concentrated in vacuo. The product 
was purified via flash chromatography using 15% EtOAc/hexanes as the eluent 
(0.8 mmol, 80%). Spectral data for the azide matched literature reports.11 
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Step 2: A flame dried 20 mL scintillation vial equipped with a magnetic stir bar 
was charged with 10% Pd/C (42.0 mg). To the vial was added degassed ethanol 
(8 mL) and the β-azido-α-hydroxy ester (0.8 mmol, 1 equiv). The reaction vessel 
was purged with H2 (3 times), then put under 1 atm of H2 (balloon). The reaction 
mixture was stirred for 24 h, filtered through a plug of celite, then concentrated in 
vacuo providing 47 without need for further purification (0.78 mmol, 98% yield.)  
Analytical data for (2R,3R)-ethyl 3-amino-2-hydroxy-3-phenylpropanoate (+)-47: 
1H NMR (400 MHz, CDCl3): δ 7.31-7.26 (m, 5H), 6.96-6.91 (m, 1H), 4.45-4.44 (d, 
J = 4.0 Hz, 1H), 4.32-4.31 (d, J = 3.6 Hz, 1H), 4.12-4.07 (m, 2H), 2.27 (bs, 3H), 
1.18-1.15 (t, J = 7.2 Hz, 3H); 13C NMR (150 MHz, CDCl3): δ 172.5, 128.6, 128.3, 
127.7, 127.3, 126.9, 74.8, 61.5, 58.2, 14.0; IR (thin film cm-1): 2924, 1733, 1558, 
1541, 1507, 1457, 1209, 1073, 1024, 700; TLC (6% MeOH/DCM): RF 0.19; 
HRMS (ESI): Calcd. for [M + H]+ C11H15NO3: 210.1130, Found: 210.1126.; [α]D25 
= +200.75 (c = 0.66, CHCl3). 
2.5.8 Synthesis of (+)-43b from 47 
 
To a flame dried 1-dram vial equipped with a magnetic stir bar was added (+)-47 
(0.05 mmol, 1 equiv), THF (0.5 mL), and Et3N (0.05 mmol, 1 equiv). The vial was 
cooled to 0 °C followed by the addition of benzyl chloroformate (0.05 mmol, 1 
equiv). The reaction was slowly warmed to room temperature then diluted with 
EtOAc and water. The organic layer was washed with water (3 x 10 mL), brine, 
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and dried over Na2SO4. Concentration in vacuo afforded the α-hydroxy ester 
which was purified by flash chromatography using 30% EtOAc/Hexanes 
providing 43b (0.03 mmol, 62% yield). SFC analysis: WO column, 7% MeOH, 1.5 
mL/min, 150 bar, 210 nm; tR (minor) = 12.0 min, tR (major) = 9.5 min, 94:6 er.  
2.5.9 Boc Deprotection of 43a 
 
A 1 dram vial equipped with a magnetic stir bar was charged with 43a (0.1 mmol, 
1 equiv), and DCM (.8 mL, .12 M). Trifluoroacetic acid (2.5 mmol, 25 eq) was 
then added and stirred at room temperature for 2 hours followed by removal of 
solvent in vacuo. Crude extracts were dissolved in EtOAc. The organic layer was 
washed with water (3 x 10 mL), brine, and dried over Na2SO4. Concentration in 
vacuo afforded the deprotected product (0.07 mmol, 72%) whose analytical 
properties matched those of independently synthesized (+)-47 [α]D25 -275.92 (c = 
0.50, CHCl3). 
2.5.10 Cbz Deprotection of (−)-43b 
 
 To a flame dried 1 dram vial equipped with a magnetic stir bar was added 
with 43b (0.1 mmol, 1 equiv), and CHCl3 (1.0 mL, 0.1 M). Trimethylsilyl iodide 
(0.25 mmol, 2.5 equiv) was then added dropwise stirred at rt for 25 min followed 
by removal of solvent in vacuo. The product was purified via flash 
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chromatography using 6% MeOH/DCM as the eluent, providing amino alcohol 47 
(0.8 mmol, 80%), whose analytical properties (except for rotation) matched those 
of independently synthesized (+)-47.  
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CHAPTER 3 
 
N-HETEROCYCLIC CARBENE-CATALYZED DYNAMIC KINETIC 
RESOLUTIONS OF β-STEREOGENIC α-KETO ESTERS 
 
3.1 Introduction 
 Our research efforts into the ATH-DKR of α-keto esters illustrated that the 
kinetic acidity of selected β-stereogenic α-keto esters was sufficient for reductive 
transformations (Chapter 2). We were cognizant that using carbon-based 
nucleophiles in a DKR of α-keto esters would provide expeditious access to a 
host of chemically diverse glycolates not available via simple hydrogenation. To 
this end we examined the addition of enolates, indoles, and various allylation 
strategies as platforms for asymmetric dynamic addition of carbon nucleophiles 
to β-halo α-keto esters (Scheme 1); however our efforts did not provide tractable 
methods for any of these additions. 
 Scheme 1. Attempted Carbon Based Nucleophile Additions to β-Halo 
 α-Keto Esters 
 
 
 Concurrent with these unsuccessful investigations our group was able to 
achieve highly stereoselective DyKAT addition of both nitromethane and acetone 
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to β-bromo α-keto ester 1 under the control of cinchona alkaloid derived catalysts 
3 and 5 respectively (Scheme 2).1 As we continued evaluating potential carbon 
based nucleophiles our attention was drawn to the use of NHC catalysts for 
promoting both dynamic cross-benzoin and homoenolate couplings. 
 Scheme 2. DyKAT Addition of Acetone and Nitromethane to β-Bromo 
 α-Keto Esters 
 
 
 We believe these reactions to be well suited to our intended goal for a 
number of reasons including 1) the wide breadth of available chiral NHC catalysts, 
2) the utility of the installed carbonyl functional groups, and 3) the tolerance of 
this catalyst class to basic conditions (advantageous for ensuring facile substrate 
racemization). To this latter point, NHC catalysts had previously been deployed in 
a successful resolution manifold where substrate enantiomerization was 
mandatory. Scheidt demonstrated the NHC-catalyzed DKR transformation of β-
keto ester 6 forming β-lactone 8 in good yield and stereoselectivity via the 
intermediacy of an azolium enolate (Scheme 3).2,3 This report was of particular 
interest to us as  the enantiomerization of 6 occurs via Hünig’s base mediated 
enolization. NHC-catalyzed simple kinetic resolutions were also known for both [3 
+ 3] and [3 + 4] cycloadditions of azomethine imines and enals.4,5 
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 Scheme 3. NHC Catalyzed DKR for the Formation of β-Lactones 
 
 In light of these previous works, we began examining dynamic NHC 
catalyzed cross-benzoin and homoenolate couplings of aldehydes with β-halo α-
keto esters (Scheme 4); these studies are the focus of this chapter.  
 Scheme 4. Proposed NHC catalyzed DKR of β-Halo α-Keto Esters 
 
 
3.2 Dynamic Kinetic Asymmetric Cross-Benzoin Additions of β-Stereogenic 
α-Keto Esters* 
 
 The benzoin condensation is a carbene- or cyanide-catalyzed reaction 
that couples two carbonyl compounds to give α-hydroxy ketones via carbon-
carbon bond formation. The reaction proceeds with concurrent generation of a 
stereogenic center and is the archetype of a catalytic umpolung (polarity 
inversion) reaction.6-12 Its significance and widespread use largely flow from two 
defining characteristics: (1) its capacity to generate useful and ubiquitous α-
                                         
*Reproduced in part by permission of the American Chemical Society: Goodman, C. G.; Johnson, J. S. J. Am. Chem. Soc. 
2014, 136, 14698-14701. 
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hydroxy ketones, and (2) the 100% atom efficiency inherent to the reaction. As a 
consequence, significant research effort has been devoted to various aspects of 
the transformation.  
 A host of methods exist for the asymmetric homobenzoin reaction (the 
coupling of two identical aldehydes).13-18 The union of two different carbonyls 
(cross-benzoin addition) poses a unique challenge in controlling the 
chemoselectivity of these reactions (i.e. constitutional isomer distribution), 
particularly in the intermolecular manifold; however, it presents the possibility of 
accessing a more diverse set of α-hydroxy ketones.19-21 
Multiple asymmetric cross-benzoin additions have been achieved through the 
deployment of miscellaneous strategies and reagents using enzymatic22-27  and 
metallophosphite26  catalysis. Of greater interest to us were reports which 
detailed the use of carbene29-32 catalysts; in separate communications, Zeitler 
and Gravel reported cross-benzoin couplings with α-keto esters.
 The first of these uses pyroglutamic acid derived NHC precatalyst 11 for 
the coupling of α-keto ester 9  and acetaldehyde providing α-hydroxy ketone 12 
in 48% yield and 76% ee (Scheme 5A).31 Subsequently it was reported that the 
carbene generated from salt 15 exhibited a signficant improvement in 
enantioselection and yield for coupling of aliphatic aldehydes and aryl α-keto 
esters (Scheme 5B).32  
 As we surveyed the literature we were cognizant that a limitation in all of 
these methods is that they generate only a single stereocenter during the C-C 
bond forming event. A non-enzymatic cross-benzoin coupling that generated 
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more than one stereocenter, and thus a higher level of complexity, had not been 
reported previous to our work.33 Generating vicinal stereocenters during the 
cross-benzoin C−C bond construction with excellent levels of diastereo- and 
enantiocontrol was anticipated to be challenging. 
 Scheme 5. NHC-Catalyzed Cross-Benzoin Couplings with α-Keto 
 Esters 
 
 
 Additionally while the cross-benzoin procedures noted above do utilize α-
keto esters, all previous asymmetric examples have used ketones bearing 
aromatic substituents, rendering them more electrophillic as well as non-
enolizable.30,31 In order for a NHC-catalyzed DKR to be achieved, the previously 
unknown use of enolizable α-keto esters was compulsory.  Aside from potentially 
deleterious effects on simple electrophile reactivity, this structural change also 
brings with it the possibility of undesired homo- and cross-aldolization in addition 
to the known benzoin dimerization (Scheme 6).  We were aware that our 
projected reaction conditions were mechanistically viable for promoting all of 
these processes.15-18,34,35 Accordingly, we sought to identify conditions that would 
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chemoselectively deliver the cross-benzoin product while fulfilling the required 
parameters for a DKR. 
 Scheme 6. Chemoselectivity Challenges for the Coupling of 
 Aldehydes (blue) and Enolizable α-Keto Esters (red) in the 
 Presence of Base and Carbene 
 
 
 
 With these challenges in mind we began by examining the coupling of 
benzaldehyde and β-chloro-α-keto ester 17a. Using NHC catalyst 19,36 glycolate 
18a was delivered with 96:4 er, and 4.5:1 dr, but only 25% conversion of 17a 
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the irreversible nature of formation, or heightened nucleophilicity, of the Breslow 
intermediate is critical for reactivity38 The importance of using an electron rich 
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catalysts 1530 and 2232 routinely gave low conversion of starting material (Table 
1, entries 3, 5, 7 and 9).  
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K2CO3 were optimal, providing tertiary alcohol 18b with >20:1 diastereoselection 
and 96:4 er (Table 1, entry 10). Efforts to further increase stereoselectivity via 
introduction of steric bulk at the ester position only resulted in reduced reactivity 
and stereoselectivity (Table 1, entry 11). Under identical conditions chloro variant 
17a delivered ketone 18a with identical enantioselectivity, but a dr of 14:1 (Table 
1, entry 12). Due to the higher sense of diastereoselection, we elected to 
examine the scope of the reaction using β-bromo-α-keto esters.  
 Next we began modifying the structure of 17 in order to probe the 
allowable steric and electronic parameters of this cross-benzoin process 
(Scheme 7). Varying the arene on the α-keto ester delivered 18c and 18e without 
loss of reaction fidelity. Removing the arene as well as changing the carbon 
chain length provided 18d, 18f, and 18g cleanly with high stereoselectivity. 
Inclusion of a β-branch point gave product 18h with >20:1 dr and 94:6 er, albeit in 
only 60% conversion of starting material (as measured by 1H NMR using an 
internal mesitylene standard.) 
Variation of the aldehyde also provided data regarding reaction generality. 
While both para- and meta-tolualdehyde were well tolerated (18i and 18j), ortho-
tolualdehyde proved to be too sterically encumbered, giving no reaction. 
Electron-rich and -poor aldehydes were slow to react providing 18l and 18m with 
good stereoselectivity but incomplete conversion after 18 h. While longer reaction 
time did not increase the yield, a slight increase in catalyst loading provided full 
conversion of the β-bromo α-keto ester (20 mol % catalyst loading was only 
required for substrate 17m).18  
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 Table 1: Catalyst and Substrate Optimization for the Asymmetric 
 Cross-Benzoin 
 
entry X catalyst solvent conv. 
(%) 
drb erc 
1 Cl 19 THF 25 4.5:1 96:4 
2 Cl 20 THF 100 14:1 95:5 
3 Cl 15 THF 40 1.5:1 98:2 
4 Cl 21 THF 100 >20:1 90:10 
5 Br 19 THF <5 -- -- 
6 Br 20 THF >95 >20:1 94:6 
7 Br 15 THF <5 -- -- 
8 Br 21 THF 30 -- -- 
9 Br 22 THF <5 -- -- 
10 Br 20 TBME 100 >20:1 96:4 
11d Br 20 TBME 54 17:1 81:19 
12 Cl 20 TBME 100 14:1 96:4 
a) All reactions were run on a 0.10 mmol scale. b) Determined by 1H NMR 
analysis of the crude reaction mixture. c) Determined by chiral SFC analysis. d) 
Run with the iPr ester. 
Heteroaromatic 18n was isolated in >20:1 dr, and 75:25 er, while indole-
derived 18p was obtained with 10:1 dr and 98:2 er. One limitation of this method 
at the current level of development is the requirement of aromatic aldehydes in 
order to achieve high enantioselectivity, highlighted by the use of  
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 Scheme 7. Cross-Benzoin Additions of Aldehydes to β-Bromo α-Keto 
 Estersa 
 
 
a) All reactions were run on a 0.20 mmol scale at room temperature for 16 h. 
Diastereomeric ratios were determined by 1H NMR, enantiomeric ratios by chiral 
HPLC or SFC. Yields are of isolated products. b) Yield in parentheses represents 
a 1H NMR yield utilizing ferrocene as an internal standard c) The product was 
reduced with NaBH4 and the e.r. of the diol was analyzed. d) Yield in parentheses 
represents a 1H NMR yield utilizing mesitylene as an internal standard. e) The 
mass balance is unreacted α-keto ester. f) Reaction was run using 20 mol % of 
catalyst 20. g) Isolated yield is reported for the diol formed via reduction of 18p 
with NaBH4. The enantiomeric ratio was determined via Mosher ester analysis of 
the isolated diol.  
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isobutyraldehyde, which provided 18o with 14:1 diastereoselectivity but only 
54:46 er. 
Coupling of 17b with benzaldehyde on a 1 g scale resulted in 91% yield of 18b 
without loss of stereoselectivity and with 74% catalyst recovery. Of particular note 
in this trial was that benzoin 23 was also isolated in 9% yield (Scheme 8).
 Scheme 8. Gram Scale Reaction of 17b and Benzaldehyde 
 
 The obtention of 23 led us to consider the broader question of the 
chemoselectivity in the developed cross-benzoin reaction. We considered the 
possibility that homo-benzoin formation was the faster process, but reversible 
under the reaction conditions. In this scenario the cross-benzoin reaction would 
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corresponding diols 24 with >20:1 diastereoselection for the reduction step 
(Scheme 10).40,41  
 Scheme 9. Determining the Source of the Observed Cross-Benzoin 
 Chemoselectivity 
 
 
 Scheme 11 (top) shows the results of a X-ray diffraction study of 24m, 
carried out to assign the relative and absolute stereochemistries as (1R,2S,3S).42 
By analogy the cross-benzoin adducts were assigned as (2S,3S).   
 Scheme 10. Reduction of the Cross-Benzoin Products  
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selects for the reactive enantiomer of the α-keto ester in part through strong 
facial bias imparted by the indane subunit, but also through the 
orienting/activating effect of the hydroxyl group.46 
The precise orientation of the two reactants with respect to the axis of the 
forming bond (illustrated in red) is not known, but the gross features described 
above are likely to be relevant (Scheme 11 bottom). 
Scheme 11. Absolute and Relative Stereochemistry and Proposed 
Transition State for the Dynamic-Benzoin 
  
 
 At the completion of these studies we had developed the first 
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subsequent investigation into the NHC-catalyzed homoenolate addition of enals 
to  β-halo α-keto esters.  
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3.3 Enantioconvergent Synthesis of Functionalized y-Butyrolactones via 
(3+2)-Annulation** 2 
 
Successful development of a NHC catalyzed dynamic cross-benzoin 
indicated that the proposed dynamic homoenolate addition of enals to β-halo α-
keto esters (Scheme 4) might be viable providing that appropriate catalytic 
conditions could be identified. Developing this specific transformation was 
attractive to us for two primary reasons; 1) it would generate densely 
functionalized and stereocomplex γ-butyrolactones, and 2) it would establish 
three distinct stereocenters during they key C−C bond forming event (Scheme 
12).  
 To this second point, even as the number of dynamic methodologies have 
grown, surprisingly few generate greater than two stereocenters. The conversion 
of racemic alcohols into optically pure acetates enabled by redox processing is a 
prototypical example of a DKR that sets one sterecenter56 (see Chapter 1 for a 
thorough discussion) while most dynamic transformations of configurationally 
labile α- or β-oxo esters (see Chapters 1-3 for a full discussion and specific 
examples) establish two stereocenters.57-61  
 Stereodynamic methods that generate three stereocenters are extremely 
limited.58,62-64 Further most of these methods use catalyst or substrate control to 
independently establish one stereocenter and dynamic bond formation to furnish 
the other two. Our group’s dynamic reduction of β-substituted α-keto esters with 
                                         
**Reproduced in part by permission of the American Chemical Society: Goodman, C. G.; Walker, M. M.; Johnson, J. S. J. 
Am. Chem. Soc. 2015, 137, 122-125. 
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subseqent diastereoselective lactonization discussed in Chapter 2 serves as one 
such example.58 Another case of this ‘2 + 1’ type approach to dynamic 
stereocomplexity is sulfa-Michael addition to nitro-olefin 27 followed by dynamic 
Michael addition to form 30. The initial sulfa-Michael was shown to be reversible 
which renders the the second Michael addition a dynamic process (Scheme 
13A).63 
 Scheme 12. Levels of Stereocomplexity Present in DKR Reactions 
 
A counter-example whereby simultaneous generation of all three 
stereocenters occurs during the same step are reported cross-aldol to chiral 
racemic aldehydes.65-68 In one report, Britton shows aldol addition of ketone 31 to 
in situ generated α-chloro aldehyde 32 producing chlorohydrin 33 in 62% yield, 
2.5:1 dr and 95% ee (Scheme 13B). While proline catalyzes both the chlorination 
of propanal and the aldol addition, the authors took care to demonstrate that 
racemization of α-chloro aldehye 32 outcompetes aldol addition.  
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As we surveyed the litereature, the only previous example of  NHC-
catalyzed DKR that provides simultaneous generation of three stereocenters was 
the NHC catalyzed intramolecular DKR transformation of β-keto esters to β-
lactones (Scheme 3) and there were no examples of stereoconvergent 
homoenolate reactions.2,3  
Our synthetic plan was built on exploitation of homoenolate (d3) 
nucleophiles generated by the union of NHCs and α,β-unsaturated aldehydes.69-
74 Since its simultaneous introduction by Bode and Glorius,69,70 this method of 
catalytic umpolung (polarity inversion) has grown to include the use of imines,75-78 
carbonyls79-84 and Michael acceptors85-91 as electrophilic components. 
Scheme 13. DKR Reactions that Establish Three Stereocenters 
 
 Of greatest relevance to our proposed reactivity, were two reports utilizing 
NHC generated homoenolates in conjunction with linear α-keto ester 
electrophiles. The first of these from the You group demonstrated the addition of 
cinnamaldehyde to aryl α-keto ester 35 generating γ-butyrolactone 36 in low 
1.5:1 dr and with 78% ee (Scheme 14A).92 The issue of diastereocontrol was 
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indirectly addressed by the Scheidt group who utilized ynal 37 in a similar 
annulation to provide 40 containing only a single stereocenter with good 
enantioselectivity (Scheme 14B).82  
 Scheme 14. Previous Homoenolate Additions to Linear α-Keto Esters 
 
 These results indicated that our proposed annulation presented a 
significant challenge in rate constant management. Aside from needing to select 
for a single stereoisomer (out of eight possibilities); by-products arising from NHC 
catalyzed cross-benzoin31,32,61 or enal dimerization,93,94 and base promoted aldol 
or conjugate addition pathways posed a legitimate concern (Scheme 15).35 
 With these difficulties in mind we began our studies by examining the 
reaction of cinnamaldehyde and α-keto ester 17a. A preliminary screen showed 
that NHC catalyst 21 delivers γ-butyrolactone 42a-Me in low regio- and 
diastereoselectivity (Table 2, entry 1).  
Using 41a, which has a more sterically demanding tert-butyl ester, in 
combination with catalyst 21 yielded lactone 42a as a single product in a 6:1 
diastereomeric ratio (dr) (Table 2, entry 2). 
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 Scheme 15. Chemoselectivity Challenges for the Carbene-Catalyzed 
 Coupling of α,β-Enals (blue) and Enolizable α-Keto Esters (red)  
 
 Taking this result as an indication that a sterically hindered ester was likely 
necessary for the efficacy of this transformation, we began a systematic 
screening of carbene catalysts with 41a (complete details for the optimization of 
ester identity, solvent utilized, and catalysts tested can be found in Chapter 3 
Section 5.7). Catalyst 44 and 45 revealed no marked increase in stereoselectivity 
(Table 2, entry 3-4). In tandem, these results indicated that increasing the steric 
bias of phenylalanine derived NHC catalysts was ineffectual to increasing 
reaction selectivity. Aminoindanol-derived catalyst 20 showed poor differentiation 
between the acyl anion and homoenolate pathway yielding a 2:1 ratio of products 
42a/43a (Table 2, entry 5). Catalyst 46 provided 42a as the sole product in 3:1 dr 
and 78:22 er (Table 2, entry 6).  
 Catalyst 47, derived from pyroglutamate, delivered exclusively 42a, in 9:1 
dr and 93:7 er (Table 2, entry 7). Implementation of catalyst 48 furnished 42a as 
a single product in 33:1 dr and 99:1 er (Table 2, entry 8).  
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Table 2: Optimization of the Homoenolate Addition of Enals to α-Keto 
 Esters 
 
 
 
entrya R cat. conv. (%) 42a:43a
b drb,c erd 
1 Me 21 100 5:1 3:1 90:10 
2 tBu 21 100 >20:1 6:1 84:16 
3 tBu 44 88 >20:1 3:1 73:27 
4 tBu 45 64 3.5:1 2:1 85:15 
5 tBu 20 100 2:1 6:1 -- 
6 tBu 46 100 >20:1 3:1 78:22 
7 tBu 47 100 >20:1 9:1 93:7 
8 tBu 48 100 >20:1 33:1 99:1 
9e tBu 48 40 > 20:1 >20:1 -- 
10f tBu 48 100 >20:1 33:1 99:1 
a) All reactions were run on a 0.10 mmol scale. b) Determined by 1H NMR 
analysis of the crude reaction mixture. c) dr is only reported for homoenolate 
product 42a d) Determined by chiral SFC analysis. e) Conducted on the 
corresponding β-bromo analog of 41a. f) 5 mol % of catalyst G. 
 Using the β-bromo α-keto ester of 41a under identical conditions 
maintained high levels of isomer selectivity but suffered from poor reactivity 
(Table 2, entry 9).  Lowering the catalyst loading to 5 mol percent had no 
deleterious effects on reaction efficiency or selectivity (Table 2, entry 10).   
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 With suitable conditions in hand we began to probe the allowable steric 
and electronic parameters of this annulation, initially by varying the identity of the 
α,β unsaturated aldehyde (Scheme 16). Changing the electronic features of the 
aldehyde delivered 42b and 42c without loss of reaction fidelity. While both meta- 
and para-tolyl-derived cinnamaldehydes cleanly delivered 42d and 42e, the 
heightened sense of steric encumbrance of ortho-substitution on the arene 
resulted in no reaction. Similarly, 42g and 42h, products that would arise from the 
addition of a trisubstituted alkene and (Z)-cinnamaldehyde respectively, were 
inaccessible. Heteroaromatic 42i was isolated in 45:1 dr and 98.5:1.5 er while 42j 
was obtained with 6:1 dr and 95:5 er. Products 42k and 42l demonstrated the 
viability of non-aromatic substitution, albeit with low dr for the addition of (E)-4-
oxobut-2-enoic acid ethyl ester.    
 Variation of the α-keto ester also provided information regarding reaction 
scope (Scheme 17). Reducing the chain length of the starting α-keto ester 
delivered 42m with 1.5:1 dr and 94.5:5.5 er. Similarly, 42n was isolated with high 
enantioselectivity but as a 4:1 mix of isomers, while sterically encumbered 41o 
resulted in no reaction. 
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Scheme 16. Variation of α−β Unsaturated Aldehydes in the 
Homoenolate Addition to β-Chloro-α-Keto Estersa 
 
 
a) All reactions were run on a 0.20 mmol scale at room temperature for 14 h. No 
acyl anion addition was observed for any example. Diastereomeric ratios were 
determined by 1H NMR; enantiomeric ratios by chiral SFC. Yields are of isolated 
products. b) Using (Z)-cinnamaldehyde.  
 
 Replacing chloride with fluoride gave 42p in 4:1 dr and 97:3 er. Products 
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substitution while heteroatom containing 42s was obtained in low yield but with 
97.5:2.5 er.   
 Scheme 17. Variation of β-Chloro α-Keto Esters in the Homoenolate 
 Addition of  Cinnamaldehydea 
 
a) All reactions were run on a 0.20 mmol scale at room temperature for 14 h. 
Diastereomeric and product ratios were determined by 1H NMR; enantiomeric 
ratios by chiral SFC. Yields are of isolated products. b) Using THF as the solvent 
c) 1H NMR yield utilizing mesitylene as an internal standard. d) Unambigious 
differentiation between formation of regioisomers and diastereomers was 
impractical, an isomeric ratio is reported. e) Identification of isomeric ratios was 
impossible. Isolation of 42s was achieved via chromatography.     
  
 The reaction of 41a with (E)-3-(thien-2-yl)acrylaldehyde on a 1 g scale 
resulted in 84% yield of 42i as a single stereoisomer. An X-ray diffraction study of 
this product was carried out to assign the relative and absolute stereochemistries 
as (3R,4R,5R) (Scheme 18).95  
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 Scheme 18. Gram Scale Reaction of 41a  
 
 Mechanistically this transformation is proposed to follow a typical 
homoenolate pathway where the conjugated Breslow intermediate is nucleophilic 
at the terminal alkene and catalyst regeneration occurs through tautomerization 
and alcohol acylation with concomitant carbene regeneration (Scheme 19).  
Scheme 19. Proposed Mechanism of the [3 + 2] Annulation 
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this outcome is consistent with diastereocontrol of the key C-C bond formation 
under the control of a Felkin-Anh or Cornforth model.43-45 
 The completion of this method netted the first stereoconvergent 
homoenolate reaction that utilizes racemic electrophiles. This NHC-catalyzed 
process between β-halo α-keto esters and α,β-unsaturated aldehydes constitutes 
a rare intermolecular dynamic kinetic resolution in which three stereocenters are 
established during the enantiodetermining step. The transformation results in 
formation of single product γ-butyrolactones bearing a fully substituted glycolic 
acid moiety in high diastereo- and enantioselectivity. The resultant vector 
between this method’s successful realization and the relative dearth of 
complexity generating DKR’s for β-oxo esters shifted our focus towards 
developing complexity building DKR’s using β-formyl amides; this work is 
discussed in Chapter 4.
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3.4 Experimental Data and Conditions for the Dynamic Kinetic Asymmetric 
Cross-Benzoin Additions of β-Stereogenic α-Keto Esters‡ 3 
 
3.4.1 General Information: 
Methods: Infrared (IR) spectra were obtained using an ASI ReactIR 1000 Fourier 
transform infrared spectrometer. Proton and carbon magnetic resonance spectra 
(1H NMR and 13C NMR) were recorded on a Bruker model DRX 400 or 600 (1H 
NMR at 400 MHz or 600 MHz and 13C NMR at 100 MHz or 150 MHz) 
spectrometer with solvent resonance as the internal standard (1H NMR: CDCl3 at 
7.26 ppm; 13C NMR: CDCl3 at 77.0 ppm). 1H NMR data are reported as follows: 
chemical shift, multiplicity (s = singlet, br s = broad singlet, d = doublet, dd = 
doublet of doublet, t = triplet, dt = doublet of triplet, q = quartet, m = multiplet), 
coupling constants (Hz), and integration. Supercritical fluid chromatography was 
performed on a Berger SFC system equipped with Chiracel AD, AS, OD, and WO 
columns as well as Regis Industries RegisPack (RP) column (φ 4.6 mm x 250 
mm). Samples were eluted with SFC grade CO2 at the indicated percentage of 
methanol with an oven temperature of 40 °C. HPLC analysis was performed on 
an Agilent Technologies 1200 system equipped with Chiralpak IA, IB, and IC 
columns (constant flow at 1.00 mL/min). Samples were eluted with the indicated 
percentages of HPLC grade isopropanol in hexanes. Optical rotations were 
measured using a 2 mL cell with a 1 dm path length on a Jasco DIP 1000 digital 
polarimiter. Mass spectra were obtained using a Micromass Quattro II (triple 
quad) instrument with nanoelectrospray ionization. Samples were prepared via 
                                         ‡
Reproduced in part by permission of the American Chemical Society: Goodman, C. G.; Johnson, J. S. J. Am. Chem. 
Soc. 2014, 136, 14698-14701. 
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diluted with either Methanol (MeOH), 0.1 M ammonium formate (MeOH), or 0.1 M 
formic acid (MeOH). Analytical thin layer chromatography (TLC) was performed 
on Sorbtec 0.25 mm silica gel 60 plates. Visualization was accomplished with UV 
light and/or either aqueous potassium permanganate KMnO4 or aqueous ceric 
ammonium molybdate (CAM) solution followed by heating. Product purification 
was accomplished using Siliaflash-P60 silica gel (40-63 µm) purchased from 
Silicycle. Unless otherwise noted all reactions were carried out in flame-dried 
glassware with magnetic stirring. Yields and diastereomeric ratios (dr) are 
reported for a specific experiment and as a result may differ slightly from those 
found in the reported tables, which represent an average of at least two trials. In 
order to overlay the SFC traces for the chiral and racemic samples two separate 
integrations of the peaks must be taken. This results in slight discrepancies 
between the integration values shown in the report and seen on the trace itself.  
Materials: NHC catalysts 16, 19, 2047,48,32 22,49 β-halo α-keto esters 17a,50 and 1-
tosyl-1H-indole-3-carbaldehyde51 were all prepared according to literature 
procedures. Potassium carbonate was purchased from Sigma Aldrich and dried 
under vacuum (5 torr) for 3 h at 110 °C. Methanol (MeOH) was distilled from 3 Å 
molecular sieves prior to use. HPLC grade chloroform (CHCl3), ethyl acetate 
(EtOAc) and ethanol (EtOH) were used directly from the bottle. Dichloromethane 
(DCM) and tetrahydrofuran (THF) were passed through a column of neutral 
alumina under nitrogen prior to use. Methyl tbutyl ether (MTBE) was distilled prior 
to use and stored over 4 Å molecular sieves. Benzaldehyde, o-tolualdehyde, m-
tolualdehyde, p-tolualdehyde, p-anisaldehyde, furfural, and isobutyraldehyde 
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were all purchased from Sigma Aldrich and distilled before use.  All other 
reagents were purchased from commercial sources and were used as received 
unless otherwise noted.  All racemic products were obtained via General 
Procedure B, Method 1 using Rovis’s achiral triazolium catalyst.48  
3.4.2 General Procedure A for the Preparation of α-Keto Esters 
 
Method 1: 
The following protocol was adopted from a literature procedure.50 A 100 
mL round-bottomed flask equipped with a magnetic stir bar was charged with 
aldehyde (10.0 mmol, 1.0 equiv), methyl dichloroacetate (13.0 mmol, 1.3 equiv), 
and THF (20 mL, 0.5 M). This solution was cooled to 0 °C and potassium tert-
butoxide (13.0 mmol, 1.3 equiv) was added in one portion. The mixture was 
warmed slowly to room temperature and stirred for 18 h, followed by dilution with 
Et2O (60 mL) and H2O (60 mL). The layers were separated and the organic layer 
was further washed with H2O (1 x 60 mL) and brine (1 x 60 mL). The organic 
extracts were dried over MgSO4, filtered and concentrated in vacuo. The crude 
residue was then dissolved in Et2O (30 mL, 0.33 M) and cooled to 0 °C. To the 
resulting solution, magnesium bromide (10.0 mmol, 1.0 equiv) was added in one 
portion. The reaction was warmed slowly to room temperature and stirred for 2 h 
followed by dilution with Et2O (60 mL) and H2O (60 mL). The layers were 
separated and the organic layer was further washed with H2O (1 x 60 mL) and 
brine (1 x 60 mL). The organic extracts were dried over MgSO4, filtered and 
MeO
O
Cl
Cl
H R
O
1) KOtBu, THF
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concentrated in vacuo. The crude residue was purified by column 
chromatography using a gradient of 10-15% EtOAc/hexanes.  
Method 2: 
 
The following protocol was adopted from a literature procedure.35  A 50 mL round-
bottomed flask equipped with a magnetic stir bar was charged with dimethyl 
oxalate (10.0 mmol, 1.0 equiv) and THF (10 mL, 1.0 M). This solution was cooled 
to -78 °C and the required Grignard reagent (1.0 M solution in THF, 11 mL, 1.1 
equiv) was added dropwise The resulting mixture was stirred at -78 °C for 2 h, 
quenched with saturated ammonium chloride, then diluted with Et2O (60 mL) and 
1 M HCl (60 mL). The layers were separated and the organic layer was further 
washed with H2O (2 x 60 mL) and brine (1 x 60 mL). The organic extracts were 
dried over MgSO4, filtered and concentrated in vacuo. The crude residue was 
then dissolved in EtOAc (130 mL, 0.075M) and CHCl3 (67 mL, 0.15 M). 
Copper(II) bromide (30 mmol, 3.0 equiv) was added in one portion and the 
reaction was heated at reflux for 12 h. The reaction was then cooled to room 
temperature and filtered through celite with Et2O. The filtrate was concentrated in 
vacuo and the crude residue was purified by column chromatography using a 
gradient of 10-15% EtOAc/hexanes.  
Grignard reagents were prepared according to the following procedure: a 
50 mL 2-neck round-bottomed flask fitted with a reflux condenser and septa were 
charged with magnesium turnings (12.0 mmol, 1.2 equiv). The apparatus was 
MeO
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X
(±)-17
MeO
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1) R-MgBr, THF -78 °C
2) CuBr2, 
    CHCl3/EtOAc 80 °C
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flame-dried under vacuum (<5 torr). After cooling to room temperature, THF (9 
mL) was added. A small portion of alkyl bromide (11.0 mmol, 1.1 equiv) dissolved 
in THF (2 mL) was then added to this solution.  
This solution was stirred until color change was observed, indicating reaction 
initiation.  The remainder of the alkyl bromide was then added at a rate that 
maintained gentle reflux of the reaction mixture. After the addition was complete, 
the reaction was then aged for 1-2 h at room temperature; and used in the 
subsequent reaction. 
Methyl 3-bromo-2-oxo-4-phenylbutanoate (17b): The title 
compound was prepared according to General Procedure A 
(Method 1) using phenylacetaldehyde (2.2 mL, 10.0 mmol), affording 17b (2.5 g, 
4.62 mmol, 47% yield) as a yellow oil. Analytical data for 17b: 1H NMR (600 MHz, 
CDCl3): δ 7.36-7.33 (m, 2H), 7.30-7.27 (m, 3H), 5.30 (t, J = 7.8 Hz, 1H), 3.92 (s, 
3H), 3.56 (dd, J = 14.4, 7.8 Hz, 1H) 3.28 (dd, J = 14.4, 7.8 Hz, 1H);  13C NMR 
(150 MHz, CDCl3): δ 184.8, 160.4, 136.3, 129.3, 128.7, 127.3, 53.4, 47.3, 38.1; 
IR (thin film): 3031, 1733,1455, 1260, 1068, 1027, 699 cm-1; TLC (15% 
EtOAc/hexane): Rf = 0.17; LRMS (ESI): Calcd. for C11H11BrO3: ([M+H]): 271.00, 
Found: 271.12.  
Methyl 3-bromo-4-(4-methoxyphenyl)-2-oxobutanoate 
(17c): The title compound was prepared according to 
General Procedure A (Method 2) using dimethyl oxalate 
(0.76 g, 5.7 mmol), affording 17c (2.5 g, 3.27 mmol, 57% yield) as a yellow oil. 
Analytical data for 17c: 1H NMR (600 MHz, CDCl3): δ 7.16 (d, J = 8.4 Hz, 2H), 
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6.84 (d, J = 8.4 Hz, 2H), 5.22 (t, J = 7.8 Hz, 1H), 3.89 (s, 3H), 3.78 (s, 3H), 3.48 
(dd, J = 14.4, 7.8 Hz, 1H) 3.20 (dd, J = 14.4, 7.8 Hz, 1H);  13C NMR (150 MHz, 
CDCl3): δ 184.9, 160.4, 158.8, 130.4, 128.4, 114.1, 55.2, 53.4, 47.5, 37.3; IR (thin 
film): 3436, 1731, 1665, 1514, 1249, 1036 cm-1; TLC (15% EtOAc/hexane): Rf = 
0.17; LRMS (ESI): Calcd. for C12H13BrO4: ([M+NH4]): 318.03, Found: 318.09.  
Methyl 3-bromo-2-oxohex-5-enoate (17d): The title compound 
was prepared according to General Procedure A (Method 2) 
using dimethyl oxalate (0.660 g, 5.0 mmol), affording 17d (0.320 g, 1.55 mmol, 
31% yield) as a yellow oil. Analytical data for 17d: 1H NMR (600 MHz, CDCl3): δ 
5.79-5.74 (m, 1H), 5.21-5.16 (m, 2H), 5.06-5.04 (t, J = 7.8 Hz, 1H), 3.91 (s, 3H), 
2.92-2.87 (m, 1H) 2.75-2.70 (m, 1H);  13C NMR (150 MHz, CDCl3): δ 184.9, 160.7, 
132.6, 119.5, 53.4, 46.2, 36.0; IR (thin film): 3480, 1736, 1644, 1438, 1258, 1163, 
1077 cm-1; TLC (15% EtOAc/hexane): Rf = 0.17; LRMS (ESI): Calcd. for 
C7H9BrO3: ([M+Na]): 239.08, Found: 239.16.  
Methyl 3-bromo-4-(4-chlorophenyl)-2-oxobutanoate (17e): 
The title compound was prepared according to General 
Procedure A (Method 2) using dimethyl oxalate (0.951 g, 7.2 
mmol), affording 17e (0.66 g, 2.16 mmol, 30% yield) as a yellow oil. Analytical 
data for 17e: 1H NMR (600 MHz, CDCl3): δ 7.27 (d, J = 8.4 Hz, 1H), 7.17 (d, J = 
8.4 Hz, 1H), 5.21 (t, J = 7.8 Hz, 1H), 3.88 (s, 3H), 3.47 (dd, J = 14.4, 7.8 Hz, 1H), 
3.20 (dd, J = 14.4, 7.8 Hz, 1H);  13C NMR (150 MHz, CDCl3): δ 184.5, 160.3, 
134.7, 133.1, 130.6, 128.7, 53.4, 46.9, 37.2; IR (thin film): 2955, 1735, 1493, 
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1255, 1081, 1016 cm-1; TLC (15% EtOAc/hexane): Rf = 0.17; LRMS (ESI): Calcd. 
for C6H7BrO3: ([M+NH4]): 321.98, Found: 322.12.  
Methyl 3-bromo-2-oxobutanoate (17f): The title compound 
was prepared according to General Procedure A (Method 1) using 
acetaldehyde (0.56 mL, 10.0 mmol) and affording 17f (0.5 g, 2.58 
mmol, 26% yield) as a yellow oil whose spectral properties matched those 
previously reported.52 
Methyl 3-bromo-2-oxopentanoate (17g): The title 
compound was prepared according to General Procedure A 
(Method 1) using propanal (0.72 mL, 10.0 mmol), affording 17g (0.34 g, 1.62 
mmol, 16% yield) as a yellow oil whose spectral properties matched those 
previously reported.53  
Methyl 3-bromo-4-methyl-2-oxopentanoate (17h): The 
title compound was prepared according to General Procedure A 
(Method 1) using isobutyraldehyde (0.912 mL, 10.0 mmol), affording 17h (0.60 g, 
2.70 mmol, 27% yield) as a yellow oil whose spectral properties matched those 
previously reported.5 
3.4.3 Preparation of Catalyst 21 
 
This catalyst was synthesized according to the literature procedure.48 Under N2, a 
50 mL flame-dried round-bottomed flask equipped with a magnetic stir bar was 
charged with trimethyloxonium tetrafluoroborate (3.6 mmol, 1.0 equiv) and 
N
H
O
iPr O
1) MeO3BF4;
    Mesityl Hydrazine
    DCM
2) HC(OEt)3,
    PhCl, 135 °C
N
O
N
NiPr
Mes
BF4
21
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capped with a septum. DCM (20 mL, 0.2 M) was added under an atmosphere of 
N2. The septum was removed and (S)-5-isopropylmorpholin-3-one11 was added 
in a single portion. The flask was capped, put under N2, and stirred vigorously for 
14 h or until homogenous. Mesityl hydrazine12 was then added in a single portion 
and the reaction mixture was stirred for an additional 6 h. The reaction was then 
concentrated in vacuo and dried under high vacuum for 15 min. The crude 
reaction mixture was dissolved in chlorobenzene (20 mL, 0.2 M) and triethyl 
orthoformate (18.0 mmol, 5.0 equiv) was added. The reaction flask was equipped 
with a reflux condenser and heated to open to the atmosphere at 135 °C for 12 h. 
A second portion of triethyl orthoformate (18.0 mmol, 5.0 equiv) was added and 
the reaction mixture was heated for an additional 24 h at 135 °C. The flask was 
then cooled to room temperature, diluted with 200 mL of toluene, and 
concentrated in vacuo. The crude residue was purified by column 
chromatography using 5% MeOH/DCM. The resultant solid was stirred in Et2O 
(100 mL) for 2 h then filtered, providing 21 (0.62 g, 1.66 mmol, 46% yield) as a 
tan solid.  Analytical data for 21: mp 165.2-166.2 °C; 1H NMR (600 MHz, CDCl3): 
δ 9.76 (s, 1H), 6.99 (s, 1H), 5.09 (d, J = 16.2 Hz, 1H) 4.99 (d, J = 16.2 Hz, 1H) 
4.29-4.20 (m, 2H), 2.48-2.43 (m, 1H), 2.37 (s, 3H), 2.03 (s, 6H) 1.07 (d, J = 6.6 
Hz, 3H) 0.98 (d, J = 6.6 Hz, 3H);  13C NMR (150 MHz, CDCl3): δ 150.3, 143.6, 
143.5, 142.0, 131.0, 129.7, 63.7, 61.6, 60.3, 31.8, 21.2, 18.7, 17.5, 17.1; IR (thin 
film): 3507, 2927, 1796, 1692, 1599, 1226, 1151 cm-1; TLC (5% MeOH/DCM): Rf 
= 0.21; LRMS (ESI): Calcd. for C17H24N3O: ([M+H-BF4]): 287.20, Found: 287.23. 
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3.4.4 Optimization Data for the Asymmetric Cross-Benzoin of 17a/17b with 
 Benzaldehyde 
 
 
 
  General Procedure B for the Optimization of the Asymmetric Cross 
 Benzoin Reaction  
To a flame dried 1-dram vial was added catalyst, (0.03 mmol, 0.15 equiv) 
β-halo α-keto ester 17 (0.2 mmol, 1.0 equiv), TBME (1 mL, 0.2 M) and aldehyde 
(0.4 mmol, 2.0 equiv).  This solution was stirred for 5 min followed by the addition 
of potassium carbonate (0.2 mmol, 1.0 equiv). This reaction mixture was then 
stirred (rate of stirring should be >800 rpm) for 14 h, filtered through a short plug 
of silica gel, and concentrated in vacuo. The crude product was purified by 
column chromatography using EtOAc/hexanes.  
Ph H
O
Ph
O
HO CO2R
X
Ph
MeO
O
O
X
Ph
K2CO3 (1.0 equiv)
catalyst (15 mol %)
Solvent (0.2 M), rt
N
O
N
N
R
N
O
N
N
R
iPr N
N
N
C6F5BF4
BF4
BF4
19:  R = C6F5
20: R = Mes
16:  R = C6F5
21: R = Mes
22
(±)-17a:  X = Cl
(±)-17b:  X = Br
+
(2.0 equiv) (2S,3S)-18a: X = Cl
(2S,3S)-18b: X = Br
H
H
OH
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Catalyst, base and solvent optimization table 
 
Trial 
 
X 
 
cat. base solvent 
T 
(°C) 
conv.  
(%) 
 
dr 
 
er 
1 Cl 16 NEt3 DCM rt 100 12:1 78:22 
2 Cl 19 NEt3 DCM rt 100 12:1 78:22 
3 Cl 16 NEt3 DCM 0 100 10:1 70:30 
4 Cl 19 NEt3 DCM 0 100 7:1 88:12 
5 Cl 16 NEt3 DCM -
4
0 
45 1.4:1 99:1 
6 Cl 19 NEt3 DCM -
4
0 
50 5.5:1 99:1 
7 Cl 22 NEt3 DCM rt <10 5.5:1 -- 
8 Br 16 K2CO3 THF rt <5 -- -- 
9 Br 19 K2CO3 THF rt <5 -- -- 
10 Br 22 K2CO3 THF rt <5 -- -- 
11 Cl 16 K2CO3 THF rt 40 1.5:1 98:2 
12 Cl 19 K2CO3 THF rt 25 4.5:1 96:4 
13 Br 21 K2CO3 THF rt 30 -- -- 
14 Br 20 K2CO3 THF rt >95 >20:1 94:6 
15 Br 20 K2CO3 THF 0 60 7:1 96:4 
16 Cl 21 K2CO3 THF rt 100 >20:1 90:10 
17 Cl 20 K2CO3 THF rt 100 14:1 95:5 
18 Br 20 K2CO3 2-Me THF rt 72 >20:1 95:5 
19 Br 20 K2CO3 DCM rt 23 >20:1 -- 
20 Br 20 K2CO3 CHCl3 rt 16 >20:1 -- 
21 Br 20 K2CO3 PhCH3 rt 78 >20:1 92:8 
22 Br 20 K2CO3 MeOH rt 100 * -- 
23 Br 20 K2CO3 EtOAc rt 100 >20:1 95:5 
24 Br 20 K2CO3 Et2O rt 100 >20:1 95:5 
25 Br 20 K2CO3 CH3CN rt 100 * -- 
26 Br 20 K2CO3 CPME rt 100 >20:1 95.5:4.5 
27 Br 20 K2CO3 TBME rt 100 >20:1 96:4 
28 Cl 20 K2CO3 Et2O rt 100 15:1 96.5:4.5 
29 Cl 20 K2CO3 CPME rt 100 15:1 97:3 
30 Cl 20 K2CO3 TBME rt 100 14:1 97.5:2.5 
31 Cl 20 NEt3 TBME rt 50 20:1 97:3 
32 Cl 20 DBU TBME rt 100 * -- 
33 Cl 20 Hunig’s TBME rt 0 -- -- 
34 Cl 20 Pyridine TBME rt 50 8:1 97.5:2.5 
35 Cl 20 Cs2CO3 TBME rt 100 >20:1 96:4 
36 Cl 20 DMAP TBME rt 100 17:1 97:3 
37 Br 20 NaOAc TBME rt 6 -- -- 
38 Br 20 NaHCO3 TBME rt 0 -- -- 
39 Br 20 Na2CO3 TBME rt 10 -- -- 
* Reaction mixture did not contain any desired cross-benzoin product.  
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3.4.5 General procedure C for the Asymmetric Cross-Benzoin Procedure 
 
Method 1: 
To a flame-dried 1-dram vial was added catalyst 20, (0.03 mmol, 0.15 
equiv) β-halo α-keto ester 17 (0.2 mmol, 1.0 equiv), TBME (1 mL, 0.2 M) and 
aldehyde (0.4 mmol, 2.0 equiv).  This solution was stirred for 5 min followed by 
the addition of potassium carbonate (0.2 mmol, 1.0 equiv). This reaction mixture 
was then stirred (rate of stirring should be >800 rpm) for 14 h, filtered through a 
short plug of silica gel, and concentrated in vacuo. The crude product was 
purified by column chromatography using EtOAc/hexanes. 
Method 2: 
To a flame dried 1-dram vial was added catalyst 20, (0.03 mmol, 0.15 
equiv) β-halo α-keto ester 17 (0.2 mmol, 1.0 equiv), and TBME (.5 mL, 0.4 M) 
followed by potassium carbonate (0.4 mmol, 2.0 equiv). This reaction mixture 
was then stirred (rate of stirring should be >800 rpm) while a 0.8 M solution of 
aldehyde in TBME (0.5 mL, 2.0 equiv) was added in 50 µL portions every 30 min 
for 5 h. Upon complete aldehyde addition the reaction was stirred an additional 9 
h then filtered through a short plug of silica gel with Et2O, and concentrated in 
vacuo. The crude residue was then purified by column chromatography using 
between 2.5% EtOAc/hexanes.  
R1 H
O
R1
O
HO CO2Me
X
R2MeO
O
O
R2
X
K2CO3 (1.0 equiv)
20 (15 mol %)
TBME (0.2 M), rt
(±)-17
+
(2.0 equiv.) 18
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Methyl (2S,3S)-2-benzoyl-3-chloro-2-hydroxy-4-
phenylbutanoate (18a): The title compound was prepared 
according to General Procedure B (Method 1) using α-keto ester 
17a (0.045 g, 0.20 mmol), and benzaldehyde (0.04 mL, 0.40 mmol) affording 18a 
(0.064 g, 0.19 mmol, 96% yield, 12:1 dr) as a clear oil. Analytical data for 18a: 1H 
NMR (600 MHz, CDCl3): δ 8.05 (d, J = 7.8 Hz, 2H), 7.60-7.58 (m, 1H), 7.48-7.45 
(m, 2H), 7.35-7.33 (m, 5H), 7.28-7.26 (m, 1H), 5.15 (dd, J = 10.7, 2.1 Hz, 1H) 
4.30 (s, 1H), 3.82 (s, 3H), 3.24 (dd, J = 14.4, 2.2 Hz, 1H) 2.91 (dd, J = 14.4, 10.7 
Hz, 1H); 13C NMR (150 MHz, CDCl3): δ 193.6, 170.4, 137.7, 134.6, 133.8, 129.8, 
129.5, 128.5, 128.4, 126.9, 86.3, 67.1, 54.4, 39.1; IR (thin film): 3507, 2927, 1796, 
1692, 1599, 1226, 1151 cm-1; TLC (10% EtOAc/hexane): Rf = 0.26; LRMS (ESI): 
Calcd. for C18H17ClO4: ([M+H]): 333.09, Found: 333.21; SFC: Regis RP, 5% 
MeOH, flow rate = 3.0 mL/min, λ = 210 nm, tR (major) = 3.7 min tR (minor)  = 4.3 min, 
96:4 er; [α]D = +45.8 (c = 0.03, DCM) 
Methyl (2S,3S)-2-benzoyl-3-bromo-2-hydroxy-4-
phenylbutanoate (18b): The title compound was prepared 
according to General Procedure B (Method 1) using α-keto ester 17b (0.054 g, 
0.20 mmol), and benzaldehyde (0.04 mL, 0.40 mmol) affording 18b (0.071 g, 
0.19 mmol, 94% yield, >20:1 dr) as a clear oil. Analytical data for 18a: 1H NMR 
(600 MHz, CDCl3): δ 8.07 (d, J = 7.8 Hz, 2H), 7.61-7.58 (m, 1H), 7.47-7.45 (m, 
2H), 7.34-7.19 (m, 5H), 5.22-5.20 (m, 1H) 4.37 (s,1H), 3.85 (s, 3H), 3.32-3.31 (m, 
1H) 3.04-2.98 (m, 1H); 13C NMR (150 MHz, CDCl3): δ 193.4, 170.5, 138.2, 134.7, 
133.8, 129.8, 129.4, 128.5, 128.3, 126.9, 86.5, 60.9, 54.4, 39.9; IR (thin film): 
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3066, 2089, 2699, 1746, 1692, 1421, 1244 cm-1; TLC (10% EtOAc/hexane): Rf = 
0.26; LRMS (ESI): Calcd. for C18H17BrO4: ([M+H]): 377.23, Found: 377.15; SFC: 
Regis RP, 5% MeOH, flow rate = 3.0 mL/min, λ = 210 nm, tR (major) = 4.5 min tR 
(minor)  = 5.0 min, 96:4 er; [α]D = +39.8 (c = 0.03, DCM) 
Methyl (2S,3S)-2-benzoyl-3-bromo-2-hydroxy-4-(4-
methoxyphenyl)butanoate (18c): The title compound was 
prepared according to General Procedure B (Method 2) 
using α-keto ester 17c (0.060 g, 0.20 mmol), and benzaldehyde (0.04 mL, 0.40 
mmol) affording 18c (0.050g, 0.15 mmol, 61% yield, >20:1 dr) as a clear oil. 
Analytical data for 18a: 1H NMR (600 MHz, CDCl3): δ 8.06 (d, J = 7.8 Hz, 2H), 
7.60-7.57 (m, 1H), 7.47-7.44 (m, 2H), 7.26-7.23 (m, 2H) 6.87 (d, J = 8.4 Hz, 2H), 
5.16 (dd, J = 10.8, 2.3 Hz, 1H) 4.35 (s,1H), 3.82-3.81 (m, 6H),  3.24 (dd, J = 15.0, 
2.3 Hz, 1H) 2.95 (dd, J = 15.0, 10.8 Hz, 1H); 13C NMR (150 MHz, CDCl3): δ 193.4, 
170.5, 158.5, 134.7, 133.8, 130.4, 130.3, 129.8, 128.5, 113.7, 86.5, 61.5, 55.2, 
54.4, 39.0; IR (thin film): 3059, 2989, 2306, 1715, 1429, 1267, 896 cm-1; TLC 
(10% EtOAc/hexane): Rf = 0.14; LRMS (ESI): Calcd. for C19H19BrO5: ([M+H]): 
407.05, Found: 407.08; SFC: Regis RP, 5% MeOH, flow rate = 3.0 mL/min, λ = 
210 nm, 18c could not be directly analyzed via SFC, see compound 24c for 
enantiomeric analysis; [α]D = +39.8 (c = 0.03, DCM) 
Methyl (2S,3S)-2-benzoyl-3-bromo-2-hydroxyhex-5-enoate 
(18d): The title compound was prepared according to General 
Procedure B (Method 1) using α-keto ester 17d (0.044 g, 0.20 
mmol), and benzaldehyde (0.04 mL, 0.40 mmol) affording 18d (0.046g, 0.15 
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mmol, 74% yield, 17:1 dr) as a white solid. Analytical data for 18d: mp 68.6-
70.0 °C; 1H NMR (600 MHz, CDCl3): δ 8.01-8.00 (m, 2H), 7.58-7.57 (m, 1H), 
7.45-7.42 (m, 2H), 5.89-5.83 (m, 1H) 5.17-5.14 (m, 2H) 5.02 (dd, J = 10.8, 3 Hz, 
1H), 4.22 (s,1H), 3.83 (s, 3H), 2.68-2.65 (m, 1H) 2.64-2.56 (m, 1H);  13C NMR 
(150 MHz, CDCl3): δ 193.4, 170.5, 134.72, 134.70, 133.7, 129.8, 128.5, 118.2, 
86.4, 58.9, 54.4, 37.8; IR (thin film): 3059, 2989, 2306, 1715, 1614, 1420, 1267 
cm-1; TLC (10% EtOAc/hexane): Rf = 0.22; LRMS (ESI): Calcd. for C14H15BrO4: 
([M+Na]): 350.16, Found: 350.16; 18d could not be directly analyzed via SFC, 
see compound 24d for enantiomeric analysis; [α]D = +14.8 (c = 0.01, DCM). 
Methyl (2S,3S)-2-benzoyl-3-bromo-4-(4-chlorophenyl)-2-
hydroxybutanoate (18e): The title compound was prepared 
according to General Procedure B (Method 1) using α-keto 
ester 17e (0.061 g, 0.20 mmol), and benzaldehyde (0.04 mL, 0.40 mmol) 
affording 18e (0.050 g, 0.12 mmol, 61% yield, 12:1 dr) as a clear oil. Analytical 
data for 18e: 1H NMR (600 MHz, CDCl3): δ 8.07 (d, J = 4.2 Hz, 2H), 7.63-7.61 (m, 
1H), 7.50-7.47 (m, 2H), 7.36-7.28 (m, 4H), 5.16-5.14 (m, 1H) 4.36 (s,1H), 3.85 (s, 
3H), 3.30 (d, J = 15.0 Hz, 1H) 3.00 (dd, J = 15.0, 10.8 Hz, 1H); 13C NMR (150 
MHz, CDCl3): δ 193.3, 170.4, 136.7, 134.5, 133.9, 132.7, 130.7, 129.8, 128.5, 
128.5, 86.3, 60.5, 54.5, 39.3; IR (thin film): 3507, 3059, 2309, 1748, 1692, 1228, 
1151 cm-1; TLC (10% EtOAc/hexane): Rf = 0.21; LRMS (ESI): Calcd. for 
C18H16BrClO4: ([M+H]):411.00, Found: 411.14; 2e could not be directly analyzed 
via SFC, see compound 24e for enantiomeric analysis; [α]D = +44.9 (c = 0.02, 
DCM). 
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Methyl (2S,3S)-2-benzoyl-3-bromo-2-hydroxybutanoate (18f): 
The title compound was prepared according to General Procedure B 
(Method 1) using α-keto ester 17f (0.039 g, 0.20 mmol), and benzaldehyde (0.04 
mL, 0.40 mmol) affording 18f (0.042g, 0.14 mmol, 70% yield, 14:1 dr) as a clear 
oil. Analytical data for 18f: 1H NMR (600 MHz, CDCl3): δ 8.02 (d, J = 7.8 Hz, 2H), 
7.58-7.55 (m, 1H), 7.44-7.42 (m, 2H), 5.16 (q, J = 6.6 Hz, 1H) 4.17 (s,1H), 3.83 (s, 
3H), 1.72 (d, J = 6.6 Hz, 3H); 13C NMR (150 MHz, CDCl3): δ 193.0, 170.7, 134.6, 
133.8, 129.8, 128.5, 86.2, 54.3, 53.4, 20.6; IR (thin film): 3507, 2936, 2309, 1746, 
1692, 1166, 1050 cm-1; TLC (10% EtOAc/hexane): Rf = 0.24; LRMS (ESI): Calcd. 
for C12H13BrO4: ([M+H]): 301.01, Found: 300.99; SFC: Chiracel AD, 5% MeOH, 
flow rate = 1.5 mL/min, λ = 210 nm, tR (major) = 5.7 min tR (minor)  = 6.1 min, 93:7 er; 
[α]D = +26.1 (c = 0.02, DCM) 
Methyl (2S,3S)-2-benzoyl-3-bromo-2-hydroxypentanoate (18g): The title 
compound was prepared according to General Procedure B 
(Method 1) using α-keto ester 17g (0.042 g, 0.20 mmol), and 
benzaldehyde (0.04 mL, 0.40 mmol) affording 18g (0.046g, 0.15 mmol, 73% yield, 
>20:1 dr) as a white solid. Analytical data for 18g: 1H NMR (600 MHz, CDCl3): δ 
8.01-8.00 (m, 2H), 7.58-7.55 (m, 1H), 7.44-7.42 (m, 2H), 4.92 (dd, J = 9, 4.2 Hz, 
1H) 4.17 (s,1H), 3.83 (s, 3H), 1.87-1.82 (m, 2H), 1.11 (t, J = 7.2 Hz, 3H);  13C 
NMR (150 MHz, CDCl3): δ 193.7, 170.6, 134.8, 133.7, 129.8, 128.5, 86.8, 62.8, 
54.4, 26.9, 12.8; IR (thin film): 3507, 2935, 1748, 1692, 1228, 1189 cm-1; TLC 
(10% EtOAc/hexane): Rf = 0.24; LRMS (ESI): Calcd. for C13H15BrO4: ([M+H]): 
315.02, Found: 315.06; SFC: Chiracel AD, 5% MeOH, flow rate = 1.5 mL/min, λ 
 
 
 162 
= 210 nm, tR (major) = 5.9 min tR (minor)  = 6.4 min, 94:6 er; [α]D = +12.5 (c = 0.02, 
DCM) 
Methyl (2R,3S)-2-benzoyl-3-bromo-2-hydroxy-4-
methylpentanoate (18h): The title compound was prepared 
according to General Procedure B (Method 1) using α-keto ester 17h (0.044 g, 
0.20 mmol), benzaldehyde (0.04 mL, 0.40 mmol) and mesitylene as an internal 
standard (0.028 mL, 0.20 mmol) affording 18h (0.026g, 0.08 mmol, 65% 1H NMR 
yield, 40% isolated yield, >20:1 dr) as a clear oil. Analytical data for 18h: 1H NMR 
(600 MHz, CDCl3): δ 7.98 (d, J = 7.2 Hz, 2H), 7.57-7.55 (m, 1H), 7.44-7.42 (m, 
2H), 5.08 (d, J = 3 Hz, 1H) 4.22 (s,1H), 3.83 (s, 3H), 2.09-2.05 (m, 1H), 1.06 (d, J 
= 6.6 Hz, 3H) 1.00 (d, J = 6.6 Hz, 3H);  13C NMR (150 MHz, CDCl3): δ 193.5, 
170.7, 135.0, 133.5, 129.8, 128.4, 88.0, 67.2, 54.4, 31.5, 23.1, 19.8; IR (thin film): 
3507, 2966, 1740, 1692, 1159, 409 cm-1; TLC (10% EtOAc/hexane): Rf = 0.29; 
LRMS (ESI): Calcd. for C14H17BrO4: ([M+H]): 329.03, Found: 329.13; SFC: Regis 
RP, 5% MeOH, flow rate = 1.5 mL/min, λ = 210 nm, tR (major) = 4.0 min tR (minor)  = 
4.3 min, 94:6 er; [α]D = +18.3 (c = 0.01, DCM) 
Methyl (2S,3S)-3-bromo-2-hydroxy-2-(4-methylbenzoyl)-4-
phenylbutanoate (18i): The title compound was prepared 
according to General Procedure B (Method 1) using α-keto ester 17b (0.054 g, 
0.20 mmol), and p-tolualdehyde (0.05 mL, 0.40 mmol) affording 18i (0.060g, 0.15 
mmol, 77% yield, >20:1 dr) as a clear oil. Analytical data for 18i: 1H NMR (600 
MHz, CDCl3): δ 8.02 (d, J = 7.8 Hz, 2H), 7.36-7.28 (m, 7H), 5.23 (dd, J = 10.7, 
2.3 Hz, 1H) 4.36 (s, 1H), 3.84 (s, 3H), 3.34 (dd, J = 14.6, 2.3 Hz, 1H) 3.02 (dd, J 
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= 14.6, 10.7 Hz, 1H), 2.45 (s, 3H);  13C NMR (150 MHz, CDCl3): δ 192.7, 170.6, 
145.0, 138.3, 132.0, 130.0, 129.4, 129.2, 128.3, 126.8, 86.4, 61.1, 54.3, 39.9, 
21.7; IR (thin film): 3507, 2927, 1746, 1684, 1607, 1151 cm-1; TLC (10% 
EtOAc/hexane): Rf = 0.24; LRMS (ESI): Calcd. for C19H19BrO4: ([M+H]): 391.05, 
Found: 391.15; SFC: Regis RP, 10% MeOH, flow rate = 1.5 mL/min, λ = 210 nm, 
tR (major) = 9.7 min tR (minor)  = 11.1 min, 97:3 er; [α]D = +20.7 (c = 0.02, DCM) 
Methyl (2S,3S)-3-bromo-2-hydroxy-2-(3-methylbenzoyl)-4-
phenylbutanoate (8j): The title compound was prepared 
according to General Procedure B (Method 1) using α-keto ester 17b (0.054 g, 
0.20 mmol), and m-tolualdehyde (0.05 mL, 0.40 mmol) affording 18j (0.066g, 
0.17 mmol, 85% yield, >20:1 dr)  as a clear oil. Analytical data for 18j: 1H NMR 
(600 MHz, CDCl3): δ 7.87-7.84 (m, 2H), 7.41-7.40 (m, 1H), 7.35-7.26 (m, 6H), 
5.22 (m, 1H) 4.31 (s,1H), 3.82 (s, 3H), 3.31-3.28 (d, J = 12.6 Hz, 1H) 3.02-2.97 
(dd, J = 14.4, 11.4 Hz, 1H), 2.41 (s, 3H);  13C NMR (150 MHz, CDCl3, two 
coincident aromatic resonances): δ 193.7, 170.5, 138.4, 138.2, 134.7, 134.6, 
130.2, 129.4, 128.4, 127.0, 126.9, 86.5, 70.0, 54.4, 39.9, 21.4 (two coincident 
resonances); IR (thin film): 3507, 2927, 1746, 1692, 1607, 1143 cm-1; TLC (10% 
EtOAc/hexane): Rf = 0.24; LRMS (ESI): Calcd. for C19H19BrO4: ([M+Na]): 413.04, 
Found: 413.12; HPLC: Chiralpak IC, 5% iPrOH, flow rate = 1.0 mL/min, λ = 230 
nm, tR (major) = 5.1 min tR (minor)  = 5.7 min, 96:4 er; [α]D = +39.8 (c = 0.03, DCM) 
Methyl (2S,3S)-3-bromo-2-hydroxy-2-(2-methylbenzoyl)-4-
phenylbutanoate (18k): No reaction was observed using 
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General Procedure B (Method 1) with α-keto ester 17b (0.054 g, 0.20 mmol), and 
o-tolualdehyde (0.05 mL, 0.40 mmol).  
Methyl (2S,3S)-3-bromo-2-hydroxy-2-(4-
methoxybenzoyl)-4-phenylbutanoate (18l): The title 
compound was prepared according to General Procedure B 
(Method 1) using α-keto ester 17b (0.054 g, 0.20 mmol), p-anisaldehyde (0.05 
mL, 0.40 mmol), and mesitylene as an internal standard (0.028 mL, 0.20 mmol) 
resulting in 50% conversion of 17b and affording 18l (0.040 g, 0.10 mmol, 49% 
yield, >20:1 dr)  as a clear oil. Analytical data for 18l: 1H NMR (400 MHz, CDCl3): 
δ 8.13 (d, J = 8.8 Hz, 2H), 7.33-7.32 (m, 5H), 6.93 (d, J = 8.8 Hz, 2H), 5.20 (dd, J 
= 10.7, 2.2 Hz, 1H) 4.33 (s,1H), 3.88 (s, 3H), 3.80 (s, 3H),  3.33 (dd, J = 14.8, 2.2 
Hz, 1H) 2.99 (dd, J = 14.8, 10.7 Hz, 1H);  13C NMR (150 MHz, CDCl3): δ 191.1, 
107.8, 164.2, 138.3, 132.6, 129.4, 128.3, 127.3, 126.8, 113.8, 86.4, 61.3, 55.5, 
54.3, 39.9; IR (thin film): 3066, 2989, 2309, 1746, 1684, 1599, 1420, 1159 cm-1; 
TLC (10% EtOAc/hexane): Rf = 0.15; LRMS (ESI): Calcd. for C19H19BrO5: 
([M+Na]): 429.03, Found: 429.18; SFC: Regis RP, 10% MeOH, flow rate = 1.5 
mL/min, λ = 210 nm, tR (major) = 9.7 min tR (minor)  = 12.1 min, 98:2 er; [α]D = +8.23 
(c = 0.02, DCM) 
Methyl (2S,3S)-3-bromo-2-(4-chlorobenzoyl)-2-hydroxy-4-
phenylbutanoate (18m): The title compound was prepared 
according to General Procedure B (Method 1) using α-keto 
ester 17b (0.054 g, 0.20 mmol), 4-Chlorobenzaldehyde (0.056 g, 0.40 mmol) and 
mesitylene as an internal standard (0.028 mL, 0.20 mmol) resulting in 71% 
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conversion of 17b and affording 18m (0.036 g, 0.09 mmol, 44% yield >20:1 dr) 
as a clear oil. With 20 mol % of catalyst 17b went to full conversion and 18m was 
obtained with identical selectivity but higher isolated yield (0.066 g, 0.16 mmol, 
80% yield >20:1 dr). Analytical data for 18m: 1H NMR (600 MHz, CDCl3): δ 8.02 
(d, J = 8.4 Hz, 2H), 7.43 (d, J = 8.4 Hz, 2H), 7.34-7.33 (m, 4H), 7.29-7.26 (m, 1H), 
5.17 (dd, J = 10.8, 1.8 Hz, 1H) 4.27 (s,1H), 3.82 (s, 3H), 3.30 (dd, J = 15.0, 1.8 
Hz, 1H) 3.00 (dd, J = 15.0, 10.8 Hz, 1H);  13C NMR (150 MHz, CDCl3): δ 192.1, 
170.4, 140.5, 138.1, 132.9, 131.4, 129.4, 128.8, 128.4, 127.0, 86.6, 60.8, 54.5, 
39.9; IR (thin film): 3630, 3507, 3059, 2958, 2308, 1746, 1692, 1591, 1097, 1026 
cm-1; TLC (10% EtOAc/hexane): Rf = 0.28; LRMS (ESI): Calcd. for C18H16BrClO4: 
([M+Na]): 411.00, Found: 411.14; 18m could not be directly analyzed via SFC, 
see compound 24m for enantiomeric analysis; [a]D = +24.6 (c = 0.03, DCM) 
Methyl (2S,3S)-3-bromo-2-(furan-2-carbonyl)-2-hydroxy-4-
phenylbutanoate (18n): The title compound was prepared 
according to General Procedure B (Method 1) using α-keto ester 17b (0.054 g, 
0.20 mmol), and furfural (0.03 mL, 0.40 mmol) affording 2n (0.052g, 0.14 mmol, 
71% yield, >20:1 dr) as a clear oil. Analytical data for 2n: 1H NMR (600 MHz, 
CDCl3): δ 7.69 (d, J = 1.2 Hz, 1H), 7.64 (d, J = 3.6 Hz, 1H), 7.32-7.29 (m, 4H), 
6.58 (dd, J = 3.6, 1.2 Hz, 1H), 5.15 (dd, J = 11.4, 2.4 Hz, 1H) 4.47 (s,1H), 3.81 (s, 
3H), 3.28 (dd, J = 15.0, 2.4 Hz, 1H) 3.00 (dd, J = 14.4, 10.8 Hz, 1H);  13C NMR 
(150 MHz, CDCl3): δ 180.9, 169.8, 149.5, 148.2, 138.0, 129.4, 128.3, 126.9, 
123.1, 112.6, 85.8, 59.7, 54.4, 39.6; IR (thin film): 3507, 1746, 167, 1466, 1159, 
1027, 818, 617 cm-1; TLC (10% EtOAc/hexane): Rf = 0.35; LRMS (ESI): Calcd. 
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for C16H15BrO5: ([M+H]): 367.02, Found: 367.02; SFC: Regis RP, 5% MeOH, flow 
rate = 3.0 mL/min, λ = 210 nm, tR (major) = 4.3 min tR (minor)  = 7.0 min, 75.5:25.5 er; 
[α]D = +4.7 (c = 0.02, DCM) 
Methyl (S)-2-((S)-1-bromo-2-phenylethyl)-2-hydroxy-4-methyl-
3-oxopentanoate (18o): The title compound was prepared 
according to General Procedure B (Method 2) using α-keto ester 17b (0.054 g, 
0.20 mmol), and isobutyraldehyde (0.02 mL, 0.40 mmol) affording 18o (0.039 g, 
0.12 mmol, 59% yield 10:1 dr) as a clear oil. Analytical data for 18o: 1H NMR 
(600 MHz, CDCl3): δ 7.33-7.30 (m, 2H), 7.27-7.25 (m, 3H), 5.75 (dd, J = 9.0, 4.5 
Hz, 1H) 3.86 (s, 3H), 3.25 (dd, J = 14.1, 4.5 Hz, 1H) 3.07 (dd, J = 14.1, 9.0 Hz, 
1H) 2.61-2.57 (m, 1H), 1.15 (d, J = 7.2 Hz, 3H), 1.11 (d, J = 7.2 Hz, 3H);  13C 
NMR (150 MHz, CDCl3): δ 189.5, 176.3, 160.2, 135.3, 129.4, 128.5, 127.2, 75.7, 
53.1, 36.2, 33.4, 18.64, 18.60; IR (thin film): 3059, 2989, 2688, 2410, 2308, 1760, 
1429, 1267, 896 cm-1; TLC (10% EtOAc/hexane): Rf = 0.15; LRMS (ESI): Calcd. 
for C15H19BrO4: ([M+H]): 343.05, Found: 343.04; HPLC: Chiralpak IC, 5% iPrOH, 
flow rate = 1.0 mL/min, λ = 230 nm, tR (major) = 9.1 min tR (minor)  = 9.9 min, 58:42 er; 
[α]D = +2.3 (c = 0.02, DCM) 
Methyl (2S,3S)-3-bromo-2-hydroxy-4-phenyl-2-(1-tosyl-1H-
indole-3-carbonyl)butanoate (18p): The title compound was 
prepared according to General Procedure B (Method 1) using α-keto ester 17b 
(0.054 g, 0.20 mmol), and 1-tosyl-1H-indole-3-carbaldehyde (0.119 g, 0.40 mmol). 
18a was not isolable from 1-tosyl-1H-indole-3-carbaldehyde and was reduced 
with NaBH4 24p (0.074 g, 0.13 mmol, 65% yield, 10:1 dr), was isolated by 
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column chromatography using 15% EtOAc/hexanes. See compound 24p for all 
characterization data.   
3.4.6 Attempting the Cross-Benzoin Reaction Using Homo-Benzoin Product 
23 
 
 
To a flame dried 1-dram vial was added catalyst 20, (0.03 mmol, 0.15 
equiv) β-halo α -keto ester 1 (0.2 mmol, 1.0 equiv), TBME (1 mL, 0.2 M) and 
benzoin product 23 (0.2 mmol, 1.0 equiv). This solution stirred for 5 minutes 
followed by the addition of potassium carbonate (0.2 mmol, 1.0 equiv). This 
reaction was stirred for 14 h, filtered through a short plug of silica gel with Et2O, 
and concentrated in vacuo for analysis by 1H NMR.  
 
3.4.7 Procedure for the Gram Scale Asymmetric Cross-Benzoin 
To a flame dried 50 mL round bottom flask was added catalyst 21, (0.55 
mmol, 0.15 equiv) β-halo α-keto ester 17b (3.7 mmol, 1.0 equiv), TBME (19 mL, 
0.2 M) and benzaldehyde (7.4 mmol, 2.0 equiv).  This solution stirred for 5 
minutes followed by the addition of potassium carbonate (3.7 mmol, 1.0 equiv). 
This reaction was stirred (rate of stirring should be >800 rpm) for 14 h, filtered 
through celite with DCM, and concentrated in vacuo. The resulting precipitate 
was dissolved in MeOH and quenched with (1.1 mmol, 0.3 equiv conc. HCl).  The 
solvent was removed in vacuo and the crude residue was purified by column 
chromatography with 5% EtOAc/hexanes until 18b (1.26 g, 91% yield, >20:1 dr, 
95.5:4.5 er) had eluted from the column (TLC analysis). At this point the eluent 
Ph
O
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K2CO3 (1.0 equiv.)
20 (15 mol %)
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was changed to 2.5% MeOH/DCM in order to recover the HCl salt of catalyst 21 
(0.15 g, 74% recovery based on the HCl salt). 
3.4.8 General Procedure D for the Reduction of Cross-Benzoin Products 
 
A flame dried scintillation vial was charged with cross-benzoin product 18, 
diluted with MeOH (to 0.5 M), and cooled to 0 °C. NaBH4  (5.0 equiv) was added 
and the reaction was stirred at 0 °C for 7 min, then quenched with saturated 
NH4Cl and diluted with Et2O (15 mL) and H2O (10 mL). The layers were 
separated and the organic layer was further washed with brine (1 x 10 mL). The 
organic extracts were dried over MgSO4, filtered and concentrated in vacuo.  In 
general no further purification was required but if necessary diols 24 could be 
purified by column chromatography using an eluent of 15% 
EtOAc/hexanes.  
Methyl (2S,3S)-3-bromo-2-hydroxy-2-((R)-
hydroxy(phenyl)methyl)-4-(4-methoxyphenyl)butanoate (24c): The title 
compound was prepared according to General Procedure C using 18c (0.030 g, 
0.074 mmol), affording 24c (0.027 g, 0.66 mmol, 91% yield, >20:1 dr) as a white 
solid. Analytical data for 24c: mp 124.5-125.5 °C; 1H NMR (400 MHz, CDCl3): δ 
7.42-7.40 (m, 2H), 7.38-7.32 (m, 3H), 7.26-7.19 (m, 2H) 6.87-6.85 (m, 2H), 5.07 
(d, J = 7.6, Hz, 1H) 4.79 (dd, J = 11.4, 2.0 Hz, 1H), 3.84-3.79 (m, 4H), 3.72 (s, 
3H), 3.60 (s, 1H),  3.52 (d, J = 14.4 Hz, 1H) 2.99 (dd, J = 14.4, 11.4 Hz, 1H), 2.85 
(d, J = 8.1 Hz, 1H);  13C NMR (150 MHz, CDCl3): δ 172.5, 158.5, 138.7, 130.31, 
R1
O
HO CO2Me
Br
R2
NaBH4
MeOH (0.5 M), 0 °C
R1
OH
HO CO2Me
Br
R2
24
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130.29, 128.6, 128.2, 126.7, 113.7, 75.4, 82.7, 60.8, 55.2, 53.2, 37.2; IR (thin 
film): 2927, 2866, 1738, 1514, 803, 602 cm-1; TLC (15% EtOAc/hexane): Rf = 
0.21; LRMS (ESI): Calcd. for C19H21BrO5: ([M+H]): 409.07, Found: 409.17; SFC: 
Regis RP, 15% MeOH, flow rate = 3.0 mL/min, λ = 210 nm, tR (major) = 5.5 min tR 
(minor)  = 10.8 min, 96:4 er; [α]D = -24.8 (c = 0.005, DCM) 
Methyl (2S,3S)-3-bromo-2-hydroxy-2-((R)-
hydroxy(phenyl)methyl)hex-5-enoate (24d): The title compound 
was prepared according to General Procedure C using 18d (0.040 
g, 0.13 mmol), affording 24d (0.039 g, 0.13 mmol, 98% yield, >20:1 dr) as a white 
solid. Analytical data for 24c mp 72.1-73.0 °C: 1H NMR (600 MHz, CDCl3): δ 
7.38-7.30 (m, 5H), 5.92-5.85 (m, 1H), 5.19-5.15 (m, 2H) 4.99 (d, J = 8.4, Hz, 1H) 
4.57 (dd, J = 10.8, 2.4 Hz, 1H), 3.73 (s, 3H), 3.55 (s, 1H), 3.55 (s, 1H), 2.91-2.86 
(m, 2H), 2.66-2.60 (m, 1H);  13C NMR (150 MHz, CDCl3): δ 172.6, 138.6, 134.9, 
128.6, 128.2, 126.8, 118.0, 75.4, 82.5, 58.1, 53.2, 36.2; IR (thin film): 2924, 1731, 
1454, 1242, 1024, 701 cm-1; TLC (15% EtOAc/hexane): Rf = 0.12; LRMS (ESI): 
Calcd. for C14H17BrO4: ([M+NH4]): 347.22, Found: 347.22; 
SFC: Regis RP, 5% MeOH, flow rate = 3.0 mL/min, λ = 210 
nm, tR (major) = 7.7 min tR (minor)  = 8.7 min, 95.5:4.5 er; [α]D = -20.1 (c = 0.007, 
DCM) 
Methyl (2S,3S)-3-bromo-2-((R)-(4-chlorophenyl)(hydroxy)methyl)-2-hydroxy-
4-phenylbutanoate (24m): The title compound was prepared according to 
General Procedure C using 18m (0.031 g, 0.075 mmol), affording 24m (0.030 g, 
0.073 mmol, 97% yield, >20:1 dr) as a white solid. This solid was then 
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recrystallized from 5% EtOAc/hexanes. Analytical data for 24m: mp 149.2-
150.0 °C; 1H NMR (600 MHz, CDCl3): δ 7.38-7.26 (m, 9H), 5.06 (d, J = 8.2 Hz, 
1H), 4.78 (dd, J = 11.3, 2.6 Hz, 1H), 3.72 (s, 3H), 3.64 (s, 1H), 3.58 (dd, J = 14.6, 
2.6 Hz, 1H), 3.03 (dd, J = 22.4, 14.6 Hz, 1H) 2.98 (d, J = 8.2 Hz, 1H);  13C NMR 
(150 MHz, CDCl3): δ 172.4, 138.1, 137.2, 134.5, 131.0, 129.3, 128.4, 128.2, 
126.9, 82.6, 74.7, 60.0, 53.4, 38.1; IR (thin film): 3059, 2989, 2688, 2309, 1738, 
1429, 1267 cm-1; TLC (15% EtOAc/hexane): Rf = 0.41; LRMS (ESI): Calcd. for 
C18H18BrClO4: ([M+Na]): 435.00, Found: 435.09; SFC: Regis RP, 15% MeOH, 
flow rate = 3.0 mL/min, λ = 210 nm, tR (major) = 4.4 min tR (minor)  = 8.2 min, 98:2 er 
(>99.9:0.1 recrystallized); [α]D = -56.3 (c = 0.004, DCM) 
 
Methyl (2S,3S)-3-bromo-2-hydroxy-2-((R)-hydroxy(1-tosyl-
1H-indol-3-yl)methyl)-4-phenylbutanoate (24p): The title 
compound was prepared according to General Procedure C 
using 18p affording 24p (0.074 g, 0.13 mmol, 65% yield, 10:1 dr) as a white solid. 
Analytical data for 24p: mp 74.8-75.2 °C; 1H NMR (600 MHz, CDCl3): δ 7.97 (d, J 
= 7.8 Hz, 1H), 7.81 (d, J = 7.8 Hz, 1H), 7.73-7.68 (m, 3H), 7.35-7.25 (m, 7H), 
7.18 (d, J = 7.8 Hz, 2H), 5.42-5.41 (m, 1H), 4.71 (d, J = 10.8 Hz, 1H), 3.83 (s, 1H), 
3.77 (s, 3H), 3.56 (d, J = 14.4 Hz, 1H), 3.02-2.97 (m, 1H) 2.33 (s, 3H);  13C NMR 
(150 MHz, CDCl3): δ 172.8, 145.1, 138.0, 135.0, 134.9, 129.9, 128.4, 126.9, 
126.8, 126.7, 125.1, 124.3, 123.3, 121.4, 121.1, 113.5, 83.0, 74.7, 69.7, 59.4, 
53.4, 38.3, 21.5; IR (thin film): 3059, 2989, 2306, 1738, 1429, 1267, 896 cm-1; 
TLC (15% EtOAc/hexane): Rf = 0.21; LRMS (ESI): Calcd. for C27H26BrNO6S: 
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([M+Na]): 594.06, Found: 594.06; 24p could not be directly analyzed via SFC, 
see compound 25 for enantiomeric analysis; [α]D = -24.8 (c = 0.007, DCM) 
3.4.9 Synthesis of the Mosher ester of 24p  
 
A flame dried scintillation vial was loaded with cross-benzoin diol 24p (0.035 
mmol, 1.0 equiv), (R)- α-methoxy- α-trifluoromethylphenylacetic acid (0.042 mmol, 
1.2 equiv) and DCM (2.0 mL, 0.02 M). To this was added N,N-
dicyclohexylcarboimide (0.07 mmol, 2.0 equiv) and 4-dimethylaminopyridine 
(0.035 mmol, 1.0 equiv) This reaction mixture was stirred at rt for 18 h then 
filtered through celite. The filtrate was then diluted with 1M HCl (10 mL) and 
EtOAc (10 mL). The layers were separated and the organic layer was further 
washed with 1 M NaOH (2 x 10 mL) and brine (1 x 10 mL). The organic extracts 
were dried over MgSO4, filtered and concentrated in vacuo.  The reaction mixture 
was purified by column chromatography using an eluent of 10% EtOAc/hexanes 
providing 26 as a clear oil (22 mg, 0.031 mmol, 89% yield, 98:2 er). 
 Analytical data for (2S,3R)-methyl 3-benzyl-2-((R)-(1-tosyl-1H-indol-3-yl)((R)-
3,3,3-trifluoro-2-methoxy-2-phenylpropanoyloxy)methyl)oxirane-2-
carboxylate (26): 1H NMR (600 MHz, CDCl3): δ 7.88 (d, J = 8.4 Hz, 1H), 7.63 (d, 
J = 8.4 Hz, 2H), 7.57 (s, 1H), 7.40-7.39 (d, J = 7.8 Hz, 1H), 7.28-7.21 (m, 4H), 
7.09-7.00 (m, 9H), 6.96 (s, 1H), 3.82 (s, 3H), 3.42 (s, 3H), 2.90-2.86 (m, 1H), 
OH Br
Ph
HO CO2Me
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2.76-2.72 (m, 2H) 2.25 (s, 3H);  13C NMR (150 MHz, CDCl3): δ 167.8, 165.3, 
145.2, 135.6, 134.7, 134.5, 131.3, 129.8, 129.5, 128.8, 128.7, 128.4, 128.0, 
127.5, 127.1, 126.9, 126.7, 125.0, 123.6, 121.0, 114.2, 113.4, 71.0, 63.2, 60.3, 
55.5, 52.9, 33.9, 29.7 21.5 (two coincident peaks); 19F NMR (376 MHz, CDCl3): 
δmajor 71.85 δminor 71.6, 98:2 er; IR (thin film): 3059, 2989, 2306, 1738, 1429, 1267, 
896 cm-1; TLC (15% EtOAc/hexane): Rf = 0.21 
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3.5 Experimental Data and Conditions for the Enantioconvergent Synthesis 
of Funcionalized y-Butyrolactones via (3+2)-Annulation‡‡ 4 
 
3.5.1 General Information 
 Methods: Infrared (IR) spectra were obtained using an ASI ReactIR 1000 
Fourier transform infrared spectrometer. Proton and carbon magnetic resonance 
spectra (1H NMR and 13C NMR) were recorded on a Bruker model DRX 600 (1H 
NMR at 600 MHz and 13C NMR at 151 MHz) spectrometer with solvent 
resonance as the internal standard (1H NMR: CDCl3 at 7.26 ppm; 13C NMR: 
CDCl3 at 77.0 ppm). 1H NMR data are reported as follows: chemical shift, 
multiplicity (s = singlet, br s = broad singlet, d = doublet, dd = doublet of doublet, t 
= triplet, dt = doublet of triplet, q = quartet, m = multiplet), coupling constants (Hz), 
and integration. Supercritical fluid chromatography (SFC) was performed on a 
Berger SFC system equipped with Chiracel AD, AS, OD, and WO columns as 
well as Regis Industries RegisPack (RP) column (φ 4.6 mm x 250 mm). Samples 
were eluted with SFC grade CO2 at the indicated percentage of methanol 
(MeOH) with an oven temperature of 40 °C.  Optical rotations were measured 
using a 2 mL cell with a 1 dm path length on a Jasco DIP 1000 digital polarimiter. 
Mass spectra were obtained using a Finnigan linear trap quadrapole Fourier 
transform (LTQ-FT) spectrometer. Samples were prepared via dilution with 
MeOH and doping with 0.1 M ammonium formate (MeOH). Analytical thin layer 
chromatography (TLC) was performed on Sorbtec 0.25 mm silica gel 60 plates. 
Visualization was accomplished with UV light and/or either aqueous potassium 
                                         ‡‡ 
Reproduced in part by permission of the American Chemical Society: Goodman, C. G.; Walker, M. M.; Johnson, J. S. 
J. Am. Chem. Soc. 2015, 137, 122-125. 
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permanganate KMnO4 or aqueous ceric ammonium molybdate (CAM) solution 
followed by heating. Product purification was accomplished using Siliaflash-P60 
silica gel (40-63 µm) purchased from Silicycle. Unless otherwise noted all 
reactions were carried out in flame-dried glassware with magnetic stirring. Yields 
and diastereomeric ratios (dr) are reported for a specific experiment and as a 
result may differ slightly from those found in the reported tables, which represent 
an average of at least two trials. In order to overlay the SFC traces for the chiral 
and racemic samples two separate integrations of the peaks must be taken. This 
results in slight discrepancies between the integration values shown in the report 
and seen on the trace itself.  
 Materials: NHC catalysts 20,61 44,37 47,96 β-halo α-keto ester 17a,35 
41m,97 41p-s35 and α,β-unsaturated aldehydes98,99 were all prepared according 
to literature procedures. Potassium carbonate was purchased from Sigma Aldrich 
and dried under vacuum (5 torr) for 3 h at 110 °C. HPLC grade chloroform 
(CHCl3), ethyl acetate (EtOAc), acetonitrile (ACN), and ethanol (EtOH) were used 
directly from the bottle. Dichloromethane (DCM), diethyl ether (Et2O), toluene 
(PhCH3) and tetrahydrofuran (THF) were passed through a column of neutral 
alumina under nitrogen prior to use. Methyl tert-butyl ether (MTBE) was distilled 
prior to use and stored over 4 Å molecular sieves. Cinnamaldehyde was 
purchased from Sigma Aldrich and distilled before use.  All other reagents were 
purchased from commercial sources and were used as received unless 
otherwise noted.  All racemic products were obtained via General Procedure B, 
using an achiral N-mesityl triazolium catalyst.100 
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3.5.2 Preparation of Catalyst 45 
 
The following protocol is an adaptation of a literature procedure.48 Under 
N2, a 50 mL flame-dried round-bottomed flask equipped with a magnetic stir bar 
was charged with trimethyloxonium tetrafluoroborate (7.0 mmol, 1.0 equiv) and 
capped with a septum. To this flask, DCM (35 mL, 0.2 M) was added under an 
atmosphere of N2. The septum was removed and (R)-5-benzylpyrrolidin-2-one 
(7.0 mmol, 1.0 equiv) 101 was added in a single portion. The flask was capped, 
put under N2, and stirred vigorously for 6 h or until homogenous. Mesityl 
hydrazine (7.0 mmol, 1.0 equiv)100 was then added in a single portion and the 
reaction mixture was stirred for an additional 6 h. The reaction was then 
concentrated in vacuo and dried under high vacuum for 15 min. The crude 
reaction mixture was dissolved in chlorobenzene (35 mL, 0.2 M) and triethyl 
orthoformate (35.0 mmol, 5.0 equiv) was added. The reaction flask was equipped 
with a reflux condenser and heated open to the atmosphere at 135 °C for 12 h. A 
second portion of triethyl orthoformate (35.0 mmol, 5.0 equiv) was added and the 
reaction mixture was heated for an additional 24 h at 135 °C. The flask was then 
cooled to room temperature, diluted with 50 mL of toluene, and concentrated in 
vacuo. The crude residue was stirred in EtOAc (50 mL) for 2 h then filtered, 
providing 45 (0.74 g, 1.77 mmol, 25% yield) as a tan solid.   
Mes
H
N
N
N
Bn
BF4
45
HO N
H
Bn
1) MeO3BF4;
    Mesityl Hydrazine
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(R)-5-benzyl-2-mesityl-6,7-dihydro-5H-pyrrolo[2,1-c][1,2,4]triazol-2-ium (45): 
Analytical data for 45: 1H NMR (600 MHz, CDCl3) δ 9.18 (s, 1H), 7.27 (m, 3H), 
7.23-7.18 (m, 2H), 6.95 (s, 2H), 5.43-5.39 (m, 1H), 3.35-3.28 (m, 2H), 3.12-3.00 
(m, 2H), 2.88-2.83 (m, 1H), 2.67-2.62 (m, 1H), 2.33 (s, 3H), 2.03 (s, 6H); 13C 
NMR (151 MHz, CDCl3): δ 162.3, 141.9, 140.4, 135.0, 134.6, 129.6, 129.5, 129.0, 
127.7, 61.7, 39.6, 32.0, 21.4, 21.1, 17.2; IR (thin film): 1056, 1035, 649, 633 cm-1; 
TLC (2.5% MeOH/DCM): Rf = 0.13; HRMS (ESI): Calcd. for C21H24BF4N3: ([M+H-
BF4]): 318.1965, Found: 318.1966.  
 3.5.3 Preparation of Catalyst 21 
 
The following protocol is an adaptation of a literature procedure.48 Under 
N2, a 50 mL flame-dried round-bottomed flask equipped with a magnetic stir bar 
was charged with trimethyloxonium tetrafluoroborate (5.3 mmol, 1.0 equiv) and 
capped with a septum. To the flask, DCM (26 mL, 0.2 M) was added under an 
atmosphere of N2. The septum was removed and (S)-5-isopropyl-6,6-
dimethylmorpholin-3-one (5.3 mmol, 1.0 equiv)102 was added in a single portion. 
The flask was capped, put under N2, and stirred vigorously for 6 h or until 
homogenous. Mesityl hydrazine (5.3 mmol, 1.0 equiv)100 was then added in a 
single portion and the reaction mixture was stirred for an additional 6 h. The 
reaction was then concentrated in vacuo and dried under high vacuum for 15 min. 
The crude reaction mixture was dissolved in chlorobenzene (26 mL, 0.2 M) and 
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triethyl orthoformate (26.5 mmol, 5.0 equiv) was added. The reaction flask was 
equipped with a reflux condenser and heated open to the atmosphere at 135 °C 
for 12 h. A second portion of triethyl orthoformate (26.5 mmol, 5.0 equiv) was 
added and the reaction mixture was heated for an additional 24 h at 135 °C. The 
flask was then cooled to room temperature, diluted with 50 mL of toluene, and 
concentrated in vacuo. The crude residue was then purified by column 
chromatography using 2.5% MeOH/DCM. The resulting oil was stirred in hexanes 
until precipitation occurred, then filtered, providing 21 (1.50 g, 3.73 mmol, 71% 
yield) as a tan solid.   
(S)-5-benzyl-2-mesityl-6,6-dimethyl-5,6-dihydro-8H-[1,2,4]triazolo[3,4-
c][1,4]oxazin-2-ium (D): Analytical data for 21: 1H NMR (600 MHz, CDCl3) δ 
8.41 (s, 1H), 7.33 (t, J = 7.5 Hz, 2H), 7.25 – 7.22 (m, 3H), 6.90 (s, 2H), 5.28 (dd, 
J = 11.8, 4.5 Hz, 1H), 5.22 (d, J = 17.4 Hz, 1H), 5.06 (d, J = 17.5 Hz, 1H), 3.51 
(dd, J = 13.9, 4.5 Hz, 1H), 2.95 (dd, J = 14.0, 11.8 Hz, 1H), 2.29 (s, 3H), 1.81 (s, 
9H), 1.59 (s, 3H), 1.47 (s, 3H); 13C NMR (151 MHz, CDCl3): δ 148.7, 143.7, 142.2, 
134.5, 129.7, 129.7, 129.5, 128.2, 74.0, 63.2, 56.8, 36.8, 25.0, 22.1, 21.1, 17.0; 
IR (thin film): 1085, 1063, 561 cm-1; TLC (50% EtOAc/hexane): Rf = 0.03; HRMS 
(ESI): Calcd. for C23H228BF4N3O: ([M+H-BF4]): 363.2305, Found: 363.2304.  
3.5.4 Preparation of Catalyst 46 
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The following protocol is an adaptation of a literature procedure.48 Under 
N2, a 50 mL flame-dried round-bottomed flask equipped with a magnetic stir bar 
was charged with trimethyloxonium tetrafluoroborate (2.0 mmol, 1.0 equiv) and 
capped with a septum. To the flask, DCM (10 mL, 0.2 M) was added under an 
atmosphere of N2. The septum was removed and (S)-5-isopropyl-6,6-
diphenylmorpholin-3-one (2.0 mmol, 1.0 equiv)102 was added in a single portion. 
The flask was capped, put under N2, and stirred vigorously for 6 h or until 
homogenous. Mesityl hydrazine (2.0 mmol, 1.0 equiv)100 was then added in a 
single portion and the reaction mixture was stirred for an additional 6 h. The 
reaction was then concentrated in vacuo and dried under high vacuum for 15 min. 
The crude reaction mixture was dissolved in chlorobenzene (10 mL, 0.2 M) and 
triethyl orthoformate (10.0 mmol, 5.0 equiv) was added. The reaction flask was 
equipped with a reflux condenser and heated open to the atmosphere at 135 °C 
for 12 h. A second portion of triethyl orthoformate (10.0 mmol, 5.0 equiv) was 
added and the reaction mixture was heated for an additional 24 h at 135 °C. The 
flask was then cooled to room temperature, diluted with 20 mL of toluene, and 
concentrated in vacuo. The crude residue was then purified by column 
chromatography using 2.5% MeOH/DCM. The resulting solid was stirred in 40% 
EtOAc/hexanes at 70 ˚C for 1 h, then filtered, providing 46 (0.30 g, 0.57 mmol, 
29% yield) as a white solid.   
(S)-5-benzyl-2-mesityl-6,6-diphenyl-5,6-dihydro-8H-[1,2,4]triazolo[3,4-
c][1,4]oxazin-2-ium (46): Analytical data for 46: mp 162.8-163.4 ˚C 1H NMR 
(600 MHz, CDCl3) δ 8.97 (s, 1H), 7.59 (m, 4H), 7.42 (t, J = 7.7 Hz, 2H), 7.37 (t, J 
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= 7.7 Hz, 2H), 7.32 – 7.30 (m, 3H), 7.27 – 7.22 (m, 4H), 6.89 (s, 2H), 6.47 (dd, J 
= 10.5, 5.3 Hz, 1H), 5.40 (d, J = 17.2 Hz, 1H), 4.88 (d, J = 17.2 Hz, 1H), 3.00 – 
2.92 (m, 2H), 2.29 (s, 3H), 1.72 (s, 9H); 13C NMR (151 MHz, CDCl3): δ 148.9, 
143.4, 142.3, 140.1, 136.9, 134.3, 130.5, 129.8, 129.7, 129.6, 129.0, 128.9, 
128.1, 128.1, 127.1, 81.8, 60.5, 57.7, 37.3, 21.1, 16.7; IR (thin film): 1739, 1365, 
1228, 1217, 1204, 1085, 1064 cm-1; TLC (50% EtOAc/hexane): Rf = 0.14; HRMS 
(ESI): Calcd. for C33H32BF4N3O: ([M+H-BF4]): 487.2618, Found: 487.2611.  
3.5.5 Preparation of Catalyst 48 
 
Under N2, a 50 mL flame-dried round-bottomed flask equipped with a 
magnetic stir bar was charged with trimethyloxonium tetrafluoroborate (8.3 mmol, 
1.0 equiv) and capped with a septum. To the flask, DCM (40 mL, 0.2 M) was 
added under an atmosphere of N2. The septum was removed and (S)-5-(((tert-
butyldimethylsilyl)oxy)diphenylmethyl)pyrrolidin-2-one (8.3 mmol, 1.0 equiv)103 
was added in a single portion. The flask was capped, put under N2, and stirred 
vigorously for 6 h or until homogenous. Mesityl hydrazine (8.3 mmol, 1.0 equiv)100 
was then added in a single portion and the reaction mixture was stirred for an 
additional 6 h. The reaction was then concentrated in vacuo and dried under high 
vacuum for 15 min. The crude reaction mixture was dissolved in chlorobenzene 
(40 mL, 0.2 M) and triethyl orthoformate (41.5 mmol, 5.0 equiv) was added. The 
reaction flask was equipped with a reflux condenser and heated open to the 
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atmosphere at 135 °C for 12 h. A second portion of triethyl orthoformate (41.5 
mmol, 5.0 equiv) was added and the reaction mixture was heated for an 
additional 24 h at 135 °C. The flask was then cooled to room temperature, diluted 
with 50 mL of toluene, and concentrated in vacuo. The crude residue was then 
purified by column chromatography using 40% EtOAc/hexanes, providing 48 
(3.98 g, 6.52 mmol, 79% yield) as an off-white solid.   
(S)-5-(((tert-butyldimethylsilyl)oxy)diphenylmethyl)-2-mesityl-6,7-dihydro-
5H-pyrrolo[2,1-c][1,2,4]triazol-2-ium (48): Analytical data for 48: 1H NMR (600 
MHz, CDCl3) δ 7.53-7.36 (m, 9H), 6.99 (s, 2H), 6.29 (d, J = 9.1 Hz, 1H), 3.38 (q, J 
= 10.6, 9.6 Hz, 1H), 2.87 (dd, J = 17.4, 10.3 Hz, 1H), 2.34 (s, 3H), 2.07 (s, 6H), 
1.85 (s, 1H), 1.67 (s, 1H), 0.92 (s, 9H), -0.31 (s, 6H); 13C NMR (151 MHz, CDCl3): 
δ 163.8, 142.1, 140.3, 140.0, 131.5, 129.7, 129.0, 128.5, 82.3, 29.7, 26.1, 21.1, 
21.1, 18.7, 17.26, 3.3, -3.5 (multiple coincident/broad resonances in the aryl 
region due to restricted rotation); IR (thin film): 2365, 2339, 1061, 1026, 838, 780 
cm-1; TLC (40% EtOAc/hexane): Rf = 0.14; LRMS (ESI): Calcd. for 
C33H42BF4N3OSi: ([M+H-BF4]): 525.32, Found: 525.27. 
3.5.6 General Procedure A: Preparation of α-Keto Esters 
 
The following protocol was adopted from a literature procedure.61,50 A 100 
mL round-bottomed flask equipped with a magnetic stir bar was charged with 
aldehyde (10.0 mmol, 1.0 equiv), tert-butyl dichloroacetate97 (13.0 mmol, 1.3 
equiv), and THF (20 mL, 0.5 M). This solution was cooled to 0 °C and potassium 
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tert-butoxide (13.0 mmol, 1.3 equiv) was added in one portion. The mixture was 
warmed slowly to room temperature and stirred for 18 h, followed by dilution with 
Et2O (60 mL) and H2O (60 mL). The layers were separated and the organic layer 
was further washed with H2O (1 x 60 mL) and brine (1 x 60 mL). The organic 
extracts were dried over MgSO4, filtered and concentrated in vacuo. The crude 
residue was then filtered through a short plug of SiO2 with 15% EtOAc/hexanes, 
concentrated in vacuo, then dissolved in THF. To the resulting solution, 
tetrabutylammonium chloride (1.0 mmol, 0.10 equiv) was added in one portion. 
The reaction was stirred for 12 h at the indicated temperature followed by dilution 
with H2O (60 mL). The layers were separated and the aqueous layer was further 
extracted with DCM (2 x 60 mL). The organic extracts were combined, dried over 
MgSO4, filtered, and concentrated in vacuo. The crude residue was purified by 
column chromatography using a gradient of 5-10% EtOAc/hexanes.  
tert-butyl 4-chloro-2,3-dioxopentanoate (41n): The title 
compound was prepared according to General Procedure A (stirred 
at rt after addition of tetrabutylammonium chloride) using 
acetaldehyde (0.56 mL, 10.0 mmol), affording 41n (0.95 g, 4.32 mmol, 43% yield) 
as a yellow oil.  Analytical data for 41n: 1H NMR (600 MHz, CDCl3) δ 4.99 (q, J = 
6.8 Hz, 1H), 1.65 (d, J = 6.9 Hz, 3H), 1.56 (s, 9H); 13C NMR (151 MHz, CDCl3): δ 
188.3, 160.2, 85.2, 54.1, 27.8, 18.7; IR (thin film): 2359, 2335, 1159, 668 cm-1; 
TLC (5% EtOAc/hexane): Rf = 0.24; HRMS (ESI): Calcd. for C8H13ClO3: 
([M+Na+MeOH]): 247.0713, Found: 247.0710. 
tBuO
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tert-butyl 4-chloro-5-methyl-2,3-dioxohexanoate (41o): The title 
compound was prepared according to General Procedure A (stirred 
at 60 ˚C after addition of tetrabutylammonium chloride) using isobutyraldehyde 
(0.91 mL, 10.0 mmol), affording 41o (0.98 g, 3.95 mmol, 40% yield) as a yellow 
oil. Analytical data for 1o: 1H NMR (600 MHz, CDCl3) δ 4.71 (d, J = 6.2 Hz, 1H), 
2.42 (m, 1H), 1.56 (s, 9H), 1.05 (m, 6H); 13C NMR (151 MHz, CDCl3): δ 188.7, 
160.5, 85.1, 30.7, 27.8, 27.6, 19.9, 17.9; IR (thin film): 1724, 1372 cm-1; TLC 
(10% EtOAc/hexane): Rf = 0.11; LRMS (ESI): Calcd. for C10H17ClO3: ([M+NH4]): 
238.12, Found: 238.27. 
3.5.7 Optimization Data for the Asymmetric Homoenolate Addition of 41a 
With (E)-PhCH=CHCHO 
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General procedure B for Optimization of the Asymmetric 
Homoenolate Addition of Cinnamaldehyde to 41: To a flame dried 1-dram vial 
was added catalyst, (0.01 mmol, 0.10 equiv) β-halo α-keto ester 1 (0.1 mmol, 1.0 
equiv), solvent (0.5 mL, 0.2 M) and cinnamaldehyde (0.2 mmol, 2.0 equiv).  This 
solution was stirred for 5 min followed by the addition of potassium carbonate 
(0.1 mmol, 1.0 equiv). This reaction mixture was then stirred (rate of stirring 
should be >800 rpm) for 14 h, filtered through a short plug of silica gel with Et2O, 
and concentrated in vacuo. When necessary the product was purified by column 
chromatography using a gradient of 5-10% EtOAc/hexanes. 
Ester, catalyst, base, and solvent optimization table: 
Entry	 R	=	 X	=	 Cat	 Solvent	 Base	 Conv.	
(%)	
42a:43a	 dra	 era	
1	 Me	 Cl	 21	 DCM	 K2CO3	 100	 6:1	 5:1	 75:25	
2	 Me	 Cl	 44	 DCM	 K2CO3	 100	 5:1	 3:1	 76:24	
3	 Me	 Cl	 21	 PhCH3	 K2CO3	 55	 5.5:1	 2:1	 --	
4	 Me	 Cl	 21	 Et2O	 K2CO3	 100	 5:1	 3:1	 90:10	
5	 Me	 Cl	 21	 THF	 EtNiPr2	 57	 5:1	 2:1	 80:20	
6	 Me	 Cl	 21	 THF	 DMAPa	 76	 10:1	 3:1	 80:20	
7	 Me	 Cl	 21	 THF	 NEt3	 0	 --	 --	 --	
8	 Me	 Cl	 21	 THF	 TMG	 100	 5.5:1	 1:1	 --	
9	 Me	 Cl	 21	 Et2O	 K2CO3	 100	 >20:1	 6:1	 84:16	
10	 tBu	 Br	 21	 Et2O	 K2CO3	 100	 >20:1	 2:1	 --	
11	 tBu	 Cl	 44	 Et2O	 K2CO3	 100	 2:1	 6:1	 --	
12	 tBu	 Cl	 45	 Et2O	 K2CO3	 100	 >20:1	 3:1	 78:22	
13	 tBu	 Cl	 20	 Et2O	 K2CO3	 88	 >20:1	 3:1	 73:27	
14	 tBu	 Cl	 46	 Et2O	 K2CO3	 64	 3.5:1	 2:1	 85:15	
15	 tBu	 Cl	 47	 Et2O	 K2CO3	 100	 >20:1	 9:1	 93:7	
16	 tBu	 Br	 48	 Et2O	 K2CO3	 40	 >20:1	 >20:1	 --	
17	 tBu	 Cl	 48	 Et2O	 K2CO3	 100	 >20:1	 33:1	 99:1	
a) Only reported for product 42a. 
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3.5.8 General procedure B: Asymmetric (3+2)-Annulation 
 
 
Method 1: 
To a flame-dried 1-dram vial was added catalyst 48, (0.01 mmol, 0.05 
equiv) β-halo α-keto ester 1 (0.2 mmol, 1.0 equiv), Et2O (1 mL, 0.2 M) and α,β-
unsaturated aldehyde (0.4 mmol, 2.0 equiv).  This solution was stirred for 5 min 
followed by the addition of potassium carbonate (0.2 mmol, 1.0 equiv). This 
reaction mixture was then stirred (rate of stirring should be >800 rpm) for 14 h, 
filtered through a short plug of silica gel with Et2O, and concentrated in vacuo. 
The crude product was purified by column chromatography using EtOAc/hexanes. 
In certain instances minor impurities remained after purification, in these cases a 
1H NMR yield utilizing mesitylene (0.20 mmol) as an internal standard is provided.   
Method 2: For instances where product 42 and unreacted α,β-unsaturated 
aldehyde are inseparable by chromatography.  
To a flame-dried 1-dram vial was added catalyst 48, (0.01 mmol, 0.05 
equiv) β-halo α-keto ester 1 (0.2 mmol, 1.0 equiv), Et2O (1 mL, 0.2 M) and α,β-
unsaturated aldehyde (0.4 mmol, 2.0 equiv).  This solution was stirred for 5 min 
followed by the addition of potassium carbonate (0.2 mmol, 1.0 equiv). This 
reaction mixture was then stirred (rate of stirring should be >800 rpm) for 14 h, 
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filtered through a short plug of silica gel with Et2O, and concentrated in vacuo. 
The crude product was dissolved in MeOH (1 mL) then cooled to -78 ˚C.  NaBH4  
(5.0 equiv) was added and the reaction was stirred at -78 ˚C  for 10 min, then 
quenched with saturated NH4Cl and diluted with Et2O (15 mL) and H2O (10 mL). 
The layers were separated and the organic layer was further washed with brine 
(1 x 10 mL). The organic extracts were dried over MgSO4, filtered and 
concentrated in vacuo.  The crude product was purified by column 
chromatography using EtOAc/hexanes.  
(2R,3S)-tert-butyl 2-((R)-1-chloro-2-phenylethyl)-5-oxo-3-
phenyltetrahydrofuran-2-carboxylate (42a): The title compound 
was prepared according to General Procedure B (Method 1) using 
α-keto ester 41a (0.054 g, 0.20 mmol), and (E)-cinnamaldehyde 
(0.04 mL, 0.40 mmol) affording 42a (0.070 g, 0.18 mmol, 87% yield, 33:1 dr) as a 
white solid. The diastereomer ratio was determined by 1H NMR spectroscopic 
analysis of the crude reaction mixture by comparison of the integration of the 
resonances at δ 4.60 (minor diastereomer) and δ 4.34 (major diastereomer). 
Analytical data for 42a: mp 133.2-133.4 ˚C; 1H NMR (600 MHz, CDCl3) δ 7.38-
7.32 (m, 5H), 7.22-7.18 (m, 3H), 6.92 (dd, 2H), 4.29 (dd, J = 8.9, 3.0 Hz, 1H), 
3.88 (dd, J = 11.4, 2.0 Hz, 1H), 3.17 (dd, J = 14.5, 2.0 Hz, 1H), 3.09 (dd, J = 17.9, 
8.8 Hz, 1H), 2.82 (dd, J = 18.0, 3.0 Hz, 1H), 2.75 (dd, J = 14.5, 11.5 Hz, 1H), 
1.61 (s, 9H); 13C NMR (151 MHz, CDCl3): δ 174.8, 167.5, 136.9, 136.4, 129.2, 
128.9, 128.6, 128.4, 128.2, 126.8, 90.3, 84.6,  62.0, 46.7, 38.9, 36.1, 27.9; IR 
(thin film): 2360, 2339, 1794, 1515, 1366, 1228, 1216 cm-1; TLC (10% 
O
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EtOAc/hexane): Rf = 0.24; HRMS (ESI): Calcd. for C23H25ClO4: ([M+NH4]): 
418.1785, Found: 418.1784; SFC OD, 10% MeOH, flow rate = 1.5 mL/min, λ = 
210 nm, tR (major) = 6.3 min tR (minor)  = 10.2 min, 99:1 er; [α]D = +18.6 (c = 0.01, 
DCM). 
 (2R,3S)-tert-butyl 2-((R)-1-chloro-2-phenylethyl)-3-(4-
methoxyphenyl)-5-oxotetrahydrofuran-2-carboxylate (42b): 
The title compound was prepared according to General 
Procedure B (Method 2) using α-keto ester 41a (0.054 g, 0.20 mmol), and (E)-3-
(4-methoxyphenyl)acrylaldehyde (0.066 g, 0.40 mmol) affording 42b (0.052 g, 
0.12 mmol, 60% yield, 49:1 dr) as a colorless oil. The diastereomer ratio was 
determined by 1H NMR spectroscopic analysis of the crude reaction mixture by 
comparison of the integration of the resonances at δ 4.59 (minor diastereomer) 
and δ 4.35 (major diastereomer). Analytical data for 42b: 1H NMR (600 MHz, 
CDCl3) δ 7.24-7.17 (m, 4H), 6.97-6.96 (m, 2H), 6.89-6.86 (m, 2H), 4.24 (dd, J = 
8.8, 2.9 Hz, 1H), 3.84 (dd, J = 11.3, 2.1 Hz, 1H), 3.79 (s, 3H), 3.20 (dd, J = 14.5, 
2.0 Hz, 1H), 3.07 (dd, J = 17.9, 8.9 Hz, 1H), 2.80-2.71 (m, 2H). 1.60 (s, 9H); 13C 
NMR (151 MHz, CDCl3): δ 174.9, 167.6, 159.5, 137.1, 129.8, 129.3, 128.3, 126.8, 
114.2, 90.5, 84.5, 62.1, 55.3, 46.1, 39.1, 36.4, 28.0 (two coincident resonances); 
IR (thin film): 1794, 1735, 1515, 1369, 1229, 1216 cm-1; TLC (10% 
EtOAc/hexane): Rf = 0.11; HRMS (ESI): Calcd. for C24H27ClO5: 
([M+NH4]):448.1891, Found: 448.1890; SFC OD, 5% MeOH, flow rate = 3.0 
mL/min, λ = 210 nm, tR (major) = 7.6 min tR (minor)  = 12.0 min, 99:1 er; [α]D = +3.9 (c 
= 0.01, DCM). 
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2R,3S)-tert-butyl 2-((R)-1-chloro-2-phenylethyl)-3-(4-
chlorophenyl)-5-oxotetrahydrofuran-2-carboxylate (42c): The 
title compound was prepared according to General Procedure B 
(Method 2) using α-keto ester 41a (0.054 g, 0.20 mmol), and (E)-
3-(4-chlorophenyl)acrylaldehyde (0.066 g, 0.40 mmol) affording 42c (0.060 g, 
0.14 mmol, 69% yield, 34:1 dr) as a colorless oil. The diastereomer ratio was 
determined by 1H NMR spectroscopic analysis of the crude reaction mixture by 
comparison of the integration of the resonances at δ 4.55 (minor diastereomer) 
and δ 4.38 (major diastereomer). Analytical data for 42c: 1H NMR (600 MHz, 
CDCl3) δ 7.33-7.30 (m, 2H), 7.27-7.20 (m, 5H), 7.00 (d, J = 7.0 Hz, 2H), 4.28 (dd, 
J = 8.7, 2.6 Hz, 1H), 3.76 (dd, J = 11.4, 2.0 Hz, 1H), 3.29 (dd, J = 14.6, 2.0 Hz, 
1H), 3.09 (dd, J = 20.8, 11.4 Hz, 1H), 2.79-2.71 (m, 2H), 1.61 (s, 9H); 13C NMR 
(151 MHz, CDCl3): δ 174.4, 167.1, 136.8, 135.2, 134.4, 130.0, 129.2, 129.1, 
128.4, 127.0, 90.1, 84.8, 61.7, 46.3, 39.3, 36.5, 28.0; IR (thin film): 1795, 1735, 
1515, 1368, 1228, 1217 cm-1; TLC (10% EtOAc/hexane): Rf = 0.26; HRMS (ESI): 
Calcd. for C23H24Cl2O4: ([M+NH4]): 452.1396, Found: 452.1395; SFC OD, 10% 
MeOH, flow rate = 1.5 mL/min, λ = 210 nm, tR (major) = 4.8 min tR (minor)  = 7.1 min, 
97.5:2.5 er; [α]D = +2.4 (c = 0.008, DCM). 
(2R,3S)-tert-butyl 2-((R)-1-chloro-2-phenylethyl)-5-oxo-3-(p-
tolyl)tetrahydrofuran-2-carboxylate (42d): The title compound 
was prepared according to General Procedure B (Method 1) 
using α-keto ester 41a (0.054 g, 0.20 mmol), and (E)-3-(p-
tolyl)acrylaldehyde (0.58 g, 0.40 mmol) affording 42d (0.062 g, 0.15 mmol, 73% 
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yield, 43:1 dr) as a colorless oil. The diastereomer ratio was determined by 1H 
NMR spectroscopic analysis of the crude reaction mixture by comparison of the 
integration of the resonances at δ 4.61 (minor diastereomer) and δ 4.31 (major 
diastereomer). Analytical data for 42d: 1H NMR (600 MHz, CDCl3) δ 7.23-7.16 (m, 
7H), 6.96-6.94 (m, 2H), 4.25 (dd, J = 8.8, 2.9 Hz, 1H), 3.88 (dd, J = 11.4, 2.0 Hz, 
1H), 3.19 (dd, J = 14.5, 2.1 Hz, 1H), 3.08 (dd, J = 17.9, 8.9 Hz, 1H), 2.81-2.74 (m, 
2H), 2.34 (s, 3H), 1.61 (s, 9H); 13C NMR (151 MHz, CDCl3): δ 174.9, 167.6, 138.2, 
137.1, 133.4, 129.6, 129.3, 128.5, 128.2, 126.8, 90.4, 84.5, 62.0, 46.5, 39.0, 36.2, 
27.93, 21.0; IR (thin film): 1795, 1735, 1369, 1228, 1216 cm-1; TLC (10% 
EtOAc/hexane): Rf = 0.27; HRMS (ESI): Calcd. for C24H27ClO4: ([M+NH4]): 
432.1942, Found: 432.1941; SFC OD, 10% MeOH, flow rate = 1.5 mL/min, λ = 
210 nm, tR (major) = 6.0 min tR (minor)  = 9.7 min, 97.5:2.5 er; [α]D = +9.4 (c = 0.02, 
DCM). 
(2R,3S)-tert-butyl 2-((R)-1-chloro-2-phenylethyl)-5-oxo-3-(m-
tolyl)tetrahydrofuran-2-carboxylate (42e): The title 
compound was prepared according to General Procedure B 
(Method 1) using α-keto ester 41a (0.054 g, 0.20 mmol), and 
(E)-3-(m-tolyl)acrylaldehyde (0.58 g, 0.40 mmol) affording 42e (0.062 g, 0.15 
mmol, 73% yield, 32:1 dr) as a white solid. The diastereomer ratio was 
determined by 1H NMR spectroscopic analysis of the crude reaction mixture by 
comparison of the integration of the resonances at δ 4.60 (minor diastereomer) 
and δ 4.30 (major diastereomer). Analytical data for 42e: mp 116.0-116.6 ˚C; 1H 
NMR (600 MHz, CDCl3) δ 7.28-7.12 (m, 7H), 6.93-6.92 (m, 2H), 4.25 (dd, J = 8.9, 
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3.1 Hz, 1H), 3.93 (dd, J = 11.4, 2.0 Hz, 1H), 3.15 (dd, J = 14.5, 2.0 Hz, 1H), 3.08 
(dd, J = 18.0, 8.9 Hz, 1H), 2.82 (dd, J = 18.0, 3.1 Hz, 1H), 2.76 (dd, J = 14.5, 
11.4 Hz, 1H), 2.35 (s, 3H), 1.62 (s, 9H); 13C NMR (151 MHz, CDCl3): δ 174.8, 
167.6, 138.7, 137.1, 136.4, 129.4, 129.2, 129.2, 128.8, 128.2, 126.8, 125.5, 90.4, 
84.5, 62.1, 46.8, 38.9, 36.0, 27.9, 21.4; IR (thin film): 1795, 1734, 1369, 1158, 
839, 750, 699 cm-1; TLC (10% EtOAc/hexane): Rf = 0.24; HRMS (ESI): Calcd. for 
C24H27ClO4: ([M+NH4]): 432.1942, Found: 432.1940; SFC OD, 5% MeOH, flow 
rate = 3.0 mL/min, λ = 210 nm, tR (major) = 4.1 min tR (minor)  = 6.7 min, 98.5:1.5 er; 
[α]D = +16.7 (c = 0.03, DCM). 
(2R,3S)-tert-butyl 2-((R)-1-chloro-2-phenylethyl)-5-oxo-3-
(thiophen-2-yl)tetrahydrofuran-2-carboxylate (42i): The title 
compound was prepared according to General Procedure B 
(Method 1) using α-keto ester 41a (0.054 g, 0.20 mmol), and (E)-3-
(thiophen-2-yl)acrylaldehyde (0.055 g, 0.40 mmol) affording 42i (0.069 g, 0.17 
mmol, 85% yield, 50:1 dr) as a white solid. The diastereomer ratio was 
determined by 1H NMR spectroscopic analysis of the crude reaction mixture by 
comparison of the integration of the resonances at δ 4.38 (minor diastereomer) 
and δ 4.27 (major diastereomer). Analytical data for 42i: mp 161.8-162.1 ˚C; 1H 
NMR (600 MHz, CDCl3) δ 7.34 (d, J = 5.1 Hz, 1H), 7.25-7.20 (m, 3H), 7.13 (d, J = 
3.5 Hz, 1H), 7.05 (dd, J = 5.1, 3.6 Hz, 1H), 6.91 (d, J = 6.5 Hz, 2H), 4.54 (dd, J = 
9.1, 6.0 Hz, 1H), 4.20 (dd, J = 11.5, 2.0 Hz, 1H), 3.20-3.13 (m, 1H), 3.15-3.09 (m, 
1H), 2.98 (dd, J = 17.9, 6.0 Hz, 1H), 2.72 (m, 1H), 1.61 (s, 9H); 13C NMR (151 
MHz, CDCl3): δ 173.2, 167.2, 137.9, 136.8, 129.2, 128.3, 127.4, 127.3, 126.9, 
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125.9, 89.8, 84.9, 62.7, 42.4, 38.6, 36.6, 27.9; IR (thin film): 1796, 1751, 1369, 
1158, 755, 700 cm-1; TLC (10% EtOAc/hexane): Rf = 0.18; HRMS (ESI): Calcd. 
for C21H23ClO4S: ([M+NH4]): 424.1350, Found: 424.1348; SFC OD, 10% MeOH, 
flow rate = 3.0 mL/min, λ = 210 nm, tR (major) = 3.7 min tR (minor)  = 8.5 min, 99.5:0.5 
er; [α]D = +24.0 (c = 0.03, DCM). 
(2R,3S)-tert-butyl 2-((R)-1-chloro-2-phenylethyl)-3-(furan-2-yl)-5-
oxotetrahydrofuran-2-carboxylate (42j): The title compound was 
prepared according to General Procedure B (Method 2) using α-
keto ester 41a (0.045 g, 0.20 mmol), and (E)-3-(furan-2-
yl)acrylaldehyde (0.49 g, 0.40 mmol) affording 42j (0.070 g, 0.18 mmol, 89% 
yield, 6:1 dr) as a white solid. The diastereomer ratio was determined by 1H NMR 
spectroscopic analysis of the crude reaction mixture by comparison of the 
integration of the resonances at δ 4.26 (minor diastereomer) and δ 4.06 (major 
diastereomer).  Analytical data for 42j: mp 143.2-144.0 ˚C;  1H NMR (600 MHz, 
CDCl3) δ 7.46 (d, J = 1.8 Hz, 1H), 7.27-7.20 (m, 3H), 7.03 (dd, J = 6.8, 1.7 Hz, 
2H), 6.42-6.40 (m, 2H), 4.33 (dd, J = 8.3, 6.2 Hz, 1H), 4.00 (dd, J = 11.5, 2.1 Hz, 
1H), 3.08 (dd, J = 14.4, 2.1 Hz, 1H), 2.99 (m, 2H), 2.74 (m, 1H), 1.58 (s, 9H); 13C 
NMR (151 MHz, CDCl3): δ 173.4, 167.0, 149.1, 142.8, 136.9, 129.2, 128.3, 126.9, 
111.0, 110.2, 89.8, 84.6, 62.8, 40.9, 38.4, 33.4, 27.9; IR (thin film): 1797, 1735, 
1370, 1155, 1133 cm-1; TLC (10% EtOAc/hexane): Rf = 0.12; HRMS (ESI): Calcd. 
for C21H23ClO5: ([M+NH4]): 408.1578, Found: 408.1576; SFC OD, 3.9% MeOH, 
flow rate = 3.0 mL/min, λ = 210 nm, tR (major) = 4.3 min tR (minor)  = 9.7 min, 96:4 er; 
[α]D = +25.9 (c = 0.02, DCM). 
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 (2R,3S)-tert-butyl 2-((R)-1-chloro-2-phenylethyl)-5-oxo-3-((E)-
styryl)tetrahydrofuran-2-carboxylate (42k): The title 
compound was prepared according to General Procedure B 
(Method 1) using α-keto ester 41a (0.054 g, 0.20 mmol), and 
(2E,4E)-5-phenylpenta-2,4-dienal (0.063 g, 0.40 mmol) affording 42k (0.067 g, 
0.15 mmol, 74% yield, 40:1.5:1 dr) as a white solid. The diastereomer ratio was 
determined by 1H NMR spectroscopic analysis of the crude reaction mixture by 
comparison of the integration of the resonances at δ 4.75 (minor diastereomer), δ 
4.62 (minor diastereomer), and δ 4.41 (major diastereomer).  Analytical data for 
42k: mp 133.2-133.4 ˚C; 1H NMR (600 MHz, CDCl3) δ 7.40-7.34 (m, 4H), 7.31-
7.22 (m, 4H), 7.16-7.15 (m, 2H), 6.67 (d, J = 15.9 Hz, 1H), 6.33 (dd, J = 15.9, 7.9 
Hz, 1H), 4.32 (dd, J = 11.5, 2.0 Hz, 1H), 3.82 (q, J = 7.8 Hz, 1H), 3.31 (dd, J = 
14.3, 2.0 Hz, 1H), 2.95-2.86 (m, 2H), 2.74 (dd, J = 17.9, 6.5 Hz, 1H), 1.58 (s, 9H); 
13C NMR (151 MHz, CDCl3): δ 173.7, 167.3, 136.6, 135.7, 135.1, 129.3, 128.8, 
128.5, 128.4, 127.1, 126.4, 122.9, 89.7, 84.4, 63.2, 44.7, 39.0, 34.5, 27.9; IR 
(thin film): 1796, 1735, 1370, 1197, 1157, 1133, 749, 700 cm-1; TLC (10% 
EtOAc/hexane): Rf = 0.14; HRMS (ESI): Calcd. for C25H27ClO4: ([M+NH4]): 
444.1942, Found: 444.1946; SFC Regis RP, 2.5% MeOH, flow rate = 1.5 mL/min, 
λ = 210 nm, tR (major) = 13.4 min tR (minor)  = 16.3 min, 97:3 er; [α]D = -48.6 (c = 0.03, 
DCM). 
 (2R,3S)-tert-butyl 2-((R)-1-chloro-2-phenylethyl)-5-oxo-3-((E)-
styryl)tetrahydrofuran-2-carboxylate (42l): The title compound 
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was prepared according to General Procedure B (Method 1) using α-keto ester 
1a (0.045 g, 0.20 mmol), and (E)-cinnamaldehyde (0.04 mL, 0.40 mmol) affording 
42l (0.052 g mix of diastereomers + aldehyde dimerization, 43% 1H NMR yield,  
>20:1 dr) as a colorless oil. The diastereomer ratio was determined by 1H NMR 
spectroscopic analysis of the crude reaction mixture by comparison of the 
integration of the resonances at δ 4.77 (minor diastereomer) and δ 4.55 (major 
diastereomer). Analytical data for 42l: 1H NMR (600 MHz, CDCl3) major 
diastereomer: δ 7.36-7.23 (m, 5H), 4.50 (dd, J = 11.4, 2.1 Hz, 1H), 4.30-4.19 (m, 
2H), 3.79-3.75 (m, 1H), 3.39 (dd, J = 14.2, 2.0 Hz, 1H), 2.91-2.82 (m, 3H), 1.56 (s, 
9H), 1.29-1.24 (m, 3H); minor diastereomer: δ 7.36-7.23 (m, 5H), 4.73 (dd, J = 
11.2, 2.3 Hz, 1H), 4.30-4.19 (m, 2H), 3.57 (dd, J = 14.6, 2.3 Hz, 1H), 3.20 (dd, J 
= 18.0, 10.4 Hz, 1H), 2.91-2.82 (m, 3H), 1.50 (s, 9H), 1.34 (t, J = 7.2 Hz, 3H);  
13C NMR major diastereomer (151 MHz, CDCl3): δ 172.5, 169.9, 166.3, 136.8, 
129.4, 128.5, 127.1, 87.9, 84.9, 62.2, 61.9, 46.3, 39.2, 32.9, 27.9, 14.0; IR (thin 
film): 1800, 1734, 1369, 1259, 1197, 1153, 750 cm-1; TLC (10% EtOAc/hexane): 
Rf = 0.30; HRMS (ESI): Calcd. for C20H25ClO6: ([M+NH4]): 414.1684, Found: 
414.1700; SFC Regis OD, 2-8% MeOH gradient, linear ramp rate, flow rate = 1.5 
mL/min, λ = 210 nm, tR (major) = 8.9 min tR (minor)  = 12.3 min, 94:6 er; [α]D = +14.4 
(c = 0.03, DCM). 
Synthesis of (2R,3S)-tert-butyl 2-((R)-chloro(phenyl)methyl)-5-oxo-3-
phenyltetrahydrofuran-2-carboxylate (42m) and (2R)-2-(tert-
butoxy)-2-((R)-chloro(phenyl)methyl)-5-phenyldihydrofuran-O
O
tBuO2C H
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Cl
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3(2H)-one (43m): The title compounds were prepared according to General 
Procedure B (Method 1) using α-keto ester 41m (0.051 g, 0.20 mmol), (E)-
cinnamaldehyde (0.04 mL, 0.40 mmol), and THF as the solvent (1.0 mL, 0.2 M) 
affording both the major and minor diastereomers of 42m major (0.036 g , 0.09 
mmol, 47% yield, >30:1 dr) and 42m minor (0.020 g, 0.05 mmol, 26% yield) in a 
1.5:1 ratio as white solids.  
 The diastereomeric ratio of 42m was determined by 1H NMR spectroscopic 
analysis of the crude reaction mixture by comparison of the integration of the 
resonances at δ 5.47 (minor diastereomer), and δ 4.79 (major diastereomer). 
Analytical data for 42m major: mp 153.8-154.0 ˚C; 1H NMR (600 MHz, CDCl3) δ 
7.58 (d, J = 7.0 Hz, 2H), 7.47-7.39 (m, 5H), 7.27-7.26 (m, 3H), 4.74 (s,1H), 3.98 
(dd, J = 12.4, 9.9 Hz, 1H), 3.50 (dd, J = 17.6, 12.4 Hz, 1H), 2.92 (dd, J = 17.6, 
10.0 Hz, 1H), 1.14 (s, 9H); 13C NMR (151 MHz, CDCl3): δ 174.2, 167.3, 137.5, 
133.1, 129.5, 129.0, 128.9, 128.7, 128.6, 128.4, 89.3, 84.0, 63.2, 49.2, 34.1, 
27.3; IR (thin film): 2364, 2341, 1796, 1753, 1369, 1125, 700 cm-1; TLC (10% 
EtOAc/hexane): Rf = 0.15; HRMS (ESI): Calcd. for C22H23ClO4: ([M+NH4]): 
404.1629, Found: 404.1627; SFC OD, 5% MeOH, flow rate = 3.0 mL/min, λ = 
210 nm, tR (major) = 5.0 min tR (minor)  = 6.9 min, 97:3 er; [α]D = +76.5 (c = 0.01, 
DCM). 
Analytical data for 2m minor: mp 109.8-110.2 ˚C 1H NMR (600 MHz, CDCl3) δ 
7.55-7.53 (m, 2H), 7.39-7.27 (m, 8H), 5.41 (s, 1H), 4.33 (t, J = 9.6 Hz, 1H), 3.13 
(dd, J = 17.7, 9.3 Hz, 1H), 3.06 (dd, J = 17.7, 9.7 Hz, 1H), 0.77 (s, 9H); 13C NMR 
(151 MHz, CDCl3): δ 174.4, 165.3, 137.0, 136.0, 129.2, 129.1, 128.9, 128.5, 
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128.4, 128.2, 91.2, 84.0, 64.4, 48.0, 34.0, 26.9; IR (thin film): 1735, 1365, 1228, 
1217, 529, 519 cm-1; TLC (10% EtOAc/hexane): Rf = 0.22; HRMS (ESI): Calcd. 
for C22H23ClO4: ([M+NH4]): 404.1629, Found: 404.1627; SFC OD, 10% MeOH, 
flow rate = 1.5 mL/min, λ = 210 nm, tR (major) = 6.8 min tR (minor)  = 8.9 min, 95:5 er; 
[α]D = -11.6 (c = 0.01, DCM). 
(2R,3S)-tert-butyl 2-((R)-1-chloroethyl)-5-oxo-3-
phenyltetrahydrofuran-2-carboxylate  (42n): The title 
compound was prepared according to General Procedure B 
(Method 2) using α-keto ester 41n (0.038 g, 0.20 mmol), and (E)-
cinnamaldehyde (0.04 mL, 0.40 mmol) affording 42n (0.032 g 4:1 mix of isomers, 
52% 1H NMR yield) as a colorless oil. The isomer ratio was determined by 1H 
NMR spectroscopic analysis of the crude reaction mixture by comparison of the 
integration of the resonances at δ 5.45 (minor product), and δ 4.25 (major 
product) in conjunction with the resonances at δ 1.77 (minor product), and δ 1.43 
(major product). Analytical data for 42n: 1H NMR (600 MHz, CDCl3) δ 7.37-7.34 
(m, 3H), 7.29-7.26 (m, 2H), 4.22 (dd, J = 8.7, 2.7 Hz, 1H), 3.84 (q, J = 6.7 Hz, 
1H), 3.03 (dd, J = 17.9, 8.7 Hz, 1H), 2.74 (dd, J = 17.9, 2.7 Hz, 1H), 1.57 (s, 9H), 
1.40 (d, J = 6.7 Hz, 3H); 13C NMR (151 MHz, CDCl3): δ 174.9, 167.5, 128.8, 
128.7, 128.3, 128.1, 90.6, 84.4, 55.4, 46.8, 36.4, 27.9, 20.0; IR (thin film): 2363, 
1792, 1734, 1457, 1369, 1228, 1205, 1134 cm-1; TLC (10% EtOAc/hexane): Rf = 
0.22; HRMS (ESI): Calcd. for C17H21ClO4: ([M+NH4]): 342.1472, Found: 
342.1469; SFC OD, 2.5% MeOH, flow rate = 1.5 mL/min, λ = 210 nm, tR (major) = 
2.3 min tR (minor)  = 2.7 min, 97:3 er; [α]D = +19.0 (c = 0.008, DCM). 
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 (2R,3S) tert-butyl-2-((R)-fluoro(phenyl)methyl)-5-oxo-3-
phenyltetrahydrofuran-2-carboxylate (42p): The title compound 
was prepared according to General Procedure B (Method 1) using 
α-keto ester 41p35 (0.048 g, 0.20 mmol), and (E)-cinnamaldehyde 
(0.04 mL, 0.40 mmol) affording 42p (0.055 g, 0.15 mmol, 74% yield, 4:1 dr) as a 
white solid. The diastereomer ratio was determined by 1H NMR spectroscopic 
analysis of the crude reaction mixture by comparison of the integration of the 
resonances at δ 5.94 (minor diastereomer) and δ 5.43 (major diastereomer). 
Analytical data for 42p: mp 98.8-99.4 ˚C; 1H NMR (600 MHz, CDCl3) δ 7.48-7.39 
(m, 8H), 7.33-7.29 (m, 2H), 5.41 (d, J = 43.3 Hz, 1H), 3.93 (dd, J = 12.6, 9.4 Hz, 
1H), 3.37-3.32 (m, 1H), 2.93-2.88 (m, 1H), 1.26 (s, 9H); 13C NMR (151 MHz, 
CDCl3): δ 174.0, 166.6 (d, JC-F  = 10.6 Hz), 133.6, 133.3 (d, JC-F  = 10.6 Hz), 129.6 
(d, JC-F  = 3.0 Hz), 129.4 (d, JC-F  = 3.0 Hz), 128.9 (d, JC-F  = 6.0 Hz), 128.7, 128.6, 
128.1, 92.6 (d, JC-F  = 181.2 Hz), 88.6 (d, JC-F  = 21.1 Hz), 84.0, 49.5,  34.2, 27.6; 
19F NMR (376 MHz, CDCl3) δ -180.13; IR (thin film): 1797, 1756, 1130, 768, 521 
cm-1; TLC (10% EtOAc/hexane): Rf = 0.08; LRMS (ESI): Calcd. for C22H23FO4: 
([M+NH4]): 388.19, Found: 388.31; SFC OD, 10% MeOH, flow rate = 1.5 mL/min, 
λ = 210 nm, tR (major) = 5.3 min tR (minor)  = 6.7 min, 97:3 er; [α]D = +42.1 (c = 0.02, 
DCM). 
 (2R,3S) tert-butyl -2-((R)-1-chlorobut-3-en-1-yl)-5-oxo-3-
phenyltetrahydrofuran-2-carboxylate (42q): The title compound 
was prepared according to General Procedure B (Method 1) using 
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α-keto ester 41q35 (0.044 g, 0.20 mmol), and (E)-cinnamaldehyde (0.04 mL, 0.40 
mmol) affording 42q (0.053 g, 0.15 mmol, 76% yield, 11:1 dr) as a white solid. 
The diastereomer ratio was determined by 1H NMR spectroscopic analysis of the 
crude reaction mixture by comparison of the integration of the resonances at δ 
4.46 (minor diastereomer) and δ 4.28 (major diastereomer). Analytical data for 
42q: mp 120.0-120.6 ˚C; 1H NMR (600 MHz, CDCl3) δ 7.37-7.33 (m, 3H), 7.28-
7.27 (m, 2H), 5.64-5.57 (m, 1H), 5.01-4.93 (m, 2H), 4.24 (d, J = 7.8 Hz, 1H), 3.64 
(d, J = 11.1 Hz, 1H), 3.03 (dd, J = 17.8, 8.7 Hz, 1H), 2.75-2.72 (m, 1H), 2.59-2.55 
(m,1H), 2.35-2.29 (m, 1H), 1.57 (s, 9H); 13C NMR (151 MHz, CDCl3): δ 174.8, 
167.35, 136.7, 133.4, 128.8, 128.6, 128.4, 118.2, 90.3, 84.5, 60.0, 46.9, 37.4, 
36.3, 27.9; IR (thin film): 2979, 1731, 1246, 1152, 1126, 698 cm-1; TLC (10% 
EtOAc/hexane): Rf = 0.18; LRMS (ESI): Calcd. for C19H23ClO4: ([M+NH4]): 368.16, 
Found: 368.31; SFC OD, 5% MeOH, flow rate = 3.0 mL/min, λ = 210 nm, tR (major) 
= 2.2 min tR (minor)  = 2.6 min, 97.2:2.5 er; [α]D = +35.2 (c = 0.03, DCM). 
 (2R,3S) tert-butyl -2-((R)-1-chloro-4-(trimethylsilyl)but-3-yn-
1-yl)-5-oxo-3-phenyltetrahydrofuran-2-carboxylate (42r): 
The title compound was prepared according to General 
Procedure B (Method 2) using α-keto ester 41r35 (0.058 g, 0.20 
mmol), and (E)-cinnamaldehyde (0.04 mL, 0.40 mmol) affording 42r (0.065 g, 
0.15 mmol, 77% yield, 17:1 dr) as a white solid. The diastereomer ratio was 
determined by 1H NMR spectroscopic analysis of the crude reaction mixture by 
comparison of the integration of the resonances at δ 4.71 (minor diastereomer) 
and δ 4.32 (major diastereomer). Analytical data for 42r: mp 124.8-125.4 ˚C; 1H 
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NMR (600 MHz, CDCl3) δ 7.40-7.36 (m, 3H), 7.27-7.26 (m, 2H), 4.28 (dd, J = 8.7, 
2.2 Hz, 1H), 3.72 (dd, J = 10.7, 2.6 Hz, 1H), 3.04 (dd, J = 17.9, 8.6 Hz, 1H), 2.88 
(dd, J = 17.7, 2.6 Hz, 1H), 2.70 (dd, J = 17.9, 2.2 Hz, 1H), 2.62 (dd, J = 17.7, 
10.7 Hz, 1H), 1.55 (s, 9H), 0.09 (s, 9H); 13C NMR (151 MHz, CDCl3): δ 174.5, 
166.7, 136.7, 129.0, 128.6, 128.4, 101.65, 89.8, 87.3, 84.8, 58.1, 46.6, 36.6, 27.9, 
25.6, -0.2; IR (thin film): 2980, 1799, 1734, 1248, 1151, 1122, 841, 699 cm-1; TLC 
(10% EtOAc/hexane): Rf = 0.17; LRMS (ESI): Calcd. for C22H29ClO4Si: 
([M+NH4]): 438.19, Found: 438.33; SFC OD, 5% MeOH, flow rate = 3.0 mL/min, 
λ = 210 nm, tR (major) = 2.1 min tR (minor)  = 2.4 min, 96.5:3.5 er; [α]D = +27.6 (c = 
0.02, DCM). 
 (2R,3S) tert-butyl -2-((R)-2-(benzyloxy)-1-chloroethyl)-5-oxo-3-
phenyltetrahydrofuran-2-carboxylate (42s): The title compound 
was prepared according to General Procedure B (Method 2) 
using α-keto ester 41s35 (0.065 g, 0.20 mmol), and (E)-
cinnamaldehyde (0.04 mL, 0.40 mmol) affording 42s (0.030 g isomeric mix of 
products, 28% 1H NMR yield) as a colorless oil. The exact isomer ratio was not 
possible to determine. For product purity a second chromatographic purification 
using an eluent gradient of 7.5-10% Et2O/Hexanes was run after initial 
purification using EtOAc/Hexanes.  Analytical data for 42s: 1H NMR (600 MHz, 
CDCl3) δ 7.35-7.26 (m, 10H), 4.43-4.38 (m, 2H), 4.22-4.21 (m, 1H), 3.68 (d, J = 
10.9 Hz, 1H), 3.33-3.31 (m, 2H), 3.09-2.98 (m, 1H), 2.74-2.71 (m, 1H), 2.02-1.86 
(m, 2H), 1.80-1.69 (m, 2H), 1.56 (s, 9H), 1.43-1.39 (m, 2H).; 13C NMR (151 MHz, 
CDCl3): δ 174.9, 167.5, 138.4, 128.7, 128.7, 128.3, 128.3, 128.3, 127.5, 127.5, 
O
O
tBuO2C H
ClBnO
3
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90.5, 84.3,  72.8, 69.2, 46.9, 36.3, 30.1, 27.9, 27.2, 26.9; IR (thin film): 2980, 
1795, 1729, 1157, 1124, 697 cm-1; TLC (10% EtOAc/hexane): Rf = 0.12; LRMS 
(ESI): Calcd. for C26H31ClO5: ([M+NH4]): 476.22, Found: 476.28; SFC OD, 10% 
MeOH, flow rate = 1.5 mL/min, λ = 210 nm, tR (major) = 8.1 min tR (minor)  = 9.0 min, 
98.5:1.5 er; [α]D = +23.9 (c = 0.02, DCM). 
3.5.9 Procedure for the Gram Scale Asymmetric (3+2)-Annulation 
 
To a flame dried 50 mL round bottom flask was added catalyst G, (0.19 
mmol, 0.05 equiv) β-halo α-keto ester 1i (3.5 mmol, 1.0 equiv), Et2O (19 mL, 0.2 
M) and cinnamaldehyde (7.0 mmol, 2.0 equiv).  This solution stirred for 5 min 
followed by the addition of potassium carbonate (3.5 mmol, 1.0 equiv). This 
reaction was stirred (rate of stirring should be >800 rpm) for 14 h, filtered through 
a short plug of SiO2 with 20% EtOAc/hexanes, and concentrated in vacuo. The 
resultant crude material was then stirred with 20% Et2O/hexanes and filtered 
providing 2i (1.20 g, 84% yield, >30:1 dr, >99.5:0.5 er) as a white solid which was 
recrystallized from a 1:1 solution of DCM/MeOH by slow solvent evaporation 
providing crystals suitable for X-Ray diffraction.  
H
O
tBuO
O
O
Cl
K2CO3 (1.0 equiv)
48 (5 mol %)
Et2O (0.2 M), rt
+
O
O
tBuO2C H
Cl
(±)-41i(2.0 equiv) 42
PhS
S
Ph
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3.5.10 Procedure for the Hydrogenation of 42k 
 
Step 2: A flame dried 20 mL scintillation vial equipped with a magnetic stir 
bar was charged with 10% Pd/C (3.0 mg). To the vial was added degassed 
ethanol (2 mL) and 42k (0.08 mmol, 1 equiv). The reaction vessel was purged 
with H2 (3 times), then put under 1 atm of H2 (balloon). The reaction mixture was 
stirred for 24 h, filtered through a plug of celite, then concentrated in vacuo 
providing 49k without need for further purification (0.35g, 0.08 mmol, 99% yield). 
Analytical data for 49k: 1H NMR (600 MHz, CDCl3) δ 7.35-7.22 (m, 8H), 7.17 (d, 
J = 7.5 Hz, 2H), 4.32-4.30 (m, 1H), 3.30-3.28 (m, 1H), 2.90-2.80 (m, 3H), 2.77-
2.72 (m, 1H), 2.60-2.55 (m, 1H), 2.50 (dd, J = 17.6, 6.9 Hz, 1H), 2.39-2.34 (m, 
1H), 1.83-1.76 (m, 1H), 1.48 (s, 9H); 13C NMR (151 MHz, CDCl3): δ 173.9, 167.3, 
139.9, 136.6, 129.3, 128.7, 128.5, 128.3, 127.2, 126.6, 89.4, 84.1, 77.2, 77.0, 
76.8, 62.4, 41.2, 39.4, 34.2, 33.8, 30.1, 27.8; IR (thin film): 1790, 1752, 1128, 573 
cm-1; TLC (10% EtOAc/hexane): Rf = 0.08; LRMS (ESI): Calcd. for C25H29ClO4: 
([M+NH4]): 446.21, Found: 446.34; [α]D = -6.1 (c = 0.01, DCM). 
  
H2 (1 atm)
MeOH (0.05 M), rt
O
O
tBuO2C H
Cl
42k
Ph Ph
Pd/C (10 %)
O
O
tBuO2C H
Cl
49k
Ph Ph
99%
 
 
 200 
3.6 REFERENCES 
 
1) Corbett, M. T.; Johnson, J. S. “Dynamic kinetic asymmetric transformations of 
β-stereogenic α-ketoesters by direct aldolization. Angew. Chem., Int. Ed. 2014, 
53, 255-259. 
 
2) Cohen, D. T.; Eichman, C. C.; Phillips, E. M.; Zarefsky, E. R.; Scheidt, K. A. 
“Catalytic dynamic kinetic resolutions with N-heterocyclic carbenes: asymmetric 
synthesis of highly substituted β-lactones.” Angew. Chem. Int. Ed. 2012, 51, 
7309-7313. 
 
3) Johnston, R. C.; Cohen, D. T.; Eichman, C. C.; Scheidt, K. A.; Cheong, P. H-Y. 
“Catalytic kinetic resolution of a dynamic racemate: highly stereoselective β-
lactone formation by N-heterocyclic carbene catalysis.” Chem. Sci. 2014, 5, 
1974-1982. 
 
4) Chan, A.; Scheidt, K.A. “Highly stereoselective formal [3 + 3] cycloaddition of 
enals and azomethine Imines catalyzed by N-heterocyclic carbenes.” J. Am. 
Chem. Soc. 2007, 129, 5334-5335.  
 
5) Wang, M.; Huang, Z.; Xu, J.; Chi, Y. R. “N-Heterocyclic carbene-catalyzed 
[3+4] cycloaddition and kinetic resolution of azomethine imines.” J. Am. Chem. 
Soc. 2014, 136, 1214-1217. 
 
6) Liebig, J.; Wöhler, F. “Untersuchungen über das radikal der benzoesäure.”Ann. 
Pharm., 1832, 3, 249-282. 
 
7) Hassner, A, Rai, K. M.  "The benzoin and related acyl anion equivalent 
reactions." In Comprehensive Organic Synthesis; Trost, B. M., Fleming, I., Eds.; 
Pergamon Press: Oxford, 1991; Vol. 1; pp 541-577. 
 
8) Ide, W.S.; Buck, J.S. Org. React. 1948, 4, 269-304. 
 
9) Bugaut, X.; Glorius, F. “Organocatalytic umpolung: N-heterocyclic carbenes 
and beyond.” Chem. Soc. Rev. 2012, 41, 3511-3522. 
  
10) Johnson, J. S. “Catalyzed reactions of acyl anion equivalents.” Angew. 
Chem., Int. Ed. 2004, 43, 1326-1328. 
 
11) DiRocco, D. A.; Rovis, T. "Asymmetric benzoin and Stetter reactions." In 
Stereoselective Synthesis 2: Stereoselective Reactions of Carbonyl and Imino 
Groups; Molander, G. A., Ed.; Georg Thieme Verlag: Stuttgart-New York; Vol. 
2011; pp 835-862. 
 
 
 
 201 
12) O’Bryan, E. A.; Scheidt, K. A.  "Acyloin coupling reactions." In 
Comprehensive Organic Synthesis II; Knochel, P., Molander, G. S., Eds.; 
Elsevier, 2014; Vol. 3; pp 621-655. 
 
13) Enders, D.; Bruer, K.; Teles J. H. “A novel asymmetric benzoin reaction 
catalyzed by a chiral triazolium salt. Preliminary communication.” Helv. Chim. 
Acta 1996, 79, 1217-1221. 
 
14) Knight, R. L.; Leeper, F. J. “Comparison of chiral thiazolium and triazolium 
salts as asymmetric catalysts for the benzoin condensation.” J. Chem. Soc. 
Perkin Trans. 1 1998, 12, 1891-1893. 
 
15) Enders, D.; Kallfass, U. “An efficient nucleophilic carbene catalyst for the 
asymmetric benzoin condensation.” Angew. Chem., Int. Ed. 2002, 41, 1743-1745. 
 
16) Ma, Y.; Wei, S.; Wu, J.; Yang, F.; Liu, B.; Lan, J.; Yang, S.; You, J. “From 
mono-triazolium salt to bis-triazolium salt: improvement of the asymmetric 
intermolecular benzoin condensation.” Adv. Synth. Catal. 2008, 350, 2645-2651. 
 
17) Enders, D.; Han, J. “Synthesis of enantiopure triazolium salts from 
pyroglutamic acid and their evaluation in the benzoin condensation.” 
Tetrahedron: Asymmetry 2008, 19, 1367-1371. 
 
18)  Baragwanath, L.; Rose, C. A.; Zeitler, K.; Connon, S. J. “Highly 
enantioselective benzoin condensation reactions involving a bifunctional protic 
pentafluorophenyl-substituted triazolium precatalyst.” J. Org. Chem. 2009, 74, 
9214-9217.  
 
19) Rose, C. A.; Gundala, S.; Connon, S. J.; Zeitler, K. “Chemoselective crossed 
acyloin condensations: catalyst and substrate control.” Synthesis 2011, 190-198. 
 
20) Jin, M. Y.; Kim, S. M.; Han, H.; Ryu, D. H.; Yang, J. W. “Switching 
regioselectivity in crossed acyloin condensations between aromatic aldehydes 
and acetaldehyde by altering N-heterocyclic carbene catalysts.” Org. Lett. 2011, 
13, 880-883. 
 
21) Langdon, S. M.; Wilde, M. D.; Thai, K.; Gravel, M. “Chemoselective N-
heterocyclic carbene-catalyzed cross-benzoin reactions: importance of the fused 
ring in triazolium salts.” J. Am. Chem. Soc., 2014, 136, 7539-7542. 
 
22) Iding, H.; Dünnwald, T.; Greiner, L.; Liese, A.; Müller, M.; Siegert, P.; 
Grötzinger, J.; Demir, A. S.; Pohl, M. “Benzoylformate decarboxylase from 
pseudomonas putida as stable catalyst for the synthesis of chiral 2-hydroxy 
ketones.” Chem.-Eur. J., 2000, 6, 1483-1495. 
 
 
 
 202 
23) Demir, A. S.; Pohl, M.; Janzen, E.; Müller, M. “Enantioselective synthesis of 
hydroxy ketones through cleavage and formation of acyloin linkage. Enzymatic 
kinetic resolution via C–C bond cleavage.” J. Chem. Soc., Perkin Trans. 1, 2001, 
633-635. 
 
24) Dünkelmann, P.; Kolter-Jung, D.; Nitsche, A.; Demir, A. S.; Siegert, P.; 
Lingen, B.; Baumann, M.; Pohl, M.; Müller, M. “Development of a donor−acceptor 
concept for enzymatic cross-coupling reactions of aldehydes:  the first 
asymmetric cross-benzoin condensation.” J. Am. Chem. Soc. 2002, 124, 12084-
12085. 
 
25) Pohl, M.; Lingen, B.; Müller, M. “Thiamin-diphosphate-dependent enzymes: 
new aspects of asymmetric C C Bond formation.” Chem.-Eur. J. 2002, 8, 
5288-5295. 
 
26) Lehwald, P.; Richter, M.; Röhr, C.; Liu, H.; Müller, M. “Enantioselective 
intermolecular aldehyde–ketone cross-coupling through an enzymatic 
carboligation reaction.” Angew. Chem., Int. Ed. 2010, 49, 2389-2392. 
 
27) Beigi, M.; Waltzer, S.; Fries, A.; Eggeling, L.; Sprenger, G. A.; Müller, M. 
“TCA cycle involved enzymes SucA and Kgd, as well as MenD: efficient 
biocatalysts for asymmetric C–C Bond formation.” Org. Lett. 2013, 15, 452-455. 
 
28) Linghu, X.; Potnick, J. R.; Johnson, J. S. “Metallophosphites as umpolung 
catalysts:  the enantioselective cross silyl benzoin reaction.”  J. Am. Chem. Soc. 
2004, 126, 3070-3071. 
 
29) Enders, D.; Grossmann, A.; Fronert, J.; Raabe, G. “N-heterocyclic 
carbene catalysed asymmetric cross-benzoin reactions of heteroaromatic 
aldehydes with trifluoromethyl ketones.” Chem. Commun. 2010, 46, 6282-6284. 
 
30) O’Toole, S. E.; Rose, C. A.; Gundala, S.; Zeitler, K.; Connon, S. J. “Highly 
chemoselective direct crossed aliphatic−aromatic acyloin condensations with 
triazolium-derived carbene catalysts.” J. Org Chem. 2011, 76, 347-357.    
 
31) Rose, C. A.; Gundala, S.; Fagan, C. –L.; Franz, J. F.; Connon, S. J.; Zeitler, 
K. “NHC-catalysed, chemoselective crossed-acyloin reactions.” Chem. Sci. 2012, 
3, 735-740. 
 
32) Thai, K.; Langdon, S. M.; Bilodeau, F.; Gravel, M. “Highly chemo- and 
enantioselective cross-benzoin reaction of aliphatic aldehydes and α-ketoesters.” 
Org. Lett., 2013, 15, 2214-2217. 
 
33) Müller, C. R.; Pérez-Sanchez, M.; Dominguez de Maria, P. 
“Benzaldehyde lyase-catalyzed diastereoselective C–C bond formation by 
 
 
 203 
simultaneous carboligation and kinetic resolution.” Org. Biomol. Chem. 2013, 11, 
2000-2004. 
 
34) O’Toole, S. E.; Connon, S. J. “The enantioselective benzoin 
condensation promoted by chiral triazoliumprecatalysts: stereochemical 
control via hydrogen bonding.” Org. Biomol. Chem. 2009, 7, 3584-3593. 
 
35) Steward, K. M.; Corbett, M. T.; Goodman, C. G.; Johnson, J. S. “Asymmetric 
synthesis of diverse glycolic acid scaffolds via dynamic kinetic resolution of α-
keto esters.” J. Am. Chem. Soc. 2012, 134, 20197-20206. 
 
36) Kerr, M. S.; Rovis, T. “Enantioselective synthesis of quaternary stereocenters 
via a catalytic asymmetric stetter reaction.” J. Am. Chem. Soc. 2004, 126, 8876-
8877. 
 
37) He, M.; Struble, J. R.; Bode, J. W. “Highly enantioselective azadiene 
Diels−Alder reactions catalyzed by chiral N-heterocyclic carbenes.” J. Am. Chem. 
Soc. 2006, 128, 8418-8420. 
 
38) Mahatthananchai, J.; Bode, J. W. “On the mechanism of N-heterocyclic 
carbene-catalyzed reactions involving acyl azoliums.” Acc. Chem. Res., 2014, 47, 
696-707. 
 
39) Murry, J. A.; Frantz, D. E.; Soheili, A.; Tillyer, R.; Grabowski, E. J.; Reider, P. 
J. “Synthesis of α-amido ketones via organic catalysis:  thiazolium-catalyzed 
cross-coupling of aldehydes with acylimines.” J. Am. Chem. Soc. 2001, 123, 
9696-9697. 
 
40) Drutu, I.; Krygowski, E. S.; Wood, J. L. “Reactive enols in synthesis 2. 
synthesis of (+)-latifolic acid and (+)-latifoline.” J. Org. Chem., 2001, 66, 7025-
7029. 
 
41) Nagase, R.; Oguni, Y.; Ureshino, S.; Mura, H.; Misaki, T.; Tanabe, Y. 
“Asymmetric Ti-crossed Claisen condensation: application to concise asymmetric 
total synthesis of alternaric acid.” Chem. Commun., 2013, 49, 7001-7003.   
 
42) CCDC 1009331 contains the supplementary crystallographic data for this 
paper. This data can be obtained free of charge from the Cambridge 
Crystallographic Centre via www.ccdc.cam.ac.uk/data_request/cif.  The structure 
in Scheme 11 was generated with CYLview: Legault, C. Y. CYLview, version 
1.0b; Université de Sherbrooke: Sherbrooke, QC, 2009; http://www.cylview.org. 
 
43) Mengel, A.; Reiser, O. “Around and beyond Cram's rule.” Chem. Rev. 1999, 
99, 1191-1224.   
 
 
 
 204 
44) Evans, D. A.; Siska, S. J.; Cee, V. J. “Resurrecting the Cornforth model for 
carbonyl addition: studies on the origin of 1,2-asymmetric induction in enolate 
additions to heteroatom-substituted aldehydes.” Angew. Chem., Int. Ed. 2003, 42, 
1761-1765. 
 
45) Cee, V. J.; Cramer, C. J.; Evans, D. A. “Theoretical investigation of 
enolborane addition to α-heteroatom-substituted aldehydes. relevance of the 
Cornforth and polar Felkin−Anh models for asymmetric induction.” J. Am. Chem. 
Soc. 2006, 128, 2920-2930. 
 
46) Dudding, T.; Houk, K. N. “Computational predictions of stereochemistry in 
asymmetric thiazolium- and triazolium-catalyzed benzoin condensations.” Proc. 
Natl. Acad. Sci. U.S.A. 2004, 101, 5770-5775. 
 
47) Vora, H. U.; Lathrop, H. P.; Reynolds, N. T.; Kerr, M. S.; Read de Alaniz, J.; 
Rovis, T. “Preparation of chiral and achiral triazolium salts: carbene precursors 
with demonstrated synthetic utility.” Org. Synth. 2010, 87, 350-361. 
 
48) Kobayashi, S.; Kinoshita, T.; Uehara, H.; Sudo, T.; Ryu, I. “Organocatalytic 
enantioselective synthesis of nitrogen-substituted dihydropyran-2-ones, a key 
synthetic intermediate of 1β-methylcarbapenems.” Org. Lett. 2009, 11, 3934-
3937. 
 
49) Massey, R. S.; Collett, C. J.; Lindsay, A. G.; Smith, A. D.; O’Donoghue, A. C. 
“Proton transfer reactions of triazol-3-ylidenes: kinetic acidities and carbon acid 
pKa values for twenty triazolium salts in aqueous solution.” J. Am. Chem. Soc. 
2012, 134, 20421-20432. 
 
50) Saifina, D. F.; Ganieva, V. R.; Mamedov, V. A. “Darzens reaction in the 
synthesis of 3-(α-chloroalkyl)quinoxalin-2(1H)-ones.” Russ. J. Org. Chem. 2009, 
45, 1244-1247. 
 
51) Yang, L.; Deng, G.; Wang, D-X.; Huang, Z-T.; Zhu, J-P.; Wang, M-X. “Highly 
efficient and stereoselective n-vinylation of oxiranecarboxamides and 
unprecedented 8-endo-epoxy-arene cyclization:  expedient and biomimetic 
synthesis of some Clausena alkaloids.” Org. Lett. 2007, 9, 1387-1390 
 
52) Rothman, J. H. “Syntheses of heterocyclic ethenyl c-nucleosides for 
recognition of inverted base pairs within the dna triple helix by stereoselective 
intramolecular cyclization and olefin metathesis.” J. Org. Chem. 2009, 74, 925-
928. 
 
53) Cornwall C.; Dell, C. P.; Knight D. W. “Regioselectivity in the lithiation of 
methyl-substituted thiazole- and oxazole-carboxylic acids and carboxamides: 
general methods for the elaboration of trisubstituted thiazoles and oxazoles.” J. 
Chem. Soc., Perkin Trans. 1 1991, 2417-2428. 
 
 
 205 
 
54) Nagasaki, A.; Adachi, Y.; Yonezawa, Y.; Shin, C-G. “Useful synthesis of 
various thiazole and polythiazolyl derivatives from thiocarboxamide and β-
bromoacyl compound.” Heterocycles, 2003, 60, 321-335. 
. 
 
55) Medine, J. R.; Becker, C. J.; Blackledge, C. W.; Duquenne, C.; Feng, Y.; 
Grant, S. W.; Heerding, D.; Li, W. H.; Miller, W. H.; Romeril, S. P.; Scherzer, D.; 
Shu, A.; Bobko, M. A.; Chadderton, A. R.; Dumble, M.; Gardiner, C. M.; Gilbert, 
S.; Liu, Q.; Rabindran, S. K.; Sudakin, V.; Xiang, H.; Brady, P. G.; Campobasso, 
N.; Ward, P.; Axten, J. M. “Structure-based design of potent and selective 3-
phosphoinositide-dependent kinase-1 (pdk1) inhibitors.” J. Med. Chem. 2011, 54, 
1871-1895. 
 
56) Lee, S. Y.; Murphy, J. M.; Ukai, A.; Fu, G. C. “Nonenzymatic dynamic kinetic 
resolution of secondary alcohols via enantioselective acylation: synthetic and 
mechanistic studies.” J. Am. Chem. Soc. 2012, 134, 15149-15153. 
 
57) Noyori, R.; Ikeda, T.; Ohkuma, T.; Widhalm, M.; Kitamura, M.; Takaya, H.; 
Akutagawa, S.; Sayo, N.; Saito, T. “Stereoselective hydrogenation via dynamic 
kinetic resolution.” J. Am. Chem. Soc. 1989, 111, 9134-9135. 
 
58) Steward, K. M.; Gentry, E. C.; Johnson, J. S. “Dynamic kinetic resolution of 
α-keto esters via asymmetric transfer hydrogenation.” J. Am. Chem. Soc. 2012, 
134, 7329-7332. 
 
59) Steward, K. M.; Corbett, M. T.; Goodman, C. G.; Johnson, J. S. “Asymmetric 
synthesis of diverse glycolic acid scaffolds via dynamic kinetic resolution of α-
keto esters.” J. Am. Chem. Soc. 2012, 134, 20197-20206. 
 
60) Goodman, C.G.; Do, D. T.; Johnson J. S. “Asymmetric synthesis of anti-β-
amino-α-hydroxy esters via dynamic kinetic resolution of β-amino-α-keto esters.” 
Org Lett, 2013, 15, 2446-2449. 
 
61) Goodman, C. G.; Johnson, J. S. “Dynamic kinetic asymmetric cross-benzoin 
additions of β-stereogenic α-keto esters.” J. Am. Chem. Soc. 2014, 136, 14698-
14701. 
 
62) Wang, X.-F.; Hua, Q.-L.; Cheng, Y.; An, X.-L.; Yang, Q.-Q.; Chen, J.-R.; 
Xiao, W.-J. “Organocatalytic asymmetric sulfa-Michael/Michael addition 
reactions: a strategy for the synthesis of highly substituted chromans with a 
quaternary stereocenter.” Angew. Chem., Int. Ed. 2010, 49, 8379-8383. 
 
63) Yang, W.; Yang, Y.; Du, D-M. “Squaramide–tertiary amine catalyzed 
asymmetric cascade sulfa-Michael/Michael addition via dynamic kinetic 
 
 
 206 
resolution: access to highly functionalized chromans with three contiguous 
stereocenters.” Org. Lett. 2013, 15, 1190-1193. 
 
64) Meninno, S.; Croce, G.; Lattanzi, A. “Asymmetric synthesis of trisubstituted 
tetrahydrothiophenes bearing a quaternary stereocenter via double Michael 
reaction involving dynamic kinetic resolution.” Org. Lett. 2013, 15, 3436-3439. 
 
65) Reyes, E.; Córdova, A. “Amino acid-catalyzed dynamic kinetic asymmetric 
transformations (DYKAT): one-step de novo synthesis of polyketide sugars from 
racemic β-hydroxy aldehydes.” Tetrahedron Lett. 2005, 46, 6605−6609. 
 
66) Ward, D. E.; Jheengut, V.; Aokinnusi, O. T. “Enantioselective direct 
intermolecular aldol reactions with enantiotopic group selectivity and dynamic 
kinetic resolution.” Org. Lett. 2005, 7, 1181−1184. 
 
67) Ward, D. E.; Jheengut, V.; Beye, G. E.; Gillis, H. M.; Karagiannis, A.; Becerril-
Jimenez, F. “Enantioselective direct aldol reactions of achiral ketones with 
racemic enolizable α-substituted aldehydes: scope and limitations.” Synlett 2011, 
508−512. 
 
68) Bergeron-Brlek, M.; Teoh, T.; Britton, R. “A tandem organocatalytic α-
chlorination–aldol reaction that proceeds with dynamic kinetic resolution: a 
powerful tool for carbohydrate synthesis.” Org. Lett. 2013, 15, 3554−3557. 
 
69) Burstein, C.; Glorius, F. “Organocatalyzed conjugate umpolung of α,β-
unsaturated aldehydes for the synthesis of γ-butyrolactones.” Angew. Chem., Int. 
Ed. 2004, 43, 6205-6208. 
 
70) Sohn, S. S.; Rosen, E. L.; Bode, J. W. “N-heterocyclic carbene-catalyzed 
generation of homoenolates:  γ-butyrolactones by direct annulations of enals and 
aldehydes.” J. Am. Chem. Soc. 2004, 126, 14370-14371. 
 
71) Enders, D.; Niemeier, O.; Henseler, A. “Organocatalysis by N-heterocyclic 
carbenes.” Chem. Rev. 2007, 107, 5606-5655. 
 
72) Nair, V.; Vellalath, S.; Babu, B. P. “Recent advances in carbon–carbon bond-
forming reactions involving homoenolates generated by NHC catalysis.” Chem. 
Soc. Rev. 2008, 37, 2691-2698. 
 
73) Nair, V.; Menon, R. S.; Biju, A. T.; Sinu, C. R.; Paul, R. R.; Jose, A.; 
Sreekumar, V. “Employing homoenolates generated by NHC catalysis in carbon–
carbon bond-forming reactions: state of the art.” Chem. Soc. Rev. 2011, 40, 
5336-5346. 
 
 
 
 207 
74) Vora, H. U.; Wheeler, P.; Rovis, T. “Exploiting acyl and enol azolium 
intermediates via N-hetero- cyclic carbene-catalyzed reactions of α-reducible 
aldehydes.” Adv. Synth. Catal. 2012, 354, 1617-1639.  
 
75) Rommel, M.; Fukuzumi, T.; Bode, J. W. “Cyclic ketimines as superior 
electrophiles for nhc-catalyzed homoenolate additions with broad scope and low 
catalyst loadings.” J. Am. Chem. Soc. 2008, 130, 17266-17267. 
 
76) Raup, D. E. A.; Cardinal-David, B.; Holte, D.; Scheidt, K. A. “Cooperative 
catalysis by carbenes and Lewis acids in a highly stereoselective route to γ-
lactams.” Nature Chem. 2010, 2, 766-771. 
 
77) Zhang, B.; Feng, P.; Sun, L-H.; Cui, Y.; Ye, S.; Jiao, N. “N-heterocyclic 
carbene-catalyzed homoenolate additions with N-aryl ketimines as electrophiles: 
efficient synthesis of spirocyclic γ-lactam oxindoles.” Chem. Eur. J. 2012, 18, 
9198-9203. 
 
78) Lv, H.; Tiwari, B.; Mo, J.; Xing, C.; Chi, Y. R. “Highly enantioselective addition 
of enals to isatin-derived ketimines catalyzed by N-heterocyclic carbenes: 
synthesis of spirocyclic γ-lactams.” Org. Lett, 2012, 14, 5412-5415.  
 
79) Sun, H.-L.; Shen, L.-T.; Ye, S. “Highly diastereo- and enantioselective NHC-
catalyzed [3+2] annulation of enals and isatins.” Chem. Commun., 2011, 47, 
10136-10138. 
 
80) Dugal-Tessier, J.; O’Bryan, E. A.; Schroeder, T. B. H.; Cohen, D. T.; Scheidt, 
K. A. “An N-heterocyclic carbene/Lewis acid strategy for the stereoselective 
synthesis of spirooxindole lactones.” Angew. Chem., Int. Ed. 2012, 51, 4963-
4967. 
 
81) Jang, K. P.; Hutson, G. E.; Johnston, R. C.; McCusker, E. O.; Cheong, P. H-
Y.; Scheidt, K. A. “Asymmetric homoenolate additions to acyl phosphonates 
through rational design of a tailored N-heterocyclic carbene catalyst.” J. Am. 
Chem. Soc. 2014, 136, 76-79. 
 
82) Lee, A.; Scheidt, K. A. “A cooperative N-heterocyclic carbene/chiral 
phosphate catalysis system for allenolate annulations.” Angew. Chem., Int. Ed. 
2014, 53, 7594-7598. 
 
83) Li, J-L.; Sahoo, B.; Daniliuc, C-G.; Glorius, F. “Conjugate umpolung of β,β-
disubstituted enals by dual catalysis with an N-heterocyclic carbene and a 
Brønsted acid: facile construction of contiguous quaternary stereocenters.” 
Angew. Chem., Int. Ed. 2014, 53, 10515-10519. 
 
 
 
 208 
84) Zheng, C.; Yao, W.; Zhang, Y.; Ma, C. “chiral spirooxindole–butenolide 
synthesis through asymmetric N-heterocyclic carbene-catalyzed formal (3 + 2) 
annulation of 3-bromoenals and isatins.” Org. Lett. 2014, 16, 5028-5031. 
 
85) Cardinal-David, B.; Raup, D. E. A.; Scheidt, K. A. “Cooperative N-heterocyclic 
carbene/Lewis acid catalysis for highly stereoselective annulation reactions with 
homoenolates.” J. Am. Chem. Soc. 2010, 132, 5345-5347. 
 
86) Cohen, D. T.; Cardinal-David, B.; Roberts, J. M.; Sarjeant, A. A.; Scheidt, K. 
A. “NHC-catalyzed/titanium(iv)−mediated highly diastereo- and enantioselective 
dimerization of enals.” Org. Lett. 2011, 13, 1068-1071. 
 
87) Cohen, D. T.; Cardinal-David, B.; Scheidt, K. A. “Lewis acid activated 
synthesis of highly substituted cyclopentanes by the N-heterocyclic carbene 
catalyzed addition of homoenolate equivalents to unsaturated ketoester.” Angew. 
Chem., Int. Ed. 2011, 50, 1678-1682. 
 
88) Izquierdo, J.; Orue, A.; Scheidt, K. A. “A dual Lewis base activation strategy 
for enantioselective carbene-catalyzed annulations.” J. Am. Chem. Soc. 2013, 
135, 10634-10637. 
 
89) Lv, H.; Jia, W-Q.; Sun, L-H.; Ye, S. “N-heterocyclic carbene catalyzed [4+3] 
annulation of enals and o-quinone methides: highly enantioselective synthesis of 
benzo-ε-lactones.” Angew. Chem., Int. Ed. 2013, 52, 8607-8610. 
 
90) White, N. A.; DiRocco, D. A.; Rovis, T. “Asymmetric N-heterocyclic carbene 
catalyzed addition of enals to nitroalkenes: controlling stereochemistry via the 
homoenolate reactivity pathway to access δ-lactams.” J. Am. Chem. Soc. 2013, 
135, 8504-8507. 
 
91) Guo, C.; Schedler, M.; Daniliuc, C. G.; Glorius, F. “N-heterocyclic carbene 
catalyzed formal [3+2] annulation reaction of enals: an efficient enantioselective 
access to spiro-heterocycles.” Angew. Chem., Int. Ed. 2014, 53, 10232-10236. 
 
92) Li, Y.; Zhao, Z-A.; He, H.; You, S.-L. “Stereoselective synthesis of γ-
butyrolactones via organocatalytic annulations of enals and keto esters.” Adv. 
Synth. Catal. 2008, 350, 1885-1890. 
 
93) Sohn, S. S.; Bode, J. W. “Catalytic generation of activated carboxylates from 
enals:  a product-determining role for the base.”  Org. Lett. 2005, 7, 3873-3876 
 
94) Cohen, D. T.; Scheidt, K. A. “Cooperative Lewis acid/N-
heterocyclic carbene catalysis.” Chem. Sci. 2012, 3, 53-57. 
 
 
 
 209 
95) CCDC 1023584 contains the supplementary crystallographic data for this 
paper. This data can be obtained free of charge from the Cambridge 
Crystallographic Centre via www.ccdc.cam.ac.uk/data_request/cif.   
 
96) Huang, X-L.; He, L.; Shao, P-L.; Ye, S. “[4+2] Cycloaddition of ketenes 
with N-benzoyldiazenes catalyzed by N-heterocyclic carbenes.” Angew. Chem., 
Int. Ed. 2009, 48, 192-195. 
 
97) Marmedov, V. A.; Berdnikov, E. A.; Tsuboi, S.; Hamamoto, H.; Komiyama, T.; 
Gorbunova, E. A.; Gubaidullin, A. T.; Litvinov, I. A. “Substituted benzaldehydes in 
the darzens condensation with alkyl dihaloacetates.” Russ. Chem Bull., Int. Ed. 
2006, 55, 1455-1463. 
 
98) Patil, N. T.; Singh, V. “Synthesis of 1,3,5-trisubstituted pyrazolines viaZn(II)-
catalyzed doublehydroamination of enynes with aryl hydrazines.” Chem. 
Commun. 2011, 47, 11116-11118. 
 
99) Chandra, A.; Pigza, J. A.; Han, J-S.; Mutnick, D.; Johnston, J. N. “Total 
synthesis of the lycopodium alkaloid (+)-Serratezomine A.” J. Am. Chem. Soc. 
2009, 131, 3470-3471.  
 
100) Ling, K. B.; Smith, A. D. “α-Aroyloxyaldehydes: scope and limitations as 
alternatives to α-haloaldehydes for NHC-catalysed redox transformations.” Chem. 
Commun. 2011, 47, 373-375. 
 
101) Kerr, M. S.; Read de Alaniz, J. Rovis, T. “An efficient synthesis of achiral 
and chiral 1,2,4-triazolium salts:  bench stable precursors for N-heterocyclic 
carbenes.” J. Org. Chem. 2005, 70, 5725-5728. 
 
103) Zhang, Y-R.; He, L.; Wu, X.; Shao, P-L.; Ye, S. “Chiral N-heterocyclic 
carbene catalyzed Staudinger reaction of ketenes with imines:  highly 
enantioselective synthesis of N-boc β-lactams.” Org. Lett. 2008, 10, 277-280. 
 
 
 
 
 
 
 
210 
 
 
CHAPTER 4 
 
COMPLEXITY GENERATING DYNAMIC KINETIC RESOLUTIONS OF β-OXO 
ACID DERIVATIVES 
 
4.1 Introduction 
  As our investigations targeting DKRs that employ β-stereogenic α-keto 
esters progressed, we focused on sigmatropic rearrangements as a DKR 
platform. Inspired by the Reuping group’s report of chiral acid catalyzed aza-
allylation of aldehyde 1 using amino-allyl donor 2a (Scheme 1 top),1-2 we noted 
that the development of a chiral phosphoric acid catalyzed dynamic [3,3]-aza-
Cope or [3,3]-oxonia-Cope would deliver functionally useful and stereochemically 
rich products (Scheme 1 bottom).  
Scheme 1. Stereoconvergent Sigmatropic Processes 
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Preliminary studies indicated that the development of an aza-Cope was 
more promising proposal based on lack of reactivity in initial oxonia-Cope 
rearrangement trials; our focus centered solely on the development of the aza-
Cope rearrangement.   
While catalytic asymmetric sigmatropic rearrangements are well-
established,3-5 examples of enantioselective 2-aza-Cope rearrangements are 
limited.1,2 Of some note was the Overman lab’s report of a dynamic 2-aza-Cope 
utilizing stereochemically defined aminoallyl reagent 5 to generate amino allyl 6 
(Figure 2), where epimerization occurs via enamine-iminium tautomerization.6-7 
However, previous to our work there were no examples of a 2-aza-Cope reaction 
where enantiocontrol was imparted via chiral catalyst.  
Scheme 2. Previous 2-Aza-Cope DKR 
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group. This modification did enhance reactivity as 50% of 7a was converted to 
8a, but in low dr (Table 1, entry 3). Employing BINOL derived chiral phosphoric 
acids 1014 and 1115 increased reactivity; without appreciable stereoselectivity 
(Table 1, entries 5,6). We thought that using a sterically encumbering tert-butyl 
ester might impart higher stereoselectivity; however, it had only detrimental 
effects on reactivity (Tabe 1 entries 6,7).  
 Table 1: Attempts to Effect the 2-Aza-Cope Transformation Using β-
Stereogenic α-Keto Estersa 
 
 
 
Trial R1 R2 R3 X catalyst solvent T (˚C) conv (%) drb erc 
1 Me Ph Ph Br 11 CHCl3 80 * -- -- 
2 Me Ph H Cl 11 CHCl3 80 30 -- -- 
3 Me 2-OH-C6H3 H Cl 11 CHCl3 80 50 2:1 -- 
4 Me 2-OH-C6H3 H Cl 9 PhCH3 70 100 4:1 53:47 
5 Me 2-OH-C6H3 H Cl 10 PhCH3 70 100 2:1 55:45 
6 tBu 2-OH-C6H3 H Cl 9 PhCH3 70 20 3:1 55:45 
7 tBu 2-OH-C6H3 H Cl 10 PhCH3 70 40 2:1 53:47 
* reaction mixture is complex by 1H NMR a) All reactions were run on a 0.10 
mmol scale. b) Determined by 1H NMR analysis of the crude reaction mixture. c) 
Determined by chiral HPLC analysis. 
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for the carbene catalyzed reactions) and was likely critical for substrate 
racemization. In light of this, we questioned whether the rate of racemization was 
suitable for a DKR to occur under the buffered conditions provided by 2 and 
phosphoric acids.  
 A racemization study of enantioenriched 7 revealed that under the 
reaction conditions full enantiomerization to the racemate takes > 18 h, indicating 
that racemization via tautomerization is likely slower than the rate of sigmatropic 
rearrangement (Table 2).  
Table 2: Racemization Study of β-Bromo α-Keto Ester 7c Under the 
Proposed Reaction Conditionsa 
 
 
time (h) er 
0 83.5:16.5 
0.25 83:17 
0.5 83:17 
0.75 82.5:17.5 
1 82.5:17.5 
2 80:20 
18 66:34 
a) 0.07 mmol aliquots of the reaction mixture were drawn at the indicated 
timepoints, diluted with MeOH and reduced with NaBH4. The reduction proceeds 
with >20:1 diastereoselectivity. Chiral SFC was used to analyze er values.  
 
We were still interested in effecting a dynamic aza-Cope; however, due to 
the inability of 7 to achieve kinetically useful enantiomerization, we shifted to the 
use of β-formyl acid derivatives. We anticipated this would enhance the rate of 
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We were also cognizant that the use of β-formyl esters as opposed to α-
keto esters presented a unique opportunity to expand the range of carbon-based 
nucleophiles in DKRs of β-oxo esters. As discussed in Chapter 1 the 
hydrogenative DKR of β-oxo esters is an indispensable synthetic technology 
used to generate hectoton quantities of optically enriched β-hydroxy esters 
annually (Scheme 3A),16 yet non-hydride based enantioconvergent methods for 
these substrates remain scarce.  
Scheme 3. Impact of Developing a 2-Aza-Cope of β-Oxo Acid 
Derivatives 
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diketo esters has also been reported.21,22  A 2-aza-Cope reaction using racemic 
β-oxo acid derivatives represents an advance in the field of non-hydrogenative 
DKRs as it establishes new C-N and C-C bonds and vicinal stereogenic centers, 
generating new β2,3-amino acid derivatives (Scheme 3B).23  
 
4.2 Asymmetric Synthesis of β-Amino Amides by Catalytic 
Enantioconvergent 2-Aza-Cope Rearrangement*1 
 
Our studies using β-formyl acid derivatives began with β-formyl ester 13 
and achiral phosphinic acid 11 as the catalyst; however, neither elevated 
temperature nor the use of hydrogen bonding solvents resulted in any product 
other than enamine 14 (Table 3, entries 1-4). As our studies progressed it 
became clear that 14 was impervious to [3,3]-rearrangement under any 
conditions that could be rendered catalytic. The use of triflic acid under thermal 
conditions was required before appreciable amounts of rearranged product were 
observable (Table 3 entry 7,8). We attributed this circumstance to a debilitating 
thermodynamic preference for the unreactive enamine relative to the needed 
iminium ion 14•H+ (Scheme 4).  
Considering our inadvertant overcorrection, we speculated that replacing 
the ester with a more sterically demanding dialkyl amide might provide a proper 
balance by destabilizing the enamine tautomer through A(1,3) strain24,25 while still 
maintaining a faster rate of enantiomerization than was observed with α-keto 
ester 7 (Scheme 4). 
 
                                         
*Reproduced in part by permission of the American Chemical Society: Goodman, C. G.; Johnson, J. S. J. Am. Chem. Soc. 
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Table 3: Attempts to Effect the 2-Aza-Cope Transformation Using α-
Stereogenic β-Formyl Estersa 
 
 
Trial R1 R2 cat solvent temp (˚C) 14:15b 
1 2-OH-C6H3 H 11 PhCH3 75 >50:1 
2 Ph Ph 11 PhCH3 120 >50:1 
3 Ph Ph 11 MeOH 70 >20:1 
4 Ph Ph 11 H2O 70 >20:1 
5 Ph Ph TsOH PhCH3 80 6:1 
6 Ph Ph TsOH MeOH 80 12:1 
7 Ph Ph TfOH PhCH3 80 1:6 
8 Ph Ph TfOH MeOH 80 2:3 
a) All reactions were run on a 0.10 mmol scale using 0.1 mmol of catalyst. b) 
Determined by 1H NMR analysis of the crude reaction mixture.  
 
Of potential concern is a reasonable body of literature demonstrating 
stereoselective addition reactions of enantiopure α-stereogenic-β-oxo amides 
and imides that do not epimerize (or racemize) at the α-carbon.26- As previously 
discussed the use of these sterically encumbering dialkyl amides provides one of 
the most common routes to stereochemically defined non-quaternary α-
stereogenic β-keto esters (see Chapter 1 Section 2.4 for a full discussion.)  
In order to test our hypothesis against this literature precedent we 
subjected β-formyl amide (±)-16a and allyl amine 2a to chiral phosphoric acid 9, 
forming β-amino amide 18a in 7:1 dr and 96:4 er (Table 4, entry 1). A screen of 
chiral phosphoric acids revealed 9 and 1918 as the best candidates for further 
optimization (full details of these trials can be found in Chapter 4 Section 3.6). 
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Scheme 4. Proposal for Achieving Facile Racemization 
 
Elevating the reaction temperature increased the reaction rate with little 
loss of stereoselection (Table 4, entry 3 and 4). Using cyclopentyl methyl ether 
(CPME) as a solvent increased the stereoselectivity for both catalyst 9 and 19 
(Table 1, entry 5 and 6). With catalyst 9 and CHCl3 as the solvent, ketimine 18a 
was obtained in 10:1 dr and 97:3 er (Table 4, entry 7). Lowering the catalyst 
loading to 2.5 mol % had no detrimental effects on reactivity or selectivity (Table 
4, entry 9).   
We used modified conditions for a crossed-Claisen condensation 
synthesizing diverse β-formyl amides in order to test the tolerance of our 
optimized 2-aza-Cope rearrangement to various substrates (Scheme 5).32,33 An 
array of β-formal amides 16 were synthesized in 37-85% yield; however, a 
complication of these synthetic procedures was that many of the formed 
aldehydes were inseparable from various impurities using SiO2 chromatography. 
These impurities did not impinge upon the rearrangement, but to compensate we 
opted for a reaction stoichiometry of 1.0:1.2 (2:16) and calculated yields based 
on the amine component. 
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Table 4: Optimization of Aza-Allylation Conditionsa 
 
entry cat. T 
(º C) 
solvent conv 
(%) 
drb erc 
1 9 rt PhCH3 100 7:1 96:4 
2 19 rt PhCH3 50 -- -- 
3 9 80 PhCH3 100 7:1 95:5 
4 19 80 PhCH3 100 20:1 87:13 
5 9 60 CPME 100 8:1 98:2 
6 19 60 CPME 100 >20:1 89:11 
7 9 60 CHCl3 100 10:1 97:3 
8 19 60 CHCl3 100 >20:1 93:7 
9d 9 60 CHCl3 100 10:1 97:3 
a) All reactions were run on a 0.10 mmol scale. b) Determined by 1H NMR 
analysis of the crude reaction mixture. c) Determined by chiral HPLC analysis. d) 
2.5 mol % of catalyst. 
 
 With an array of β-formyl amides in hand and suitable reaction conditions 
determined, we began to probe the allowable steric and electronic parameters of 
this rearrangement, initially by studying the effects of substrate variation at α-
substituent (Scheme 6).  
The phenylacetic acid derivative 18b was obtained in 1.1:1 dr and 85:15 
er.  An α-allyl aldehyde provided 18c in 8:1 dr and 91.5:8.5 er, while inclusion of 
a pendant heteroatom provided 18d in 2:1 dr and 90.5:9.5 er.  
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 Scheme 5. Synthesis of α-Stereogenic β-Formyl Amidesa 
 
a) Reactions were run on a 1.0-2.0 mmol scale. Isolated yields are reported b) 
Yield determined by 1H NMR using 0.1 mmol of 2,4,6-(OMe)3C6H3 as an internal 
standard. c) Synthesized according to an alternate protocol employing 2.5 equiv 
TiCl4, 3.5 equiv NEt3, and 10.0 equiv ethyl formate.   
 
The less sterically demanding α-methyl substitution gave 18e in 3:1 dr and 
82:18 er.  The use of larger α-substituents, as represented by 18f (R = cHex) and 
18g (R =  iPr), restored higher levels of stereoselection. 
Electronically differentiated benzyls provided 18i and 18j with >10:1 dr and 
97:3 er. Using 2-furyl and 2-thenyl instead of benzyl derivatives yielded products 
18k and 18l with high stereocontrol.  
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Cognizant that modifying the amide identity would result in differentiated 
diamines after amide reduction, we next examined structural variation at that 
position (Scheme 7). The β-amino amides generated from piperidine 18m, 
pyrrolidine 18n, and dimethyl amine 18o were all formed in high yield and 
stereoselectivity. We also probed the allowed variance of the allyl amine donor. 
Internally substituted allyl amine 2b provided the formal aza-methallylation 
adduct 18p in 60% yield with 5:1 dr and 80:20 er. Terminally substituted allyl 
amine donors condensed with the β-formyl amide 16, but did not undergo [3,3]-
rearrangement, results we attribute to greater steric encumbrance at the reaction 
site. Product stereochemistry was determined by  X-ray diffraction of 18g 
(Scheme 8) to be (2R,3S).34 
For our final investigations we turned our attention to assessing the 
reactivity of the product β-imino amides. Hydrolysis of 18a to form primary amine 
20 proceeded under mild conditions and in 99% yield (Scheme 9A). 
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Scheme 6. Variation of the α-Substituent in the [3,3]-Rearrangement 
of α-Stereogenic-β-Formyl Estersa 
 
a) All reactions were run on a 0.20 mmol scale at 60 ºC for 24 h. 
Diastereomeric ratios were determined by 1H NMR or HPLC analysis of the crude 
reaction mixture; enantiomeric ratios by chiral SFC or HPLC. Yields are of 
isolated products. b) Yield reported is of the primary amine after hydrolysis of the 
benzophenone imine. c) Run at 130 ºC under microwave irradiation for 6 h. d) 
Run on a 0.10 mmol scale. 
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Scheme 7. Variation of Amide and Allyl Amine Identity in the [3,3]-
Rearrangement of α-Stereogenic-β-Formyl Estersa 
 
a) All reactions were run on a 0.20 mmol scale at 60 ºC for 24 h. 
Diastereomeric ratios were determined by 1H NMR or HPLC analysis of the crude 
reaction mixture; enantiomeric ratios by chiral SFC or HPLC. Yields are of 
isolated products.  b) Yield reported is of the primary amine after hydrolysis of the 
benzophenone imine. 
 
Initial reduction of 18a with LiAlH4 results in an intermediate aldehyde 
which can be further reduced by sodium borohydride to form benzhydryl-
protected amino alcohol 21 in 95% yield (Scheme 9B). If the benzophenone 
imine is cleaved prior to reduction, the diamine 22 is obtained in good yield 
(Scheme 9C). Finally, diene 18c underwent facile ring-closing metathesis with 
Grubb’s 2nd generation catalyst to provide cyclohexene 23 in 98% yield (Scheme 
9D).  
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Scheme 8. Determination of Relative and Absolute Stereochemistry 
of the [3,3]-Aza Cope Rearrangement 
 
The completion of these studies netted a stereoconvergent 2-aza-Cope 
reaction employing stereocontrol from a chiral organic acid catalyst. This DKR 
between homoallylic amines and α-stereogenic-β-formyl amides constitutes a 
rare example of a non-hydrogenative DKR reaction of β-oxo acid derivatives and 
delivers new β-amino amides in high diastereo- and enantioselectivity. Using β-
formyl amides was critical to providing the rate of racemization necessary for 
stereoconvergence, striking a balance between kinetic  acidity and confomational 
preference. Additionally the rearranged products can be readily converted into an 
array of functional small molecule building blocks. 
Scheme 9. Chemical Transformation of Aza-Cope Products  
 
Mechanistic studies delineating the factors that lead to the observed 
stereoselectivity and the use of this information in the development of other 
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stereoconvergent reactions of racemization-prone β-oxo carboxylic acid 
derivatives are of interest for future studies.
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4.3 Experimental Data and Conditions for the Asymmetric Synthesis of β-
Amino Amides by Catalytic Enantioconvergent 2-Aza-Cope 
Rearrangement‡2 
 
4.3.1 General Information 
Methods: Infrared (IR) spectra were obtained using an ASI ReactIR 1000 Fourier 
transform infrared spectrometer. Proton and carbon magnetic resonance spectra 
(1H NMR and 13C NMR) were recorded on a Bruker model DRX 600 (1H NMR at 
600 MHz and 13C NMR at 151 MHz) or a Bruker model 500 (1H NMR at 500 MHz 
and 13C NMR at 125 MHz) spectrometer with solvent resonance as the internal 
standard (1H NMR: CDCl3 at 7.26 ppm; 13C NMR: CDCl3 at 77.0 ppm). 1H NMR 
data are reported as follows: chemical shift, multiplicity (s = singlet, br s = broad 
singlet, d = doublet, dd = doublet of doublets, ddd = doublet of doublet of 
doublets, dddd = doublet of doublet of doublet of doublets, t = triplet, dt = doublet 
of triplets, q = quartet, m = multiplet), coupling constants (Hz), and integration. 
Supercritical fluid chromatography (SFC) was performed on a Berger SFC 
system equipped with Chiracel AD, AS, OD, and WO columns as well as a Regis 
Industries RegisPack (RP) column (φ 4.6 mm x 250 mm). Samples were eluted 
with SFC grade CO2 at the indicated percentage of methanol (MeOH) with an 
oven temperature of 40 °C. High pressure liquid chromatography (HPLC) was 
performed on a Perkin Elmer flexar photodiode array (PDA) system equipped 
with Daicel IA, IB, IC, and ID columns (φ 4.6 mm x 250 mm) Optical rotations 
were measured using a 2 mL cell with a 1 dm path length on a Jasco DIP 1000 
digital polarimiter. Mass spectra were obtained using a Finnigan linear trap 
                                         ‡
Reproduced in part by permission of the American Chemical Society: Goodman, C. G.; Johnson, J. S. J. Am. Chem. 
Soc. 2015, 137, 14574-14577. 
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quadrapole Fourier transform (LTQ-FT) spectrometer. Samples were prepared 
via dilution with MeOH. Analytical thin layer chromatography (TLC) was 
performed on Sorbtec 0.25 mm silica gel 60 plates. Visualization was 
accomplished with UV light and/or either aqueous potassium permanganate 
KMnO4 or aqueous ninhydrin solution followed by heating. Product purification 
was accomplished using Siliaflash-P60 silica gel (40-63 µm) purchased from 
Silicycle. Microwave irradiation was performed using a CEM Discover microwave 
(50/60 Hz, 300 W). Unless otherwise noted all reactions were carried out in 
flame-dried glassware with magnetic stirring. Yields, diastereomeric- (dr) and 
enantiomeric ratios (er) are reported for a specific experiment and as a result 
may differ slightly from those found in the reported tables, which represent an 
average of at least two trials. In order to overlay the SFC traces for the chiral and 
racemic samples two separate integrations of the peaks must be taken. This 
results in slight discrepancies between the integration values shown in the report 
and seen on the trace itself.  
Materials: Phosphoric acid catalysts 9,14 10,15 19,31 24,33 25-26,34 27,15 
morpholine amides,35 7,36 2a,1 and 1337 were all prepared according to literature 
procedures. 3 Ǻ molecular sieves were purchased from Sigma Aldrich and dried 
for 24 h at 180 °C before use. Chloroform (CHCl3), acetonitrile (ACN), 2-methyl 
tetrahydrofuran (2-Me THF), cyclopentyl methyl ether (CPME), Methyl tert-butyl 
ether (MTBE), and dichloroethane (DCE) were purchased from Sigma Aldrich 
and used directly from the bottle. Dichloromethane (DCM), diethyl ether (Et2O), 
toluene (PhCH3) and tetrahydrofuran (THF) were passed through a column of 
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neutral alumina under nitrogen prior to use. Triethylamine (TEA) was distilled 
from calcium hydride prior to use.  All other reagents were purchased from 
commercial sources and were used as received unless otherwise noted.  All 
racemic products were obtained via General Procedure E, using 
diphenylphosphinic acid.  
4.3.2 Complete Reaction Data for the Asymmetric 2-Aza Cope 
Rearrangement of β-halo α-Keto Esters 
 
 
General procedure A for developing the asymmetric 2-aza Cope rearrangement 
of β-halo-α-keto esters: To a 1-dram vial was added catalyst, (0.01 mmol, 0.10 
equiv) β-formyl amide 7 (0.14 mmol, 1.4 equiv), solvent (0.5 mL, 0.2 M) 3 Ǻ 
molecular sieves (50 mg), and allyl amine (0.1 mmol, 1.0 equiv).  This solution 
was stirred at the indicated temperature for 24 h filtered through a short plug of 
silica with DCM, and concentrated in vacuo. 
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R1 R2 R3 X cat. solvent T (˚C) conv (%) dr er 
Me Ph Ph Br 11 PhCH3 80 mess -- -- 
Me Ph Ph Br 11 CHCl3 80 mess -- -- 
Me Ph Ph Cl 11 PhCH3 80 36 -- -- 
Me Ph Ph Cl 11 CHCl3 80 17 -- -- 
Me Ph Ph Cl 11 THF 60 27 -- -- 
Me Ph Ph Cl 11 CH3CN 60 37 -- -- 
Me 2-OH-C6H3 H Cl 11 CHCl3 80 50 2:1 -- 
tBu 2-OH-C6H3 H Cl 11 PhCH3 80 mess -- -- 
tBu 2-OH-C6H3 H Cl 9 PhCH3 80 mess -- -- 
tBu 2-OH-C6H3 H Cl 10 PhCH3 80 mess -- -- 
Me 2-OH-C6H3 H Cl 9 PhCH3 70 100 4:1 53:47 
Me 2-OH-C6H3 H Cl 10 PhCH3 70 100 2:1 55:45 
tBu 2-OH-C6H3 H Cl 9 PhCH3 70 20 3:1 55:45 
tBu 2-OH-C6H3 H Cl 10 PhCH3 70 40 2:1 53:47 
 
4.3.3 Racemization Study of Enantioenriched α-Halo-β-Keto Esters Under 
Buffered Conditions 
 
time (h) er 
0 83.5:16.5 
0.25 83:17 
0.5 83:17 
0.75 82.5:17.5 
1 82.5:17.5 
2 80:20 
18 66:34 
 
A flame dried scintillation vial was loaded with enantioenriched 738 (0.33 mmol, 
1.0 equiv), diphenylmethanamine (0.06 mmol, 0.20 equiv), phosphinic acid (0.03 
mmol, 0.10 equiv), 3 Ǻ molecular sieves (500 mg), followed by PhCH3 (3.5 mL). 
The mixture was stirred at room temp with 0.5 mL aliquots of reaction mixture 
being drawn at the indicated time-points. These aliquots were immediately diluted 
with MeOH (2 mL) and cooled to 0 ˚C followed by addition of a single portion of 
iPrO2C
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Br
Bn
P
O
OHPh
Ph
NH2
Ph Ph
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NaBH4 (0.1 mmol, 2.0 equiv). (This reduction proceeds with >20:1 
diastereoselectivity.)38 This solution was stirred for 5 min, quenched with 
saturated NH4Cl (2 mL) and partitioned between EtOAc (10 mL) and H2O (10 
mL). The layers were separated and the organic layer was washed with H2O (2 x 
10 mL), brine (1 x 10 mL), dried over MgSO4, and concentrated in vacuo.  The er 
of the crude alcohol was analyzed by chiral SFC without further purification. 
Chiralpak AS, 3% MeOH, pressure = 150 bar, flow rate = 1.5 mL/min, λ = 210 nm, 
tR (major) 5.0 min, tR (minor) 6.3 min. 
4.3.4 Tested Reaction Conditions to Promote the 2-Aza Cope 
Rearrangement of α-Substituted-β-Formyl Esters 
 
 
 
General procedure B for development of the 2-aza Cope rearrangement of α-
substituted-β-formyl esters: To a 1-dram vial were added catalyst, (0.10 mmol, 
1.0 equiv) β-formyl amide 1337 (0.14 mmol, 1.4 equiv), 3 Ǻ molecular sieves (50 
mg), solvent (0.5 mL, 0.2 M) and allyl amine 2a (0.1 mmol, 1.0 equiv).  This 
solution was stirred at the indicated temperature for 24 h, filtered through a short 
plug of silica with DCM, and concentrated in vacuo for analysis.
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R1 R2 acid solvent T (˚C) 5:12 
2-OH-C6H3 H Ph2PO2H PhCH3 75 >50:1 
Ph Ph Ph2PO2H PhCH3 70 >50:1 
Ph Ph Ph2PO2H PhCH3 120 >50:1 
Ph Ph Ph2PO2H MeOH 70 >20:1 
Ph Ph Ph2PO2H H2O 70 >20:1 
Ph Ph Ph2PO2H CH3CN 70 >20:1 
Ph Ph TsOH PhCH3 80 6:1 
Ph Ph TsOH MeOH 80 12:1 
Ph Ph TfOH PhCH3 80 1:6 
Ph Ph TfOH MeOH 80 2:3 
 
4.3.5 Preparation of Allyl Amine 2b 
 
A 25 mL round-bottomed flask equipped with a magnetic stir bar was flame dried 
and cooled to rt under an atmosphere of N2. The flask was charged with 4-
methyl-2,2-diphenylpent-4-enoic acid (2.0 mmol, 1.0 equiv), DMF (0.1 mmol, 0.05 
equiv), and DCM (10 mL, 0.2 M) then cooled to 0 ˚C. Oxalyl chloride (2.2 mmol, 
1.1 equiv) was added dropwise and the resulting mixture was warmed slowly to rt 
and stirred for 1 h. The reaction mixture was concentrated in vacuo, then 
redissolved in DCM (10 mL) and cooled to 0 ˚C. Sodium azide (6.0 mmol, 3.0 
equiv) and tetrabutylammonium chloride (0.1 mmol, 0.05 equiv) were added 
successively and the reaction mixture was stirred at rt for 2 h. The mixture was 
then partitioned between H2O (20 mL) and Et2O (20 mL). The layers were 
separated and the organic layer was washed with H2O (2 x 20 mL) and brine (1 x 
Ph
HO2C
Ph
Me
C2O2Cl2, DMF;
NaN3, NBu4+Cl-
PhCH3, 110 °C
1)
2)
3) NaOH/Dioxane
80 °C
Ph
NH2
Ph
Me
2b
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20 mL). The organic extracts were dried over MgSO4, filtered, and concentrated 
in vacuo. The crude azide was redissolved in PhCH3 (5 mL) and heated, open to 
air, at 110 ˚C for 5 h. The solvent was removed in vacuo, the crude isocyanate 
was redissolved in a 1:1 solution of 2 M NaOH/dioxane (4 mL, 0.5 M) and heated 
to 80 ˚C for 1 h. The mixture was partitioned between H2O (10 mL) and EtOAc 
(10 mL), the layers were separated and the organic layer was further washed 
with H2O (2 x 10 mL) and brine (1 x 10 mL), then dried over MgSO4 and 
concentrated in vacuo.  The crude product was purified by column 
chromatography using a gradient of 10-15% acetone/hexane affording 2b (0.22 g, 
0.92 mmol, 46% yield) as a clear oil. Note: amine 2b shows existence of slow 
rotation (rotamers) in 1H NMR spectra obtained at ambient temperature. 
Analytical data for 2b: 1H NMR (500 MHz, CDCl3) δ 7.47 – 7.45 (m, 4H), 7.35-
7.32 (m, 4H), 7.27 – 7.24 (m, 2H), 4.97 (s, 1H), 4.79 (s, 1H), 3.12 (s, 2H), 2.98 (s, 
2H), 1.23 (s, 3H); 13C NMR (125 MHz, CDCl3): δ 148.1, 142.2, 127.9, 126.7, 
126.3, 116.2, 59.7, 50.5, 24.1; IR (thin film): 1492, 1445, 1032, 899 cm-1; TLC 
(5% EtOAc/hexane): Rf = 0.16; LRMS (ESI): Calcd. for C17H19N: ([M+Na]): 
260.14, Found: 260.27. 
Acylation of 2b to form 2b-Ac eliminates the observed rotamers.  
 
A 1-dram vial equipped with a magnetic stir bar was flame dried and cooled to rt 
under an atmosphere of N2. The flask was charged with 2b (0.1 mmol, 1.0 equiv) 
and DCM (1.0 mL) then cooled to 0 ˚C. TEA (0.1 mmol, 2.0 equiv) was added to 
Ph
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Cl Me
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the solution followed by dropwise addition of acetyl chloride (0.12 mmol, 1.2 
equiv). The reaction mixture was slowly warmed to rt and stirred for 18 h. The 
mixture was then partitioned between H2O (20 mL) and EtOAc (20 mL), the 
layers were separated and the organic layer was further washed with H2O (2 x 20 
mL) and brine (1 x 20 mL). The organic layer was dried over MgSO4, filtered, and 
concentrated in vacuo. The crude residue was purified by column 
chromatography using a gradient of 15-30% acetone/hexane affording 2b-Ac 
(0.022 g, 0.08 mmol, 79% yield) as a clear oil. Analytical data for 2b-Ac: 1H NMR 
(500 MHz, CDCl3) δ 7.32 – 7.26 (m, 8H), 7.24-7.21 m, 2H), 6.41 (s, 1H), 4.99 (s, 
1H), 4.67 (s, 1H), 3.30 (s, 2H), 2.04 (s, 3H), 1.26 (s, 3H); 13C NMR (126 MHz, 
CDCl3): δ 169.0, 144.6, 142.1, 128.0, 126.9, 126.8, 116.3, 63.7, 46.9, 24.4, 24.1; 
IR (thin film): 1655, 1526, 1493, 1446, 697 cm-1; TLC (30% acetone/hexane): Rf = 
0.22; HRMS (ESI): Calcd. for C19H21NO: ([M+H]): 280.1678, Found: 280.1702. 
4.3.6 General Procedure C: Preparation of β-Formyl Amide 16 
Method 1: 
 
A 25 mL round-bottomed flask equipped with a magnetic stir bar was flame dried 
and cooled to rt under an atmosphere of N2. The flask was cooled to -78 ˚C and 
then charged with freshly prepared 0.7 M LDA (4.3 mL, 3.0 equiv). The 
morpholine amide (1.0 mmol, 1.0 equiv) was added dropwise and stirred at -78 
˚C for 10 min then 0 ˚C for 1 h. The mixture was cooled to -78 ˚C followed by 
dropwise addition of methyl formate (10.0 mmol, 10.0 equiv). The solution was 
O
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O
R
O
N
O
R
O
H
LDA (3.0 equiv)
HCO2Me (10.0 equiv)
Et2O, -78 °C − rt
(±)-16
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warmed slowly to room temperature, then stirred for 12 h, followed by careful 
quenching with 2 M HCl (10 mL) and dilution with DCM (30 mL). The layers were 
separated and the aqueous layer was further extracted with DCM (3 x 30 mL). 
The organic extracts were dried over MgSO4, filtered and concentrated in vacuo. 
The crude residue was purified by column chromatography using a gradient of 
15-30% acetone/hexane. The β-formyl amide products were often inseparable 
from unidentified byproducts. In these cases a 1H NMR yield of the crude 
reaction mixture, using 1,3,5-trimethoxybenzene (0.2 mmol) as an internal 
standard, is reported.   
Method 2: 
 
A 1-dram vial equipped with a magnetic stir bar was flame dried and cooled to rt 
under an atmosphere of N2. The flask was charged with morpholine amide (1.0 
mmol, 1.0 equiv), ethyl formate (10.0 mmol, 10.0 equiv), and DCM (0.3 mL) then 
cooled to 0 ˚C. To this solution TiCl4 (2.5 mmol, 2.5 equiv) in DCM (0.3 mL) was 
added by syringe pump (30 min) followed by syringe pump addition of 
triethylamine (3.5 mmol, 3.5 equiv) over 30 min. The reaction mixture was slowly 
warmed to rt and stirred for 18 h, followed by quenching with 2 M HCl (10 mL) 
and dilution with DCM (30 mL). The layers were separated and the aqueous layer 
was further extracted with DCM (3 x 30 mL). The combined organic extracts were 
dried over MgSO4, filtered and concentrated in vacuo. The crude residue was 
purified by column chromatography using a gradient of 15-30% acetone/hexane. 
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The β-formyl amide products were often inseparable from unidentified byproducts. 
In these cases a 1H NMR yield of the crude reaction mixture, using 1,3,5-
trimethoxybenzene (0.2 mmol) as an internal standard, is reported. 
2-benzyl-3-morpholino-3-oxopropanal (16a): The title compound was prepared 
according to General Procedure C (Method 1) using 1-
morpholino-3-phenylpropan-1-one (0.44 g, 2.0 mmol), affording 
16a (0.36 g, 1.44 mmol, ~95% purity, 63% 1H NMR yield) as a 
clear oil.  Analytical data for 16a: 1H NMR (600 MHz, CDCl3) δ 9.74 (d, J = 2.4 Hz, 
1H), 7.34 – 7.29 (m, 2H), 7.29-7.27 (m, 1H), 7.26-7.22 (m, 2H), 3.76-3.73 (m, 1H), 
3.70 (ddd, J = 12.7, 6.2, 2.4 Hz, 1H), 3.63 (ddd, J = 11.1, 6.0, 2.4 Hz, 1H), 3.56 – 
3.41 (m, 3H), 3.32-3.28 (m, 1H), 3.25 (m, 2H), 3.03-2.99 (m, 1H), 2.96-2.92 (m, 
1H); 13C NMR (151 MHz, CDCl3): δ 198.3, 167.1, 137.3, 129.0, 128.8, 127.1, 
66.5, 66.1, 56.5, 46.2, 42.2, 34.4; IR (thin film): 1724, 1635, 1441, 1113 cm-1; 
TLC (30% acetone/hexane): Rf = 0.16; HRMS (ESI): Calcd. for C14H17NO3: 
([M+H]): 248.1286, Found: 248.1282. 
3-morpholino-3-oxo-2-phenylpropanal (16b): The title compound was 
prepared according to General Procedure C (Method 2) using 1-1-
morpholino-2-phenylethan-1-one (0.21 g, 1.0 mmol), affording 16b 
(0.20 g, 0.86 mmol, ~75% purity, 83% 1H NMR yield) as a clear oil.  
Analytical data for 16b: 1H NMR (600 MHz, CDCl3) δ 9.82 – 9.81 (m, 1H), 7.41 – 
7.38 (m, 2H), 7.35 – 7.29 (m, 2H), 7.15 – 7.14 (m, 1H), 4.50 (d, J = 3.4 Hz, 1H), 
3.75 – 3.72 (m, 1H), 3.68 – 3.65 (m, 1H), 3.57 – 3.48 (m, 4H), 3.36-3.32 (m, 2H), 
3.21 – 3.14 (m, 2H); 13C NMR (151 MHz, CDCl3): δ 196.1, 167.3, 131.1, 129.4, 
H
O
N
O
O
H
O
N
O
O
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128.3, 128.2, 66.3, 65.8, 60.9, 45.6, 41.7; IR (thin film): 1725, 1635, 1440, 1113 
cm-1; TLC (30% acetone/hexane): Rf = 0.17; HRMS (ESI): Calcd. for C13H15NO3: 
([M+H]): 234.1130, Found: 234.1126. 
2-(morpholine-4-carbonyl)pent-4-enal (16c): The title compound was prepared 
according to General Procedure C (Method 1) using 1-1-
morpholinopent-4-en-1-one (0.17 g, 1.0 mmol), affording 16c (0.13 
g, 0.66 mmol, ~92% purity, 55% 1H NMR yield) as a clear oil.  Analytical data for 
16c: 1H NMR (400 MHz, CDCl3) δ 9.56 (d, J = 2.2 Hz, 1H), 5.79-5.68 (m, 1H), 
5.13 – 5.06 (m, 2H), 3.70 – 3.42 (m, 8H), 2.66 (t, J = 7.1 Hz, 2H); 13C NMR (100 
MHz, CDCl3): δ 198.1, 166.6, 133.6, 118.0, 66.7, 66.6, 54.5, 46.2, 42.3, 31.6; IR 
(thin film): 1642, 1595, 1432, 1171 cm-1; TLC (30% acetone/hexane): Rf = 0.17; 
HRMS (ESI): Calcd. for C10H15NO3: ([M+H]): 198.1130, Found: 198.1126. 
4-(benzyloxy)-2-(morpholine-4-carbonyl)butanal (16d): The title 
compound was prepared according to General Procedure C 
(Method 1) using 4-(benzyloxy)-1-morpholinobutan-1-one (0.26 g, 
1.0 mmol), affording 16d as a 4:1 mixture of 16d to unreacted morpholine amide 
(0.23 g, 0.79 mmol, ~69% purity, 53% 1H NMR yield) as a clear oil.  Analytical 
data for 6d: 1H NMR (500 MHz, CDCl3) δ 9.60 (d, J = 2.4 Hz, 1H), 7.34 – 7.26 (m, 
5H), 4.48 – 4.42 (m, 2H), 3.75-3.42 (m, 9H), 2.31-2.225 (m, 1H), 2.17-2.11 (m, 
1H); 13C NMR (126 MHz, CDCl3): δ 198.1, 167.0, 137.7, 128.2, 127.5, 127.4, 
72.8, 67.0, 66.5, 66.4, 52.0, 46.0, 42.0, 27.6.; IR (thin film): 1724, 1635, 1437, 
1113 cm-1; TLC (22.5% acetone/hexane): Rf = 0.11; HRMS (ESI): Calcd. for 
C16H21NO4: ([M+H]): 292.1549, Found: 292.1545. 
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2-methyl-3-morpholino-3-oxopropanal (16e): The title 
compound was prepared according to General Procedure C 
(Method 1) using 1-morpholinopropan-1-one (0.21 g, 1.5 mmol), 
affording 16e (0.17 g, 01.0 mmol, 67% yield) as a clear oil.  Analytical data for 
16e: 1H NMR (600 MHz, CDCl3) δ 9.62 (d, J = 2.2 Hz, 1H), 3.73–3.65 (m, 5H), 
3.58 – 3.43 (m, 4H), 1.40 (d, J = 7.2, 3H); 13C NMR (151 MHz, CDCl3): δ 198.5, 
168.1, 66.8, 66.6, 49.2, 46.2, 42.2, 11.8; IR (thin film): 1725, 1625, 1436, 1225, 
1113, 1030 cm-1; TLC (30% acetone/hexane): Rf = 0.13; HRMS (ESI): Calcd. for 
C8H13NO3: ([M+Na]): 194.0793, Found: 194.0788. 
2-cyclohexyl-3-morpholino-3-oxopropanal (16f): The title 
compound was prepared according to General Procedure C 
(Method 1) using 2-cyclohexyl-1-morpholinoethan-1-one (0.21 g, 
1.0 mmol), affording 16f (0.18 g, 0.75 mmol, ̴ 97% purity, 85% 1H NMR yield) as 
a clear oil.  Analytical data for 16f: 1H NMR (600 MHz, CDCl3) δ 9.57 (d, J = 4.6 
Hz, 1H), 3.68 – 3.43 (m, 8H), 3.16 (dd, J = 9.5, 4.6 Hz, 1H), 2.29 – 2.22 (m, 1H), 
1.72 – 1.62 (m, 6H), 1.30-1.20 (m, 2H), 1.14 – 1.06 (m, 1H), 1.01-0.86 (m, 2H); 
13C NMR (126 MHz, CDCl3): δ 200.5, 166.7, 66.8, 66.6, 61.6, 46.2, 42.2, 37.8, 
30.9, 30.6, 25.9, 25.8; IR (thin film): 1721, 1629, 1433, 1115 cm-1; TLC (22.5% 
acetone/hexane): Rf = 0.26; HRMS (ESI): Calcd. for C13H21NO3: ([M+H]): 
240.1599, Found: 240.1595. 
3-methyl-2-(morpholine-4-carbonyl)butanal (16g): The title 
compound was prepared according to General Procedure C 
(Method 1) using 3-methyl-1-morpholinobutan-1-one (0.17 g, 1.0 
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mmol), affording 16g (0.17 g, 0.86 mmol, ̴ 90% purity, 70% 1H NMR yield) as a 
clear oil.  Analytical data for 16g: 1H NMR (600 MHz, CDCl3) δ 9.56 (d, J = 4.4 Hz, 
1H), 3.70 – 3.51 (m, 7H), 3.47-3.44 (m, 1H), 3.10 (dd, J = 9.3, 4.4 Hz, 1H), 2.56-
2.50 (m, 1H), 0.96-0.94 (m, 6H); 13C NMR (151 MHz, CDCl3): δ 200.2, 166.8, 
66.8, 66.6, 62.4, 46.2, 42.2, 28.5, 20.7, 19.9.; IR (thin film): 1723, 1635, 1440, 
1263, 1117 cm-1; TLC (30% acetone/hexane): Rf = 0.27; HRMS (ESI): Calcd. for 
C10H17NO3: ([M+H]): 200.1286, Found: 200.1282. 
2-(cyclopropylmethyl)-3-morpholino-3-oxopropanal (16h): The 
title compound was prepared according to General Procedure C 
(Method 1) using 3-cyclopropyl-1-morpholinopropan-1-one (0.18 g, 
1.0 mmol), affording 16h (0.20 g, 0.86 mmol, ̴ 95% purity) as a clear oil.  
Analytical data for 16h: 1H NMR (600 MHz, CDCl3) δ 1H NMR (600 MHz, 
Chloroform-d) δ 9.56 (d, J = 3.1 Hz, 1H), 3.72 – 3.49 (m, 8H), 3.45-3.37 (m, 2H), 
1.91-1.87 (m, 2H), 1.34 – 1.21 (m, 2H), 0.87 (t, J = 6.9 Hz, 3H); 13C NMR (151 
MHz, CDCl3): δ 199.1, 167.2, 66.7, 66.6, 55.2, 46.1, 42.2, 29.2, 27.2, 22.5, 13.7; 
IR (thin film): 1631, 1436, 1269, 1115 cm-1; TLC (30% acetone/hexane): Rf = 
0.35; LRMS (ESI): Calcd. for C11H17NO3: ([M+Na]): 234.11, Found: 234.30. 
 2-(4-bromobenzyl)-3-morpholino-3-oxopropanal (16i): The title compound 
was prepared according to General Procedure C (Method 1) 
using 3-(4-bromophenyl)-1-morpholinopropan-1-one (0.60 g, 
2.0 mmol), affording 16i (0.59 g, 1.8 mmol, ̴ 90% purity) as a 
clear oil.  Analytical data for 16i: 1H NMR (600 MHz, CDCl3) δ 9.61 (d, J = 2.3 Hz, 
1H), 7.39 – 7.36 (m, 2H), 7.04 (d, J = 8.1 Hz, 2H), 3.70-3.66 (m, 1H), 3.60 – 3.43 
H
O
N
O
O
H
O
N
O
O
Br
 
238 
(m, 6H), 3.33 – 3.28 (m, 2H), 3.19 – 3.01 (m, 4H); 13C NMR (151 MHz, CDCl3): δ 
197.5, 166.4, 136.3, 131.7, 130.6, 120.8, 66.5, 66.1, 56.3, 46.1, 42.2, 33.2; IR 
(thin film): 1625, 1488, 1115, 1071, 760 cm-1; TLC (30% acetone/hexane): Rf = 
0.18; LRMS (ESI): Calcd. for C14H16BrNO3: ([M+Na]): 348.02, Found: 348.25. 
 2-(4-methoxybenzyl)-3-morpholino-3-oxopropanal (16j): 
The title compound was prepared according to General 
Procedure C (Method 1) using 3-(4-methoxyphenyl)-1-
morpholinopropan-1-one (0.50 g, 2.0 mmol), affording 16j 
(0.23 g, 0.82 mmol, ̴ 90% purity) as a clear oil.  Analytical data for 16j: 1H NMR 
(600 MHz, CDCl3) δ 9.69 (d, J = 2.7 Hz, 1H), 7.11 – 7.08 (m, 2H), 6.89 – 6.53 (m, 
2H), 3.77 (s, 3H), 3.69 – 3.55 (m, 4H), 3.55-3.41 (m., 4H), 3.36 – 3.26 (m, 2H), 
3.17-3.15 (m, 2H), 3.05-2.98 (m, 2H); 13C NMR (151 MHz, CDCl3): δ 198.6, 167.2, 
130.1, 129.2, 114.18,  66.61, 66.21, 56.84, 55.29, 46.20, 42.22, 33.65; IR (thin 
film): 1628, 1513, 1247, 1114, 1031, 749 cm-1; TLC (30% acetone/hexane): Rf = 
0.07; HRMS (ESI): Calcd. for C15H19NO4: ([M+Na]): 300.12, Found: 300.29. 
 2-(furan-2-ylmethyl)-3-morpholino-3-oxopropanal (16k): The title compound 
was prepared according to General Procedure C (Method 1) using 
3-(furan-2-yl)-1-morpholinopropan-1-one (0.20 g, 1.0 mmol), 
affording 16k (0.11 g, 0.45 mmol, ̴ 90% purity) as a clear oil.  Analytical data for 
16k: 1H NMR (500 MHz, CDCl3) δ 9.62 (d, J = 2.2 Hz, 1H), 7.30 (m, 1H), 6.28-
6.27 (m, 1H), 6.09-6.08 (m, 1H), 3.87 – 3.84 (m, 1H), 3.64 – 3.55 (m, 5H), 3.48 – 
3.40 (m, 2H), 3.36 – 3.24 (m, 2H), 3.21-3.16 (m, 1H); 13C NMR (151 MHz, 
CDCl3): δ 197.4, 197.4, 166.6, 151.1, 141.9, 110.7, 107.6,  66.7, 66.5, 53.8, 46.3, 
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42.4, 26.4; IR (thin film): 1621, 1443, 1114, 1070, 1012 cm-1; TLC (30% 
acetone/hexane): Rf = 0.11; HRMS (ESI): Calcd. for C12H15NO4: ([M+Na]): 260.09, 
Found: 260.35. 
 3-morpholino-3-oxo-2-(thiophen-2-ylmethyl)propanal (16l): 
The title compound was prepared according to General Procedure 
C (Method 1) using 1-morpholino-3-(thiophen-2-yl)propan-1-one 
(0.23 g, 1.0 mmol), affording 16l (0.11 g, 0.43 mmol, ̴ 90% purity) as a clear oil.  
Analytical data for 16l: 1H NMR (500 MHz, CDCl3) δ 9.63 (d, J = 2.4 Hz, 1H), 
7.16-7.15 (m, 1H), 6.92-6.91 (m, 1H), 6.85 – 6.81 (m, 1H), 3.78 (td, J = 7.4, 2.4 
Hz, 1H), 3.68 – 3.51 (m, 5H), 3.47 – 3.39 (m, 3H), 3.27-3.17 (m, 2H); 13C NMR 
(125 MHz, CDCl3): δ 197.36, 166.38, 139.29, 127.17, 126.36, 124.63, 66.58, 
66.32, 56.86, 46.30, 42.37, 28.02; IR (thin film): 1624, 1437, 1269, 1112, 1067, 
1025 cm-1; TLC (30% acetone/hexane): Rf = 0.16; HRMS (ESI): Calcd. for 
C12H15NO3S: ([M+H]): 276.06, Found: 276.30. 
2-benzyl-3-oxo-3-(piperidin-1-yl)propanal (16m): The title compound was 
prepared according to General Procedure C (Method 1) using 3-
phenyl-1-(piperidin-1-yl)propan-1-one (0.20 g, 1.0 mmol), affording 
16m (0.23 g, 0.95 mmol, ̴ 90% purity, 83% 1H NMR yield) as a clear oil.  
Analytical data for 16m: 1H NMR (600 MHz, CDCl3) δ 9.69 (d, J = 2.6 Hz, 1H), 
7.30-7.27 (m, 2H), 7.24 – 7.19 (m, 3H), 3.80 (td, J = 7.5, 2.6 Hz, 1H), 3.63-3.59 
(m, 1H), 3.46-3.42 (m, 1H), 3.23-3.19 (m, 3H), 3.11-3.06 (m, 1H), 1.54-1.48 (m, 
4H), 1.43 – 1.33 (m, 1H), 1.01 – 0.95 (m, 1H); 13C NMR (151 MHz, CDCl3): δ 
198.6, 166.5, 137.6, 128.9, 128.6, 126.7, 56.8, 46.9, 43.0, 34.2, 25.9, 25.3, 24.1.; 
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IR (thin film): 1723, 1635, 1444, 700 cm-1; TLC (22.5% acetone/hexane): Rf = 
0.20; HRMS (ESI): Calcd. for C15H19NO2: ([M+H]): 246.1494, Found: 246.1490. 
2-benzyl-3-oxo-3-(pyrrolidin-1-yl)propanal (16n): The title 
compound was prepared according to General Procedure C 
(Method 1) using 3-phenyl-1-(pyrrolidin-1-yl)propan-1-one (0.22 g, 
1.0 mmol), affording 16n (0.16 g, 0.67 mmol, ̴ 83% purity, 59% 1H NMR yield) as 
a clear oil.  Analytical data for 16n: 1H NMR (600 MHz, CDCl3) δ 9.73 (d, J = 2.8 
Hz, 1H), 7.29 – 7.20 (m, 5H), 3.59 (ddd, J = 9.0, 5.9, 2.8 Hz, 1H), 3.47 – 3.37 (m, 
2H), 3.32 – 3.23 (m, 2H), 3.18 (dd, J = 13.6, 5.9 Hz, 1H), 2.78-2.74 (m, 1H), 1.81 
– 1.76 (m, 2H), 1.73-1.67 (m, 1H), 1.65 – 1.60 (m, 1H); 13C NMR (151 MHz, 
CDCl3): δ 198.7, 166.6, 137.6, 128.8, 128.5, 126.7, 59.7, 46.5, 45.7, 34.1, 25.7, 
24.1.; IR (thin film): 1629, 1604, 1455, 1072 cm-1; TLC (22.5% acetone/hexane): 
Rf = 0.26; HRMS (ESI): Calcd. for C14H17NO2: ([M+H]): 232.1337, Found: 
232.1332. 
2-benzyl-N,N-dimethyl-3-oxopropanamide (16o): The title 
compound was prepared according to General Procedure C 
(Method 1) N,N-dimethyl-3-phenylpropanamide (0.18 g, 1.0 mmol), 
affording 16o (0.17 g, 0.82 mmol, 82% yield) as a clear oil.  Analytical data for 
16o: 1H NMR (600 MHz, CDCl3) δ 9.70 (d, J = 2.7 Hz, 1H), 7.31-7.28 (m, 2H), 
7.25 – 7.20 (m, 3H), 3.79 (td, J = 7.5, 2.7 Hz, 1H), 3.23 (d, J = 7.5 Hz, 2H), 2.92 
(s, 3H), 2.71 (s, 3H); 13C NMR (151 MHz, CDCl3): δ 198.5, 168.4, 137.6, 128.9, 
128.6, 126.8, 57.3, 37.1, 35.5, 34.2.; IR (thin film): 1723, 1635, 1497, 1401 cm-1; 
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TLC (22.5% acetone/hexane): Rf = 0.08; HRMS (ESI): Calcd. for C12H15NO2: 
([M+H]): 206.1181, Found: 206.117 
4.3.7 Full Optimization Data for the Asymmetric 2-aza Cope Rearrangement 
of β-Formyl Amides 
 
 
General procedure D for optimization of the asymmetric 2-aza Cope 
rearrangement of β-formyl amides: To a 1-dram vial were added catalyst, (0.01 
mmol, 0.10 equiv) β-formyl amide 16a (0.14 mmol, 1.4 equiv), 3 Ǻ molecular 
sieves (50 mg), solvent (0.5 mL, 0.2 M) and allyl amine 2a (0.1 mmol, 1.0 equiv). 
This solution was stirred at the indicated temperature for the indicated time, 
filtered through a short plug of celite with DCM, and concentrated in vacuo
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Trial Catalyst solvent T (˚C) time (h) 18a:17 dr er 
1 9 PhCH3 rt 24 1:1 -- 92:8 
2 10 PhCH3 rt 24 1:5 -- 91:9 
3 19 PhCH3 rt 24 1:1.5 -- 68:32 
4 24 PhCH3 rt 24 3:1 -- 85:15 
5 25 PhCH3 rt 24 1:1.5 -- 66:34 
6 26 PhCH3 rt 24 1:1.5 -- 68:32 
7 27 PhCH3 rt 24 <1:50 -- -- 
8 27 PhCH3 80 12 1:2 -- 70:30 
9 9 PhCH3 80 12 >20:1 7:1 95.5:4.5 
10 19 PhCH3 80 12 >20:1 20:1 86.5:13.5 
11 9 PhCH3 rt 48 >20:1 7:1 95:5 
12 19 PhCH3 rt 48 1:1 -- -- 
13 9 CHCl3 60 12 >20:1 10:1 97:3 
14 19 CHCl3 60 12 >20:1 >20:1 93:7 
15 9 DCE 60 12 >20:1 10:1 95:5 
16 19 DCE 60 12 >20:1 >20:1 88:12 
17 9 MTBE 60 12 >20:1 7:1 97:3 
18 19 MTBE 60 12 3:1 -- -- 
19 9 CPME 60 12 >20:1 8:1 98:2 
20 19 CPME 60 12 >20:1 >20:1 89:11 
21 9 CH3CN 60 12 >20:1 2.5:1 92:8 
22 19 CH3CN 60 12 mess -- -- 
23 9 THF 60 12 >20:1 1.4:1 97.5:2.5 
24 19 THF 60 12 mess -- -- 
25 9 2-Me THF 60 12 >20:1 7:1 95:5 
26 19 2-Me THF 60 12 5:1 -- -- 
27 9a CHCl3 60 12 >20:1 10:1 97:3 
28 9b CHCl3 60 24 >20:1 10:1 97:3 
29 9c CHCl3 60 24 4:1 -- -- 
a) Using 5 mol % of 9 b) Using 2.5 mol % of 9 c) Using 1 mol % of 9  
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4.3.8 General procedure E for the Asymmetric 2-Aza Cope Rearrangement 
of β-Formyl Amides 
 
Note: As indicated above, the aldehyde is often carried forward with some 
quantity of inseparable impurities.  In practice these impurities did not interfere 
with the subsequent rearrangement, but for the purposes of simplifying yield 
calculations, a slight excess of the aldehyde was used relative to the homoallyl 
amine and the yield was calculated based on the latter.  
 
Method 1: To a 1-dram vial were added catalyst, (0.005 mmol, 0.025 equiv) β-
formyl amide 16 (0.24 mmol, 1.2 equiv), 3 Å molecular sieves (100 mg), solvent 
(1.0 mL, 0.2 M) and homoallyl amine 2 (0.2 mmol, 1.0 equiv).  This solution was 
stirred at 60 °C for 18 h then filtered through a short plug of celite with DCM, and 
concentrated in vacuo. The crude residue was purified by column 
chromatography using a gradient of 10-15% acetone/hexane. The rearranged α-
stereogenic-β-amino amide products were often inseparable from unidentified 
byproducts by chromatography. In these cases products were either 
recrystallized from 0.5% EtOAc/hexane or deprotected to the corresponding 
primary amine according to General Procedure F. Note: all er values are of 
material prior to recrystallization.  
Method 2: To a microwave vial was added catalyst, (0.005 mmol, 0.025 equiv) β-
formyl amide 16 (0.24 mmol, 1.2 equiv), 3 Ǻ molecular sieves (100 mg), solvent 
(1.0 mL, 0.2 M) and homoallyl amine 2 (0.2 mmol, 1.0 equiv).  This solution was 
24 h
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stirred under microwave irradiation at 130 ˚C for 6 h then filtered through a short 
plug of celite with DCM, and concentrated in vacuo. The crude residue was 
purified by column chromatography using a gradient of 10-15% acetone/hexane. 
The rearranged α-stereogenic-β-amino amide products were often inseparable 
from unidentified byproducts by chromatography. In these cases products were 
recrystallized from 0.5% EtOAc/hexane. Note: all er values of material prior to 
recrystallization.  
General procedure F for the Hydrolysis of β-Amino Amide 18 
 
To a 1-dram vial was added 18, (0.2 mmol, 1.0 equiv) hydroxylamine 
hydrochloride (1.0 mmol, 5.0 equiv), and 2:1 THF:H2O (2.0 mL, 0.1 M).  This 
solution was stirred at rt for 18 h then partitioned between 2 M HCl (10 mL) and 
Et2O (10 mL). The aqueous layer was washed with Et2O (3 x 10 mL), basified to 
pH 14 with 2 M NaOH, extracted with DCM (3x 50 mL), dried over MgSO4, 
filtered then concentrated in vacuo to provide primary amine 20 without need for 
further purification.  
(2R,3S)-2-benzyl-3-((diphenylmethylene)amino)-1 
morpholinohex-5-en-1-one (18a): The title compound was 
prepared according to General Procedure E (Method 1) using β-
formyl amide 16a (0.059 g, 0.24 mmol), and homoallyl amine 2a 
(0.045 g, 0.20 mmol) affording 18a whose diastereomer ratio was determined as 
 NH2OH•HCl,
THF/H2O (2:1)
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10:1 by 1H NMR spectroscopic analysis of the crude reaction mixture by 
comparison of the integration of the resonances at δ 5.20-5.11 (minor 
diastereomer) and δ 5.06-5.00 (major diastereomer). As product 18a was 
inseparable from minor unidentified impurities it was deprotected using General 
Procedure F to amine 20a (0.050 g, 0.17 mmol, 87% yield, >20:1 dr) for final 
characterization.  
Analytical data for 18a: 1H NMR (600 MHz, CDCl3) δ 7.71 – 7.69 (m, 2H), 7.49 – 
7.37 (m, 6H), 7.28 – 7.18 (m, 7H), 5.86-5.79 (m, 1H), 5.06 – 5.00 (m, 2H), 3.94-
3.90 (m, 1H), 3.75 – 3.72 (m, 1H), 3.57 – 3.54 (m, 1H), 3.34 – 3.22 (m, 4H), 3.18-
3.14 (m, 1H), 2.92-2.88 (m, 2H), 2.72 (t, J = 12.1 Hz, 1H), 2.51-2.47 (m, 1H), 
2.31-2.29 (m, 2H); 13C NMR (151 MHz, CDCl3): δ 172.1, 168.5, 140.1, 139.8, 
136.9, 135.5, 129.9, 129.2, 128.5, 128.4, 128.3, 128.3, 128.0, 127.9, 126.4, 
117.0, 66.6, 66.0, 63.7, 48.7, 46.1, 41.78, 39.5, 37.9.; IR (thin film): 1742, 1630, 
1259, 1015, 701 cm-1; TLC (15% acetone/hexane): Rf = 0.14; HRMS (ESI): Calcd. 
for C30H32N2O2: ([M+H]): 453.2542, Found: 453.2533; HPLC ID, 97% 
hexanes/IPA, flow rate = 1.0 mL/min, λ = 230 nm, tR (major) = 12.6 min tR (minor)  = 
18.2 min, 97:3 er; [α]D = +34.6 (c = 0.03, DCM).  
Analytical data for 20a: 1H NMR (500 MHz, CDCl3) δ 7.30 – 
7.23 (m, 2H), 7.35 – 7.19 (m, 3H), 5.84-5.75 (m, 1H), 5.17-5.14 
(m, 2H), 3.76-3.75 (m, 1H), 3.56 (dd, J = 8.7, 5.1 Hz, 1H), 3.34-
3.31 (m, 1H), 3.28 – 3.20 (m, 3H), 3.16 – 3.06 (m, 2H), 2.96-
2.81 (m, 3H), 2.52 (ddd, J = 11.3, 8.2, 2.9 Hz, 1H), 2.33-2.31 (m, 1H), 2.08-2.02 
(m, 1H), 1.63 (s, 2H); 13C NMR (126 MHz, CDCl3): δ 172.8, 139.7, 135.2, 129.2, 
O
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128.5, 126.5, 118.2, 66.6, 66.1, 52.6, 51.8, 49.1, 46.1, 41.9, 35.6.; IR (thin film): 
1738, 1618, 1445, 1365, 1231, 1113 cm-1; TLC (10% MeOH/DCM): Rf = 0.40; 
HRMS (ESI): Calcd. for C17H24N2O2: ([M+H]): 289.1916, Found: 289.1910; [α]D = 
-6.4 (c = 0.003, DCM).  
 (2R,3S)-3-((diphenylmethylene)amino)-1-morpholino-2-
phenylhex-5-en-1-one (18b): The title compound was 
prepared according to General Procedure E (Method 2) using β-
formyl amide 16b (0.056 g, 0.24 mmol), and homoallyl amine 2a 
(0.045 g, 0.20 mmol) affording 18b (0.028 g, 0.06 mmol, 31% yield, >20:1 dr) as 
a white solid after recrystallization. The crude diastereomer ratio was determined 
as 1.1:1 by 1H NMR spectroscopic analysis of the crude reaction mixture by 
comparison of the integration of the resonances at δ 6.01-5.94 (minor 
diastereomer) and δ 5.66-5.61 (major diastereomer).   
Analytical data for 18b: mp: 121.4-122.2 ˚C 1H NMR (500 MHz, CDCl3) δ 7.44 – 
7.43 (m, 2H), 7.35 – 7.17 (m, 12H), 6.39 (d, J = 7.3 Hz, 2H), 6.01-5.93 (m, 1H), 
5.13 – 5.09 (m, 2H), 4.15-4.13 (m, 2H), 3.72 – 3.63 (m, 2H), 3.57-3.50 (m, 4H), 
3.40-3.35 (m, 1H), 3.19-3.14 (m, 1H), 2.61-2.52 (m, 2H); 13C NMR (126 MHz, 
CDCl3): δ 170.27, 137.43, 136.59, 136.03, 129.49, 129.13, 128.30, 128.24, 
127.91, 127.78, 127.76, 127.74, 127.03, 117.02, 66.73, 66.36, 64.61, 53.23, 
46.10, 42.07, 40.03; IR (thin film): 1640, 1432, 1114, 699 cm-1; TLC (15% 
acetone/hexane): Rf = 0.15; HRMS (ESI): Calcd. for C29H30N2O2: ([M+H]): 
439.2385, Found: 439.2377; HPLC IC, 96% hexanes/IPA, flow rate = 1.0 mL/min, 
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λ = 230 nm, tR (major) = 7.1 min tR (minor)  = 8.5 min, 84.5:15.5 er; [α]D = +96.7 (c = 
0.03, DCM).  
 (2R,3S)-2-allyl-3-((diphenylmethylene)amino)-1-morpholinohex-5-en-1-one  
(18c): The title compound was prepared according to General 
Procedure E (Method 1) using β-formyl amide 16c (0.056 g, 
0.24 mmol), and homoallyl amine 2a (0.045 g, 0.20 mmol) 
affording 18c (0.072 g, 0.16 mmol, 80% yield,  >20:1 dr) as a white solid after 
recrystallization. The crude diastereomer ratio was determined as 8:1 by UHPLC 
analysis of the crude reaction mixture by comparison of the peaks at 7.7 min 
(minor diastereomer) and  7.9 min (major diastereomer).   
Analytical data for 18c: mp: 118.0-118.4 ˚C 1H NMR (500 MHz, CDCl3) δ 7.60 – 
7.82 (m, 2H), 7.45 – 7.31 (m, 6H), 7.14-7.12 m, 2H), 5.76-5.64 (m, 2H), 5.08 – 
4.96 (m, 4H), 3.79 – 3.49 (m, 8H), 3.14-3.10 (m, 1H), 2.34-2.26 (m, 4H); 13C 
NMR (126 MHz, CDCl3): δ 172.3, 168.4, 140.0, 136.8, 135.9, 135.5, 129.9, 128.4, 
128.4, 128.3, 128.0, 127.9, 117.1, 116.8, 67.0, 66.8, 63.4, 46.4, 45.86, 42.0, 39.3, 
35.3; IR (thin film): 1625, 1444, 1232, 1115, 916, 697 cm-1; TLC (15% 
acetone/hexane): Rf = 0.14; HRMS (ESI): Calcd. for C26H30N2O2: ([M+H]): 
403.2385, Found: 403.2378; HPLC IC, 90% hexanes/IPA, flow rate = 1.0 mL/min, 
λ = 230 nm, tR (major) = 5.8 min tR (minor)  = 7.7 min, 92:8 er; [α]D = +40.5 (c = 0.03, 
DCM). 
(2R,3S)-2-(2-(benzyloxy)ethyl)-3-((diphenylmethylene)amino)-1-
morpholinohex-5-en-1-one (18d): The title compound was 
prepared according to General Procedure E (Method 1) using β-
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formyl amide 16d (0.070 g, 0.24 mmol), and homoallyl amine 2a (0.045 g, 0.20 
mmol) affording 18d whose diastereomer ratio was determined as 2:1 by 1H 
NMR spectroscopic analysis of the crude reaction mixture by comparison of the 
integration of the resonances at δ 7.56-7.55 (minor diastereomer) and δ 7.62-
7.61 (major diastereomer). As product 18d was inseparable from minor 
unidentified impurities it was deprotected using General Procedure F to amine 
20d (0.043 g, 0.13 mmol, 65% yield, >20:1 dr) for final characterization.  
Analytical data for 18d: 1H NMR (600 MHz, CDCl3) δ 7.63-7.62 (m, 2H), 7.46 – 
7.28 (m, 11H), 7.16 – 7.15 (m, 2H), 5.75 – 5.68 (m, 1H), 5.05-5.02 (m, 2H), 4.52 
– 4.43 (m, 2H), 3.80-3.76 (m, 1H), 3.69 – 3.60 (m, 2H), 3.59-3.51 (m, 7H), 3.41-
3.37 (m, 1H), 3.33-3.29 (m, 1H), 2.35-2.32 (m, 2H), 1.95-1.90 (m, 2H); 13C NMR 
(151 MHz, CDCl3): δ 172.7, 168.0, 140.0, 138.2, 136.8, 135.61, 129.9, 128.5, 
128.3, 128.3, 128.2, 127.9, 127.9 127.5, 127.4, 117.1, 72.7, 68.1, 66.9, 66.7, 
63.7, 46.3, 42.5, 41.9, 39.2, 30.5; IR (thin film): 1625, 1444, 1115, 749, 697 cm-1; 
TLC (15% acetone/hexane): Rf = 0.10; HRMS (ESI): Calcd. for C32H36N2O3: 
([M+H]): 497.2804, Found: 497.2794; HPLC IC, 85% hexanes/IPA, flow rate = 
1.0 mL/min, λ = 230 nm, tR (major) = 9.8 min tR (minor)  = 13.4 min, 91:9 er; [α]D = 
+15.9 (c = 0.03, DCM).  
Analytical data for 20d: 1H NMR (600 MHz, CDCl3) δ 7.35 – 
7.26 (m, 5H), 5.78 – 5.71 (m, 1H), 5.12 – 5.09 (m, 2H), 4.49 – 
4.41 (m, 2H), 3.67-3.62 (m, 1H), 3.59 – 3.48 (m, 8H), 3.40-3.36 
(m, 1H), 3.03 – 3.00 (m, 1H), 2.92-2.88 (m, 1H), 2.326 – 2.22 (m, 1H), 2.04-1.94 
(m, 3H), 1.57 (bs, 2H); 13C NMR (151 MHz, CDCl3): δ 173.4, 138.2, 135.4, 128.3, 
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127.6, 127.5, 118.0, 72.8, 68.1, 67.0, 66.8, 52.8, 46.3, 42.6, 42.0, 40.2, 28.4; IR 
(thin film): 1632, 1495, 705 cm-1; TLC (10% MeOH/DCM): Rf = 0.37; HRMS 
(ESI): Calcd. for C19H28N2O3: ([M+H]): 333.2178, Found: 333.2169; [α]D = +2.77 
(c = 0.013, DCM).  
(2R,3S)-3-((diphenylmethylene)amino)-2-methyl-1-morpholinohex-5-en-1-
one (18e): The title compound was prepared according to 
General Procedure E (Method 1) using β-formyl amide 16e 
(0.04 g, 0.24 mmol), and homoallyl amine 2a (0.045 g, 0.20 mmol) affording 18e 
as a clear oil. The diastereomer ratio was determined by 1H NMR spectroscopic 
analysis of the crude reaction mixture by comparison of the integration of the 
resonances at δ 1.18 (minor diastereomer) and δ 1.13 (major diastereomer). As 
product 18e was inseparable from minor unidentified impurities it was 
deprotected using General Procedure F to amine 20e (0.028 g, 0.13 mmol, 66% 
yield, 3:1 dr) for final characterization.  
Analytical data for 18e: 1H NMR (600 MHz, CDCl3) δ 7.64-7.62 (m, 2H), 7.48 – 
7.29 (m, 6H), 7.19-7.16 (m, 2H), 5.82-5.73 (m, 1H), 5.08-5.04 (m, 2H), 3.82 – 
3.77 (m, 1H), 3.73 – 3.52 (m, 9H), 3.38 – 3.30 (m, 1H), 3.011-3.06 (m, 1H), 1.13 
(d, J = 7.2 Hz, 3H); 13C NMR (151 MHz, CDCl3): δ 173.6, 168.1, 140.2, 137.0, 
135.3, 129.8, 128.4, 128.3, 128.3, 128.0, 128.0, 117.0, 66.7, 63.6, 46.1, 41.9, 
40.1, 39.4, 15.6; IR (thin film): 1626, 1432, 1115, 783 cm-1; TLC (15% 
acetone/hexane): Rf = 0.12; HRMS (ESI): Calcd. for C24H28N2O2: ([M+H]): 
377.2229, Found: 377.2217; SFC OD, 3% MeOH, flow rate = 3.0 mL/min, λ = 
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210 nm, tR (major) = 9.0 min tR (minor)  = 8.2 min, 82:18 er; [α]D = +34.1 (c = 0.02, 
DCM).  
Analytical data for 20e: 1H NMR (500 MHz, CDCl3) δ 5.82 – 5.72 (m, 1H), 5.15 – 
5.08 (m, 2H), 3.68-3.60 (m, 6H), 3.51-3.48 (m, 2H), 3.10-3.06 
(m, 1H), 2.66 – 2.61 (m, 1H), 2.23 – 2.18 (m, 1H), 2.07-2.01 (m, 
1H), 1.62 (bs, 2H), 1.13 (d, J = 6.9 Hz, 3H); 13C NMR (126 MHz, CDCl3): δ 174.4, 
135.4, 117.8, 67.0, 66.7, 52.4, 46.1, 41.9, 40.0, 39.8, 12.4; IR (thin film): 1622, 
1466, 1444, 1116 cm-1; TLC (10% MeOH/DCM): Rf = 0.16; HRMS (ESI): Calcd. 
for C11H20N2O2: ([M+H]): 213.1578, Found: 289.213.1595; [α]D = -2.8 (c = 0.008, 
DCM).  
 (2R,3S)-2-cyclohexyl-3-((diphenylmethylene)amino)-1-
morpholinohex-5-en-1-one (18f): The title compound was 
prepared according to General Procedure E (Method 1) using β-
formyl amide 6f (0.057 g, 0.24 mmol), and homoallyl amine 2a 
(0.045 g, 0.20 mmol) affording 18f (0.071 g, 0.16 mmol, 80% yield, >20:1 dr) as a 
white solid after recrystallization. A single diastereomer was observed by 1H 
NMR spectroscopic analysis of the crude reaction mixture.  
Analytical data for 18f: mp: 127.8-128.1 ˚C 1H NMR (500 MHz, CDCl3) δ 7.60 – 
7.58 (m, 2H), 7.45 – 7.30 (m, 6H), 7.12 – 7.11 (m, 2H), 5.72 – 5.64 (m, 1H), 4.99 
– 4.95 (m, 2H), 3.85-3.82 (m, 1H), 3.76 – 3.60 (m, 4H), 3.58 – 3.43 (m, 4H), 2.78 
(t, J = 6.9 Hz, 1H), 2.52-2.46 (m, 1H), 2.40-2.35 (m, 1H), 1.76-1.69 (m, 1H), 1.64 
– 1.58 (m, 4H), 1.53-1.50 (m, 1H), 1.21 – 1.04 (m, 3H), 0.84 – 0.76 (m, 2H); 13C 
NMR (126 MHz, CDCl3): δ 171.9, 166.9, 139.8, 136.7, 136.4, 129.9, 128.4, 128.3, 
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128.3, 128.0, 127.7, 116.6, 67.2, 66.7, 61.2, 50.4, 46.9, 41.8, 38.1, 37.6, 31.6, 
30.3, 26.5, 26.4, 26.2.; IR (thin film): 1625, 1444, 1115, 769, 698 cm-1; TLC (15% 
acetone/hexane): Rf = 0.21; HRMS (ESI): Calcd. for C29H36N2O2: ([M+H]): 
445.2855, Found: 445.2847; HPLC ID, 90% hexanes/IPA, flow rate = 1.0 mL/min, 
λ = 230 nm, tR (major) = 6.6 min tR (minor)  = 10.8 min, 95.5:4.5 er; [α]D = +30.8 (c = 
0.04, DCM). 
 (2R,3S)-3-((diphenylmethylene)amino)-2-isopropyl-1-morpholinohex-5-en-
1-one (18g): The title compound was prepared according to 
General Procedure E (Method 1) using β-formyl amide 16g 
(0.046 g, 0.24 mmol), and homoallyl amine 2a (0.045 g, 0.20 
mmol) affording 18g (0.042 g, 0.10 mmol, 52% yield,  >20:1 dr) as a white solid 
after recrystallization. The crude diastereomer ratio was determined as 13:1 by 
1H NMR spectroscopic analysis of the crude reaction mixture by comparison of 
the integration of the resonances at δ 5.19-5.07 (minor diastereomer) and δ 5.00-
4.92 (major diastereomer). 
Analytical data for 18g: mp: 127.8-128.1 ˚C 1H NMR (500 MHz, CDCl3) δ 7.60 – 
7.59 (m, 2H), 7.45 – 7.35 (m, 4H), 7.35 – 7.30 (m, 2H), 7.14 – 7.12 (m, 2H), 5.73-
5.65 (m, 1H), 4.99 – 4.96 (m, 2H), 3.84-3.80 (m, 1H), 3.76-3.67 (m, 2H), 3.65 – 
3.46 (m, 6H), 2.77-2.74 (t, J = 6.9 Hz, 1H), 2.47 – 2.35 (m, 2H), 2.09-2.03 (m, 
1H), 0.82 (d, J = 6.8 Hz, 3H), 0.76 (d, J = 6.7 Hz, 3H); 13C NMR (126 MHz, 
CDCl3): δ 171.8, 167.0, 139.7, 136.7, 136.3, 129.9, 128.4, 128.3, 128.0, 127.8, 
116.6, 67.2, 66.7, 61.9, 51.1, 46.9, 41.8, 37.8, 28.4, 21.1, 20.0; IR (thin film): 
1625, 1444, 1225, 910, 697 cm-1; TLC (15% acetone/hexane): Rf = 0.11; HRMS 
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(ESI): Calcd. for C26H32N2O2: ([M+H]): 405.2542, Found: 405.2535; HPLC IC, 
90% hexanes/IPA, flow rate = 1.0 mL/min, λ = 230 nm, tR (major) = 8.7 min tR (minor)  
= 9.4 min, 94:6 er; [α]D = +16.7 (c = 0.01, DCM). 
(2R,3S)-2-(cyclopropylmethyl)-3-((diphenylmethylene)amino)-1-
morpholinohex-5-en-1-one (18h): The title compound was 
prepared according to General Procedure E (Method 1) using β-
formyl amide 16h (0.050 g, 0.24 mmol), and homoallyl amine 2a 
(0.045 g, 0.20 mmol, ) affording 18h (0.072 g, 0.18 mmol, 86% yield,  12:1 dr) as 
clear oil. The crude diastereomer ratio was determined 1H NMR spectroscopic 
analysis of the crude reaction mixture by comparison of the integration of the 
resonances at δ 5.42-5.40 (minor diastereomer) and δ 5.69-5.68 (major 
diastereomer).  
Analytical data for 18h: 1H NMR (500 MHz, CDCl3) δ  7.61 – 7.60 (m, 2H), 7.59 – 
7.28 (m, 6H), 7.16 – 7.14 (m, 2H), 5.74-5.68 (m, 1H), 5.03-5.0 (m, 2H), 3.77 – 
3.61 (m, 8H), 3.07 – 3.04 (m, 1H), 2.32 – 2.29 (m, 1H), 1.65 – 1.62 (m, 1H), 1.55-
1.50 (m, 1H), 1.31-1.21 (m, 2H), 1.13-1.10 (m, 1H) 0.87 (t, J = 7.3 Hz, 3H); 13C 
NMR (126 MHz, CDCl3): δ 173.1, 140.1, 136.9, 135.7, 129.8, 128.4, 128.3, 128.0, 
126.5, 126.3, 117.0, 67.1, 66.8, 63.8, 46.5, 45.8, 42.0, 39.3, 30.8, 29.8, 22.9, 
14.0; IR (thin film): 1638, 1445, 1227, 1115 cm-1; TLC (15% acetone/hexane): Rf 
= 0.19; LRMS (ESI): Calcd. for C27H32N2O2: ([M+H]): 439.24, Found: 439.40; 
HPLC ID, 90% hexanes/IPA, flow rate = 1.0 mL/min, λ = 230 nm, tR (major) = 8.5 
min tR (minor)  = 18.0 min, 92:8 er; [α]D = +35.8 (c = 0.03, DCM).  
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(2R,3S)-2-(4-bromobenzyl)-3-((diphenylmethylene)amino)-1-morpholinohex-
5-en-1-one (18i): The title compound was prepared according 
to General Procedure E (Method 1) using β-formyl amide 16i 
(0.078 g, 0.24 mmol), and homoallyl amine 2a (0.045 g, 0.20 
mmol) affording 18i as clear oil. The diastereomer ratio was determined as 13:1 
by 1H NMR spectroscopic analysis of the crude reaction mixture by comparison 
of the integration of the resonances at δ 5.06-5.00 (minor diastereomer) and δ 
5.32-5.28 (major diastereomer). As product 18i was inseparable from minor 
unidentified impurities it was deprotected using General Procedure F to amine 
20i (0.061 g, 0.17 mmol, 83% yield, >20:1 dr) for final characterization.  
Analytical data for 18i: 1H NMR (500 MHz, CDCl3) δ  7.66 – 7.64 (m, 2H), 7.47 – 
7.34 (m, 8H), 7.17 – 7.15 (m, 2H), 7.05 – 7.03 (m, 2H), 5.77 (ddt, J = 17.2, 10.2, 
7.2 Hz, 1H), 5.18 – 4.81 (m, 2H), 3.87-3.84 (m, 1H), 3.64-3.60 (m, 1H), 3.58 – 
3.53 (m, 1H), 3.39 – 3.17 (m, 5H), 2.92 – 2.81 (m, 2H), 2.73 – 2.68 (m, 2H), 2.29-
2.26 (m, 2H); 13C NMR (126 MHz, CDCl3): δ 171.75, 168.59, 139.91, 138.86, 
136.75, 135.31, 131.30, 130.91, 129.96, 128.45, 128.41, 128.32, 128.00, 127.79, 
120.08, 117.18, 66.62, 66.09, 63.49, 48.40, 46.07, 41.75, 39.35, 36.97 cm-1; TLC 
(15% acetone/hexane): Rf = 0.12; LRMS (ESI): Calcd. for C30H31BrN2O2: 
([M+Na]): 553.15, Found: 553.33; HPLC ID, 90% hexanes/IPA, flow rate = 1.0 
mL/min, λ = 230 nm, tR (major) = 10.7 min tR (minor)  = 20.5 min, 97:3 er; [α]D = +39.3 
(c = 0.02, DCM).  
Analytical data for 20i: 1H NMR (600 MHz, CDCl3) δ  7.36 – 
7.25 (m, 2H), 7.04-3.52 (m, 1H), 3.42 – 3.23 (m, 3H), 3.18-3.12 
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(m, 2H), 2.98-2.95 (m, 1H), 2.89-2.85 (m, 2H), 2.81-2.78  (m, 1H), 2.74-2.71 (m, 
1H), 2.28-2.24 (m, 1H), 2.02-1.98 (m, 1H), 1.88-1.84 (m, 2H); 13C NMR (151 MHz, 
CDCl3): δ  172.3, 138.6, 134.9, 131.3, 130.8, 120.1, 118.3, 66.6,  66.1, 52.4, 48.7, 
46.0, 41.8, 40.0, 34.8; IR (thin film): 1620, 1479, 1115, 1011 cm-1; TLC (10% 
MeOH/DCM): Rf = 0.24; LRMS (ESI): Calcd. for C17H23BrN2O2: ([M+H]): 367.10, 
Found: 367.25; [α]D = +9.8 (c = 0.01, DCM).  
((2R,3S)-3-((diphenylmethylene)amino)-2-(4-
methoxybenzyl)-1-morpholinohex-5-en-1-one (18j): The 
title compound was prepared according to General Procedure 
E (Method 1) using β-formyl amide 16j (0.033 g, 0.12 mmol), 
and homoallyl amine 2a (0.022 g, 0.10 mmol) affording 18j as clear oil. The 
diastereomer ratio was determined as 14:1 by 1H NMR spectroscopic analysis of 
the crude reaction mixture by comparison of the integration of the resonances at 
δ 6.87-6.86 (minor diastereomer) and δ 6.81-6.80 (major diastereomer). As 
product 18j was inseparable from minor unidentified impurities it was deprotected 
using General Procedure F to amine 20j (0.046 g, 0.14 mmol, 72% yield, >20:1 
dr) for final characterization.  
Analytical data for 18j: 1H NMR (500 MHz, CDCl3) δ 7.81 – 7.57 (m, 2H), 7.49 – 
7.29 (m, 6H), 7.21 – 7.13 (m, 2H), 7.12 – 6.96 (m, 2H), 6.92 – 6.45 (m, 2H), 5.87 
– 5.66 (m, 1H), 5.01-4.97 (m, 2H), 3.94 – 3.82 (m, 1H), 3.77 (s, 3H), 3.66-3.63 (m, 
1H), 3.53-3.52 (m, 1H), 3.34 – 3.23 (m, 4H), 3.19-3.15 (m, 1H), 2.90 – 2.80 (m, 
2H), 2.66 – 2.60 (m, 2H), 2.27 – 2.75 (m, 2H); 13C NMR (126 MHz, CDCl3): δ 
172.3, 168.5, 140.1, 137.0, 135.6, 131.8, 130.1, 129.9, 128.5, 128.3, 128.0, 
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127.9, 117.0, 113.7, 66.6, 66.1, 63.6, 55.3, 48.8, 46.1, 41.8, 39.5, 36.9; IR (thin 
film): 1629, 1511, 1259, 1029, 809 cm-1; TLC (15% acetone/hexane): Rf = 0.12; 
LRMS (ESI): Calcd. for C31H34N2O3: ([M+Na]): 505.25, Found: 505.35; HPLC IC, 
90% hexanes/IPA, flow rate = 1.0 mL/min, λ = 230 nm, tR (major) = 16.9 min tR (minor)  
= 28.3 min, 94:6 er; [α]D = +20.8 (c = 0.02, DCM).  
Analytical data for 20j: 1H NMR (600 MHz, CDCl3) δ 7.08 (dd, 
J = 8.5, 1.8 Hz, 2H), 6.79 (dd, J = 8.5, 1.8 Hz, 2H), 5.80 – 
5.73 (m, 1H), 5.14 – 5.11 (m, 2H), 3.77 (s, 3H), 3.69-3.67 (m, 
1H), 3.55 – 3.53 (m, 1H), 3.35 – 3.29 (m, 3H), 3.17 – 3.13 (m, 
2H), 2.99-2.97 (m, 1H), 2.90 – 2.80 (m, 2H), 2.79 – 2.76 (m, 1H), 2.68-2.64 (m, 
1H), 2.30 – 2.27 (m, 1H), 2.03-2.00 (m, 1H), 1.66 (bs, 2H); 13C NMR (151 MHz, 
CDCl3): δ 172.8, 158.2, 135.2, 131.5, 130.1, 118.2, 113.8, 66.7, 66.2, 55.2, 52.5, 
49.2, 46.0, 41.8, 40.2, 34.7; IR (thin film): 1622, 1453, 1248, 703 cm-1; TLC (10% 
MeOH/DCM): Rf = 0.19; LRMS (ESI): Calcd. for C18H26N2O: ([M+H]): 319.20, 
Found: 319.37; [α]D = +12.9 (c = 0.01, DCM).  
(2R,3S)-3-((diphenylmethylene)amino)-2-(furan-2-ylmethyl)-1-
morpholinohex-5-en-1-one (18k): The title compound was 
prepared according to General Procedure E (Method 1) using β-
formyl amide 16k (0.057 g, 0.24 mmol), and homoallyl amine 2a 
(0.045 g, 0.20 mmol) affording 18h as clear oil. The diastereomer ratio was 
determined as 10:1 by 1H NMR spectroscopic analysis of the crude reaction 
mixture by comparison of the integration of the resonances at δ 5.19-5.11 (minor 
diastereomer) and δ 5.06-5.01 (major diastereomer). As product 18k was 
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inseparable from minor unidentified impurities it was deprotected using General 
Procedure F to amine 20k (0.049 g, 0.18 mmol, 88% yield, >20:1 dr) for final 
characterization.  
Analytical data for 18k: 1H NMR (500 MHz, CDCl3) δ 7.65 – 7.63 (m, 2H), 7.46 – 
7.28 (m, 7H), 7.16 – 7.13 (m, 2H), 6.25 (dd, J = 3.2, 1.9 Hz, 1H), 5.99 (d, J = 3.1 
Hz, 1H), 5.80-5.73 (m, 1H), 5.04 – 4.99 (m, 2H), 3.86-3.84 (m, 1H), 3.69-3.65 (m, 
1H), 3.61-3.57 (m, 1H), 3.50 – 3.32 (m, 5H), 3.21-3.20 (m, 1H), 3.14-3.11 (m, 1H), 
2.91 – 2.79 (m, 2H), 2.30 – 2.27 (m, 2H); 13C NMR (126 MHz, CDCl3): δ 172.1, 
168.6, 153.5, 141.0, 139.9, 136.8, 135.4, 130.0, 128.5, 128.3, 128.0, 127.8, 
117.2, 66.8, 66.4, 63.3, 46.1, 45.4, 41.9, 39.4, 29.7; IR (thin film): 1642, 1443, 
1114, 1008, 699 cm-1; TLC (15% acetone/hexane): Rf = 0.12; LRMS (ESI): Calcd. 
for C28H30N2O3: ([M+Na]): 465.21, Found: 465.25; HPLC ID, 90% hexanes/IPA, 
flow rate = 1.0 mL/min, λ = 230 nm, tR (major) = 21.7 min tR (minor)  = 24.8 min, 
94.5:5.5 er; [α]D = +26.2 (c = 0.03, DCM).  
Analytical data for 20k: 1H NMR (600 MHz, CDCl3) δ 7.28 (m, 1H), 6.26-6.25 (m, 
1H), 6.02-6.01 (m, 1H), 5.78-5.71 (m, 1H), 5.313 –5.09 (m, 2H), 
3.71-3.68 (m, 1H), 3.62-3.58 (m, 1H), 3.52 – 3.50 (m, 1H), 3.46 
– 3.31 (m, 3H), 3.20-3.16 (m, 2H), 3.12 – 3.10 (m, 1H), 3.07 – 2.97 (m, 3H), 2.27-
2.24 (m, 1H), 2.04-2.00 (m, 1H), 1.55 (s, 2H); 13C NMR (151 MHz, CDCl3): 
δ172.9, 153.4, 141.2, 135.0, 118.3, 110.6, 66.8, 66.5, 52.4, 46.1, 45.6, 45.6, 42.0, 
40.2, 27.6; IR (thin film): 1624, 1442, 1114, 1009  cm-1; TLC (10% MeOH/DCM): 
Rf = 0.21; LRMS (ESI): Calcd. for C15H22N2O3: ([M+H]): 279.17, Found: 279.22; 
[α]D = +3.0 (c = 0.02, DCM).  
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(2R,3S)-3-((diphenylmethylene)amino)-1-morpholino-2-(thiophen-2-
ylmethyl)hex-5-en-1-one (18l): The title compound was prepared according to 
General Procedure E (Method 1) using β-formyl amide 16l (0.030 g, 0.12 mmol), 
and homoallyl amine 2a (0.022 g, 0.10 mmol) affording 18l as clear oil. The 
diastereomer ratio was determined as 20:1 by 1H NMR spectroscopic analysis of 
the crude reaction mixture by comparison of the integration of the resonances at 
δ 5.17-5.49 (minor diastereomer) and δ 5.80-5.74 (major diastereomer). As 
product 18l was inseparable from minor unidentified impurities it was deprotected 
using General Procedure F to amine 20h (0.027 g, 0.09 mmol, 92% yield, >20:1 
dr) for final characterization.  
Analytical data for 18l: 1H NMR (500 MHz, CDCl3) δ 7.65-7.63 m, 2H), 7.46 – 
7.33 (m, 5H), 7.16 – 7.09 (m, 3H), 6.89-6.88 (m, 1H), 6.78 (d, J = 3.3 Hz, 1H), 
5.77-5.72 (m, 1H), 5.04 – 4.99 (m, 2H), 3.85-3.82 (m, 1H), 3.78-3.74 (m, 1H), 
3.60-3.56 (m, 1H), 3.44-3.40 (m, 1H), 3.37 – 3.24 (m, 4H), 3.18 – 3.15 (m, 1H), 
3.04 (d, J = 2.7 Hz, 2H), 2.84-2.80 (m, 1H), 2.29 – 2.27 (m, 2H); 13C NMR (126 
MHz, CDCl3): δ 171.9, 168.8, 141.9, 140.0, 136.8, 135.3, 130.0, 128.5, 128.4, 
128.0, 127.9, 126.9, 125.9, 123.8, 117.3, 66.7, 66.3, 63.5, 48.9, 46.3, 42.0, 39.4, 
31.4; IR (thin film): 1742, 1630, 1443, 1114 cm-1; TLC (15% acetone/hexane): Rf 
= 0.11; LRMS (ESI): Calcd. for C28H30N2O2S: ([M+Na]): 481.19, Found: 481.30; 
HPLC IC, 90% hexanes/IPA, flow rate = 1.0 mL/min, λ = 230 nm, tR (major) = 10.13 
min tR (minor)  = 13.33 min, 95:5 er; [α]D = +39.3 (c = 0.02, DCM).  
Analytical data for 20l: 1H NMR (600 MHz, CDCl3) δ 7.11-7.10 
(m, 1H), 6.90-6.88  (m, 1H), 6.79 (d, J = 3.4 Hz, 1H), 5.75 (dddd, 
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J = 16.6, 10.7, 8.2, 6.1 Hz, 1H), 5.15-5.11 (m, 2H), 3.81-3.77 (m, 1H), 3.61-3.59 
(m, 1H), 3.46-3.44 (m, 1H), 3.38 – 3.22 (m, 5H), 3.17 – 3.12 (m, 2H), 2.91 – 2.86 
(m, 2H), 2.30 – 2.27 (m, 1H), 2.05-2.01 (m, 1H), 1.87 (d, J = 10.7 Hz, 1H); 13C 
NMR (151 MHz, CDCl3): δ 172.6, 141.8, 135.0, 127.0, 125.9, 123.8, 118.4, 66.8, 
66.4, 52.5, 49.3, 46.3, 46.3, 42.0, 40.2, 29.4.; IR (thin film): 1620, 1443, 1114, 
644 cm-1; TLC (10% MeOH/DCM): Rf = 0.24; LRMS (ESI): Calcd. for 
C15H22N2O2S: ([M+H]): 295.14, Found: 295.29; [α]D = +3.3 (c = 0.02, DCM).  
(2R,3S)-2-benzyl-3-((diphenylmethylene)amino)-1-(piperidin-
1-yl)hex-5-en-1-one (18m): The title compound was prepared 
according to General Procedure E (Method 1) using β-formyl 
amide 16m (0.073 g, 0.24 mmol), and homoallyl amine 2a (0.045 g, 0.20 mmol) 
affording 18m as clear oil. The diastereomer ratio was determined as 13:1 by 1H 
NMR spectroscopic analysis of the crude reaction mixture by comparison of the 
integration of the resonances at δ 5.17-5.12 (minor diastereomer) and δ 5.04-
5.01 (major diastereomer). As product 7h was inseparable from minor 
unidentified impurities it was deprotected using General Procedure F to amine 
20m (0.050 g, 0.17 mmol, 87% yield, >20:1 dr) for final characterization.  
Analytical data for 18m: 1H NMR (500 MHz, CDCl3) δ 7.70 – 7.69 (m, 2H), 7.49 – 
7.36 (m, 6H), 7.28 – 7.16 (m, 7H), 5.78-5.75 (m, 1H), 5.04 – 5.00 (m, 2H), 3.92-
3.88 (m, 1H), 3.69-3.65 (m, 1H), 3.41-3.36 (m, 1H), 3.21-3.17 (m, 1H), 3.07-2.86 
(m, 2H), 2.87 (dd, J = 12.4, 3.5 Hz, 1H), 2.77 (t, J = 12.0 Hz, 1H), 2.32-2.30 (m, 
2H), 1.42-1.36 (m, 3H), 1.26 – 1.18 (m, 2H), 0.54-0.47 (m, 1H); 13C NMR (126 
MHz, CDCl3): δ 171.5, 168.4, 140.2, 140.1, 137.0, 135.8, 129.8, 129.2, 128.4, 
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128.4, 128.2, 128.1, 128.0, 127.9, 126.0, 116.9, 63.8, 48.8, 46.7, 42.5, 39.4, 37.8, 
25.7, 25.4, 24.3; IR (thin film): 1627, 1444, 1228, 697 cm-1; TLC (15% 
acetone/hexane): Rf = 0.27; HRMS (ESI): Calcd. for C31H34N2O: ([M+H]): 
451.2749, Found: 451.2743; HPLC IC, 92% hexanes/IPA, flow rate = 1.0 mL/min, 
λ = 230 nm, tR (major) = 9.0 min tR (minor)  = 6.8 min, 94:6 er; [α]D = +29.5 (c = 0.05, 
DCM).  
Analytical data for 20m: 1H NMR (500 MHz, CDCl3) δ 7.29-7.25 (m, 2H), 7.20-
7.17 (m, 3H), 5.80 (dddd, J = 16.9, 10.7, 8.4, 6.1 Hz, 1H), 5.18 – 
5.14 (m, 2H), 3.70-3.66 (m, 1H), 3.24 – 3.15 (m, 2H), 3.06 – 2.89 
(m, 5H), 2.34 – 2. 
30 (m, 1H), 2.08-2.02 (dt, J = 13.8, 8.2 Hz, 1H), 1.68 (bs, 2H), 1.45-1.39 (m, 3H), 
1.27 – 1.19 (m, 2H), 0.63-0.56 (m, 1H); 13C NMR (126 MHz, CDCl3): δ 172.3, 
140.0, 135.5, 129.2, 128.3, 126.1, 118.0, 52.7, 49.0, 46.7, 42.7, 40.2, 35.3, 25.9, 
25.5, 24.3.; IR (thin film): 1622, 1453, 1248, 703 cm-1; TLC (10% MeOH/DCM): 
Rf = 0.32; HRMS (ESI): Calcd. for C18H26N2O: ([M+Na]): 309.1898, Found: 
309.1928; [α]D = +3.3 (c = 0.02, DCM).  
 (2R,3S)-2-benzyl-3-((diphenylmethylene)amino)-1-
(pyrrolidin-1-yl)hex-5-en-1-one (18n): The title compound was 
prepared according to General Procedure E (Method 1) using β-
formyl amide 16n (0.055 g, 0.24 mmol), and allyl amine 2a (0.045 g, 0.20 mmol) 
affording 18n as clear oil. The crude diastereomer ratio was determined as 11:1 
by 1H NMR spectroscopic analysis of the crude reaction mixture by comparison 
of the integration of the resonances at δ 5.17-5.12 (minor diastereomer) and δ 
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5.04-5.01 (major diastereomer). As product 18n was inseparable from minor 
unidentified impurities it was deprotected using General Procedure F to amine 
20n (0.046 g, 0.17 mmol, 84% yield, >20:1 dr) for final characterization.  
Analytical data for 18n: 1H NMR (600 MHz, CDCl3) δ 7.68 – 7.66 (m, 2H), 7.45 – 
7.34 (m, 6H), 7.26 – 7.14 (m, 7H), 5.82-5.75 (m, 1H), 5.00 – 4.97 (m, 2H), 3.91-
3.87 (m, 1H), 3.32-3.25 (m, 2H), 3.22-3.18 (m, 1H), 3.10-3.06 (m, 1H), 2.83 (dd, J 
= 12.5, 3.6 Hz, 1H), 2.73 (t, J = 12.1 Hz, 1H), 2.38 – 2.32 (m, 3H), 1.66-1.57 (m, 
2H), 1.54-1.49 (m, 1H), 1.37-1.33 (m, 1H); 13C NMR (151 MHz, CDCl3): δ 171.9, 
168.3, 140.2, 140.0, 137.0, 135.9, 129.8, 129.1, 128.4, 128.4, 128.2, 128.0, 
128.0, 128.0, 126.1, 116.8, 63.6, 52.5, 46.3, 45.3, 39.5, 37.6, 25.7, 24.1; IR (thin 
film): 1629, 1445, 765, 697 cm-1; TLC (15% acetone/hexane): Rf = 0.16; HRMS 
(ESI): Calcd. for C30H32N2O: ([M+H]): 437.2593, Found: 437.2584; HPLC ID, 
90% hexanes/IPA, flow rate = 1.0 mL/min, λ = 230 nm, tR (major) = 11.6 min tR (minor)  
= 8.7 min, 95:5 er; [α]D = +48.6 (c = 0.04, DCM).  
Analytical data for 20n: 1H NMR (600 MHz, CDCl3) δ 7.26 – 7.14 (m, 5H), 5.81– 
5.75 (m, 1H), 5.13 – 5.10 (m, 2H), 3.33-3.25 (m, 2H), 3.18 – 3.08 
(m, 2H), 2.99 – 2.91 (m, 2H), 2.65 – 2.61 (m, 1H), 2.44-2.40 (m, 
1H), 2.34-2.30 (m, 1H), 2.20-2.05 (m, 1H), 1.68-1.60 (m, 4H), 1.55-1.49 (m, 1H), 
1.42-1.35 (m, 1H); 13C NMR (151 MHz, CDCl3): δ 172.7, 139.9, 135.5, 129.0, 
128.2, 126.2, 118.0, 52.3, 52.2, 46.3, 45.3, 40.2, 35.0, 25.7, 24.1; IR (thin film): 
1620, 1452 cm-1; TLC (10% MeOH/DCM): Rf = 0.35; HRMS (ESI): Calcd. for 
C17H24N2O: ([M+H]): 273.1978, Found: 273.1960; [α]D = +47.0 (c = 0.01, DCM).  
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 (2R,3S)-2-benzyl-3-((diphenylmethylene)amino)-N,N-dimethylhex-5-
enamide (18o): The title compound was prepared according to 
General Procedure E (Method 1) using β-formyl amide 16o 
(0.049 g, 0.24 mmol), and allyl amine 2a (0.045 g, 0.20 mmol) affording 18o 
(0.072 g, 0.17 mmol, 87% yield,  13:1 dr) as clear oil. The diastereomer ratio was 
determined as 8:1 by 1H NMR spectroscopic analysis of the crude reaction 
mixture by comparison of the integration of the resonances at δ 5.18-5.14 (minor 
diastereomer) and δ 5.05-5.01 (major diastereomer).  
Analytical data for 18o: 1H NMR (500 MHz, CDCl3) δ 7.69-7.67 (m, 2H), 7.46 – 
7.34 (m, 6H), 7.26 – 7.14 (m, 8H), 5.78 – 5.75 (m, 1H), 5.03 – 4.97 (m, 2H), 3.91-
3.87 (m, 1H), 3.32 (ddd, J = 12.0, 8.7, 3.5 Hz, 1H), 2.86 (dd, J = 12.5, 3.5 Hz, 
1H), 2.75-2.71 (m, 4H), 2.41 (s, 3H), 2.32-2.29 (m, 2H); 13C NMR (126 MHz, 
CDCl3): δ 173.5, 168.4, 140.2, 134.0, 137.0, 135.8, 129.8, 129.0, 128.4, 128.4, 
128.2, 128.0, 128.0, 127.9, 126.1, 116.9, 63.7, 49.5, 39.4, 37.7, 36.9, 35.2; IR 
(thin film): 1637, 1445, 913, 765, 698 cm-1; TLC (15% acetone/hexane): Rf = 
0.16; HRMS (ESI): Calcd. for C28H30N2O: ([M+H]): 411.2436, Found: 411.2428; 
HPLC IC, 90% hexanes/IPA, flow rate = 1.0 mL/min, λ = 230 nm, tR (major) = 7.6 
min tR (minor)  = 6.6 min, 93:7 er; [α]D = +53.7 (c = 0.03, DCM).  
 (2R,3S)-2-benzyl-3-((diphenylmethylene)amino)-5-methyl-1-
morpholinohex-5-en-1-one (18p): The title compound was 
prepared according to General Procedure E (Method 1) using β-
formyl amide 16a (0.059 g, 0.24 mmol), and allyl amine 2b 
(0.047 g, 0.20 mmol) affording 18p  as clear oil. The crude diastereomer ratio 
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was determined as 5:1 by 1H NMR spectroscopic analysis of the crude reaction 
mixture by comparison of the integration of the resonances at δ 7.57-7.55 (minor 
diastereomer) and δ 7.68-7.67 (major diastereomer). As product 18p was 
inseparable from minor unidentified impurities it was deprotected using General 
Procedure F to amine 20p (0.036 g, 0.12 mmol, 60% yield, >20:1 dr) for final 
characterization.  
Analytical data for 18p: 1H NMR (600 MHz, CDCl3) δ 7.68-7.67 (m, 2H), 7.47 – 
7.36 (m, 6H), 7.30-7.17 (m, 7H), 4.79-4.60 (m, 2H), 3.97-3.94 (m, 1H), 3.73-3.67 
(m, 1H), 3.57-3.53 (m, 1H), 3.33 – 3.23 (m, 4H), 3.19 – 3.15 (m, 1H), 2.97-2.92 
(m, 2H), 2.84-2.80 (m, 1H), 2.57-2.53 (m, 1H), 2.30 (dd, J = 13.0, 8.2 Hz, 1H), 
2.18 (dd, J = 13.0, 3.5 Hz, 1H), 1.45 (s, 3H); 13C NMR (151 MHz, CDCl3): δ 172.0, 
168.2, 142.7, 140.2, 139.9, 136.7, 129.8, 129.2, 128.5, 128.3, 128.3, 128.3, 
128.2, 128.0, 126.3, 113.8, 66.6, 66.1, 62.6, 49.0, 46.1, 43.4, 41.8, 37.8, 23.0; IR 
(thin film): 1736, 1625, 1444, 1228, 1114, 700 cm-1; TLC (15% acetone/hexane): 
Rf = 0.18; HRMS (ESI): Calcd. for C31H34N2O2: ([M+H]): 467.2698, Found: 
467.2690; [α]D = -7.4 (c = 0.03, DCM).  
Analytical data for 20p: 1H NMR (500 MHz, CDCl3) δ 7.03 – 7.24 
(m, 2H), 7.23 – 7.19 (m, 3H), 4.91 (s, 1H), 4.84 (s, 1H), 3.77-
3.74 (m, 1H), 3.60 – 3.55 (m, 1H), 3.35 – 3.23 (m, 4H), 3.15 
(ddd, J = 13.3, 8.2, 3.2 Hz, 1H), 3.08 (dd, J = 12.4, 3.7 Hz, 1H), 2.98 – 2.90 (m, 
2H), 2.86-2.82 (m, 1H), 2.54 (ddd, J = 11.3, 8.1, 2.9 Hz, 1H), 2.23 (dd, J = 13.3, 
4.2 Hz, 1H), 1.98 (dd, J = 13.3, 9.6 Hz, 1H), 1.76 (s, 3H), 1.69 (bs, 2H); 13C NMR 
(126 MHz, CDCl3): δ 172.8, 142.8, 139.7, 129.2, 128.5, 126.5, 113.6, 66.7, 66.1, 
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50.5, 49.3, 46.1, 44.2, 41.9, 35.5, 21.8, IR (thin film): 1114 cm-1; TLC (10% 
MeOH/DCM): Rf = 0.35; HRMS (ESI): Calcd. for C18H26N2O2: ([M+H]): 303.2078, 
Found: 303.2065; HPLC ID, 30% hexanes/IPA, flow rate = 1.0 mL/min, λ = 210 
nm, tR (major) = 11.5 min tR (minor)  = 9.0 min, 80:20 er; [α]D = +9.6 (c = 0.006, DCM).  
4.3.9 Procedure for the Generation of Amino Alcohol 21 
 
A flame dried 1-dram vial equipped with a magnetic stir bar was charged with 18a 
(0.025 g, 0.06 mmol, 1.0 equiv) and THF (0.6 mL) then cooled to 0 ˚C. A single 
portion of LiAlH4 (0.22 mmol, 4.0 equiv) was added to the mixture which was 
slowly warmed to rt then stirred for 1 h. The solution was then cooled to 0 ˚C, 
quenched by slow addition of 2 M NaOH (0.2 mL), filtered through a short plug of 
celite with DCM, dried over MgSO4 and concentrated in vacuo. The crude 
aldehyde was dissolved in MeOH and cooled to 0 ˚C. A single portion of NaBH4 
(0.12 mmol, 2.0 equiv) was added to the mixture, stirred for 10 min, quenched 
with saturated NH4Cl (3 mL), then partitioned between EtOAc (10 mL) and H2O 
(10 mL). The layers were separated and the organic layer was further washed 
with H2O (2 x 10 mL) and brine (1 x 10 mL), dried over MgSO4, filtered, and 
concentrated in vacuo. The crude residue was purified by column 
chromatography using a gradient of 15% acetone/hexane affording 21 (0.020 g, 
0.05 mmol, 98% yield). Analytical data for 21: 1H NMR (500 MHz, CDCl3) δ 7.32 
– 7.21 (m, 11H), 7.11-7.06 (m, 4H), 5.52-5.43 (m, 1H), 5.18 – 5.11 (m, 2H), 4.99 
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(s, 1H), 3.78 (dd, J = 10.8, 8.8 Hz, 1H), 3.67 (dd, J = 10.8, 3.6 Hz, 1H), 2.76 (td, J 
= 6.9, 2.6 Hz, 1H), 2.53 (dd, J = 13.4, 8.0 Hz, 1H), 2.43 – 2.32 (m, 4H); 13C NMR 
(151 MHz, CDCl3): δ 142.5, 142.4, 140.1, 135.5, 128.8, 128.5, 128.5, 128.4, 
127.6, 127.4, 127.2, 127.1, 126.0, 118.5, 64.9, 63.2, 56.1, 41.0, 33.6, 33.5.; IR 
(thin film): 1708, 1360, 1221, 703 cm-1; TLC (40% EtOAc/hexane): Rf = 0.18; 
HRMS (ESI): Calcd. for C26H29NO: ([M+H]): 372.2327, Found: 372.2320; [α]D = -
2.8 (c = 0.009, DCM). 
4.3.10 Procedure for the Generation of 1,3-Diamine 22 
 
To a 1-dram vial was added 18o, (0.030 g, 0.07 mmol, 1.0 equiv) hydroxylamine 
hydrochloride (035 mmol, 5.0 equiv), and 2:1 THF:H2O (0.7 mL, 0.1 M).  This 
solution was stirred at rt for 18 h then partitioned between 2M HCl (10 mL) and 
Et2O (10 mL). The aqueous layer was washed with Et2O (3 x 10 mL), basified to 
pH 12 with 2M NaOH, extracted with DCM (3x 50 mL), dried over MgSO4 then 
concentrated in vacuo. The remaining residue was then dissolved in THF (0.6 
mL) and cooled to 0 ˚C. A single portion of LiAlH4 (0.22 mmol, 4.0 equiv) was 
added to the mixture which was slowly warmed to rt then stirred for 1 h. The 
solution was then cooled to 0 ˚C, quenched by slow addition of 2 M NaOH (0.2 
mL), filtered through a short plug of celite with DCM, dried over MgSO4, filtered, 
and concentrated in vacuo. The crude residue was purified by column 
chromatography using a gradient of 2.5-10% MeOH/DCM (with 0.1% AcOH 
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modifier) affording 22 (0.009 g, 0.04 mmol, 53% yield, >20:1 dr).   Analytical data 
for 10: 1H NMR (500 MHz, CDCl3) δ 7.31 – 7.28 (m, 2H), 7.22 – 7.19 (m, 3H), 
5.92-5.84 (m, 1H), 5.26 – 5.23 (m, 2H), 4.27 (bs, 2H), 3.38-3.34 (m, 1H), 2.81-
2.80 (m, 1H),  2.73-2.70 (m, 1H), 2.61 (dd, J = 14.0, 6.5 Hz, 1H), 2.50-2.46 (m, 
1H), 2.34-2.20 (m, 8H), 2.00-1.99 (m, 1H); 13C NMR (125 MHz, CDCl3): δ 138.3, 
133.2, 128.9, 128.7, 126.6, 119.9, 60.3, 53.9, 45.4, 37.2, 36.1, 33.3, 29.8; IR 
(thin film): 1495, 1454, 1229, 911, 699 cm-1; TLC (10% MeOH/DCM): Rf = 0.36; 
HRMS (ESI): Calcd. for C15H24N2: ([M+H]): 233.2017, Found: 233.2012; [α]D = 
35.52 (c = 0.003, DCM). 
4.3.11 Procedure for the Generation of Cyclohexene 23 
 
To a flame dried 1-dram vial under an atmosphere of N2 was added Grubb’s 
second generation catalyst,39 (0.001 g, 0.003 mmol, 0.05 equiv), 18c (0.020 g, 
0.05 mmol, 1.0 equiv) and PhCH3 (1.0 mL, 0.05 M).  This solution was stirred at 
80 ˚C for 2 h then loaded directly onto a short plug of SiO2 and eluted with a 
gradient of 10-25% acetone/hexane providing 23 (0.018 g, 0.05 mmol, 97% yield) 
without need for further purification.   Analytical data for 23: 1H NMR (600 MHz, 
CDCl3) δ 7.61-7.59 (d, J = 7.4 Hz, 2H), 7.50 – 7.41 (m, 3H), 7.36 – 7.29 (m, 4H), 
7.15 – 7.14 (m, 2H), 5.94-5.91 (m, 1H), 5.74 – 5.71 (m, 1H), 3.94-3.93 (m, 1H), 
3.71 – 3.55 (m, 3H), 3.44 – 3.35 (m, 2H), 3.28 – 3.22 (m, 2H), 3.16-3.11 (m, 1H), 
2.94 – 2.87 (m, 2H), 2.44-2.39 (m, 1H), 2.20 – 2.16 (m, 1H), 2.10-2.06 (m, 1H); 
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13C NMR (151 MHz, CDCl3): δ 171.69, 167.15, 140.23, 136.91, 129.79, 128.86, 
128.38, 128.07, 127.92, 126.53, 123.23, 66.69, 66.21, 56.08, 56.05, 45.75, 41.74, 
40.78, 33.04, 24.43; IR (thin film): 1641, 1443, 1114 cm-1; TLC (25% 
EtOAc/hexane): Rf = 0.09; HRMS (ESI): Calcd. for C24H26N2O2: ([M+H]): 
375.2072, Found: 375.2065; [α]D = -9.6 (c = 0.01, DCM).  
4.3.12 Testing for Reversibility of [3,3]-Aza Cope Rearrangement 
 
To eliminate speculation that the aza-Cope might be a reversible process the 
minor diastereomer of product 18o (0.013 g, 0.03 mmol) was isolated in 20:1 dr 
and stirred with catalyst 9 (0.001g, 0.001 mmol) and CDCl3 (0.3 mL, 0.1 M) at 
60 °C for 24 hours. Direct 1H NMR analysis of the reaction mixtures showed no 
change in diastereomeric ratio implicating a non-reversible [3 , 3] process.  
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